data_2fhw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fhw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.04 -171.14 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.449 0.166 . . . . 0.0 110.646 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.53 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 67.5 mtp180 -86.27 129.02 34.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.211 0.529 . . . . 0.0 109.965 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -125.69 117.42 23.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.407 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 69.2 m -113.22 122.01 46.18 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.98 -104.97 0.13 Allowed Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.396 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -57.59 -33.69 68.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.547 ' O ' ' HB1' ' B' ' 17' ' ' ALA . 53.8 mm-40 -70.82 -34.89 72.19 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.564 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 41.3 t80 -62.15 -54.08 46.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.334 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.592 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.5 mt -59.51 -50.69 78.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.505 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.591 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.0 mmp_? -62.22 -33.24 74.19 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.732 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' B' ' 13' ' ' GLU . . . -65.18 -39.52 93.0 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.551 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 91.7 t -59.7 -49.04 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-O 121.92 0.867 . . . . 0.0 108.714 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.592 HG12 ' O ' ' B' ' 15' ' ' ILE . 13.9 mm -59.72 -52.69 58.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.165 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.433 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.5 m-30 -56.51 -45.39 81.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.201 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.774 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 23.4 p -63.57 -39.8 95.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.36 0.6 . . . . 0.0 110.876 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 59.4 m -81.55 -13.25 58.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.03 -30.19 0.33 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.351 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.14 -49.29 4.08 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.62 -0.324 . . . . 0.0 112.502 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.5 m -105.18 41.47 1.35 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.291 0.567 . . . . 0.0 110.538 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.501 ' NH1' ' HB3' ' A' ' 24' ' ' CYS . 54.7 ttt180 -98.7 -36.35 9.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.556 ' HD1' HG21 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.848 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.584 ' OD2' ' HB3' ' A' ' 4' ' ' ALA . 3.2 p30 . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.65 -49.85 43.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.37 . . . . 0.0 110.735 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.407 ' HA ' HD22 ' A' ' 3' ' ' LEU . 70.6 mt -70.57 -50.69 34.69 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.787 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.584 ' HB3' ' OD2' ' A' ' 1' ' ' ASP . . . -59.66 -36.64 76.82 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.67 90.05 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.501 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.534 HD23 HD12 ' A' ' 23' ' ' LEU . 33.4 tp -72.26 -40.0 68.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.0 t -53.27 -41.55 65.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.527 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.3 m -59.16 -44.48 92.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.395 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -72.73 -39.4 66.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.619 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.507 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 82.4 m -60.8 -38.24 84.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.565 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 51.4 t -81.23 -43.1 19.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.015 0.436 . . . . 0.0 110.786 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -65.35 -51.25 61.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.852 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.486 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 13.0 m0 -113.61 -55.55 2.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.384 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.54 174.92 14.2 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.1 m -147.5 147.54 30.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.852 0.326 . . . . 0.0 110.72 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.539 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.5 m -94.78 164.44 12.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.28 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -53.02 -36.89 61.02 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -53.51 57.6 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.345 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.99 -42.68 99.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.428 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.551 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 34.2 mt -70.77 -46.09 70.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.664 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.774 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 66.3 m -64.6 -27.14 68.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.6 m -68.92 -3.87 14.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.932 0.396 . . . . 0.0 111.54 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.534 HD12 HD23 ' A' ' 6' ' ' LEU . 93.8 mt -91.47 -4.26 55.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.68 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.501 ' HB3' ' NH1' ' B' ' 26' ' ' ARG . 71.0 m . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.327 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.341 -0.303 . . . . 0.0 112.341 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.64 -172.15 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.681 0.24 . . . . 0.0 110.714 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.533 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 53.0 mtp85 -87.15 127.39 35.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -124.07 119.0 28.22 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.802 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 82.5 m -115.09 120.62 40.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.594 0.235 . . . . 0.0 111.556 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.41 -103.36 0.07 OUTLIER Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.945 -0.571 . . . . 0.0 114.269 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -57.63 -35.29 70.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.482 ' HB3' HD12 ' B' ' 9' ' ' LEU . 3.2 mp0 -69.26 -35.46 76.11 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.579 ' O ' HG23 ' B' ' 18' ' ' VAL . 33.6 t80 -61.95 -51.95 66.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.062 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.54 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.6 mt -59.03 -48.58 86.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.408 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 5.9 mmp_? -61.92 -38.11 87.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.336 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.485 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -63.13 -38.2 90.25 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.299 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 14' ' ' PHE . 98.8 t -59.97 -50.82 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.54 HG12 ' O ' ' B' ' 15' ' ' ILE . 7.6 mm -57.26 -50.88 75.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.845 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -57.76 -41.88 82.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.209 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.735 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 22.8 p -66.91 -43.78 82.49 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.62 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.01 -37.86 89.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.705 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.73 -31.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.638 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.84 28.35 42.57 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 32.5 p -172.09 88.79 0.1 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -167.36 -38.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.646 0.736 . . . . 0.0 110.057 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.52 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.502 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t -72.24 -44.71 63.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 123.54 0.525 . . . . 0.0 109.791 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 3' ' ' LEU . 11.0 mp -69.49 -54.48 14.04 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.531 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.52 74.45 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.4 81.94 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.699 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.496 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 40.6 tp -70.75 -43.37 68.95 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.8 t -52.43 -42.66 64.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.635 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 t -58.93 -43.28 91.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.196 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.9 m -74.1 -38.66 63.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.999 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.496 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 70.8 m -60.14 -41.51 92.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.76 0.314 . . . . 0.0 111.08 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 42.8 t -81.54 -39.28 24.89 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.024 0.44 . . . . 0.0 111.042 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.421 ' CB ' ' HZ1' ' A' ' 12' ' ' LYS . 6.2 ttpm? -68.68 -43.82 75.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.82 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.431 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 10.5 m0 -123.48 -56.33 1.71 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.123 0.487 . . . . 0.0 111.385 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.89 173.6 15.49 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.2 m -147.23 145.91 29.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.117 0.459 . . . . 0.0 111.033 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.484 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.5 m -94.4 168.72 10.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.536 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -54.64 -37.97 66.31 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.847 0.356 . . . . 0.0 110.884 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.54 -53.96 51.49 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.493 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.57 -44.1 97.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.6 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.704 ' HB ' HG23 ' B' ' 21' ' ' THR . 34.0 mt -70.54 -44.36 77.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.22 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.735 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 67.6 m -65.53 -18.81 65.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.406 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.2 m -65.58 -11.38 43.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.045 0.45 . . . . 0.0 110.518 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.422 ' HA ' HD22 ' A' ' 23' ' ' LEU . 77.4 mt -111.08 26.53 10.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.823 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 95.9 m . . . . . 0 C--O 1.257 1.477 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.32 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.21 178.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 O-C-N 122.847 -0.208 . . . . 0.0 110.47 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.528 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 68.3 mtp180 -86.7 129.08 35.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.144 0.497 . . . . 0.0 110.039 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -123.99 118.24 26.56 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.271 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 84.3 m -114.38 120.06 39.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.8 -103.59 0.09 OUTLIER Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.882 -0.599 . . . . 0.0 114.309 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -57.89 -34.53 69.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' B' ' 17' ' ' ALA . 2.9 mp0 -69.11 -35.55 76.57 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.547 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 38.6 t80 -62.94 -50.08 72.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.095 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.639 ' O ' HG12 ' B' ' 19' ' ' ILE . 66.8 mt -59.5 -50.66 79.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.964 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.643 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.1 mmp_? -62.43 -33.39 74.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.435 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' B' ' 13' ' ' GLU . . . -63.11 -43.3 98.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.529 HG21 ' O ' ' B' ' 14' ' ' PHE . 96.3 t -58.31 -48.1 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.673 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.4 mm -57.84 -49.54 80.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.877 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.452 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.4 m-30 -58.61 -43.23 89.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.98 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.742 HG22 ' HB ' ' A' ' 20' ' ' ILE . 11.1 p -65.64 -40.58 92.66 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.716 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 37.4 m -67.01 -34.66 78.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.251 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.68 -37.31 0.13 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.04 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 106.56 -42.53 1.89 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -112.04 41.09 2.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.4 0.619 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.419 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 77.2 ttt180 -96.31 -36.61 10.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.412 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.673 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.698 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 4' ' ' ALA . 27.7 p-10 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.97 -42.02 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.089 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.581 HD11 ' N ' ' A' ' 3' ' ' LEU . 10.7 mp -68.52 -58.15 4.74 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.999 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB2' ' OD1' ' A' ' 1' ' ' ASP . . . -59.74 -35.01 73.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.98 -46.93 93.06 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.437 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 42.5 tp -72.7 -42.98 63.63 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 t -51.26 -43.64 61.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.973 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -58.3 -43.89 88.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.509 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.2 m -74.13 -36.69 64.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.931 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.504 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 83.6 m -60.46 -39.87 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.957 0.408 . . . . 0.0 110.343 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 42.7 t -81.27 -42.98 19.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.947 0.404 . . . . 0.0 110.563 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HG2' ' CD1' ' A' ' 13' ' ' TRP . 18.8 ttpp -62.9 -50.16 71.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.941 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.509 ' CD1' ' HG2' ' A' ' 12' ' ' LYS . 32.4 m0 -118.66 -54.32 2.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.546 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 141.54 174.46 14.43 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 92.1 m -147.11 146.41 29.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.916 0.358 . . . . 0.0 110.894 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.513 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.5 m -93.99 169.64 10.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.997 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -55.1 -38.39 68.07 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.962 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -51.25 70.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.605 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.513 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -61.57 -45.58 93.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.924 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.742 ' HB ' HG22 ' B' ' 21' ' ' THR . 31.5 mt -70.75 -42.37 77.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.36 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 47.0 m -65.72 -20.23 66.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 111.025 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.7 t -66.49 -10.39 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.506 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.462 HD12 HD21 ' A' ' 6' ' ' LEU . 82.2 mt -109.62 23.6 14.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.184 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 C--O 1.256 1.405 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.18 179.589 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.49 HG12 ' O ' ' B' ' 6' ' ' GLY . 15.2 m -148.64 -168.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.524 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.4 mtp180 -88.22 130.36 35.1 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.18 0.514 . . . . 0.0 109.789 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.571 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.3 mm? -124.06 114.64 19.99 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.409 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 78.7 m -109.12 117.66 34.72 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 46.06 -100.36 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 O-C-N 123.871 0.732 . . . . 0.0 114.384 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -53.71 -38.45 64.28 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.285 0.634 . . . . 0.0 112.138 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' B' ' 17' ' ' ALA . 3.4 mm-40 -70.74 -36.34 73.1 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.571 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 35.6 t80 -63.52 -53.49 51.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.487 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.566 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.4 mt -59.13 -48.29 87.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.626 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.505 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 5.2 tpt180 -66.14 -32.88 74.6 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.264 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' B' ' 13' ' ' GLU . . . -62.93 -39.89 95.96 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.466 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 91.3 t -60.3 -49.83 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.734 HD12 ' CD1' ' B' ' 27' ' ' TRP . 35.8 mm -55.19 -50.79 61.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.335 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.473 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.9 m-30 -58.49 -46.07 87.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.924 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.497 ' HG1' HG21 ' A' ' 20' ' ' ILE . 18.2 p -65.1 -39.22 92.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.044 0.449 . . . . 0.0 110.756 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . 0.496 ' HB3' HH11 ' B' ' 26' ' ' ARG . 78.6 m -66.91 -26.55 66.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.503 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.32 -19.75 0.23 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.283 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.39 -50.42 4.33 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 112.329 -0.308 . . . . 0.0 112.329 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -101.18 29.2 4.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.315 0.578 . . . . 0.0 110.39 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.496 HH11 ' HB3' ' B' ' 22' ' ' CYS . 72.3 ttt180 -88.65 -33.27 17.66 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.744 0.783 . . . . 0.0 109.491 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.734 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.312 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.71 -45.32 66.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 123.424 0.452 . . . . 0.0 109.955 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 3' ' ' LEU . 10.7 mp -69.81 -54.05 15.37 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.534 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.08 -36.78 73.34 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.91 -49.43 75.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.766 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.71 -39.63 73.3 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.6 t -55.27 -43.59 74.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.37 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.6 m -60.86 -35.58 76.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.555 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 m -80.35 -38.49 30.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.58 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 52.2 m -61.73 -41.79 98.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 110.716 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.431 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 49.6 t -76.88 -40.47 47.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.931 0.396 . . . . 0.0 110.682 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.424 ' CB ' ' HZ1' ' A' ' 12' ' ' LYS . 6.8 ttpm? -69.47 -50.77 42.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.86 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.491 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 10.6 m0 -114.17 -57.1 2.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.271 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.58 -172.06 23.75 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -164.81 150.12 9.77 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.867 0.365 . . . . 0.0 110.73 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.565 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.9 m -94.04 169.77 10.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.064 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HD3' ' HG ' ' A' ' 21' ' ' SER . 10.5 tmtt? -54.42 -35.36 62.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.039 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -51.34 64.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.993 0.425 . . . . 0.0 111.474 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.476 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -58.71 -44.54 90.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.168 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 16' ' ' SER . 40.0 mt -67.69 -40.89 84.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.2 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.469 ' HG ' ' HD3' ' A' ' 17' ' ' LYS . 68.8 m -64.69 -18.09 64.67 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 m -66.39 -13.15 60.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.929 0.395 . . . . 0.0 111.047 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.547 HD11 HD13 ' A' ' 3' ' ' LEU . 3.5 mm? -95.75 -5.08 42.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.106 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 80.6 m . . . . . 0 C--O 1.257 1.453 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.33 -178.901 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.449 -0.44 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 m -148.65 -169.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.508 0.194 . . . . 0.0 110.484 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.534 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 65.5 mtp180 -86.92 127.93 35.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.19 0.519 . . . . 0.0 109.711 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -122.97 115.07 21.3 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.59 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . 0.448 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 65.0 m -109.46 119.93 40.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.53 -104.04 0.09 OUTLIER Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.464 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.43 ' HG2' HH11 ' B' ' 12' ' ' ARG . 33.4 ttp85 -56.86 -32.13 65.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.695 0.398 . . . . 0.0 111.7 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' B' ' 17' ' ' ALA . 25.5 mm-40 -70.02 -38.68 75.99 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.506 ' O ' HG21 ' B' ' 18' ' ' VAL . 39.8 t80 -59.36 -53.39 58.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.349 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.595 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.1 mt -59.45 -51.93 66.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.849 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.672 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 2.2 mmp_? -63.68 -31.72 72.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.709 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' B' ' 13' ' ' GLU . . . -65.33 -38.39 89.98 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.538 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 84.6 t -59.61 -49.73 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.69 HD13 ' CD1' ' B' ' 27' ' ' TRP . 13.4 mm -57.47 -53.41 44.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.136 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.629 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.6 m-30 -56.38 -45.09 80.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.43 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.874 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 24.7 p -65.63 -40.68 92.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.356 0.598 . . . . 0.0 111.051 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -74.32 -18.21 60.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.753 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.83 -21.89 0.23 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.917 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.45 -51.16 4.52 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.3 m -104.31 38.52 1.85 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.324 0.583 . . . . 0.0 109.771 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 9.4 tpp85 -87.48 -38.8 15.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.114 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.69 ' CD1' HD13 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.665 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.405 ' OD1' ' HB1' ' A' ' 4' ' ' ALA . 26.5 p-10 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.564 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 47.2 t -111.22 -44.19 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.157 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 3' ' ' LEU . 9.2 mp -68.99 -57.27 5.68 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.405 ' HB1' ' OD1' ' A' ' 1' ' ' ASP . . . -59.11 -33.29 70.68 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.1 -43.71 98.03 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.579 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 42.2 mt -82.2 -43.21 17.95 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.7 t -49.47 -45.14 46.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.588 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 p -62.32 -46.54 88.24 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.568 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 m -68.88 -39.47 79.79 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.35 0.26 . . . . 0.0 111.115 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.492 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 78.3 m -62.28 -38.78 90.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.916 0.389 . . . . 0.0 110.092 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.448 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 44.5 t -78.97 -44.46 22.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.099 0.476 . . . . 0.0 110.459 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -63.2 -50.24 71.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.688 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.496 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 22.1 m0 -117.08 -57.73 2.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.548 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.47 173.96 14.67 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.8 m -147.78 147.54 29.98 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 116.994 0.397 . . . . 0.0 110.61 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.543 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.7 m -95.09 163.84 13.13 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.417 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -52.51 -38.22 59.11 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.497 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -52.37 66.04 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.452 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.529 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -60.38 -44.78 95.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.587 ' HB ' HG23 ' B' ' 21' ' ' THR . 27.1 mt -70.71 -44.06 76.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.695 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.874 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 70.7 m -63.53 -25.09 68.09 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.431 -0.168 . . . . 0.0 111.382 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.7 m -64.61 -8.55 14.64 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 6' ' ' LEU . 7.8 mp -80.74 -21.94 40.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.4 m . . . . . 0 C--O 1.244 0.785 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.82 -179.311 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.086 -0.405 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 20.4 m -144.22 -167.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.616 0.246 . . . . 0.0 110.532 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -89.18 130.96 35.51 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.666 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.6 mm? -127.14 112.39 15.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.322 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 85.5 m -109.75 119.09 38.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.752 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.51 -105.55 0.16 Allowed Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.736 -0.666 . . . . 0.0 114.556 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -57.02 -32.14 65.84 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 122.752 0.421 . . . . 0.0 112.051 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 5.7 mm-40 -68.38 -40.17 81.49 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.624 ' O ' HG22 ' B' ' 18' ' ' VAL . 55.2 t80 -61.23 -53.7 53.61 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.623 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.545 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.3 mt -56.51 -50.2 74.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.037 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.503 ' NH1' HG13 ' B' ' 19' ' ' ILE . 3.7 tpt180 -67.27 -31.78 72.34 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.953 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' B' ' 13' ' ' GLU . . . -62.53 -40.4 96.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.805 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.624 HG22 ' O ' ' B' ' 14' ' ' PHE . 92.0 t -59.97 -50.37 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.709 HD12 ' CD1' ' B' ' 27' ' ' TRP . 26.7 mm -57.58 -52.46 57.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.457 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.504 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.4 m-30 -56.57 -47.6 79.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.904 -1.043 . . . . 0.0 113.4 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.82 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 21.7 p -64.18 -41.22 97.19 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.167 0.508 . . . . 0.0 111.532 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 57.3 m -77.08 -14.27 59.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.995 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.13 -29.38 0.25 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 119.778 -1.201 . . . . 0.0 113.205 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.68 -48.68 4.04 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -106.51 26.44 9.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.198 0.523 . . . . 0.0 110.16 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -84.83 -33.05 22.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.789 0.804 . . . . 0.0 109.49 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.709 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.12 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.501 ' OD1' ' HB1' ' A' ' 4' ' ' ALA . 27.2 p-10 . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.515 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 26.3 t -111.29 -42.81 4.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.111 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 3' ' ' LEU . 9.3 mp -68.86 -57.61 5.32 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.501 ' HB1' ' OD1' ' A' ' 1' ' ' ASP . . . -57.52 -33.92 68.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.72 84.86 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.373 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 62.8 mt -72.85 -39.59 66.4 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 29.3 t -52.86 -43.81 66.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.736 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.2 m -60.69 -44.82 96.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.445 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -71.12 -38.23 72.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.717 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.666 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 64.7 m -63.82 -37.18 86.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 110.865 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.43 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 34.9 t -79.62 -37.73 35.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.181 0.515 . . . . 0.0 110.297 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -73.29 -52.52 13.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.16 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -113.32 -42.3 3.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.249 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 120.16 -179.1 16.53 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.475 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.1 p -161.36 150.41 16.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.935 0.398 . . . . 0.0 111.155 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.53 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.0 m -96.9 167.33 11.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.911 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -54.21 -37.42 64.55 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.16 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -50.55 73.64 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.426 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.53 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -62.89 -45.01 94.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.094 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.573 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 24.2 mt -71.51 -42.3 72.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.681 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.82 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 70.5 m -64.04 -36.16 83.08 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.142 -0.349 . . . . 0.0 111.314 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.2 m -69.03 3.72 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.82 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.451 HD21 ' HG ' ' A' ' 3' ' ' LEU . 20.2 tp -90.04 -22.48 21.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.698 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.2 m . . . . . 0 C--O 1.243 0.73 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.91 -179.512 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.47 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m -142.35 -177.0 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.537 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 72.3 mtp180 -83.29 129.71 35.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.123 0.487 . . . . 0.0 110.339 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -123.87 118.49 27.22 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.992 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 65.8 m -117.79 119.66 35.57 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.37 -98.66 0.02 OUTLIER Glycine 0 CA--C 1.519 0.316 0 N-CA-C 114.761 0.665 . . . . 0.0 114.761 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.48 ' H ' ' HG3' ' B' ' 12' ' ' ARG . 15.6 mtm180 -53.4 -44.37 68.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.281 0.632 . . . . 0.0 111.941 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.441 ' HB3' HD11 ' B' ' 9' ' ' LEU . 3.0 mp0 -72.29 -30.98 65.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.896 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.526 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 41.7 t80 -65.1 -51.68 59.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.038 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.631 ' O ' HG12 ' B' ' 19' ' ' ILE . 80.1 mt -61.53 -49.22 85.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.865 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.559 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.5 mmp_? -62.83 -32.11 73.25 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.298 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.0 94.24 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.8 -51.11 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.832 HG22 ' HD1' ' B' ' 27' ' ' TRP . 37.9 mm -53.42 -51.42 41.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.311 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.52 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.8 m-30 -58.82 -44.74 90.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.732 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.864 HG22 ' HB ' ' A' ' 20' ' ' ILE . 17.0 p -63.7 -39.38 94.17 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.589 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 m -69.39 -31.33 69.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.652 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.39 -22.23 0.09 OUTLIER Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.674 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.21 -62.26 4.6 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.4 m -90.85 48.18 1.5 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.565 0.698 . . . . 0.0 109.641 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.415 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.8 tpm_? -112.55 -37.19 5.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.124 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.832 ' HD1' HG22 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.12 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.117 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.95 -44.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 123.511 0.507 . . . . 0.0 109.865 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 3' ' ' LEU . 10.2 mp -69.97 -54.46 13.2 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.68 -35.79 73.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.47 -49.48 73.48 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.647 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.656 HD23 HD11 ' A' ' 23' ' ' LEU . 43.5 tp -70.8 -39.93 72.83 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.9 t -55.65 -37.81 68.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.476 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 t -59.8 -41.73 91.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.882 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.7 m -76.23 -43.16 43.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.539 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 75.5 m -60.03 -39.48 86.05 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.256 0.347 . . . . 0.0 111.467 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.45 -38.72 25.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.838 0.352 . . . . 0.0 111.009 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 3.2 ttmp? -68.43 -61.5 1.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.278 0.561 . . . . 0.0 111.631 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.509 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 6.0 m0 -101.18 -54.35 2.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.902 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 138.05 174.33 13.35 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.7 m -148.56 146.61 28.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.983 0.42 . . . . 0.0 110.672 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.515 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 3.2 m -91.91 170.05 10.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.629 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HG3' HG21 ' B' ' 21' ' ' THR . 40.7 tttm -55.9 -36.87 68.13 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.682 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -52.22 66.66 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.614 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.68 -44.9 93.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.6 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.864 ' HB ' HG22 ' B' ' 21' ' ' THR . 37.4 mt -70.66 -39.6 76.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.015 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.484 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 49.3 m -65.15 -20.46 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.776 0.322 . . . . 0.0 110.669 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.5 m -68.15 -6.88 25.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.068 0.461 . . . . 0.0 110.93 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.656 HD11 HD23 ' A' ' 6' ' ' LEU . 69.1 mt -105.33 19.66 20.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.6 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.411 179.401 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.442 HG23 HD12 ' B' ' 9' ' ' LEU . 17.1 m -144.69 -171.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.525 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 61.8 mtp180 -89.88 123.93 34.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.088 0.47 . . . . 0.0 109.883 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.1 mm? -114.98 115.26 26.59 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.129 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 79.7 m -109.26 118.77 37.58 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.78 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.57 -102.57 0.05 OUTLIER Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.465 -0.789 . . . . 0.0 114.345 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' B' ' 12' ' ' ARG . 4.4 tmm_? -57.16 -32.21 66.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.239 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.416 ' HA ' ' NH1' ' B' ' 12' ' ' ARG . 5.6 tp10 -70.59 -38.28 74.0 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.516 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 45.3 t80 -59.65 -55.45 34.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.582 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.567 ' O ' HG12 ' B' ' 19' ' ' ILE . 62.3 mt -58.88 -48.52 86.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.967 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.528 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 5.1 tpt180 -65.58 -33.28 75.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.302 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -40.31 96.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.493 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 60.6 t -60.64 -49.26 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.78 HG21 ' HD1' ' B' ' 27' ' ' TRP . 39.0 mm -55.8 -51.08 63.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.308 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.528 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.3 m-30 -58.53 -46.19 87.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.047 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.643 HG23 ' HG2' ' A' ' 17' ' ' LYS . 18.4 p -65.05 -39.74 93.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.984 0.421 . . . . 0.0 110.808 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . 0.471 ' HB3' HH11 ' B' ' 26' ' ' ARG . 73.5 m -67.86 -24.39 65.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.737 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.14 -21.94 0.22 Allowed Glycine 0 C--O 1.227 -0.333 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.495 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.08 -51.58 4.49 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.7 m -101.08 27.81 5.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.411 0.624 . . . . 0.0 110.139 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.471 HH11 ' HB3' ' B' ' 22' ' ' CYS . 72.0 ttt180 -88.52 -32.8 18.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.658 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.78 ' HD1' HG21 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.202 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 45.2 t -111.99 -42.61 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.156 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.9 mt -69.26 -56.35 7.84 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.9 72.13 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.91 -43.38 98.11 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.31 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.651 HD12 HD13 ' A' ' 23' ' ' LEU . 44.9 mt -80.31 -43.14 21.75 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -49.31 -47.01 47.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.532 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.1 p -62.48 -46.57 87.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.568 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.49 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 33.1 m -67.5 -38.53 84.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.227 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 83.3 m -62.58 -39.46 93.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.921 0.391 . . . . 0.0 110.234 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 41.3 t -79.22 -44.03 22.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.237 0.541 . . . . 0.0 110.389 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.5 ttpt -62.13 -49.59 75.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.568 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.458 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 23.0 m0 -119.19 -58.07 1.96 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.579 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.9 171.94 13.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.8 m -145.72 145.6 30.93 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.853 0.326 . . . . 0.0 110.417 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.534 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 4.1 m -92.53 164.77 13.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.563 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.643 ' HG2' HG23 ' B' ' 21' ' ' THR . 10.4 tmtt? -54.27 -35.47 62.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.788 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -52.17 63.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.029 0.443 . . . . 0.0 111.737 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.32 -42.48 95.69 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.739 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.533 ' HB ' HG21 ' B' ' 21' ' ' THR . 26.6 mt -69.2 -39.57 79.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.479 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 70.3 m -66.29 -17.58 64.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.625 0.25 . . . . 0.0 111.296 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.7 m -67.58 -10.05 48.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.191 0.519 . . . . 0.0 110.345 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.651 HD13 HD12 ' A' ' 6' ' ' LEU . 95.8 mt -105.54 23.21 14.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.952 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 80.2 m . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.681 -179.552 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 CA--C 1.508 -0.364 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.524 HG12 ' O ' ' B' ' 6' ' ' GLY . 17.4 m -149.61 -167.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.537 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 62.9 mtp180 -86.27 126.12 34.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.042 0.449 . . . . 0.0 110.151 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -119.48 118.48 31.21 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.04 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 65.2 m -112.69 110.75 21.09 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.538 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 53.2 -94.56 0.01 OUTLIER Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.834 -0.621 . . . . 0.0 114.577 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.484 ' H ' ' HG3' ' B' ' 12' ' ' ARG . 12.1 mtm180 -55.64 -42.3 74.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.267 0.556 . . . . 0.0 111.138 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.46 ' O ' ' HB1' ' B' ' 17' ' ' ALA . 34.3 mp0 -68.84 -34.19 75.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.431 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' B' ' 11' ' ' GLY . 48.6 t80 -63.07 -52.31 63.22 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.829 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.619 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.3 mt -59.88 -48.56 87.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.591 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.1 mmp_? -61.86 -34.98 76.97 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.55 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' B' ' 13' ' ' GLU . . . -64.12 -41.42 97.25 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.423 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 48.9 t -58.8 -48.27 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.738 HG23 ' HD1' ' B' ' 27' ' ' TRP . 36.5 mm -56.18 -50.6 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.704 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.597 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.8 m-30 -57.29 -43.84 83.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.519 -1.218 . . . . 0.0 112.792 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.853 HG22 ' HB ' ' A' ' 20' ' ' ILE . 14.7 p -66.22 -40.83 90.59 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.328 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 34.9 m -67.45 -32.75 73.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.429 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.1 -30.28 0.09 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.31 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 92.16 -53.2 2.85 Favored Glycine 0 C--O 1.225 -0.457 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.7 m -102.39 45.66 0.96 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.584 0.707 . . . . 0.0 109.204 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.9 tpm_? -108.66 -37.92 5.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.356 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.738 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.074 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.175 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 41.9 t -112.12 -41.82 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.213 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 3' ' ' LEU . 63.7 mt -68.89 -56.67 7.17 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.04 -33.07 72.72 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.69 -43.57 97.67 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.262 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 27.0 mt -80.47 -42.95 21.67 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -48.66 -47.13 40.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.223 0.609 . . . . 0.0 111.435 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 p -63.99 -46.31 85.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.8 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.6 m -67.92 -39.11 83.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.418 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 73.2 m -62.79 -39.81 95.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.953 0.406 . . . . 0.0 110.185 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.433 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 45.9 t -78.59 -42.73 28.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.136 0.493 . . . . 0.0 110.437 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -64.27 -50.15 69.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.566 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.494 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 22.7 m0 -117.71 -58.85 1.98 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.452 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.57 172.9 14.71 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 78.7 m -147.94 147.78 30.07 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.814 0.307 . . . . 0.0 110.673 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.543 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.7 m -96.88 166.09 11.79 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.537 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.789 ' HG2' HG21 ' B' ' 21' ' ' THR . 11.3 tmtt? -53.64 -35.63 61.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.278 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -51.59 65.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.964 0.411 . . . . 0.0 111.627 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.495 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.17 -44.28 92.14 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.481 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.853 ' HB ' HG22 ' B' ' 21' ' ' THR . 27.1 mt -70.42 -35.57 62.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.495 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.523 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 68.2 m -65.32 -23.24 66.96 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.736 0.303 . . . . 0.0 110.711 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.5 m -69.13 -0.94 6.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.797 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.3 mt -108.7 13.91 24.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.206 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.473 179.553 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.534 ' H ' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.575 ' O ' HD21 ' B' ' 9' ' ' LEU . 7.2 t -134.2 165.59 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.529 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 70.0 mtp180 -74.34 130.48 39.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.377 0.608 . . . . 0.0 110.845 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.69 HD22 HD11 ' A' ' 20' ' ' ILE . 1.4 mm? -117.34 115.04 24.45 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.03 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 70.9 m -116.52 116.9 28.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.529 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.09 -101.82 0.05 OUTLIER Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.69 -0.686 . . . . 0.0 114.347 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -57.67 -36.2 71.58 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.954 0.502 . . . . 0.0 111.637 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.511 ' O ' ' HB1' ' B' ' 17' ' ' ALA . 0.4 OUTLIER -71.2 -29.97 65.82 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.9 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.661 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 47.4 t80 -68.78 -54.96 12.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.706 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.527 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.5 mt -60.65 -47.34 93.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.583 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.482 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 4.2 tpt180 -66.17 -30.22 70.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' B' ' 13' ' ' GLU . . . -63.46 -40.69 97.8 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.664 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 60.3 t -60.13 -50.45 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.666 HG21 ' HD1' ' B' ' 27' ' ' TRP . 29.1 mm -57.05 -52.22 58.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.493 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.496 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -58.51 -46.41 86.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.948 -1.023 . . . . 0.0 113.058 -178.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.747 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 19.7 p -63.53 -41.05 98.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.944 0.402 . . . . 0.0 111.679 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.9 m -74.41 -20.82 59.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.301 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.5 -30.58 0.18 Allowed Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.876 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.27 -52.3 4.49 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 112.259 -0.336 . . . . 0.0 112.259 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 15.9 p -99.42 29.05 4.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.478 0.656 . . . . 0.0 110.558 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.9 tpm_? -89.49 -36.57 15.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.997 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.666 ' HD1' HG21 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.132 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.656 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 49.0 t -109.72 -44.15 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.08 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.74 -57.63 6.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.9 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.51 -46.88 93.22 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.25 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 30.6 mt -74.4 -39.47 62.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.8 t -52.57 -38.51 60.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -59.49 -36.52 76.21 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.89 0.376 . . . . 0.0 110.795 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 m -86.33 -41.23 14.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.664 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.541 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 98.0 m -61.8 -39.43 91.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.709 0.29 . . . . 0.0 110.87 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.3 t -78.43 -39.4 38.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.927 0.394 . . . . 0.0 110.804 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.51 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 2.1 ttmp? -68.3 -57.67 5.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.202 0.525 . . . . 0.0 111.372 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.51 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 9.7 m0 -103.43 -60.91 1.49 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.288 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.83 170.06 11.98 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 83.4 m -145.32 151.4 38.26 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 117.121 0.46 . . . . 0.0 110.574 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.562 ' HB3' ' OE1' ' A' ' 19' ' ' GLU . 34.0 t -95.63 169.42 10.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.626 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HG3' HG22 ' B' ' 21' ' ' THR . 36.8 tttm -56.13 -37.16 69.07 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.149 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -52.96 63.51 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.996 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.562 ' OE1' ' HB3' ' A' ' 16' ' ' SER . 2.4 mp0 -60.62 -45.97 92.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.974 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.69 HD11 HD22 ' B' ' 9' ' ' LEU . 45.0 mt -69.32 -44.75 80.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.747 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 71.5 m -62.34 -29.03 70.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.564 0.221 . . . . 0.0 111.437 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.2 m -65.45 -4.11 5.28 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.51 HD11 ' CD1' ' A' ' 6' ' ' LEU . 10.4 mp -84.84 -19.52 32.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.706 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.894 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 12.6 m -144.92 -169.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 110.652 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 -88.12 128.96 35.43 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.673 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -125.89 113.04 16.69 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.154 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 78.9 m -111.28 116.1 30.45 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.07 -101.65 0.05 OUTLIER Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.74 -0.664 . . . . 0.0 114.404 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.687 ' NH1' ' HB2' ' B' ' 12' ' ' ARG . 5.7 mtm105 -57.34 -36.58 71.35 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.604 0.362 . . . . 0.0 111.779 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -67.32 -37.55 83.5 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.541 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 39.3 t80 -62.6 -53.05 60.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.728 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.545 ' O ' HG12 ' B' ' 19' ' ' ILE . 69.1 mt -57.35 -48.74 81.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.644 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.521 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 5.3 tpt180 -66.6 -33.03 74.76 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.05 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.32 93.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.506 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.501 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 83.7 t -60.89 -49.95 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.67 HD13 ' CD1' ' B' ' 27' ' ' TRP . 36.4 mm -53.98 -51.12 48.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.539 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -43.91 97.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.988 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.79 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 19.4 p -64.94 -41.19 95.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.757 0.313 . . . . 0.0 110.794 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . 0.434 ' HB3' HH11 ' B' ' 26' ' ' ARG . 85.7 m -63.97 -31.19 72.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.146 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.26 -21.14 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.396 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.4 -56.27 4.99 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -92.16 44.33 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.402 0.62 . . . . 0.0 110.326 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.434 HH11 ' HB3' ' B' ' 22' ' ' CYS . 75.3 ttt180 -110.04 -33.75 6.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.753 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.67 ' CD1' HD13 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.508 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.489 ' OD1' ' HB1' ' A' ' 4' ' ' ALA . 26.9 p-10 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.685 HG13 HD21 ' A' ' 23' ' ' LEU . 26.0 t -111.59 -42.26 4.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.08 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 3' ' ' LEU . 10.8 mp -69.39 -57.02 5.81 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.489 ' HB1' ' OD1' ' A' ' 1' ' ' ASP . . . -59.49 -33.66 71.61 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.02 -47.86 87.15 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.38 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.413 ' HA ' HD11 ' A' ' 6' ' ' LEU . 49.1 tp -73.02 -38.66 66.47 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 43.0 t -54.97 -41.93 71.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.288 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 t -59.22 -48.01 83.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.752 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 m -67.57 -39.41 84.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.673 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 61.4 m -61.46 -39.7 91.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 111.383 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 38.3 t -81.04 -38.61 27.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.267 0.556 . . . . 0.0 110.459 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -69.97 -53.1 19.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.297 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -114.93 -40.67 3.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.037 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 121.23 176.13 15.28 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' HD21 ' B' ' 9' ' ' LEU . 6.3 p -158.8 150.94 21.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.196 0.522 . . . . 0.0 111.465 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.501 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 8.2 m -96.62 173.34 7.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.03 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -54.86 -38.1 67.08 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.923 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -52.85 63.97 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.275 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.501 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.6 mp0 -60.08 -45.43 92.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.823 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.501 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 42.3 mt -69.47 -45.11 79.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.068 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.79 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 65.6 m -64.58 -16.7 63.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -65.43 -14.88 61.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.181 0.515 . . . . 0.0 110.371 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.685 HD21 HG13 ' A' ' 2' ' ' VAL . 72.4 mt -106.98 25.89 10.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.444 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 96.7 m . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.506 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.446 ' O ' HG13 ' B' ' 7' ' ' VAL . . . . . . . . 0 CA--C 1.509 -0.302 0 N-CA-C 112.085 -0.406 . . . . 0.0 112.085 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.446 HG13 ' O ' ' B' ' 6' ' ' GLY . 11.2 m -148.03 -173.73 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 52.3 mtt85 -82.81 133.16 35.14 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.541 0.686 . . . . 0.0 110.832 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.538 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.5 mm? -129.68 118.45 21.93 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.632 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 35.0 m -114.14 117.81 32.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 46.91 -98.61 0.01 OUTLIER Glycine 0 C--N 1.336 0.555 0 O-C-N 123.742 0.651 . . . . 0.0 114.658 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -54.15 -39.56 66.64 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.146 0.578 . . . . 0.0 111.555 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.421 ' HB3' HD11 ' B' ' 9' ' ' LEU . 34.7 mm-40 -72.03 -35.01 69.25 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.758 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.538 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 38.5 t80 -62.93 -53.48 53.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.535 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.584 ' O ' HG12 ' B' ' 19' ' ' ILE . 72.4 mt -59.31 -50.78 78.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.421 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.57 ' NH2' HG13 ' B' ' 19' ' ' ILE . 3.3 mmp_? -63.7 -31.03 72.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.503 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.413 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -64.35 -41.52 96.71 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.127 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.546 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 93.0 t -59.36 -50.86 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-O 121.9 0.857 . . . . 0.0 108.814 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.748 HG22 ' HD1' ' B' ' 27' ' ' TRP . 18.9 mm -58.24 -52.14 62.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.707 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.3 -44.4 92.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.746 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 19.9 p -62.78 -41.18 99.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.076 0.465 . . . . 0.0 110.757 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 56.5 m -75.03 -22.27 58.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.651 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.07 -29.36 0.21 Allowed Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.881 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.41 -54.86 4.48 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 38.3 p -96.03 49.11 1.13 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.323 0.582 . . . . 0.0 110.703 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.524 ' NH1' ' HB3' ' A' ' 24' ' ' CYS . 56.1 ttt180 -111.45 -36.44 5.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.255 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.748 ' HD1' HG22 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.956 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.062 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.63 -49.76 75.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.547 0.53 . . . . 0.0 110.365 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 3' ' ' LEU . 10.2 mp -61.89 -44.98 95.7 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.92 -38.19 64.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.79 0.329 . . . . 0.0 111.056 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.13 -44.2 97.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.176 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.633 HD13 HD13 ' A' ' 23' ' ' LEU . 32.3 mt -78.89 -44.4 22.85 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.245 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.2 t -48.91 -46.12 42.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.3 0.64 . . . . 0.0 111.646 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.4 p -64.69 -46.37 82.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.689 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -68.06 -39.6 82.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.431 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.559 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 73.9 m -63.11 -35.5 80.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.868 0.366 . . . . 0.0 110.618 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.6 t -83.39 -41.98 17.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.199 0.523 . . . . 0.0 110.197 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -64.8 -48.65 73.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.522 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -118.45 -53.98 2.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.503 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 134.57 169.76 12.05 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.2 m -145.24 147.44 32.4 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.922 0.361 . . . . 0.0 110.945 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.554 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.2 m -93.71 165.15 12.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.068 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -51.16 -40.12 57.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.508 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -53.71 55.25 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.693 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.554 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.99 -43.2 95.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.109 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.546 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 40.6 mt -70.9 -46.9 65.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.489 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.746 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 70.2 m -62.09 -23.72 66.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.5 m -63.93 -11.56 29.37 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.633 HD13 HD13 ' A' ' 6' ' ' LEU . 21.9 mt -85.22 -6.89 59.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HB3' ' NH1' ' B' ' 26' ' ' ARG . 77.5 m . . . . . 0 C--O 1.243 0.734 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.334 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.445 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.367 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -142.2 -171.83 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.349 . . . . 0.0 110.881 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -87.03 126.35 34.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.659 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.6 mm? -123.05 114.46 20.4 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.028 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 58.1 m -113.26 119.68 38.58 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.0 -102.64 0.06 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.92 -0.582 . . . . 0.0 114.417 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -57.13 -34.63 68.59 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.47 -33.83 69.65 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.532 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 45.3 t80 -62.61 -54.54 38.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.302 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.577 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.1 mt -58.44 -50.13 79.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.295 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.51 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.7 mmp_? -62.33 -32.72 73.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.29 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.417 ' HB2' HD11 ' A' ' 20' ' ' ILE . . . -64.56 -41.21 96.46 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.315 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.535 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 60.7 t -59.05 -50.02 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 122.042 0.925 . . . . 0.0 108.837 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.673 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.3 mm -59.04 -53.04 53.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.185 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.446 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.0 m-30 -56.3 -45.57 80.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.177 -0.92 . . . . 0.0 113.411 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 20' ' ' ILE . 15.7 p -64.44 -41.6 96.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.807 0.337 . . . . 0.0 111.42 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 58.3 m -75.58 -27.67 58.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.493 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.92 -29.52 0.08 OUTLIER Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.326 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.39 -54.13 4.65 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.749 -0.262 . . . . 0.0 112.477 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m -101.14 52.84 0.84 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.59 0.71 . . . . 0.0 110.102 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 3.5 tpm_? -115.9 -38.15 3.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.846 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.673 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.179 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.987 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 27.4 t -111.57 -42.49 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.109 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.505 HD11 ' N ' ' A' ' 3' ' ' LEU . 10.0 mp -68.87 -57.26 5.8 Favored 'General case' 0 C--O 1.218 -0.555 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 7' ' ' SER . . . -59.44 -33.47 71.31 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.16 -45.47 95.98 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.408 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 59.8 mt -78.65 -44.37 23.99 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 40.8 t -48.42 -48.71 37.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.688 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.5 p -65.82 -45.45 82.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.683 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.512 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 23.8 m -65.69 -38.27 88.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.904 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.694 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 80.0 m -63.76 -34.54 78.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.999 0.428 . . . . 0.0 110.762 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 t -85.46 -38.69 18.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.31 0.576 . . . . 0.0 110.068 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.7 ttpt -68.03 -44.49 76.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.707 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -124.13 -48.65 1.85 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.886 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 128.21 165.74 11.87 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 78.9 m -143.44 146.98 33.89 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 117.129 0.464 . . . . 0.0 111.205 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.6 m -96.27 165.41 12.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.076 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -52.36 -40.09 61.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.353 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 m -57.03 -53.75 54.53 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 123.69 0.619 . . . . 0.0 111.532 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.618 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.7 mp0 -60.64 -43.52 97.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.43 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.577 ' HB ' HG22 ' B' ' 21' ' ' THR . 31.5 mt -72.58 -39.23 61.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.264 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 23' ' ' LEU . 51.1 m -64.12 -37.95 89.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.763 0.316 . . . . 0.0 110.807 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p -69.97 7.34 0.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.022 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 21' ' ' SER . 19.6 tp -92.27 -24.38 19.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.872 0.368 . . . . 0.0 110.159 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.6 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.84 179.615 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.03 -173.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.479 0.18 . . . . 0.0 110.522 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 26.4 mmt85 -87.58 130.97 34.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.153 0.501 . . . . 0.0 110.303 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -124.94 109.16 12.66 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.731 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 42.1 m -111.54 116.56 31.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.691 0.282 . . . . 0.0 111.642 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 50.98 -103.95 0.12 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.733 -0.667 . . . . 0.0 114.54 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -57.9 -32.87 68.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 122.519 0.328 . . . . 0.0 111.563 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.439 ' HG3' HD13 ' B' ' 9' ' ' LEU . 3.6 tp10 -68.25 -38.56 81.93 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.602 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 51.0 t80 -60.95 -53.59 55.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.001 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.606 ' O ' HG12 ' B' ' 19' ' ' ILE . 63.1 mt -60.0 -49.7 82.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.688 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.605 ' NH2' HG13 ' B' ' 19' ' ' ILE . 0.1 OUTLIER -65.25 -28.58 69.45 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.881 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.83 -42.82 94.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.002 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.491 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 62.1 t -58.94 -49.22 83.91 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.079 0.943 . . . . 0.0 108.517 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.711 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.3 mm -57.79 -53.16 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.571 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.52 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.4 OUTLIER -57.92 -45.18 86.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.323 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.795 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 17.4 p -63.5 -39.55 94.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.986 0.422 . . . . 0.0 111.553 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 60.9 m -79.49 -20.77 46.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.636 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.61 -31.13 0.14 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.112 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 85.36 -56.47 4.94 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.783 -0.246 . . . . 0.0 112.516 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m -97.21 50.32 1.07 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.565 0.697 . . . . 0.0 110.155 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 7.2 tpm_? -114.42 -38.96 3.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.626 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.711 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.032 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.97 -43.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.286 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.5 mp -70.43 -56.92 5.47 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.52 -34.65 74.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.83 -46.63 93.22 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.456 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.419 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 38.5 tp -73.55 -39.78 64.45 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.5 t -53.14 -45.09 68.23 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.601 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.4 m -60.55 -42.75 97.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.391 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 m -70.74 -38.7 73.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.812 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.703 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 90.7 m -62.11 -32.72 73.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.977 0.417 . . . . 0.0 110.776 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.448 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 49.0 t -85.31 -40.31 16.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.157 0.503 . . . . 0.0 110.393 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -70.82 -48.18 55.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.403 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -114.91 -41.43 3.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.566 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 116.54 165.44 14.05 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -141.18 149.58 41.64 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.909 0.355 . . . . 0.0 111.32 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.537 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.8 m -94.61 168.07 11.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.224 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.531 ' HA ' HG21 ' B' ' 21' ' ' THR . 37.6 tttm -54.97 -37.19 66.2 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.273 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -52.59 65.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.218 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -60.83 -44.58 96.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.043 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.521 HD12 HD22 ' B' ' 9' ' ' LEU . 39.6 mt -70.62 -44.18 76.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.917 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.795 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 67.6 m -64.29 -28.7 69.9 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.522 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.1 m -69.32 -0.55 6.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.59 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.2 mt -90.62 -12.35 37.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.472 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.9 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.1 -0.953 . . . . 0.0 110.804 179.706 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.86 -173.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.7 mmm-85 -86.16 128.82 34.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.801 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -125.15 109.12 12.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.649 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 84.9 m -109.93 121.46 45.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.772 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 49.42 -106.34 0.2 Allowed Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.862 -0.608 . . . . 0.0 114.493 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.48 ' HG3' ' N ' ' B' ' 13' ' ' GLU . 8.2 ptt180 -56.18 -30.67 62.55 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.779 0.432 . . . . 0.0 111.772 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' B' ' 12' ' ' ARG . 54.8 mm-40 -70.62 -38.78 73.95 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.52 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 41.6 t80 -63.16 -51.26 67.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.402 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.645 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.6 mt -58.71 -52.59 58.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.32 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.604 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 1.5 mmp_? -65.24 -27.47 68.68 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.283 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.421 ' HB3' HD11 ' A' ' 20' ' ' ILE . . . -64.76 -43.51 93.08 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.547 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 96.9 t -60.43 -50.94 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.791 HD13 ' CD1' ' B' ' 27' ' ' TRP . 28.4 mm -54.87 -50.44 61.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.034 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.604 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -58.86 -45.92 88.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.649 -178.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.853 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 15.3 p -64.14 -38.72 92.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.003 0.43 . . . . 0.0 110.432 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' B' ' 18' ' ' VAL . 86.1 m -67.42 -25.12 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.445 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.32 -19.81 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.107 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 85.41 -48.8 4.08 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 5.3 p -104.02 25.87 9.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.454 0.645 . . . . 0.0 109.856 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.424 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 3.2 tpp85 -79.1 -36.99 39.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.006 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.791 ' CD1' HD13 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.947 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.413 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 1.6 m-20 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.52 -49.97 78.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 123.516 0.51 . . . . 0.0 110.569 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.575 HD11 ' H ' ' A' ' 3' ' ' LEU . 9.2 mp -61.77 -46.59 88.93 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.578 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 1' ' ' ASP . . . -53.0 -39.08 62.84 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.36 0.413 . . . . 0.0 110.789 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.41 -47.48 87.13 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.066 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.544 HD12 HD11 ' A' ' 23' ' ' LEU . 36.8 mt -71.54 -43.9 65.57 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -50.69 -44.97 58.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.7 m -62.91 -43.47 98.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.862 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -71.63 -41.25 69.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.081 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.696 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 74.1 m -62.33 -37.35 85.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.006 0.431 . . . . 0.0 110.752 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 48.5 t -79.29 -38.68 34.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.054 0.454 . . . . 0.0 110.481 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 37.2 ttmt -72.15 -58.46 3.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.139 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.45 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 9.4 m0 -104.81 -44.69 4.77 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.17 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 123.39 169.53 13.25 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 85.2 m -144.74 147.56 33.12 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 117.307 0.554 . . . . 0.0 111.394 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 20' ' ' ILE . 2.5 m -95.58 169.46 10.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.012 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' B' ' 21' ' ' THR . 58.4 tttp -55.7 -37.16 68.0 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.756 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -54.72 43.81 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.665 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.07 -42.29 94.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.351 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.547 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 44.9 mt -72.42 -45.8 58.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.928 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.853 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 63.1 m -64.65 -13.21 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.692 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.3 m -63.24 -19.83 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.254 0.549 . . . . 0.0 110.185 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.544 HD11 HD12 ' A' ' 6' ' ' LEU . 54.7 mt -106.77 28.11 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.148 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.599 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 58.8 m . . . . . 0 C--O 1.259 1.567 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.662 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 112.302 -0.319 . . . . 0.0 112.302 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 m -150.76 -169.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.524 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.6 mtp180 -89.69 128.16 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -121.84 114.06 20.52 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.643 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 71.5 m -108.6 119.97 41.08 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 47.54 -101.57 0.04 OUTLIER Glycine 0 CA--C 1.518 0.281 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.674 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -57.87 -34.05 69.34 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.978 0.511 . . . . 0.0 111.29 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.49 -36.81 76.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.6 ' O ' HG23 ' B' ' 18' ' ' VAL . 35.8 t80 -61.76 -52.99 61.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.169 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.536 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.3 mt -58.41 -47.73 87.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.333 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 6.4 tpt180 -65.21 -34.28 78.0 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.039 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.431 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -62.78 -39.29 93.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.807 178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.6 HG23 ' O ' ' B' ' 14' ' ' PHE . 61.0 t -60.15 -51.13 76.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.842 HG23 ' HD1' ' B' ' 27' ' ' TRP . 40.1 mm -52.68 -52.79 24.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.3 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.561 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.2 m-30 -60.37 -42.12 95.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.684 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.812 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 27.0 p -68.19 -42.53 79.78 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.352 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 47.4 m -65.33 -28.88 69.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.186 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.21 -24.21 0.09 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.492 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.9 -62.4 4.63 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.6 m -89.45 40.51 0.99 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.524 0.678 . . . . 0.0 110.177 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.412 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.8 tpm_? -105.17 -35.18 7.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.127 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.842 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.183 -1.372 . . . . 0.0 109.409 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 4' ' ' ALA . 9.9 p-10 . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.2 t -72.41 -45.06 61.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 123.487 0.492 . . . . 0.0 109.788 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 3' ' ' LEU . 74.6 mt -69.21 -53.77 18.23 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.513 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB2' ' OD1' ' A' ' 1' ' ' ASP . . . -58.66 -34.76 71.6 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.63 -49.03 83.09 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.424 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.822 HD21 HD13 ' A' ' 23' ' ' LEU . 48.9 tp -71.73 -37.91 70.52 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.5 t -54.9 -42.3 71.99 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.288 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.9 t -59.2 -42.21 90.39 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.093 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -74.04 -41.42 61.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.737 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 62.0 m -60.18 -45.56 92.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.624 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.42 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 48.1 t -74.7 -39.08 62.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.974 0.416 . . . . 0.0 110.858 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 3.2 ttmp? -68.95 -60.1 2.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.844 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.474 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 8.0 m0 -106.56 -54.74 2.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.236 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 139.77 -172.8 23.19 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' B' ' 9' ' ' LEU . 3.4 p -165.5 148.92 8.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.776 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.47 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 4.2 m -97.15 171.17 8.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.535 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HG3' HG21 ' B' ' 21' ' ' THR . 34.9 tttm -55.92 -36.28 67.56 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.493 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -51.83 68.37 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.46 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.84 -43.5 95.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.36 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.642 ' HB ' HG22 ' B' ' 21' ' ' THR . 39.8 mt -69.99 -44.94 78.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.925 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.812 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 75.2 m -64.4 -22.46 66.97 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.4 m -66.94 -8.52 30.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.917 0.389 . . . . 0.0 110.886 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.822 HD13 HD21 ' A' ' 6' ' ' LEU . 59.0 mt -116.8 26.2 10.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.536 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 70.5 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.44 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.515 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -144.69 -171.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.644 0.259 . . . . 0.0 110.847 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.509 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 70.0 mtp180 -87.87 130.39 34.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.309 0.576 . . . . 0.0 109.936 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.96 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 10.6 mp -116.25 109.4 17.35 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.562 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 72.3 m -112.14 116.95 31.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.923 0.392 . . . . 0.0 111.557 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 51.32 -109.55 0.8 Allowed Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.329 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -59.61 -29.46 68.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -69.4 -37.76 77.64 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.568 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 55.0 t80 -61.11 -55.6 30.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.078 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.65 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.5 mt -57.26 -52.31 58.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.41 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.616 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.5 mmp_? -64.03 -33.73 76.41 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.276 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.43 83.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.565 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 75.6 t -60.16 -47.71 90.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.666 HD12 ' CD1' ' B' ' 27' ' ' TRP . 21.1 mm -59.69 -51.83 68.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.089 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.438 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.3 OUTLIER -55.9 -47.38 77.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.814 -179.056 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.843 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 19.5 p -62.86 -40.54 97.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.001 0.429 . . . . 0.0 111.274 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 57.6 m -80.69 -10.57 59.72 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.22 -30.26 0.42 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.537 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.34 -52.81 4.76 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.5 m -104.16 40.35 1.48 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.472 0.653 . . . . 0.0 110.085 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -98.52 -36.08 10.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.354 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.666 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.205 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.922 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.591 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 9.5 p-10 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 39.2 t -71.56 -46.35 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.473 0.483 . . . . 0.0 109.758 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.54 HD11 ' N ' ' A' ' 3' ' ' LEU . 10.2 mp -68.85 -53.87 18.92 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.546 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.591 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -57.25 -35.46 69.75 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.05 -50.14 70.7 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.595 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 42.8 mt -70.39 -42.52 71.59 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 t -52.34 -42.44 63.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.85 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.5 t -59.11 -45.33 91.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.586 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.5 m -76.35 -38.68 55.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.96 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 67.4 m -63.0 -42.71 99.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.694 0.283 . . . . 0.0 111.419 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.69 -40.16 49.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.109 0.481 . . . . 0.0 110.427 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -67.97 -48.31 66.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.442 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.485 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 9.2 m0 -118.78 -58.72 1.93 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.356 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 141.68 -174.6 22.95 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.475 ' SG ' HD23 ' B' ' 9' ' ' LEU . 1.8 p -162.36 152.82 16.96 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.885 0.342 . . . . 0.0 110.875 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.513 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.4 m -97.37 167.57 10.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.07 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -52.56 -37.95 58.91 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.072 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.22 -50.27 74.15 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.601 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.35 -42.83 87.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.498 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.565 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 24.5 mt -72.06 -46.14 60.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.843 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 66.4 m -65.68 -34.13 77.49 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.191 -0.318 . . . . 0.0 111.579 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 t -68.58 -1.14 6.1 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.355 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.433 HD11 HD12 ' A' ' 6' ' ' LEU . 23.7 tp -85.18 -23.69 28.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.674 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.4 m . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.879 -179.547 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.2 -172.67 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 122.837 -0.214 . . . . 0.0 110.438 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.546 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 66.3 mtp180 -90.79 129.36 36.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.082 0.467 . . . . 0.0 110.051 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.7 mm? -122.14 111.92 17.57 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.178 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 97.9 m -109.76 123.14 49.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.92 -105.49 0.13 Allowed Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.57 -0.741 . . . . 0.0 114.522 178.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -60.48 -29.72 69.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.42 -35.9 73.69 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.532 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 48.2 t80 -65.18 -50.88 64.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.441 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.65 ' O ' HG12 ' B' ' 19' ' ' ILE . 66.6 mt -57.75 -50.33 77.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.877 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.556 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.7 mmp_? -63.72 -32.02 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.985 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.416 ' HB1' HD12 ' A' ' 20' ' ' ILE . . . -63.33 -44.68 94.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.118 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.474 HG21 ' O ' ' B' ' 14' ' ' PHE . 63.4 t -58.0 -50.3 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.677 HD12 ' CD1' ' B' ' 27' ' ' TRP . 34.6 mm -54.52 -50.98 54.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.147 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.476 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.1 m-30 -58.26 -45.41 87.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.747 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.769 HG22 ' HB ' ' A' ' 20' ' ' ILE . 11.9 p -63.54 -38.73 92.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.642 0.258 . . . . 0.0 111.557 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 34.0 m -70.76 -30.93 67.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.758 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.92 -22.14 0.09 OUTLIER Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.655 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 83.97 -60.03 4.89 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 112.176 -0.37 . . . . 0.0 112.176 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -92.6 48.88 1.41 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.524 0.678 . . . . 0.0 109.801 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.8 tpm_? -112.76 -37.4 4.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.985 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.677 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.988 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 39.4 t0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -108.54 -41.64 5.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.426 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.566 HD13 ' N ' ' A' ' 3' ' ' LEU . 9.3 mp -64.91 -55.4 19.54 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.8 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.49 -36.26 61.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.001 0.429 . . . . 0.0 110.306 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.93 66.53 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.034 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.713 HD21 HD11 ' A' ' 23' ' ' LEU . 44.8 tp -72.22 -39.18 68.7 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 t -54.32 -42.94 70.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.554 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.4 t -58.23 -44.11 88.09 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.203 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -74.16 -40.8 62.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.7 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 62.5 m -58.04 -44.95 87.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 111.705 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.9 t -78.2 -40.47 37.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.0 0.428 . . . . 0.0 110.995 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.407 ' CB ' ' HZ1' ' A' ' 12' ' ' LYS . 5.5 ttpm? -66.85 -49.85 64.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.849 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.532 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 8.8 m0 -119.47 -54.72 2.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.211 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.06 -171.17 25.05 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.547 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.0 p -166.45 151.05 7.72 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.182 0.515 . . . . 0.0 111.355 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.486 ' O ' HG13 ' A' ' 20' ' ' ILE . 67.6 p -93.1 165.4 12.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.569 ' HG3' HG21 ' B' ' 21' ' ' THR . 37.4 tttm -56.72 -40.14 75.15 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.362 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 m -57.33 -48.17 79.67 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.393 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -63.45 -46.29 86.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.881 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.769 ' HB ' HG22 ' B' ' 21' ' ' THR . 32.5 mt -67.46 -39.53 82.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.588 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.425 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 44.8 m -64.74 -24.43 67.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.779 0.323 . . . . 0.0 110.944 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.0 m -67.88 -5.87 18.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.138 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.713 HD11 HD21 ' A' ' 6' ' ' LEU . 10.7 mp -107.7 19.04 20.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.466 179.258 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 24.7 m -139.72 -179.96 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 13' ' ' TRP . 67.1 mtp180 -86.32 127.79 34.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.176 0.512 . . . . 0.0 110.008 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.578 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.3 mm? -122.42 117.18 25.4 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.41 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 79.3 m -115.52 120.97 41.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.826 0.345 . . . . 0.0 111.893 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 53.41 -107.83 0.67 Allowed Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.285 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -59.48 -30.39 68.5 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 17' ' ' ALA . 1.8 mm-40 -70.08 -36.63 75.07 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.624 ' O ' HG23 ' B' ' 18' ' ' VAL . 40.5 t80 -61.62 -53.04 61.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.218 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.612 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.2 mt -60.68 -49.27 85.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.347 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.528 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 5.0 mmp_? -61.89 -34.21 75.63 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.475 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' B' ' 13' ' ' GLU . . . -64.12 -40.67 96.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.278 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.624 HG23 ' O ' ' B' ' 14' ' ' PHE . 59.1 t -59.52 -49.28 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-O 122.041 0.924 . . . . 0.0 108.802 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.612 HG12 ' O ' ' B' ' 15' ' ' ILE . 20.8 mm -59.07 -52.8 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.284 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.422 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.9 OUTLIER -57.74 -45.08 86.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.312 -178.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.752 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 18.6 p -63.48 -40.51 97.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.92 0.39 . . . . 0.0 111.267 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -78.33 -26.21 46.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.652 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.66 -31.47 0.09 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 119.998 -1.096 . . . . 0.0 113.359 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 87.2 -56.83 4.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.688 -0.291 . . . . 0.0 112.521 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.5 m -99.21 51.06 0.95 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.483 0.658 . . . . 0.0 110.114 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 7.2 tpm_? -113.94 -38.82 4.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.941 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.565 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.035 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.933 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.575 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 10.9 p-10 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.09 -44.81 64.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 123.392 0.433 . . . . 0.0 109.918 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.517 HD13 ' N ' ' A' ' 3' ' ' LEU . 10.8 mp -69.48 -54.52 13.83 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.749 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.575 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -58.64 -37.14 75.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.01 -48.54 82.67 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.883 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.549 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 35.1 tp -71.0 -41.05 71.43 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 t -53.02 -41.72 64.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.675 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 m -58.81 -34.13 71.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.705 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 m -86.08 -38.27 17.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.352 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.549 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 71.1 m -60.26 -40.57 90.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.782 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.0 t -79.6 -41.56 26.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.989 0.423 . . . . 0.0 110.896 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.4 ' CB ' ' HZ1' ' A' ' 12' ' ' LYS . 7.1 ttpm? -67.57 -50.04 60.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.878 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.518 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 11.2 m0 -114.64 -56.71 2.35 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.313 -178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.32 173.17 14.09 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 99.2 m -146.66 148.56 32.18 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.824 0.345 . . . . 0.0 110.935 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.518 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.4 m -94.63 166.19 12.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.617 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -52.94 -38.85 62.4 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.943 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -53.85 53.54 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.473 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -63.3 -42.54 99.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.561 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 16' ' ' SER . 45.8 mt -70.63 -45.21 75.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.752 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 73.1 m -64.82 -27.68 69.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.605 0.24 . . . . 0.0 111.601 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.3 m -69.29 -1.74 8.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.971 0.415 . . . . 0.0 111.364 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.432 ' HA ' HD21 ' A' ' 23' ' ' LEU . 97.3 mt -90.12 -11.18 42.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.807 179.672 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.492 ' CG2' ' H ' ' B' ' 8' ' ' ARG . 6.2 p -163.46 -173.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.527 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.0 mtp180 -85.1 131.09 34.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.249 0.547 . . . . 0.0 110.398 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.587 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.2 mm? -126.44 115.76 20.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.86 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' CYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 73.1 m -111.73 120.78 43.18 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 45.56 -100.62 0.02 OUTLIER Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.57 -41.18 69.53 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.112 0.565 . . . . 0.0 111.661 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.439 ' HB3' HD13 ' B' ' 9' ' ' LEU . 14.1 mp0 -69.15 -36.08 77.03 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.587 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 46.0 t80 -61.9 -56.52 18.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.013 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ILE . . . . . 0.587 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.9 mt -58.54 -48.06 86.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.529 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.492 ' NH1' HG13 ' B' ' 19' ' ' ILE . 13.1 mmm180 -64.13 -34.24 77.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.493 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.85 -40.45 97.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.153 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.512 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 57.9 t -59.42 -49.5 83.35 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.784 HG21 ' HD1' ' B' ' 27' ' ' TRP . 19.6 mm -57.87 -53.56 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.333 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.479 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.6 m-30 -57.17 -45.21 83.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.576 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' THR . . . . . 0.822 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 21.2 p -64.89 -40.77 95.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.05 0.452 . . . . 0.0 111.378 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -76.93 -20.38 56.24 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.651 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.84 -30.4 0.16 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.094 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.4 -55.56 5.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.707 -0.283 . . . . 0.0 112.548 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.2 m -97.06 46.53 1.04 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.43 0.633 . . . . 0.0 110.335 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.42 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 7.3 tpm_? -110.41 -37.49 5.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.327 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' TRP . . . . . 0.784 ' HD1' HG21 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.372 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.408 ' OD2' ' HB1' ' A' ' 4' ' ' ALA . 3.3 p30 . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.44 -49.35 60.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.401 0.438 . . . . 0.0 110.68 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.537 HD11 ' N ' ' A' ' 3' ' ' LEU . 10.7 mp -72.17 -51.38 21.51 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.408 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.408 ' HB1' ' OD2' ' A' ' 1' ' ' ASP . . . -56.77 -37.29 70.87 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.88 -49.29 77.25 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.75 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.9 tp -71.01 -39.91 72.11 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.6 t -55.12 -42.52 73.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.406 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 t -57.77 -44.16 85.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.334 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -74.68 -40.53 61.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.969 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 56.1 m -60.3 -43.11 96.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 111.603 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.401 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 49.5 t -78.65 -39.57 36.63 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.904 0.383 . . . . 0.0 110.874 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' CB ' ' HZ1' ' A' ' 12' ' ' LYS . 5.4 ttpm? -68.31 -50.85 50.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.825 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.502 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 8.4 m0 -116.39 -55.11 2.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.29 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.6 -173.64 23.01 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -164.98 149.56 9.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.964 0.412 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.537 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 3.6 m -94.8 168.74 10.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.478 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' HG3' HG21 ' B' ' 21' ' ' THR . 37.7 tttm -54.33 -37.15 64.53 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.903 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -50.36 74.32 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.357 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -63.2 -45.18 92.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.512 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 33.2 mt -69.76 -43.13 80.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.545 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.822 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 71.4 m -64.11 -36.7 84.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.754 0.311 . . . . 0.0 111.14 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.5 m -70.13 5.19 1.74 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.667 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -92.23 -22.48 19.77 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.849 0.356 . . . . 0.0 110.234 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.8 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.025 179.668 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.02 -150.93 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.23 136.56 95.3 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.708 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.02 52.74 2.72 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.028 2.485 . . . . 0.0 112.454 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.575 ' CE1' ' HA ' ' B' ' 21' ' ' THR . 9.5 m-30 -97.74 18.49 15.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.485 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 162.22 58.08 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.04 -171.14 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.449 0.166 . . . . 0.0 110.646 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.53 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 67.5 mtp180 -86.27 129.02 34.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.211 0.529 . . . . 0.0 109.965 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -125.69 117.42 23.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.407 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 69.2 m -113.22 122.01 46.18 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.98 -104.97 0.13 Allowed Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.396 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -57.59 -33.69 68.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.547 ' O ' ' HB1' ' B' ' 17' ' ' ALA . 53.8 mm-40 -70.82 -34.89 72.19 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.564 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 41.3 t80 -62.15 -54.08 46.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.334 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.592 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.5 mt -59.51 -50.69 78.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.505 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.591 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.0 mmp_? -62.22 -33.24 74.19 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.732 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' B' ' 13' ' ' GLU . . . -65.18 -39.52 93.0 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.551 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 91.7 t -59.7 -49.04 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-O 121.92 0.867 . . . . 0.0 108.714 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.592 HG12 ' O ' ' B' ' 15' ' ' ILE . 13.9 mm -59.72 -52.69 58.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.165 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.433 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.5 m-30 -56.51 -45.39 81.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.201 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.774 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 23.4 p -63.57 -39.8 95.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.36 0.6 . . . . 0.0 110.876 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 59.4 m -81.55 -13.25 58.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.03 -30.19 0.33 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.351 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.14 -49.29 4.08 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.62 -0.324 . . . . 0.0 112.502 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.5 m -105.18 41.47 1.35 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.291 0.567 . . . . 0.0 110.538 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.501 ' NH1' ' HB3' ' A' ' 24' ' ' CYS . 54.7 ttt180 -98.7 -36.35 9.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.556 ' HD1' HG21 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.848 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.584 ' OD2' ' HB3' ' A' ' 4' ' ' ALA . 3.2 p30 . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.65 -49.85 43.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.37 . . . . 0.0 110.735 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.407 ' HA ' HD22 ' A' ' 3' ' ' LEU . 70.6 mt -70.57 -50.69 34.69 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.787 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.584 ' HB3' ' OD2' ' A' ' 1' ' ' ASP . . . -59.66 -36.64 76.82 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.67 90.05 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.501 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.534 HD23 HD12 ' A' ' 23' ' ' LEU . 33.4 tp -72.26 -40.0 68.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.0 t -53.27 -41.55 65.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.527 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.3 m -59.16 -44.48 92.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.395 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -72.73 -39.4 66.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.619 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 82.4 m -60.8 -38.24 84.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.565 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 51.4 t -81.23 -43.1 19.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.015 0.436 . . . . 0.0 110.786 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -65.35 -51.25 61.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.852 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.486 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 13.0 m0 -113.61 -55.55 2.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.384 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.54 174.92 14.2 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.1 m -147.5 147.54 30.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.852 0.326 . . . . 0.0 110.72 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.539 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.5 m -94.78 164.44 12.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.28 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -53.02 -36.89 61.02 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -53.51 57.6 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.345 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.99 -42.68 99.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.428 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.551 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 34.2 mt -70.77 -46.09 70.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.664 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.774 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 66.3 m -64.6 -27.14 68.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.6 m -68.92 -3.87 14.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.932 0.396 . . . . 0.0 111.54 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.534 HD12 HD23 ' A' ' 6' ' ' LEU . 93.8 mt -91.47 -4.26 55.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.68 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.501 ' HB3' ' NH1' ' B' ' 26' ' ' ARG . 71.0 m . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.327 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 7.7 ppt_? . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.439 ' HB2' ' H ' ' B' ' 3' ' ' ALA . . . -77.13 -149.44 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.923 0.392 . . . . 0.0 111.326 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' B' ' 2' ' ' ALA . . . -161.09 76.1 2.5 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.87 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.04 54.86 4.77 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.988 2.459 . . . . 0.0 111.144 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.666 ' CE1' ' HA ' ' B' ' 21' ' ' THR . 14.6 m-30 -81.68 34.35 0.39 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.866 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 158.88 56.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.341 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.64 -172.15 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.681 0.24 . . . . 0.0 110.714 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.533 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 53.0 mtp85 -87.15 127.39 35.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -124.07 119.0 28.22 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.802 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 82.5 m -115.09 120.62 40.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.594 0.235 . . . . 0.0 111.556 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.41 -103.36 0.07 OUTLIER Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.945 -0.571 . . . . 0.0 114.269 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -57.63 -35.29 70.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.482 ' HB3' HD12 ' B' ' 9' ' ' LEU . 3.2 mp0 -69.26 -35.46 76.11 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.579 ' O ' HG23 ' B' ' 18' ' ' VAL . 33.6 t80 -61.95 -51.95 66.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.062 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.54 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.6 mt -59.03 -48.58 86.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.408 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 5.9 mmp_? -61.92 -38.11 87.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.336 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.485 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -63.13 -38.2 90.25 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.299 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 14' ' ' PHE . 98.8 t -59.97 -50.82 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.54 HG12 ' O ' ' B' ' 15' ' ' ILE . 7.6 mm -57.26 -50.88 75.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.845 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -57.76 -41.88 82.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.209 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.735 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 22.8 p -66.91 -43.78 82.49 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.62 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.01 -37.86 89.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.705 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.73 -31.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.638 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.84 28.35 42.57 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 32.5 p -172.09 88.79 0.1 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -167.36 -38.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.646 0.736 . . . . 0.0 110.057 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.52 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.502 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t -72.24 -44.71 63.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 123.54 0.525 . . . . 0.0 109.791 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 3' ' ' LEU . 11.0 mp -69.49 -54.48 14.04 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.531 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.52 74.45 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.4 81.94 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.699 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.496 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 40.6 tp -70.75 -43.37 68.95 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.8 t -52.43 -42.66 64.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.635 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 t -58.93 -43.28 91.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.196 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.9 m -74.1 -38.66 63.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.999 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.496 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 70.8 m -60.14 -41.51 92.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.76 0.314 . . . . 0.0 111.08 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 42.8 t -81.54 -39.28 24.89 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.024 0.44 . . . . 0.0 111.042 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' CB ' ' HZ1' ' A' ' 12' ' ' LYS . 6.2 ttpm? -68.68 -43.82 75.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.82 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.431 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 10.5 m0 -123.48 -56.33 1.71 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.123 0.487 . . . . 0.0 111.385 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.89 173.6 15.49 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.2 m -147.23 145.91 29.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.117 0.459 . . . . 0.0 111.033 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.484 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.5 m -94.4 168.72 10.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.536 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -54.64 -37.97 66.31 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.847 0.356 . . . . 0.0 110.884 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.54 -53.96 51.49 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.493 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.57 -44.1 97.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.6 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.704 ' HB ' HG23 ' B' ' 21' ' ' THR . 34.0 mt -70.54 -44.36 77.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.22 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.735 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 67.6 m -65.53 -18.81 65.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.406 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.2 m -65.58 -11.38 43.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.045 0.45 . . . . 0.0 110.518 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.422 ' HA ' HD22 ' A' ' 23' ' ' LEU . 77.4 mt -111.08 26.53 10.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.823 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 95.9 m . . . . . 0 C--O 1.257 1.477 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.32 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.75 -151.8 0.34 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' B' ' 4' ' ' PRO . . . -160.47 121.0 1.66 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.652 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.561 ' HA ' HG23 ' B' ' 7' ' ' VAL . 5.3 Cg_exo -80.07 48.45 2.87 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.454 2.769 . . . . 0.0 111.492 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.549 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 4.0 m-30 -86.69 65.64 9.1 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.551 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.25 49.85 0.8 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.303 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' B' ' 4' ' ' PRO . 26.9 m -138.21 178.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 O-C-N 122.847 -0.208 . . . . 0.0 110.47 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.528 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 68.3 mtp180 -86.7 129.08 35.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.144 0.497 . . . . 0.0 110.039 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -123.99 118.24 26.56 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.271 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 84.3 m -114.38 120.06 39.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.8 -103.59 0.09 OUTLIER Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.882 -0.599 . . . . 0.0 114.309 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -57.89 -34.53 69.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' B' ' 17' ' ' ALA . 2.9 mp0 -69.11 -35.55 76.57 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.547 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 38.6 t80 -62.94 -50.08 72.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.095 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.639 ' O ' HG12 ' B' ' 19' ' ' ILE . 66.8 mt -59.5 -50.66 79.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.964 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.643 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.1 mmp_? -62.43 -33.39 74.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.435 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' B' ' 4' ' ' PRO . . . -63.11 -43.3 98.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.529 HG21 ' O ' ' B' ' 14' ' ' PHE . 96.3 t -58.31 -48.1 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.673 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.4 mm -57.84 -49.54 80.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.877 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.452 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.4 m-30 -58.61 -43.23 89.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.98 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.742 HG22 ' HB ' ' A' ' 20' ' ' ILE . 11.1 p -65.64 -40.58 92.66 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.716 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 37.4 m -67.01 -34.66 78.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.251 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.68 -37.31 0.13 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.04 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 106.56 -42.53 1.89 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -112.04 41.09 2.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.4 0.619 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.419 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 77.2 ttt180 -96.31 -36.61 10.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.412 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.673 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.698 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 4' ' ' ALA . 27.7 p-10 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.97 -42.02 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.089 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.581 HD11 ' N ' ' A' ' 3' ' ' LEU . 10.7 mp -68.52 -58.15 4.74 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.999 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB2' ' OD1' ' A' ' 1' ' ' ASP . . . -59.74 -35.01 73.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.98 -46.93 93.06 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.437 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 42.5 tp -72.7 -42.98 63.63 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 t -51.26 -43.64 61.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.973 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -58.3 -43.89 88.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.509 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.2 m -74.13 -36.69 64.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.931 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.504 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 83.6 m -60.46 -39.87 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.957 0.408 . . . . 0.0 110.343 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 42.7 t -81.27 -42.98 19.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.947 0.404 . . . . 0.0 110.563 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HG2' ' CD1' ' A' ' 13' ' ' TRP . 18.8 ttpp -62.9 -50.16 71.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.941 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.509 ' CD1' ' HG2' ' A' ' 12' ' ' LYS . 32.4 m0 -118.66 -54.32 2.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.546 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 141.54 174.46 14.43 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 92.1 m -147.11 146.41 29.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.916 0.358 . . . . 0.0 110.894 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.513 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.5 m -93.99 169.64 10.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.997 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.549 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 52.7 tttp -55.1 -38.39 68.07 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.962 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -51.25 70.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.605 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.513 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -61.57 -45.58 93.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.924 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.742 ' HB ' HG22 ' B' ' 21' ' ' THR . 31.5 mt -70.75 -42.37 77.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.36 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 47.0 m -65.72 -20.23 66.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 111.025 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.7 t -66.49 -10.39 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.506 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.462 HD12 HD21 ' A' ' 6' ' ' LEU . 82.2 mt -109.62 23.6 14.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.184 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 C--O 1.256 1.405 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.18 179.589 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 30.6 mmm-85 . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.452 ' HB1' ' H ' ' B' ' 3' ' ' ALA . . . -156.34 -150.49 0.29 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.753 0.658 . . . . 0.0 109.228 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . 0.452 ' H ' ' HB1' ' B' ' 2' ' ' ALA . . . -63.28 129.34 93.44 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 123.371 0.42 . . . . 0.0 110.746 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.93 50.15 2.71 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 123.109 2.539 . . . . 0.0 112.504 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -102.06 49.28 0.86 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.335 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 126.2 55.3 0.15 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.697 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.49 HG12 ' O ' ' B' ' 6' ' ' GLY . 15.2 m -148.64 -168.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.524 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.4 mtp180 -88.22 130.36 35.1 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.18 0.514 . . . . 0.0 109.789 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.571 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.3 mm? -124.06 114.64 19.99 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.409 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 78.7 m -109.12 117.66 34.72 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 46.06 -100.36 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 O-C-N 123.871 0.732 . . . . 0.0 114.384 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -53.71 -38.45 64.28 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.285 0.634 . . . . 0.0 112.138 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' B' ' 17' ' ' ALA . 3.4 mm-40 -70.74 -36.34 73.1 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.571 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 35.6 t80 -63.52 -53.49 51.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.487 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.566 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.4 mt -59.13 -48.29 87.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.626 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.505 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 5.2 tpt180 -66.14 -32.88 74.6 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.264 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' B' ' 13' ' ' GLU . . . -62.93 -39.89 95.96 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.466 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 91.3 t -60.3 -49.83 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.734 HD12 ' CD1' ' B' ' 27' ' ' TRP . 35.8 mm -55.19 -50.79 61.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.335 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.473 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.9 m-30 -58.49 -46.07 87.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.924 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.497 ' HG1' HG21 ' A' ' 20' ' ' ILE . 18.2 p -65.1 -39.22 92.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.044 0.449 . . . . 0.0 110.756 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.496 ' HB3' HH11 ' B' ' 26' ' ' ARG . 78.6 m -66.91 -26.55 66.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.503 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.32 -19.75 0.23 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.283 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.39 -50.42 4.33 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 112.329 -0.308 . . . . 0.0 112.329 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -101.18 29.2 4.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.315 0.578 . . . . 0.0 110.39 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.496 HH11 ' HB3' ' B' ' 22' ' ' CYS . 72.3 ttt180 -88.65 -33.27 17.66 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.744 0.783 . . . . 0.0 109.491 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.734 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.312 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.71 -45.32 66.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 123.424 0.452 . . . . 0.0 109.955 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 3' ' ' LEU . 10.7 mp -69.81 -54.05 15.37 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.534 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.08 -36.78 73.34 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.91 -49.43 75.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.766 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.71 -39.63 73.3 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.6 t -55.27 -43.59 74.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.37 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.6 m -60.86 -35.58 76.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.555 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 m -80.35 -38.49 30.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.58 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 52.2 m -61.73 -41.79 98.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 110.716 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.431 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 49.6 t -76.88 -40.47 47.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.931 0.396 . . . . 0.0 110.682 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.424 ' CB ' ' HZ1' ' A' ' 12' ' ' LYS . 6.8 ttpm? -69.47 -50.77 42.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.86 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.491 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 10.6 m0 -114.17 -57.1 2.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.271 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.58 -172.06 23.75 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -164.81 150.12 9.77 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.867 0.365 . . . . 0.0 110.73 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.565 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.9 m -94.04 169.77 10.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.064 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HD3' ' HG ' ' A' ' 21' ' ' SER . 10.5 tmtt? -54.42 -35.36 62.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.039 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -51.34 64.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.993 0.425 . . . . 0.0 111.474 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.476 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -58.71 -44.54 90.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.168 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 16' ' ' SER . 40.0 mt -67.69 -40.89 84.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.2 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.469 ' HG ' ' HD3' ' A' ' 17' ' ' LYS . 68.8 m -64.69 -18.09 64.67 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 m -66.39 -13.15 60.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.929 0.395 . . . . 0.0 111.047 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.547 HD11 HD13 ' A' ' 3' ' ' LEU . 3.5 mm? -95.75 -5.08 42.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.106 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 80.6 m . . . . . 0 C--O 1.257 1.453 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.33 -178.901 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.482 ' HB3' ' H ' ' B' ' 3' ' ' ALA . . . -126.64 -150.39 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . 0.482 ' H ' ' HB3' ' B' ' 2' ' ' ALA . . . -65.98 133.74 94.88 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.762 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.469 ' HB2' ' HB1' ' B' ' 17' ' ' ALA . 69.5 Cg_endo -74.59 52.08 2.79 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 123.048 2.499 . . . . 0.0 112.572 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.534 ' CE1' ' HA ' ' B' ' 21' ' ' THR . 9.4 m-30 -99.14 18.36 17.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.522 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 162.25 59.28 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' B' ' 4' ' ' PRO . 14.5 m -148.65 -169.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.508 0.194 . . . . 0.0 110.484 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.534 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 65.5 mtp180 -86.92 127.93 35.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.19 0.519 . . . . 0.0 109.711 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -122.97 115.07 21.3 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.59 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.448 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 65.0 m -109.46 119.93 40.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.53 -104.04 0.09 OUTLIER Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.464 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.43 ' HG2' HH11 ' B' ' 12' ' ' ARG . 33.4 ttp85 -56.86 -32.13 65.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.695 0.398 . . . . 0.0 111.7 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' B' ' 17' ' ' ALA . 25.5 mm-40 -70.02 -38.68 75.99 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.506 ' O ' HG21 ' B' ' 18' ' ' VAL . 39.8 t80 -59.36 -53.39 58.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.349 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.595 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.1 mt -59.45 -51.93 66.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.849 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.672 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 2.2 mmp_? -63.68 -31.72 72.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.709 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' B' ' 13' ' ' GLU . . . -65.33 -38.39 89.98 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.538 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 84.6 t -59.61 -49.73 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.69 HD13 ' CD1' ' B' ' 27' ' ' TRP . 13.4 mm -57.47 -53.41 44.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.136 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.629 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.6 m-30 -56.38 -45.09 80.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.43 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.874 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 24.7 p -65.63 -40.68 92.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.356 0.598 . . . . 0.0 111.051 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -74.32 -18.21 60.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.753 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.83 -21.89 0.23 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.917 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.45 -51.16 4.52 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.3 m -104.31 38.52 1.85 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.324 0.583 . . . . 0.0 109.771 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 9.4 tpp85 -87.48 -38.8 15.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.114 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.69 ' CD1' HD13 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.665 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.405 ' OD1' ' HB1' ' A' ' 4' ' ' ALA . 26.5 p-10 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.564 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 47.2 t -111.22 -44.19 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.157 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 3' ' ' LEU . 9.2 mp -68.99 -57.27 5.68 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.405 ' HB1' ' OD1' ' A' ' 1' ' ' ASP . . . -59.11 -33.29 70.68 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.1 -43.71 98.03 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.579 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 42.2 mt -82.2 -43.21 17.95 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.7 t -49.47 -45.14 46.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.588 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 p -62.32 -46.54 88.24 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.568 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 m -68.88 -39.47 79.79 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.35 0.26 . . . . 0.0 111.115 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.492 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 78.3 m -62.28 -38.78 90.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.916 0.389 . . . . 0.0 110.092 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.448 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 44.5 t -78.97 -44.46 22.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.099 0.476 . . . . 0.0 110.459 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -63.2 -50.24 71.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.688 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.496 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 22.1 m0 -117.08 -57.73 2.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.548 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.47 173.96 14.67 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.8 m -147.78 147.54 29.98 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 116.994 0.397 . . . . 0.0 110.61 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.543 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.7 m -95.09 163.84 13.13 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.417 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -52.51 -38.22 59.11 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.497 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -52.37 66.04 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.452 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.529 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -60.38 -44.78 95.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.587 ' HB ' HG23 ' B' ' 21' ' ' THR . 27.1 mt -70.71 -44.06 76.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.695 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.874 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 70.7 m -63.53 -25.09 68.09 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.431 -0.168 . . . . 0.0 111.382 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.7 m -64.61 -8.55 14.64 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 6' ' ' LEU . 7.8 mp -80.74 -21.94 40.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.4 m . . . . . 0 C--O 1.244 0.785 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.82 -179.311 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . 0.551 ' HB3' ' OE2' ' B' ' 13' ' ' GLU . 7.2 ptm85 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.49 -146.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.192 0.307 . . . . 0.0 110.31 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' B' ' 4' ' ' PRO . . . -67.09 115.68 28.07 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.0 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.658 ' HB3' HD11 ' B' ' 9' ' ' LEU . 12.1 Cg_endo -90.34 44.44 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.41 2.74 . . . . 0.0 111.844 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -93.81 68.13 3.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.516 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 101.58 53.89 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.086 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' B' ' 4' ' ' PRO . 20.4 m -144.22 -167.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.616 0.246 . . . . 0.0 110.532 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -89.18 130.96 35.51 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.666 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.6 mm? -127.14 112.39 15.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.322 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 85.5 m -109.75 119.09 38.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.752 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.51 -105.55 0.16 Allowed Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.736 -0.666 . . . . 0.0 114.556 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -57.02 -32.14 65.84 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 122.752 0.421 . . . . 0.0 112.051 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.551 ' OE2' ' HB3' ' B' ' 1' ' ' ARG . 5.7 mm-40 -68.38 -40.17 81.49 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.624 ' O ' HG22 ' B' ' 18' ' ' VAL . 55.2 t80 -61.23 -53.7 53.61 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.623 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.545 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.3 mt -56.51 -50.2 74.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.037 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.503 ' NH1' HG13 ' B' ' 19' ' ' ILE . 3.7 tpt180 -67.27 -31.78 72.34 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.953 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.469 ' HB3' ' CB ' ' B' ' 4' ' ' PRO . . . -62.53 -40.4 96.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.805 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.624 HG22 ' O ' ' B' ' 14' ' ' PHE . 92.0 t -59.97 -50.37 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.709 HD12 ' CD1' ' B' ' 27' ' ' TRP . 26.7 mm -57.58 -52.46 57.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.457 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.504 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.4 m-30 -56.57 -47.6 79.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.904 -1.043 . . . . 0.0 113.4 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.82 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 21.7 p -64.18 -41.22 97.19 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.167 0.508 . . . . 0.0 111.532 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 57.3 m -77.08 -14.27 59.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.995 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.13 -29.38 0.25 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 119.778 -1.201 . . . . 0.0 113.205 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.68 -48.68 4.04 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -106.51 26.44 9.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.198 0.523 . . . . 0.0 110.16 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -84.83 -33.05 22.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.789 0.804 . . . . 0.0 109.49 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.709 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.12 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.501 ' OD1' ' HB1' ' A' ' 4' ' ' ALA . 27.2 p-10 . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.515 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 26.3 t -111.29 -42.81 4.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.111 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 3' ' ' LEU . 9.3 mp -68.86 -57.61 5.32 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.501 ' HB1' ' OD1' ' A' ' 1' ' ' ASP . . . -57.52 -33.92 68.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.72 84.86 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.373 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 62.8 mt -72.85 -39.59 66.4 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.483 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 29.3 t -52.86 -43.81 66.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.736 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.2 m -60.69 -44.82 96.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.445 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -71.12 -38.23 72.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.717 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.666 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 64.7 m -63.82 -37.18 86.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 110.865 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.43 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 34.9 t -79.62 -37.73 35.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.181 0.515 . . . . 0.0 110.297 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -73.29 -52.52 13.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.16 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -113.32 -42.3 3.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.249 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 120.16 -179.1 16.53 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.475 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.1 p -161.36 150.41 16.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.935 0.398 . . . . 0.0 111.155 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.53 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.0 m -96.9 167.33 11.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.911 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -54.21 -37.42 64.55 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.16 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -50.55 73.64 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.426 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.53 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -62.89 -45.01 94.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.094 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.573 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 24.2 mt -71.51 -42.3 72.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.681 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.82 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 70.5 m -64.04 -36.16 83.08 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.142 -0.349 . . . . 0.0 111.314 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.2 m -69.03 3.72 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.82 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.451 HD21 ' HG ' ' A' ' 3' ' ' LEU . 20.2 tp -90.04 -22.48 21.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.698 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.2 m . . . . . 0 C--O 1.243 0.73 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.91 -179.512 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.7 56.71 3.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.9 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . 0.444 ' O ' HG21 ' B' ' 7' ' ' VAL . . . -161.34 55.33 0.61 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -86.27 38.98 0.62 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.6 2.2 . . . . 0.0 112.553 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -102.51 70.26 1.14 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.941 0.4 . . . . 0.0 111.112 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.71 46.68 2.44 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.829 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.444 HG21 ' O ' ' B' ' 3' ' ' ALA . 35.1 m -142.35 -177.0 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.537 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 72.3 mtp180 -83.29 129.71 35.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.123 0.487 . . . . 0.0 110.339 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -123.87 118.49 27.22 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.992 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 65.8 m -117.79 119.66 35.57 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.37 -98.66 0.02 OUTLIER Glycine 0 CA--C 1.519 0.316 0 N-CA-C 114.761 0.665 . . . . 0.0 114.761 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.48 ' H ' ' HG3' ' B' ' 12' ' ' ARG . 15.6 mtm180 -53.4 -44.37 68.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.281 0.632 . . . . 0.0 111.941 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.441 ' HB3' HD11 ' B' ' 9' ' ' LEU . 3.0 mp0 -72.29 -30.98 65.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.896 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.526 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 41.7 t80 -65.1 -51.68 59.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.038 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.631 ' O ' HG12 ' B' ' 19' ' ' ILE . 80.1 mt -61.53 -49.22 85.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.865 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.559 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.5 mmp_? -62.83 -32.11 73.25 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.298 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.0 94.24 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.8 -51.11 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.832 HG22 ' HD1' ' B' ' 27' ' ' TRP . 37.9 mm -53.42 -51.42 41.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.311 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.52 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.8 m-30 -58.82 -44.74 90.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.732 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.864 HG22 ' HB ' ' A' ' 20' ' ' ILE . 17.0 p -63.7 -39.38 94.17 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.589 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 m -69.39 -31.33 69.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.652 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.39 -22.23 0.09 OUTLIER Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.674 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.21 -62.26 4.6 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.4 m -90.85 48.18 1.5 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.565 0.698 . . . . 0.0 109.641 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.415 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.8 tpm_? -112.55 -37.19 5.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.124 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.832 ' HD1' HG22 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.12 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.117 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.95 -44.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 123.511 0.507 . . . . 0.0 109.865 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 3' ' ' LEU . 10.2 mp -69.97 -54.46 13.2 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.68 -35.79 73.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.47 -49.48 73.48 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.647 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.656 HD23 HD11 ' A' ' 23' ' ' LEU . 43.5 tp -70.8 -39.93 72.83 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.9 t -55.65 -37.81 68.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.476 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 t -59.8 -41.73 91.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.882 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.7 m -76.23 -43.16 43.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.539 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 75.5 m -60.03 -39.48 86.05 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.256 0.347 . . . . 0.0 111.467 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.45 -38.72 25.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.838 0.352 . . . . 0.0 111.009 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 3.2 ttmp? -68.43 -61.5 1.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.278 0.561 . . . . 0.0 111.631 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.509 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 6.0 m0 -101.18 -54.35 2.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.902 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 138.05 174.33 13.35 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.7 m -148.56 146.61 28.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.983 0.42 . . . . 0.0 110.672 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.515 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 3.2 m -91.91 170.05 10.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.629 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HG3' HG21 ' B' ' 21' ' ' THR . 40.7 tttm -55.9 -36.87 68.13 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.682 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -52.22 66.66 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.614 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.68 -44.9 93.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.6 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.864 ' HB ' HG22 ' B' ' 21' ' ' THR . 37.4 mt -70.66 -39.6 76.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.015 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.484 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 49.3 m -65.15 -20.46 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.776 0.322 . . . . 0.0 110.669 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.5 m -68.15 -6.88 25.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.068 0.461 . . . . 0.0 110.93 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.656 HD11 HD23 ' A' ' 6' ' ' LEU . 69.1 mt -105.33 19.66 20.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.6 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.411 179.401 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.56 61.28 2.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.044 0.449 . . . . 0.0 111.324 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.98 127.28 1.94 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.049 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.418 ' HB2' ' HB2' ' B' ' 17' ' ' ALA . 73.5 Cg_endo -75.62 45.66 1.5 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.168 2.578 . . . . 0.0 112.512 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -111.05 90.85 3.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.27 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 80.42 52.3 4.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.872 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.442 HG23 HD12 ' B' ' 9' ' ' LEU . 17.1 m -144.69 -171.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.525 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 61.8 mtp180 -89.88 123.93 34.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.088 0.47 . . . . 0.0 109.883 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.1 mm? -114.98 115.26 26.59 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.129 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 79.7 m -109.26 118.77 37.58 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.78 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.57 -102.57 0.05 OUTLIER Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.465 -0.789 . . . . 0.0 114.345 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' B' ' 12' ' ' ARG . 4.4 tmm_? -57.16 -32.21 66.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.239 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.416 ' HA ' ' NH1' ' B' ' 12' ' ' ARG . 5.6 tp10 -70.59 -38.28 74.0 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.516 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 45.3 t80 -59.65 -55.45 34.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.582 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.567 ' O ' HG12 ' B' ' 19' ' ' ILE . 62.3 mt -58.88 -48.52 86.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.967 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.528 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 5.1 tpt180 -65.58 -33.28 75.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.302 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' B' ' 4' ' ' PRO . . . -62.42 -40.31 96.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.493 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 60.6 t -60.64 -49.26 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.78 HG21 ' HD1' ' B' ' 27' ' ' TRP . 39.0 mm -55.8 -51.08 63.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.308 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.528 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.3 m-30 -58.53 -46.19 87.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.047 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.643 HG23 ' HG2' ' A' ' 17' ' ' LYS . 18.4 p -65.05 -39.74 93.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.984 0.421 . . . . 0.0 110.808 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.471 ' HB3' HH11 ' B' ' 26' ' ' ARG . 73.5 m -67.86 -24.39 65.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.737 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.14 -21.94 0.22 Allowed Glycine 0 C--O 1.227 -0.333 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.495 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.08 -51.58 4.49 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.7 m -101.08 27.81 5.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.411 0.624 . . . . 0.0 110.139 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.471 HH11 ' HB3' ' B' ' 22' ' ' CYS . 72.0 ttt180 -88.52 -32.8 18.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.658 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.78 ' HD1' HG21 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.202 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 45.2 t -111.99 -42.61 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.156 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.9 mt -69.26 -56.35 7.84 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.9 72.13 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.91 -43.38 98.11 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.31 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.651 HD12 HD13 ' A' ' 23' ' ' LEU . 44.9 mt -80.31 -43.14 21.75 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -49.31 -47.01 47.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.532 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.1 p -62.48 -46.57 87.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.568 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.49 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 33.1 m -67.5 -38.53 84.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.227 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 83.3 m -62.58 -39.46 93.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.921 0.391 . . . . 0.0 110.234 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 41.3 t -79.22 -44.03 22.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.237 0.541 . . . . 0.0 110.389 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.5 ttpt -62.13 -49.59 75.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.568 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.458 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 23.0 m0 -119.19 -58.07 1.96 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.579 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.9 171.94 13.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.8 m -145.72 145.6 30.93 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.853 0.326 . . . . 0.0 110.417 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.534 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 4.1 m -92.53 164.77 13.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.563 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.643 ' HG2' HG23 ' B' ' 21' ' ' THR . 10.4 tmtt? -54.27 -35.47 62.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.788 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -52.17 63.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.029 0.443 . . . . 0.0 111.737 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.32 -42.48 95.69 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.739 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.533 ' HB ' HG21 ' B' ' 21' ' ' THR . 26.6 mt -69.2 -39.57 79.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.479 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 70.3 m -66.29 -17.58 64.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.625 0.25 . . . . 0.0 111.296 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.7 m -67.58 -10.05 48.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.191 0.519 . . . . 0.0 110.345 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.651 HD13 HD12 ' A' ' 6' ' ' LEU . 95.8 mt -105.54 23.21 14.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.952 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 80.2 m . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.681 -179.552 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.29 -153.8 0.42 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.05 70.54 2.65 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.336 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.57 ' HB2' HD12 ' B' ' 9' ' ' LEU . 73.9 Cg_endo -76.3 48.88 2.44 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.806 2.337 . . . . 0.0 111.616 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.868 ' HB3' ' HB2' ' A' ' 17' ' ' LYS . 18.7 m-30 -84.82 34.03 0.54 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.604 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 162.73 53.69 0.02 OUTLIER Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.531 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.524 HG12 ' O ' ' B' ' 6' ' ' GLY . 17.4 m -149.61 -167.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.537 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 62.9 mtp180 -86.27 126.12 34.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.042 0.449 . . . . 0.0 110.151 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' B' ' 4' ' ' PRO . 2.5 mm? -119.48 118.48 31.21 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.04 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 65.2 m -112.69 110.75 21.09 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.538 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 53.2 -94.56 0.01 OUTLIER Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.834 -0.621 . . . . 0.0 114.577 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.484 ' H ' ' HG3' ' B' ' 12' ' ' ARG . 12.1 mtm180 -55.64 -42.3 74.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.267 0.556 . . . . 0.0 111.138 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.46 ' O ' ' HB1' ' B' ' 17' ' ' ALA . 34.3 mp0 -68.84 -34.19 75.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.431 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' B' ' 11' ' ' GLY . 48.6 t80 -63.07 -52.31 63.22 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.829 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.619 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.3 mt -59.88 -48.56 87.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.591 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.1 mmp_? -61.86 -34.98 76.97 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.55 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' B' ' 13' ' ' GLU . . . -64.12 -41.42 97.25 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.423 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 48.9 t -58.8 -48.27 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.738 HG23 ' HD1' ' B' ' 27' ' ' TRP . 36.5 mm -56.18 -50.6 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.704 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.597 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.8 m-30 -57.29 -43.84 83.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.519 -1.218 . . . . 0.0 112.792 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.853 HG22 ' HB ' ' A' ' 20' ' ' ILE . 14.7 p -66.22 -40.83 90.59 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.328 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 34.9 m -67.45 -32.75 73.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.429 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.1 -30.28 0.09 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.31 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 92.16 -53.2 2.85 Favored Glycine 0 C--O 1.225 -0.457 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.7 m -102.39 45.66 0.96 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.584 0.707 . . . . 0.0 109.204 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.9 tpm_? -108.66 -37.92 5.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.356 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.738 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.074 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.175 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 41.9 t -112.12 -41.82 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.213 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 3' ' ' LEU . 63.7 mt -68.89 -56.67 7.17 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.04 -33.07 72.72 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.69 -43.57 97.67 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.262 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 27.0 mt -80.47 -42.95 21.67 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -48.66 -47.13 40.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.223 0.609 . . . . 0.0 111.435 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 p -63.99 -46.31 85.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.8 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.6 m -67.92 -39.11 83.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.418 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 73.2 m -62.79 -39.81 95.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.953 0.406 . . . . 0.0 110.185 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.433 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 45.9 t -78.59 -42.73 28.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.136 0.493 . . . . 0.0 110.437 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -64.27 -50.15 69.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.566 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.494 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 22.7 m0 -117.71 -58.85 1.98 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.452 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.57 172.9 14.71 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 78.7 m -147.94 147.78 30.07 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.814 0.307 . . . . 0.0 110.673 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.543 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.7 m -96.88 166.09 11.79 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.537 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.868 ' HB2' ' HB3' ' B' ' 5' ' ' TYR . 11.3 tmtt? -53.64 -35.63 61.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.278 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -51.59 65.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.964 0.411 . . . . 0.0 111.627 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.495 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.17 -44.28 92.14 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.481 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.853 ' HB ' HG22 ' B' ' 21' ' ' THR . 27.1 mt -70.42 -35.57 62.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.495 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.523 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 68.2 m -65.32 -23.24 66.96 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.736 0.303 . . . . 0.0 110.711 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.5 m -69.13 -0.94 6.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.797 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.3 mt -108.7 13.91 24.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.206 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.473 179.553 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . 0.815 ' HD2' ' HG3' ' B' ' 13' ' ' GLU . 4.4 tpt180 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.647 0.26 . . . . 0.0 111.328 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.59 -152.78 0.41 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' B' ' 4' ' ' PRO . . . -62.2 118.3 38.4 Favored Pre-proline 0 C--N 1.323 -0.585 0 O-C-N 122.97 0.169 . . . . 0.0 110.555 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.606 ' HB3' ' HB2' ' B' ' 17' ' ' ALA . 19.6 Cg_endo -93.1 44.27 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.456 2.771 . . . . 0.0 112.591 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -106.06 83.55 1.92 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.701 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.534 ' H ' ' HA ' ' A' ' 16' ' ' SER . . . 77.71 45.83 10.36 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.575 ' O ' HD21 ' B' ' 9' ' ' LEU . 7.2 t -134.2 165.59 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.529 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 70.0 mtp180 -74.34 130.48 39.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.377 0.608 . . . . 0.0 110.845 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.69 HD22 HD11 ' A' ' 20' ' ' ILE . 1.4 mm? -117.34 115.04 24.45 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.03 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 70.9 m -116.52 116.9 28.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.529 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.09 -101.82 0.05 OUTLIER Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.69 -0.686 . . . . 0.0 114.347 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -57.67 -36.2 71.58 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.954 0.502 . . . . 0.0 111.637 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.815 ' HG3' ' HD2' ' B' ' 1' ' ' ARG . 0.4 OUTLIER -71.2 -29.97 65.82 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.9 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.661 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 47.4 t80 -68.78 -54.96 12.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.706 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.527 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.5 mt -60.65 -47.34 93.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.583 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.482 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 4.2 tpt180 -66.17 -30.22 70.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' B' ' 4' ' ' PRO . . . -63.46 -40.69 97.8 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.664 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 60.3 t -60.13 -50.45 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.666 HG21 ' HD1' ' B' ' 27' ' ' TRP . 29.1 mm -57.05 -52.22 58.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.493 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.496 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -58.51 -46.41 86.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.948 -1.023 . . . . 0.0 113.058 -178.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.747 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 19.7 p -63.53 -41.05 98.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.944 0.402 . . . . 0.0 111.679 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.9 m -74.41 -20.82 59.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.301 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.5 -30.58 0.18 Allowed Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.876 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.27 -52.3 4.49 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 112.259 -0.336 . . . . 0.0 112.259 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 15.9 p -99.42 29.05 4.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.478 0.656 . . . . 0.0 110.558 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.9 tpm_? -89.49 -36.57 15.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.997 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.666 ' HD1' HG21 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.132 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.656 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 49.0 t -109.72 -44.15 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.08 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.74 -57.63 6.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.11 -32.9 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.51 -46.88 93.22 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.25 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 30.6 mt -74.4 -39.47 62.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.8 t -52.57 -38.51 60.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -59.49 -36.52 76.21 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.89 0.376 . . . . 0.0 110.795 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 m -86.33 -41.23 14.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.664 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.541 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 98.0 m -61.8 -39.43 91.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.709 0.29 . . . . 0.0 110.87 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.3 t -78.43 -39.4 38.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.927 0.394 . . . . 0.0 110.804 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.51 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 2.1 ttmp? -68.3 -57.67 5.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.202 0.525 . . . . 0.0 111.372 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.51 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 9.7 m0 -103.43 -60.91 1.49 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.288 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.83 170.06 11.98 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 83.4 m -145.32 151.4 38.26 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 117.121 0.46 . . . . 0.0 110.574 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.562 ' HB3' ' OE1' ' A' ' 19' ' ' GLU . 34.0 t -95.63 169.42 10.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.626 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HG3' HG22 ' B' ' 21' ' ' THR . 36.8 tttm -56.13 -37.16 69.07 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.149 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -52.96 63.51 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.996 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.562 ' OE1' ' HB3' ' A' ' 16' ' ' SER . 2.4 mp0 -60.62 -45.97 92.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.974 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.69 HD11 HD22 ' B' ' 9' ' ' LEU . 45.0 mt -69.32 -44.75 80.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.747 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 71.5 m -62.34 -29.03 70.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.564 0.221 . . . . 0.0 111.437 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.2 m -65.45 -4.11 5.28 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.51 HD11 ' CD1' ' A' ' 6' ' ' LEU . 10.4 mp -84.84 -19.52 32.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.706 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.894 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.6 44.93 2.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.455 0.645 . . . . 0.0 109.636 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.32 151.13 6.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.521 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.424 ' HA ' HG21 ' B' ' 7' ' ' VAL . 58.0 Cg_endo -71.13 45.25 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.45 2.767 . . . . 0.0 112.796 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.527 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 6.2 m-30 -96.0 80.56 3.31 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.716 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . 96.82 55.12 1.24 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.46 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.424 HG21 ' HA ' ' B' ' 4' ' ' PRO . 12.6 m -144.92 -169.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 110.652 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 -88.12 128.96 35.43 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.673 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -125.89 113.04 16.69 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.154 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 78.9 m -111.28 116.1 30.45 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.07 -101.65 0.05 OUTLIER Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.74 -0.664 . . . . 0.0 114.404 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.687 ' NH1' ' HB2' ' B' ' 12' ' ' ARG . 5.7 mtm105 -57.34 -36.58 71.35 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.604 0.362 . . . . 0.0 111.779 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -67.32 -37.55 83.5 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.541 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 39.3 t80 -62.6 -53.05 60.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.728 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.545 ' O ' HG12 ' B' ' 19' ' ' ILE . 69.1 mt -57.35 -48.74 81.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.644 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.521 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 5.3 tpt180 -66.6 -33.03 74.76 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.05 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.32 93.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.506 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.501 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 83.7 t -60.89 -49.95 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.67 HD13 ' CD1' ' B' ' 27' ' ' TRP . 36.4 mm -53.98 -51.12 48.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.539 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -43.91 97.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.988 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.79 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 19.4 p -64.94 -41.19 95.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.757 0.313 . . . . 0.0 110.794 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.434 ' HB3' HH11 ' B' ' 26' ' ' ARG . 85.7 m -63.97 -31.19 72.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.146 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.26 -21.14 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.396 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.4 -56.27 4.99 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -92.16 44.33 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.402 0.62 . . . . 0.0 110.326 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.434 HH11 ' HB3' ' B' ' 22' ' ' CYS . 75.3 ttt180 -110.04 -33.75 6.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.753 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.67 ' CD1' HD13 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.508 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.489 ' OD1' ' HB1' ' A' ' 4' ' ' ALA . 26.9 p-10 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.685 HG13 HD21 ' A' ' 23' ' ' LEU . 26.0 t -111.59 -42.26 4.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.08 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 3' ' ' LEU . 10.8 mp -69.39 -57.02 5.81 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.489 ' HB1' ' OD1' ' A' ' 1' ' ' ASP . . . -59.49 -33.66 71.61 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.02 -47.86 87.15 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.38 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.413 ' HA ' HD11 ' A' ' 6' ' ' LEU . 49.1 tp -73.02 -38.66 66.47 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 43.0 t -54.97 -41.93 71.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.288 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 t -59.22 -48.01 83.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.752 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 m -67.57 -39.41 84.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.673 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 61.4 m -61.46 -39.7 91.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 111.383 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 38.3 t -81.04 -38.61 27.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.267 0.556 . . . . 0.0 110.459 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -69.97 -53.1 19.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.297 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -114.93 -40.67 3.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.037 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 121.23 176.13 15.28 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' HD21 ' B' ' 9' ' ' LEU . 6.3 p -158.8 150.94 21.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.196 0.522 . . . . 0.0 111.465 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.501 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 8.2 m -96.62 173.34 7.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.03 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.527 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 51.0 tttp -54.86 -38.1 67.08 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -52.85 63.97 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.275 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.501 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.6 mp0 -60.08 -45.43 92.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.823 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.501 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 42.3 mt -69.47 -45.11 79.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.068 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.79 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 65.6 m -64.58 -16.7 63.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -65.43 -14.88 61.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.181 0.515 . . . . 0.0 110.371 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.685 HD21 HG13 ' A' ' 2' ' ' VAL . 72.4 mt -106.98 25.89 10.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.444 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 96.7 m . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.506 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . 0.44 ' HG2' ' OE1' ' B' ' 13' ' ' GLU . 30.0 ptt-85 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.97 53.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . 0.562 ' N ' ' HD3' ' B' ' 4' ' ' PRO . . . -167.79 54.49 0.28 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.377 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' B' ' 3' ' ' ALA . 73.9 Cg_endo -99.26 41.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.15 2.566 . . . . 0.0 112.401 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -109.4 73.14 0.83 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.446 ' O ' HG13 ' B' ' 7' ' ' VAL . . . 94.37 50.75 2.14 Favored Glycine 0 CA--C 1.509 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.085 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.446 HG13 ' O ' ' B' ' 6' ' ' GLY . 11.2 m -148.03 -173.73 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 52.3 mtt85 -82.81 133.16 35.14 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.541 0.686 . . . . 0.0 110.832 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.538 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.5 mm? -129.68 118.45 21.93 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.632 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 35.0 m -114.14 117.81 32.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 46.91 -98.61 0.01 OUTLIER Glycine 0 C--N 1.336 0.555 0 O-C-N 123.742 0.651 . . . . 0.0 114.658 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -54.15 -39.56 66.64 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.146 0.578 . . . . 0.0 111.555 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.44 ' OE1' ' HG2' ' B' ' 1' ' ' ARG . 34.7 mm-40 -72.03 -35.01 69.25 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.758 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.538 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 38.5 t80 -62.93 -53.48 53.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.535 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.584 ' O ' HG12 ' B' ' 19' ' ' ILE . 72.4 mt -59.31 -50.78 78.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.421 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.57 ' NH2' HG13 ' B' ' 19' ' ' ILE . 3.3 mmp_? -63.7 -31.03 72.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.503 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.413 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -64.35 -41.52 96.71 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.127 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.546 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 93.0 t -59.36 -50.86 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-O 121.9 0.857 . . . . 0.0 108.814 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.748 HG22 ' HD1' ' B' ' 27' ' ' TRP . 18.9 mm -58.24 -52.14 62.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.707 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.3 -44.4 92.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.746 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 19.9 p -62.78 -41.18 99.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.076 0.465 . . . . 0.0 110.757 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 56.5 m -75.03 -22.27 58.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.651 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.07 -29.36 0.21 Allowed Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.881 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.41 -54.86 4.48 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 38.3 p -96.03 49.11 1.13 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.323 0.582 . . . . 0.0 110.703 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.524 ' NH1' ' HB3' ' A' ' 24' ' ' CYS . 56.1 ttt180 -111.45 -36.44 5.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.255 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.748 ' HD1' HG22 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.956 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.062 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.63 -49.76 75.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.547 0.53 . . . . 0.0 110.365 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 3' ' ' LEU . 10.2 mp -61.89 -44.98 95.7 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.92 -38.19 64.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.79 0.329 . . . . 0.0 111.056 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.13 -44.2 97.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.176 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.633 HD13 HD13 ' A' ' 23' ' ' LEU . 32.3 mt -78.89 -44.4 22.85 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.245 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.2 t -48.91 -46.12 42.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.3 0.64 . . . . 0.0 111.646 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.4 p -64.69 -46.37 82.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.689 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -68.06 -39.6 82.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.431 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.559 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 73.9 m -63.11 -35.5 80.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.868 0.366 . . . . 0.0 110.618 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.6 t -83.39 -41.98 17.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.199 0.523 . . . . 0.0 110.197 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -64.8 -48.65 73.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.522 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -118.45 -53.98 2.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.503 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 134.57 169.76 12.05 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.2 m -145.24 147.44 32.4 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.922 0.361 . . . . 0.0 110.945 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.554 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.2 m -93.71 165.15 12.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.068 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -51.16 -40.12 57.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.508 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -53.71 55.25 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.693 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.554 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.99 -43.2 95.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.109 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.546 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 40.6 mt -70.9 -46.9 65.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.489 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.746 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 70.2 m -62.09 -23.72 66.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.5 m -63.93 -11.56 29.37 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.633 HD13 HD13 ' A' ' 6' ' ' LEU . 21.9 mt -85.22 -6.89 59.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HB3' ' NH1' ' B' ' 26' ' ' ARG . 77.5 m . . . . . 0 C--O 1.243 0.734 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.334 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . 0.4 ' H2 ' ' CD ' ' B' ' 13' ' ' GLU . 54.8 ttt85 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.29 41.07 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.373 . . . . 0.0 111.419 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . 0.429 ' N ' ' HD3' ' B' ' 4' ' ' PRO . . . -173.91 61.32 0.25 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.381 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' B' ' 3' ' ' ALA . 81.3 Cg_endo -90.47 41.75 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.957 2.438 . . . . 0.0 112.709 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.434 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 5.3 m-30 -107.5 79.28 1.28 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.717 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.445 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . 86.54 51.59 3.43 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.588 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -142.2 -171.83 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.349 . . . . 0.0 110.881 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -87.03 126.35 34.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.659 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.694 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.6 mm? -123.05 114.46 20.4 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.028 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 58.1 m -113.26 119.68 38.58 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.0 -102.64 0.06 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.92 -0.582 . . . . 0.0 114.417 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -57.13 -34.63 68.59 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.4 ' CD ' ' H2 ' ' B' ' 1' ' ' ARG . 5.2 mm-40 -71.47 -33.83 69.65 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.532 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 45.3 t80 -62.61 -54.54 38.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.302 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.577 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.1 mt -58.44 -50.13 79.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.295 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.51 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.7 mmp_? -62.33 -32.72 73.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.29 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.417 ' HB2' HD11 ' A' ' 20' ' ' ILE . . . -64.56 -41.21 96.46 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.315 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.535 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 60.7 t -59.05 -50.02 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 122.042 0.925 . . . . 0.0 108.837 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.673 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.3 mm -59.04 -53.04 53.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.185 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.446 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.0 m-30 -56.3 -45.57 80.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.177 -0.92 . . . . 0.0 113.411 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 20' ' ' ILE . 15.7 p -64.44 -41.6 96.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.807 0.337 . . . . 0.0 111.42 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 58.3 m -75.58 -27.67 58.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.493 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.92 -29.52 0.08 OUTLIER Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.326 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.39 -54.13 4.65 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.749 -0.262 . . . . 0.0 112.477 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m -101.14 52.84 0.84 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.59 0.71 . . . . 0.0 110.102 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 3.5 tpm_? -115.9 -38.15 3.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.846 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.673 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.179 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.987 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 27.4 t -111.57 -42.49 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.109 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.505 HD11 ' N ' ' A' ' 3' ' ' LEU . 10.0 mp -68.87 -57.26 5.8 Favored 'General case' 0 C--O 1.218 -0.555 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 7' ' ' SER . . . -59.44 -33.47 71.31 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.16 -45.47 95.98 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.408 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 59.8 mt -78.65 -44.37 23.99 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 40.8 t -48.42 -48.71 37.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.688 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.5 p -65.82 -45.45 82.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.683 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.512 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 23.8 m -65.69 -38.27 88.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.904 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.694 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 80.0 m -63.76 -34.54 78.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.999 0.428 . . . . 0.0 110.762 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 t -85.46 -38.69 18.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.31 0.576 . . . . 0.0 110.068 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.7 ttpt -68.03 -44.49 76.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.707 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -124.13 -48.65 1.85 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.886 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 128.21 165.74 11.87 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 78.9 m -143.44 146.98 33.89 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 117.129 0.464 . . . . 0.0 111.205 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.6 m -96.27 165.41 12.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.076 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.434 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 49.3 tttp -52.36 -40.09 61.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.353 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 m -57.03 -53.75 54.53 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 123.69 0.619 . . . . 0.0 111.532 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.618 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.7 mp0 -60.64 -43.52 97.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.43 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.577 ' HB ' HG22 ' B' ' 21' ' ' THR . 31.5 mt -72.58 -39.23 61.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.264 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 23' ' ' LEU . 51.1 m -64.12 -37.95 89.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.763 0.316 . . . . 0.0 110.807 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p -69.97 7.34 0.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.022 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 21' ' ' SER . 19.6 tp -92.27 -24.38 19.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.872 0.368 . . . . 0.0 110.159 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.6 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.84 179.615 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' B' ' 1' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.362 0.125 . . . . 0.0 110.673 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.417 ' HB1' ' H ' ' B' ' 3' ' ' ALA . . . -168.54 -156.76 0.18 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . 0.483 ' O ' HG23 ' B' ' 7' ' ' VAL . . . -89.14 114.06 58.72 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.599 ' HB3' ' HB2' ' B' ' 17' ' ' ALA . 6.1 Cg_exo -78.69 46.63 2.21 Favored 'Trans proline' 0 CA--C 1.527 0.141 0 C-N-CA 123.308 2.672 . . . . 0.0 112.304 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.487 ' HD1' ' C ' ' B' ' 4' ' ' PRO . 4.0 m-30 -111.41 59.65 0.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.58 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . 98.38 51.7 1.42 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.506 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.483 HG23 ' O ' ' B' ' 3' ' ' ALA . 27.6 m -139.03 -173.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.479 0.18 . . . . 0.0 110.522 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 26.4 mmt85 -87.58 130.97 34.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.153 0.501 . . . . 0.0 110.303 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -124.94 109.16 12.66 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.731 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 42.1 m -111.54 116.56 31.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.691 0.282 . . . . 0.0 111.642 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 50.98 -103.95 0.12 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.733 -0.667 . . . . 0.0 114.54 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -57.9 -32.87 68.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 122.519 0.328 . . . . 0.0 111.563 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.439 ' HG3' HD13 ' B' ' 9' ' ' LEU . 3.6 tp10 -68.25 -38.56 81.93 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.602 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 51.0 t80 -60.95 -53.59 55.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.001 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.606 ' O ' HG12 ' B' ' 19' ' ' ILE . 63.1 mt -60.0 -49.7 82.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.688 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.605 ' NH2' HG13 ' B' ' 19' ' ' ILE . 0.1 OUTLIER -65.25 -28.58 69.45 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.881 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.599 ' HB2' ' HB3' ' B' ' 4' ' ' PRO . . . -64.83 -42.82 94.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.002 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.491 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 62.1 t -58.94 -49.22 83.91 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.079 0.943 . . . . 0.0 108.517 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.711 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.3 mm -57.79 -53.16 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.571 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.52 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.4 OUTLIER -57.92 -45.18 86.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.323 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.795 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 17.4 p -63.5 -39.55 94.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.986 0.422 . . . . 0.0 111.553 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 60.9 m -79.49 -20.77 46.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.636 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.61 -31.13 0.14 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.112 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 85.36 -56.47 4.94 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.783 -0.246 . . . . 0.0 112.516 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m -97.21 50.32 1.07 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.565 0.697 . . . . 0.0 110.155 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 7.2 tpm_? -114.42 -38.96 3.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.626 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.711 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.032 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.97 -43.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.286 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.5 mp -70.43 -56.92 5.47 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.52 -34.65 74.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.83 -46.63 93.22 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.456 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.419 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 38.5 tp -73.55 -39.78 64.45 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.5 t -53.14 -45.09 68.23 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.601 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.4 m -60.55 -42.75 97.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.391 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 m -70.74 -38.7 73.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.812 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.703 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 90.7 m -62.11 -32.72 73.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.977 0.417 . . . . 0.0 110.776 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.448 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 49.0 t -85.31 -40.31 16.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.157 0.503 . . . . 0.0 110.393 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -70.82 -48.18 55.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.403 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -114.91 -41.43 3.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.566 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 116.54 165.44 14.05 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -141.18 149.58 41.64 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.909 0.355 . . . . 0.0 111.32 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.537 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.8 m -94.61 168.07 11.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.224 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' HA ' HG21 ' B' ' 21' ' ' THR . 37.6 tttm -54.97 -37.19 66.2 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.273 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -52.59 65.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.218 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -60.83 -44.58 96.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.043 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.521 HD12 HD22 ' B' ' 9' ' ' LEU . 39.6 mt -70.62 -44.18 76.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.917 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.795 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 67.6 m -64.29 -28.7 69.9 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.522 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.1 m -69.32 -0.55 6.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.59 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.2 mt -90.62 -12.35 37.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.472 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.9 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.1 -0.953 . . . . 0.0 110.804 179.706 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . 0.412 ' O ' ' HD3' ' B' ' 4' ' ' PRO . 2.3 ttm180 . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.54 33.13 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 0.0 111.752 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . 0.468 ' O ' HG22 ' B' ' 7' ' ' VAL . . . -171.63 53.09 0.18 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.972 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.435 ' C ' ' HD1' ' B' ' 5' ' ' TYR . 98.9 Cg_endo -78.51 46.0 2.01 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.803 2.336 . . . . 0.0 113.117 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.435 ' HD1' ' C ' ' B' ' 4' ' ' PRO . 4.3 m-30 -112.3 59.02 0.63 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.057 0.456 . . . . 0.0 110.692 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.14 51.38 1.15 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.875 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.468 HG22 ' O ' ' B' ' 3' ' ' ALA . 27.4 m -140.86 -173.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.7 mmm-85 -86.16 128.82 34.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.801 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -125.15 109.12 12.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.649 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 84.9 m -109.93 121.46 45.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.772 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 49.42 -106.34 0.2 Allowed Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.862 -0.608 . . . . 0.0 114.493 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.48 ' HG3' ' N ' ' B' ' 13' ' ' GLU . 8.2 ptt180 -56.18 -30.67 62.55 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.779 0.432 . . . . 0.0 111.772 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' B' ' 12' ' ' ARG . 54.8 mm-40 -70.62 -38.78 73.95 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.52 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 41.6 t80 -63.16 -51.26 67.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.402 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.645 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.6 mt -58.71 -52.59 58.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.32 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.604 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 1.5 mmp_? -65.24 -27.47 68.68 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.283 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.421 ' HB3' HD11 ' A' ' 20' ' ' ILE . . . -64.76 -43.51 93.08 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.547 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 96.9 t -60.43 -50.94 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.791 HD13 ' CD1' ' B' ' 27' ' ' TRP . 28.4 mm -54.87 -50.44 61.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.034 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.604 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -58.86 -45.92 88.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.649 -178.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.853 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 15.3 p -64.14 -38.72 92.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.003 0.43 . . . . 0.0 110.432 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' B' ' 18' ' ' VAL . 86.1 m -67.42 -25.12 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.445 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.32 -19.81 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.107 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 85.41 -48.8 4.08 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 5.3 p -104.02 25.87 9.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.454 0.645 . . . . 0.0 109.856 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.424 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 3.2 tpp85 -79.1 -36.99 39.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.006 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.791 ' CD1' HD13 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.947 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.413 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 1.6 m-20 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.52 -49.97 78.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 123.516 0.51 . . . . 0.0 110.569 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.575 HD11 ' H ' ' A' ' 3' ' ' LEU . 9.2 mp -61.77 -46.59 88.93 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.578 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 1' ' ' ASP . . . -53.0 -39.08 62.84 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.36 0.413 . . . . 0.0 110.789 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.41 -47.48 87.13 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.066 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.544 HD12 HD11 ' A' ' 23' ' ' LEU . 36.8 mt -71.54 -43.9 65.57 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -50.69 -44.97 58.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.7 m -62.91 -43.47 98.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.862 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -71.63 -41.25 69.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.081 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.696 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 74.1 m -62.33 -37.35 85.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.006 0.431 . . . . 0.0 110.752 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 48.5 t -79.29 -38.68 34.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.054 0.454 . . . . 0.0 110.481 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 37.2 ttmt -72.15 -58.46 3.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.139 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.45 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 9.4 m0 -104.81 -44.69 4.77 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.17 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 123.39 169.53 13.25 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 85.2 m -144.74 147.56 33.12 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 117.307 0.554 . . . . 0.0 111.394 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 20' ' ' ILE . 2.5 m -95.58 169.46 10.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.012 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' B' ' 21' ' ' THR . 58.4 tttp -55.7 -37.16 68.0 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.756 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -54.72 43.81 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.665 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.07 -42.29 94.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.351 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.547 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 44.9 mt -72.42 -45.8 58.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.928 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.853 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 63.1 m -64.65 -13.21 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.692 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.3 m -63.24 -19.83 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.254 0.549 . . . . 0.0 110.185 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.544 HD11 HD12 ' A' ' 6' ' ' LEU . 54.7 mt -106.77 28.11 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.148 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.599 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 58.8 m . . . . . 0 C--O 1.259 1.567 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.662 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.33 49.98 1.86 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 111.343 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.33 126.17 0.47 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.557 ' HA ' HG22 ' B' ' 7' ' ' VAL . 87.9 Cg_endo -82.99 21.73 0.99 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.968 2.445 . . . . 0.0 112.27 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -86.28 56.44 3.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.151 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 120.04 56.98 0.24 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.302 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' B' ' 4' ' ' PRO . 13.4 m -150.76 -169.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.524 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.6 mtp180 -89.69 128.16 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -121.84 114.06 20.52 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.643 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 71.5 m -108.6 119.97 41.08 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 47.54 -101.57 0.04 OUTLIER Glycine 0 CA--C 1.518 0.281 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.674 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -57.87 -34.05 69.34 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.978 0.511 . . . . 0.0 111.29 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.49 -36.81 76.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.6 ' O ' HG23 ' B' ' 18' ' ' VAL . 35.8 t80 -61.76 -52.99 61.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.169 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.536 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.3 mt -58.41 -47.73 87.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.333 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 6.4 tpt180 -65.21 -34.28 78.0 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.039 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.431 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -62.78 -39.29 93.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.807 178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.6 HG23 ' O ' ' B' ' 14' ' ' PHE . 61.0 t -60.15 -51.13 76.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.842 HG23 ' HD1' ' B' ' 27' ' ' TRP . 40.1 mm -52.68 -52.79 24.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.3 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.561 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.2 m-30 -60.37 -42.12 95.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.684 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.812 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 27.0 p -68.19 -42.53 79.78 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.352 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 47.4 m -65.33 -28.88 69.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.186 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.21 -24.21 0.09 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.492 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.9 -62.4 4.63 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.6 m -89.45 40.51 0.99 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.524 0.678 . . . . 0.0 110.177 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.412 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.8 tpm_? -105.17 -35.18 7.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.127 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.842 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.183 -1.372 . . . . 0.0 109.409 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 4' ' ' ALA . 9.9 p-10 . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.2 t -72.41 -45.06 61.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 123.487 0.492 . . . . 0.0 109.788 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 3' ' ' LEU . 74.6 mt -69.21 -53.77 18.23 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.513 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB2' ' OD1' ' A' ' 1' ' ' ASP . . . -58.66 -34.76 71.6 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.63 -49.03 83.09 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.424 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.822 HD21 HD13 ' A' ' 23' ' ' LEU . 48.9 tp -71.73 -37.91 70.52 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.5 t -54.9 -42.3 71.99 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.288 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.9 t -59.2 -42.21 90.39 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.093 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -74.04 -41.42 61.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.737 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 62.0 m -60.18 -45.56 92.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.624 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.42 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 48.1 t -74.7 -39.08 62.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.974 0.416 . . . . 0.0 110.858 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 3.2 ttmp? -68.95 -60.1 2.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.844 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.474 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 8.0 m0 -106.56 -54.74 2.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.236 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 139.77 -172.8 23.19 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' B' ' 9' ' ' LEU . 3.4 p -165.5 148.92 8.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.776 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.47 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 4.2 m -97.15 171.17 8.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.535 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HG3' HG21 ' B' ' 21' ' ' THR . 34.9 tttm -55.92 -36.28 67.56 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.493 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -51.83 68.37 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.46 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.84 -43.5 95.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.36 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.642 ' HB ' HG22 ' B' ' 21' ' ' THR . 39.8 mt -69.99 -44.94 78.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.925 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.812 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 75.2 m -64.4 -22.46 66.97 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.4 m -66.94 -8.52 30.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.917 0.389 . . . . 0.0 110.886 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.822 HD13 HD21 ' A' ' 6' ' ' LEU . 59.0 mt -116.8 26.2 10.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.536 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 70.5 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.44 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.71 -152.35 0.5 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.18 125.65 90.78 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.658 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.496 ' HA ' HG22 ' B' ' 7' ' ' VAL . 72.7 Cg_endo -75.61 53.49 3.61 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 123.034 2.489 . . . . 0.0 112.209 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.566 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 6.9 m-30 -100.43 22.1 12.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.584 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 157.86 60.31 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' B' ' 4' ' ' PRO . 15.8 m -144.69 -171.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.644 0.259 . . . . 0.0 110.847 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.509 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 70.0 mtp180 -87.87 130.39 34.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.309 0.576 . . . . 0.0 109.936 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.96 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 10.6 mp -116.25 109.4 17.35 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.562 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 72.3 m -112.14 116.95 31.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.923 0.392 . . . . 0.0 111.557 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 51.32 -109.55 0.8 Allowed Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.329 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -59.61 -29.46 68.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -69.4 -37.76 77.64 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.568 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 55.0 t80 -61.11 -55.6 30.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.078 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.65 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.5 mt -57.26 -52.31 58.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.41 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.616 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.5 mmp_? -64.03 -33.73 76.41 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.276 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.43 83.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.565 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 75.6 t -60.16 -47.71 90.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.666 HD12 ' CD1' ' B' ' 27' ' ' TRP . 21.1 mm -59.69 -51.83 68.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.089 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.438 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.3 OUTLIER -55.9 -47.38 77.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.814 -179.056 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.843 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 19.5 p -62.86 -40.54 97.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.001 0.429 . . . . 0.0 111.274 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 57.6 m -80.69 -10.57 59.72 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.22 -30.26 0.42 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.537 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.34 -52.81 4.76 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.5 m -104.16 40.35 1.48 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.472 0.653 . . . . 0.0 110.085 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -98.52 -36.08 10.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.354 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.666 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.205 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.922 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.591 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 9.5 p-10 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 39.2 t -71.56 -46.35 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.473 0.483 . . . . 0.0 109.758 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.54 HD11 ' N ' ' A' ' 3' ' ' LEU . 10.2 mp -68.85 -53.87 18.92 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.546 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.591 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -57.25 -35.46 69.75 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.05 -50.14 70.7 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.595 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 42.8 mt -70.39 -42.52 71.59 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 t -52.34 -42.44 63.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.85 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.5 t -59.11 -45.33 91.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.586 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.5 m -76.35 -38.68 55.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.96 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 67.4 m -63.0 -42.71 99.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.694 0.283 . . . . 0.0 111.419 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.69 -40.16 49.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.109 0.481 . . . . 0.0 110.427 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -67.97 -48.31 66.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.442 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.485 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 9.2 m0 -118.78 -58.72 1.93 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.356 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 141.68 -174.6 22.95 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.475 ' SG ' HD23 ' B' ' 9' ' ' LEU . 1.8 p -162.36 152.82 16.96 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.885 0.342 . . . . 0.0 110.875 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.513 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.4 m -97.37 167.57 10.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.07 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.566 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 53.4 tttp -52.56 -37.95 58.91 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.072 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.22 -50.27 74.15 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.601 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.35 -42.83 87.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.498 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.565 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 24.5 mt -72.06 -46.14 60.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.843 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 66.4 m -65.68 -34.13 77.49 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.191 -0.318 . . . . 0.0 111.579 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 t -68.58 -1.14 6.1 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.355 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.433 HD11 HD12 ' A' ' 6' ' ' LEU . 23.7 tp -85.18 -23.69 28.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.674 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.4 m . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.879 -179.547 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.748 0.309 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.539 ' HB2' HG23 ' B' ' 7' ' ' VAL . . . -171.38 143.3 1.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.32 113.25 9.78 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 123.183 0.302 . . . . 0.0 110.355 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.692 ' HB3' ' HB3' ' B' ' 17' ' ' ALA . 44.4 Cg_endo -67.64 45.36 0.28 Allowed 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.697 2.931 . . . . 0.0 114.025 -178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.509 ' HD1' ' C ' ' B' ' 4' ' ' PRO . 4.5 m-30 -117.45 37.43 3.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.187 0.518 . . . . 0.0 109.845 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.92 47.37 0.29 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.127 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' B' ' 2' ' ' ALA . 34.3 m -140.2 -172.67 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 122.837 -0.214 . . . . 0.0 110.438 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.546 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 66.3 mtp180 -90.79 129.36 36.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.082 0.467 . . . . 0.0 110.051 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.7 mm? -122.14 111.92 17.57 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.178 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 97.9 m -109.76 123.14 49.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.92 -105.49 0.13 Allowed Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.57 -0.741 . . . . 0.0 114.522 178.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -60.48 -29.72 69.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.42 -35.9 73.69 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.532 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 48.2 t80 -65.18 -50.88 64.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.441 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.65 ' O ' HG12 ' B' ' 19' ' ' ILE . 66.6 mt -57.75 -50.33 77.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.877 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.556 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.7 mmp_? -63.72 -32.02 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.985 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.692 ' HB3' ' HB3' ' B' ' 4' ' ' PRO . . . -63.33 -44.68 94.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.118 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.474 HG21 ' O ' ' B' ' 14' ' ' PHE . 63.4 t -58.0 -50.3 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.677 HD12 ' CD1' ' B' ' 27' ' ' TRP . 34.6 mm -54.52 -50.98 54.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.147 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.476 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.1 m-30 -58.26 -45.41 87.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.747 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.769 HG22 ' HB ' ' A' ' 20' ' ' ILE . 11.9 p -63.54 -38.73 92.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.642 0.258 . . . . 0.0 111.557 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 34.0 m -70.76 -30.93 67.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.758 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.92 -22.14 0.09 OUTLIER Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.655 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 83.97 -60.03 4.89 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 112.176 -0.37 . . . . 0.0 112.176 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -92.6 48.88 1.41 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.524 0.678 . . . . 0.0 109.801 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.8 tpm_? -112.76 -37.4 4.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.985 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.677 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.988 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 39.4 t0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -108.54 -41.64 5.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.426 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.566 HD13 ' N ' ' A' ' 3' ' ' LEU . 9.3 mp -64.91 -55.4 19.54 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.8 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.49 -36.26 61.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.001 0.429 . . . . 0.0 110.306 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.93 66.53 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.034 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.713 HD21 HD11 ' A' ' 23' ' ' LEU . 44.8 tp -72.22 -39.18 68.7 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 t -54.32 -42.94 70.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.554 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.4 t -58.23 -44.11 88.09 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.203 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -74.16 -40.8 62.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.7 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 62.5 m -58.04 -44.95 87.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 111.705 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.9 t -78.2 -40.47 37.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.0 0.428 . . . . 0.0 110.995 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.407 ' CB ' ' HZ1' ' A' ' 12' ' ' LYS . 5.5 ttpm? -66.85 -49.85 64.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.849 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.532 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 8.8 m0 -119.47 -54.72 2.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.211 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.06 -171.17 25.05 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.547 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.0 p -166.45 151.05 7.72 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.182 0.515 . . . . 0.0 111.355 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.486 ' O ' HG13 ' A' ' 20' ' ' ILE . 67.6 p -93.1 165.4 12.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.569 ' HG3' HG21 ' B' ' 21' ' ' THR . 37.4 tttm -56.72 -40.14 75.15 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.362 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 m -57.33 -48.17 79.67 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.393 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -63.45 -46.29 86.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.881 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.769 ' HB ' HG22 ' B' ' 21' ' ' THR . 32.5 mt -67.46 -39.53 82.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.588 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.425 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 44.8 m -64.74 -24.43 67.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.779 0.323 . . . . 0.0 110.944 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.0 m -67.88 -5.87 18.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.138 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.713 HD11 HD21 ' A' ' 6' ' ' LEU . 10.7 mp -107.7 19.04 20.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.466 179.258 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.65 56.59 0.32 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 110.512 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.16 137.0 4.61 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.182 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.65 ' HA ' HG23 ' B' ' 7' ' ' VAL . 70.7 Cg_endo -74.63 41.01 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.193 2.596 . . . . 0.0 112.397 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.49 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 4.9 m-30 -106.92 85.79 2.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.886 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.05 50.85 3.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.712 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.65 HG23 ' HA ' ' B' ' 4' ' ' PRO . 24.7 m -139.72 -179.96 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 13' ' ' TRP . 67.1 mtp180 -86.32 127.79 34.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.176 0.512 . . . . 0.0 110.008 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.578 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.3 mm? -122.42 117.18 25.4 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.41 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 79.3 m -115.52 120.97 41.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.826 0.345 . . . . 0.0 111.893 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 53.41 -107.83 0.67 Allowed Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.285 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -59.48 -30.39 68.5 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 17' ' ' ALA . 1.8 mm-40 -70.08 -36.63 75.07 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.624 ' O ' HG23 ' B' ' 18' ' ' VAL . 40.5 t80 -61.62 -53.04 61.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.218 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.612 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.2 mt -60.68 -49.27 85.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.347 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.528 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 5.0 mmp_? -61.89 -34.21 75.63 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.475 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' B' ' 13' ' ' GLU . . . -64.12 -40.67 96.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.278 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.624 HG23 ' O ' ' B' ' 14' ' ' PHE . 59.1 t -59.52 -49.28 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-O 122.041 0.924 . . . . 0.0 108.802 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.612 HG12 ' O ' ' B' ' 15' ' ' ILE . 20.8 mm -59.07 -52.8 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.284 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.422 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.9 OUTLIER -57.74 -45.08 86.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.312 -178.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.752 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 18.6 p -63.48 -40.51 97.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.92 0.39 . . . . 0.0 111.267 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -78.33 -26.21 46.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.652 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.66 -31.47 0.09 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 119.998 -1.096 . . . . 0.0 113.359 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 87.2 -56.83 4.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.688 -0.291 . . . . 0.0 112.521 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.5 m -99.21 51.06 0.95 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.483 0.658 . . . . 0.0 110.114 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 7.2 tpm_? -113.94 -38.82 4.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.941 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.565 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.035 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.933 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.575 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 10.9 p-10 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.09 -44.81 64.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 123.392 0.433 . . . . 0.0 109.918 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.517 HD13 ' N ' ' A' ' 3' ' ' LEU . 10.8 mp -69.48 -54.52 13.83 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.749 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.575 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -58.64 -37.14 75.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.01 -48.54 82.67 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.883 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.549 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 35.1 tp -71.0 -41.05 71.43 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 t -53.02 -41.72 64.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.675 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 m -58.81 -34.13 71.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.705 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 m -86.08 -38.27 17.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.352 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.549 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 71.1 m -60.26 -40.57 90.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.782 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.0 t -79.6 -41.56 26.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.989 0.423 . . . . 0.0 110.896 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.4 ' CB ' ' HZ1' ' A' ' 12' ' ' LYS . 7.1 ttpm? -67.57 -50.04 60.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.878 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.518 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 11.2 m0 -114.64 -56.71 2.35 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.313 -178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.32 173.17 14.09 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 99.2 m -146.66 148.56 32.18 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.824 0.345 . . . . 0.0 110.935 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.518 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.4 m -94.63 166.19 12.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.617 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.49 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 47.1 tttp -52.94 -38.85 62.4 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.943 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -53.85 53.54 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.473 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -63.3 -42.54 99.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.561 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 16' ' ' SER . 45.8 mt -70.63 -45.21 75.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.752 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 73.1 m -64.82 -27.68 69.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.605 0.24 . . . . 0.0 111.601 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.3 m -69.29 -1.74 8.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.971 0.415 . . . . 0.0 111.364 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.432 ' HA ' HD21 ' A' ' 23' ' ' LEU . 97.3 mt -90.12 -11.18 42.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.807 179.672 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.95 52.62 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.985 0.421 . . . . 0.0 111.153 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.79 85.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.602 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.96 39.03 0.68 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.039 2.493 . . . . 0.0 112.7 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -114.67 90.4 3.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.898 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.21 63.13 1.99 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.188 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.492 ' CG2' ' H ' ' B' ' 8' ' ' ARG . 6.2 p -163.46 -173.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.527 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.0 mtp180 -85.1 131.09 34.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.249 0.547 . . . . 0.0 110.398 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.587 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.2 mm? -126.44 115.76 20.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.86 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 73.1 m -111.73 120.78 43.18 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 45.56 -100.62 0.02 OUTLIER Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.57 -41.18 69.53 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.112 0.565 . . . . 0.0 111.661 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.439 ' HB3' HD13 ' B' ' 9' ' ' LEU . 14.1 mp0 -69.15 -36.08 77.03 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.587 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 46.0 t80 -61.9 -56.52 18.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.013 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.587 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.9 mt -58.54 -48.06 86.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.529 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.492 ' NH1' HG13 ' B' ' 19' ' ' ILE . 13.1 mmm180 -64.13 -34.24 77.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.493 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.85 -40.45 97.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.153 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.512 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 57.9 t -59.42 -49.5 83.35 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.784 HG21 ' HD1' ' B' ' 27' ' ' TRP . 19.6 mm -57.87 -53.56 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.333 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.479 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.6 m-30 -57.17 -45.21 83.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.576 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' THR . . . . . 0.822 ' HB ' ' HG ' ' A' ' 21' ' ' SER . 21.2 p -64.89 -40.77 95.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.05 0.452 . . . . 0.0 111.378 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -76.93 -20.38 56.24 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.651 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.84 -30.4 0.16 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.094 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.4 -55.56 5.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.707 -0.283 . . . . 0.0 112.548 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.2 m -97.06 46.53 1.04 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.43 0.633 . . . . 0.0 110.335 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.42 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 7.3 tpm_? -110.41 -37.49 5.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.327 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' TRP . . . . . 0.784 ' HD1' HG21 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.372 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.408 ' OD2' ' HB1' ' A' ' 4' ' ' ALA . 3.3 p30 . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.44 -49.35 60.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.401 0.438 . . . . 0.0 110.68 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.537 HD11 ' N ' ' A' ' 3' ' ' LEU . 10.7 mp -72.17 -51.38 21.51 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.408 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.408 ' HB1' ' OD2' ' A' ' 1' ' ' ASP . . . -56.77 -37.29 70.87 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.88 -49.29 77.25 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.75 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.9 tp -71.01 -39.91 72.11 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.6 t -55.12 -42.52 73.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.406 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 t -57.77 -44.16 85.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.334 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -74.68 -40.53 61.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.969 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 56.1 m -60.3 -43.11 96.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 111.603 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.401 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 49.5 t -78.65 -39.57 36.63 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.904 0.383 . . . . 0.0 110.874 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' CB ' ' HZ1' ' A' ' 12' ' ' LYS . 5.4 ttpm? -68.31 -50.85 50.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.825 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.502 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 8.4 m0 -116.39 -55.11 2.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.29 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.6 -173.64 23.01 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -164.98 149.56 9.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.964 0.412 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.537 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 3.6 m -94.8 168.74 10.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.478 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.45 ' HG3' HG21 ' B' ' 21' ' ' THR . 37.7 tttm -54.33 -37.15 64.53 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.903 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -50.36 74.32 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.357 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -63.2 -45.18 92.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.512 ' CG2' ' HA ' ' B' ' 18' ' ' VAL . 33.2 mt -69.76 -43.13 80.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.545 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.822 ' HG ' ' HB ' ' B' ' 21' ' ' THR . 71.4 m -64.11 -36.7 84.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.754 0.311 . . . . 0.0 111.14 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.5 m -70.13 5.19 1.74 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.667 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -92.23 -22.48 19.77 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.849 0.356 . . . . 0.0 110.234 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.8 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.025 179.668 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.04 -171.14 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.449 0.166 . . . . 0.0 110.646 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.564 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 67.5 mtp180 -86.27 129.02 34.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.211 0.529 . . . . 0.0 109.965 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -125.69 117.42 23.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.407 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 69.2 m -113.22 122.01 46.18 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.98 -104.97 0.13 Allowed Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.396 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -57.59 -33.69 68.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.437 ' HB3' HD12 ' B' ' 9' ' ' LEU . 53.8 mm-40 -70.82 -34.89 72.19 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.595 ' O ' HG23 ' B' ' 18' ' ' VAL . 41.3 t80 -62.15 -54.08 46.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.334 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.596 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.5 mt -59.51 -50.69 78.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.505 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.609 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.0 mmp_? -62.22 -33.24 74.19 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.732 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.438 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -65.18 -39.52 93.0 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.81 ' HA ' HG22 ' A' ' 20' ' ' ILE . 91.7 t -59.7 -49.04 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-O 121.92 0.867 . . . . 0.0 108.714 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.778 HG23 ' HD1' ' B' ' 27' ' ' TRP . 13.9 mm -59.72 -52.69 58.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.165 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.46 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.5 m-30 -56.51 -45.39 81.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.201 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.515 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 23.4 p -63.57 -39.8 95.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.36 0.6 . . . . 0.0 110.876 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 59.4 m -81.55 -13.25 58.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.03 -30.19 0.33 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.351 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.14 -49.29 4.08 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.62 -0.324 . . . . 0.0 112.502 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.5 m -105.18 41.47 1.35 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.291 0.567 . . . . 0.0 110.538 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.51 ' NH1' ' HB3' ' A' ' 24' ' ' CYS . 54.7 ttt180 -98.7 -36.35 9.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.778 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.848 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.65 -49.85 43.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.37 . . . . 0.0 110.735 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 70.6 mt -70.57 -50.69 34.69 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.787 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.64 76.82 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.67 90.05 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.501 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.819 HD23 HD11 ' A' ' 23' ' ' LEU . 33.4 tp -72.26 -40.0 68.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.0 t -53.27 -41.55 65.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.527 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.3 m -59.16 -44.48 92.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.395 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -72.73 -39.4 66.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.619 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.493 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 82.4 m -60.8 -38.24 84.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.565 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.23 -43.1 19.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.015 0.436 . . . . 0.0 110.786 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -65.35 -51.25 61.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.852 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.505 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 13.0 m0 -113.61 -55.55 2.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.384 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.54 174.92 14.2 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.1 m -147.5 147.54 30.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.852 0.326 . . . . 0.0 110.72 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.558 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.5 m -94.78 164.44 12.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.28 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -53.02 -36.89 61.02 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -53.51 57.6 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.345 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.99 -42.68 99.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.428 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' B' ' 18' ' ' VAL . 34.2 mt -70.77 -46.09 70.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.664 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.515 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 66.3 m -64.6 -27.14 68.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.6 m -68.92 -3.87 14.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.932 0.396 . . . . 0.0 111.54 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.819 HD11 HD23 ' A' ' 6' ' ' LEU . 93.8 mt -91.47 -4.26 55.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.68 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.51 ' HB3' ' NH1' ' B' ' 26' ' ' ARG . 71.0 m . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.327 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.341 -0.303 . . . . 0.0 112.341 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.64 -172.15 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.681 0.24 . . . . 0.0 110.714 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.565 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 53.0 mtp85 -87.15 127.39 35.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -124.07 119.0 28.22 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.802 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' CYS . . . . . 0.4 ' H ' ' HB2' ' B' ' 13' ' ' GLU . 82.5 m -115.09 120.62 40.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.594 0.235 . . . . 0.0 111.556 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.41 -103.36 0.07 OUTLIER Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.945 -0.571 . . . . 0.0 114.269 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -57.63 -35.29 70.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.513 ' HB3' HD12 ' B' ' 9' ' ' LEU . 3.2 mp0 -69.26 -35.46 76.11 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.588 ' O ' HG23 ' B' ' 18' ' ' VAL . 33.6 t80 -61.95 -51.95 66.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.062 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.538 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.6 mt -59.03 -48.58 86.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.429 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 5.9 mmp_? -61.92 -38.11 87.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.336 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.489 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -63.13 -38.2 90.25 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.299 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 20' ' ' ILE . 98.8 t -59.97 -50.82 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.877 HD12 ' CD1' ' B' ' 27' ' ' TRP . 7.6 mm -57.26 -50.88 75.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.845 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -57.76 -41.88 82.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.209 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.735 HG21 ' HB ' ' A' ' 20' ' ' ILE . 22.8 p -66.91 -43.78 82.49 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.62 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.01 -37.86 89.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.705 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.73 -31.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.638 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.84 28.35 42.57 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 32.5 p -172.09 88.79 0.1 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -167.36 -38.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.646 0.736 . . . . 0.0 110.057 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.877 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.502 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t -72.24 -44.71 63.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 123.54 0.525 . . . . 0.0 109.791 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.406 ' HG ' HD13 ' A' ' 23' ' ' LEU . 11.0 mp -69.49 -54.48 14.04 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.531 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.52 74.45 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.4 81.94 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.699 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.505 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 40.6 tp -70.75 -43.37 68.95 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.8 t -52.43 -42.66 64.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.635 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 t -58.93 -43.28 91.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.196 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.9 m -74.1 -38.66 63.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.999 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 70.8 m -60.14 -41.51 92.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.76 0.314 . . . . 0.0 111.08 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.8 t -81.54 -39.28 24.89 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.024 0.44 . . . . 0.0 111.042 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -68.68 -43.82 75.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.82 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.447 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 10.5 m0 -123.48 -56.33 1.71 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.123 0.487 . . . . 0.0 111.385 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.89 173.6 15.49 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.2 m -147.23 145.91 29.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.117 0.459 . . . . 0.0 111.033 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.499 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.5 m -94.4 168.72 10.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.536 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -54.64 -37.97 66.31 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.847 0.356 . . . . 0.0 110.884 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.54 -53.96 51.49 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.493 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.57 -44.1 97.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.6 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.735 ' HB ' HG21 ' B' ' 21' ' ' THR . 34.0 mt -70.54 -44.36 77.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.22 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.471 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 67.6 m -65.53 -18.81 65.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.406 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.2 m -65.58 -11.38 43.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.045 0.45 . . . . 0.0 110.518 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.406 HD13 ' HG ' ' A' ' 3' ' ' LEU . 77.4 mt -111.08 26.53 10.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.823 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 95.9 m . . . . . 0 C--O 1.257 1.477 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.32 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.21 178.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 O-C-N 122.847 -0.208 . . . . 0.0 110.47 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.563 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 68.3 mtp180 -86.7 129.08 35.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.144 0.497 . . . . 0.0 110.039 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -123.99 118.24 26.56 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.271 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' CYS . . . . . 0.403 ' H ' ' HB2' ' B' ' 13' ' ' GLU . 84.3 m -114.38 120.06 39.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.8 -103.59 0.09 OUTLIER Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.882 -0.599 . . . . 0.0 114.309 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -57.89 -34.53 69.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.44 ' HB3' HD12 ' B' ' 9' ' ' LEU . 2.9 mp0 -69.11 -35.55 76.57 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.545 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 38.6 t80 -62.94 -50.08 72.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.095 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.646 ' O ' HG12 ' B' ' 19' ' ' ILE . 66.8 mt -59.5 -50.66 79.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.964 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.658 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.1 mmp_? -62.43 -33.39 74.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.435 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.458 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -63.11 -43.3 98.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.619 ' HA ' HG22 ' A' ' 20' ' ' ILE . 96.3 t -58.31 -48.1 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.756 HD12 ' CD1' ' B' ' 27' ' ' TRP . 18.4 mm -57.84 -49.54 80.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.877 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.466 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.4 m-30 -58.61 -43.23 89.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.98 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.798 HG21 ' HB ' ' A' ' 20' ' ' ILE . 11.1 p -65.64 -40.58 92.66 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.716 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 37.4 m -67.01 -34.66 78.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.251 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.68 -37.31 0.13 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.04 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 106.56 -42.53 1.89 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -112.04 41.09 2.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.4 0.619 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 77.2 ttt180 -96.31 -36.61 10.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.412 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.756 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.698 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.513 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 27.7 p-10 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.97 -42.02 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.089 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.52 -58.15 4.74 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.999 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.513 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.74 -35.01 73.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.98 -46.93 93.06 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.437 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.513 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 42.5 tp -72.7 -42.98 63.63 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 t -51.26 -43.64 61.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.973 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -58.3 -43.89 88.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.509 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.2 m -74.13 -36.69 64.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.931 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.513 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 83.6 m -60.46 -39.87 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.957 0.408 . . . . 0.0 110.343 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.7 t -81.27 -42.98 19.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.947 0.404 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.525 ' HG2' ' CD1' ' A' ' 13' ' ' TRP . 18.8 ttpp -62.9 -50.16 71.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.941 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.525 ' CD1' ' HG2' ' A' ' 12' ' ' LYS . 32.4 m0 -118.66 -54.32 2.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.546 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 141.54 174.46 14.43 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 92.1 m -147.11 146.41 29.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.916 0.358 . . . . 0.0 110.894 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.504 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.5 m -93.99 169.64 10.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.997 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -55.1 -38.39 68.07 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.962 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -51.25 70.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.605 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -61.57 -45.58 93.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.924 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.798 ' HB ' HG21 ' B' ' 21' ' ' THR . 31.5 mt -70.75 -42.37 77.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.36 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.46 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 47.0 m -65.72 -20.23 66.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 111.025 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.7 t -66.49 -10.39 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.506 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -109.62 23.6 14.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.184 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 C--O 1.256 1.405 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.18 179.589 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 m -148.64 -168.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.557 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.4 mtp180 -88.22 130.36 35.1 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.18 0.514 . . . . 0.0 109.789 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.563 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.3 mm? -124.06 114.64 19.99 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.409 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' CYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 78.7 m -109.12 117.66 34.72 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 46.06 -100.36 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 O-C-N 123.871 0.732 . . . . 0.0 114.384 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -53.71 -38.45 64.28 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.285 0.634 . . . . 0.0 112.138 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -70.74 -36.34 73.1 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.573 ' O ' HG23 ' B' ' 18' ' ' VAL . 35.6 t80 -63.52 -53.49 51.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.487 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.572 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.4 mt -59.13 -48.29 87.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.626 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.49 ' HA ' ' HD2' ' B' ' 16' ' ' ARG . 5.2 tpt180 -66.14 -32.88 74.6 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.264 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.89 95.96 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.587 ' HA ' HG22 ' A' ' 20' ' ' ILE . 91.3 t -60.3 -49.83 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.776 HG23 ' HD1' ' B' ' 27' ' ' TRP . 35.8 mm -55.19 -50.79 61.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.335 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.498 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.9 m-30 -58.49 -46.07 87.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.924 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.655 HG22 ' HG2' ' A' ' 17' ' ' LYS . 18.2 p -65.1 -39.22 92.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.044 0.449 . . . . 0.0 110.756 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' CYS . . . . . 0.513 ' HB3' HH11 ' B' ' 26' ' ' ARG . 78.6 m -66.91 -26.55 66.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.503 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.32 -19.75 0.23 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.283 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.39 -50.42 4.33 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 112.329 -0.308 . . . . 0.0 112.329 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -101.18 29.2 4.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.315 0.578 . . . . 0.0 110.39 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.513 HH11 ' HB3' ' B' ' 22' ' ' CYS . 72.3 ttt180 -88.65 -33.27 17.66 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.744 0.783 . . . . 0.0 109.491 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.776 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.312 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.71 -45.32 66.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 123.424 0.452 . . . . 0.0 109.955 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.81 -54.05 15.37 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.534 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.08 -36.78 73.34 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.91 -49.43 75.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.766 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.71 -39.63 73.3 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.6 t -55.27 -43.59 74.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.37 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.6 m -60.86 -35.58 76.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.555 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 m -80.35 -38.49 30.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.58 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 52.2 m -61.73 -41.79 98.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 110.716 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.416 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 49.6 t -76.88 -40.47 47.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.931 0.396 . . . . 0.0 110.682 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -69.47 -50.77 42.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.86 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.51 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 10.6 m0 -114.17 -57.1 2.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.271 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.58 -172.06 23.75 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.427 ' SG ' HD23 ' B' ' 9' ' ' LEU . 1.8 p -164.81 150.12 9.77 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.867 0.365 . . . . 0.0 110.73 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.584 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.9 m -94.04 169.77 10.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.064 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.655 ' HG2' HG22 ' B' ' 21' ' ' THR . 10.5 tmtt? -54.42 -35.36 62.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.039 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -51.34 64.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.993 0.425 . . . . 0.0 111.474 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -58.71 -44.54 90.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.168 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.587 HG22 ' HA ' ' B' ' 18' ' ' VAL . 40.0 mt -67.69 -40.89 84.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.2 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.472 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 68.8 m -64.69 -18.09 64.67 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 m -66.39 -13.15 60.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.929 0.395 . . . . 0.0 111.047 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.75 -5.08 42.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.106 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 80.6 m . . . . . 0 C--O 1.257 1.453 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.33 -178.901 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.449 -0.44 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 m -148.65 -169.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.508 0.194 . . . . 0.0 110.484 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.568 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 65.5 mtp180 -86.92 127.93 35.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.19 0.519 . . . . 0.0 109.711 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.4 mm? -122.97 115.07 21.3 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.59 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' CYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 65.0 m -109.46 119.93 40.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.53 -104.04 0.09 OUTLIER Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.464 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.439 HH11 ' HG2' ' B' ' 12' ' ' ARG . 33.4 ttp85 -56.86 -32.13 65.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.695 0.398 . . . . 0.0 111.7 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.507 ' HB3' HD12 ' B' ' 9' ' ' LEU . 25.5 mm-40 -70.02 -38.68 75.99 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.613 ' O ' HG23 ' B' ' 18' ' ' VAL . 39.8 t80 -59.36 -53.39 58.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.349 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.6 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.1 mt -59.45 -51.93 66.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.849 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.683 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 2.2 mmp_? -63.68 -31.72 72.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.709 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.33 -38.39 89.98 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.795 ' HA ' HG22 ' A' ' 20' ' ' ILE . 84.6 t -59.61 -49.73 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.756 HG23 ' HD1' ' B' ' 27' ' ' TRP . 13.4 mm -57.47 -53.41 44.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.136 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.659 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.6 m-30 -56.38 -45.09 80.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.43 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.617 HG21 ' HB ' ' A' ' 20' ' ' ILE . 24.7 p -65.63 -40.68 92.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.356 0.598 . . . . 0.0 111.051 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -74.32 -18.21 60.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.753 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.83 -21.89 0.23 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.917 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.45 -51.16 4.52 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.3 m -104.31 38.52 1.85 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.324 0.583 . . . . 0.0 109.771 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.423 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 9.4 tpp85 -87.48 -38.8 15.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.114 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.756 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.665 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.52 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.5 p-10 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 47.2 t -111.22 -44.19 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.157 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -68.99 -57.27 5.68 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.52 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.11 -33.29 70.68 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.1 -43.71 98.03 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.579 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 42.2 mt -82.2 -43.21 17.95 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 39.7 t -49.47 -45.14 46.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.588 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 p -62.32 -46.54 88.24 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.568 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 m -68.88 -39.47 79.79 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.35 0.26 . . . . 0.0 111.115 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.48 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 78.3 m -62.28 -38.78 90.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.916 0.389 . . . . 0.0 110.092 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.435 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 44.5 t -78.97 -44.46 22.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.099 0.476 . . . . 0.0 110.459 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -63.2 -50.24 71.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.688 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.511 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 22.1 m0 -117.08 -57.73 2.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.548 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.47 173.96 14.67 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.8 m -147.78 147.54 29.98 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 116.994 0.397 . . . . 0.0 110.61 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.57 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.7 m -95.09 163.84 13.13 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.417 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -52.51 -38.22 59.11 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.497 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -52.37 66.04 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.452 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -60.38 -44.78 95.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.795 HG22 ' HA ' ' B' ' 18' ' ' VAL . 27.1 mt -70.71 -44.06 76.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.695 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 70.7 m -63.53 -25.09 68.09 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.431 -0.168 . . . . 0.0 111.382 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.7 m -64.61 -8.55 14.64 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.487 HD11 HD12 ' A' ' 6' ' ' LEU . 7.8 mp -80.74 -21.94 40.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.4 m . . . . . 0 C--O 1.244 0.785 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.82 -179.311 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.086 -0.405 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 20.4 m -144.22 -167.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.616 0.246 . . . . 0.0 110.532 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -89.18 130.96 35.51 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.6 mm? -127.14 112.39 15.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.322 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 85.5 m -109.75 119.09 38.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.752 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.51 -105.55 0.16 Allowed Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.736 -0.666 . . . . 0.0 114.556 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -57.02 -32.14 65.84 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 122.752 0.421 . . . . 0.0 112.051 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.38 -40.17 81.49 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.663 ' O ' HG23 ' B' ' 18' ' ' VAL . 55.2 t80 -61.23 -53.7 53.61 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.623 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.554 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.3 mt -56.51 -50.2 74.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.037 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.527 ' HA ' ' HD2' ' B' ' 16' ' ' ARG . 3.7 tpt180 -67.27 -31.78 72.34 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.953 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.4 96.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.805 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.747 ' HA ' HG22 ' A' ' 20' ' ' ILE . 92.0 t -59.97 -50.37 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.816 HG23 ' HD1' ' B' ' 27' ' ' TRP . 26.7 mm -57.58 -52.46 57.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.457 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.55 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.4 m-30 -56.57 -47.6 79.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.904 -1.043 . . . . 0.0 113.4 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.483 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 21.7 p -64.18 -41.22 97.19 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.167 0.508 . . . . 0.0 111.532 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 57.3 m -77.08 -14.27 59.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.995 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.13 -29.38 0.25 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 119.778 -1.201 . . . . 0.0 113.205 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.68 -48.68 4.04 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -106.51 26.44 9.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.198 0.523 . . . . 0.0 110.16 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -84.83 -33.05 22.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.789 0.804 . . . . 0.0 109.49 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.816 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.12 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.541 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 27.2 p-10 . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 26.3 t -111.29 -42.81 4.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.111 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.454 ' HG ' HD21 ' A' ' 23' ' ' LEU . 9.3 mp -68.86 -57.61 5.32 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.541 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -57.52 -33.92 68.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.72 84.86 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.373 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 62.8 mt -72.85 -39.59 66.4 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 29.3 t -52.86 -43.81 66.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.736 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.2 m -60.69 -44.82 96.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.445 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -71.12 -38.23 72.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.717 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.683 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 64.7 m -63.82 -37.18 86.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 110.865 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 34.9 t -79.62 -37.73 35.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.181 0.515 . . . . 0.0 110.297 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -73.29 -52.52 13.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.16 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -113.32 -42.3 3.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.249 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 120.16 -179.1 16.53 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.48 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.1 p -161.36 150.41 16.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.935 0.398 . . . . 0.0 111.155 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.527 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.0 m -96.9 167.33 11.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.911 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.423 ' HG3' HG22 ' B' ' 21' ' ' THR . 38.2 tttm -54.21 -37.42 64.55 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.16 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -50.55 73.64 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.426 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -62.89 -45.01 94.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.094 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.747 HG22 ' HA ' ' B' ' 18' ' ' VAL . 24.2 mt -71.51 -42.3 72.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.681 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.483 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 70.5 m -64.04 -36.16 83.08 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.142 -0.349 . . . . 0.0 111.314 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.2 m -69.03 3.72 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.82 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.454 HD21 ' HG ' ' A' ' 3' ' ' LEU . 20.2 tp -90.04 -22.48 21.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.698 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.2 m . . . . . 0 C--O 1.243 0.73 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.91 -179.512 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.47 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m -142.35 -177.0 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.571 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 72.3 mtp180 -83.29 129.71 35.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.123 0.487 . . . . 0.0 110.339 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.4 mm? -123.87 118.49 27.22 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.992 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 65.8 m -117.79 119.66 35.57 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.37 -98.66 0.02 OUTLIER Glycine 0 CA--C 1.519 0.316 0 N-CA-C 114.761 0.665 . . . . 0.0 114.761 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.423 ' H ' ' HG3' ' B' ' 12' ' ' ARG . 15.6 mtm180 -53.4 -44.37 68.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.281 0.632 . . . . 0.0 111.941 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.572 ' HB3' HD12 ' B' ' 9' ' ' LEU . 3.0 mp0 -72.29 -30.98 65.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.896 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.591 ' O ' HG23 ' B' ' 18' ' ' VAL . 41.7 t80 -65.1 -51.68 59.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.038 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.642 ' O ' HG12 ' B' ' 19' ' ' ILE . 80.1 mt -61.53 -49.22 85.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.865 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.574 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.5 mmp_? -62.83 -32.11 73.25 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.298 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.547 ' HB1' HD13 ' A' ' 20' ' ' ILE . . . -63.92 -44.0 94.24 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.601 ' HA ' HG22 ' A' ' 20' ' ' ILE . 61.8 t -57.8 -51.11 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.861 HG23 ' HD1' ' B' ' 27' ' ' TRP . 37.9 mm -53.42 -51.42 41.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.311 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.534 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.8 m-30 -58.82 -44.74 90.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.732 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.861 HG21 ' HB ' ' A' ' 20' ' ' ILE . 17.0 p -63.7 -39.38 94.17 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.589 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 m -69.39 -31.33 69.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.652 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.39 -22.23 0.09 OUTLIER Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.674 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.21 -62.26 4.6 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.4 m -90.85 48.18 1.5 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.565 0.698 . . . . 0.0 109.641 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.8 tpm_? -112.55 -37.19 5.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.124 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.861 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.12 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.117 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.95 -44.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 123.511 0.507 . . . . 0.0 109.865 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.97 -54.46 13.2 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.68 -35.79 73.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.47 -49.48 73.48 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.647 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 43.5 tp -70.8 -39.93 72.83 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.9 t -55.65 -37.81 68.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.476 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 t -59.8 -41.73 91.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.882 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.7 m -76.23 -43.16 43.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.53 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 75.5 m -60.03 -39.48 86.05 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.256 0.347 . . . . 0.0 111.467 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.45 -38.72 25.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.838 0.352 . . . . 0.0 111.009 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 3.2 ttmp? -68.43 -61.5 1.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.278 0.561 . . . . 0.0 111.631 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.532 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 6.0 m0 -101.18 -54.35 2.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.902 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 138.05 174.33 13.35 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.7 m -148.56 146.61 28.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.983 0.42 . . . . 0.0 110.672 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.51 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 3.2 m -91.91 170.05 10.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.629 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.662 ' HG3' HG22 ' B' ' 21' ' ' THR . 40.7 tttm -55.9 -36.87 68.13 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.682 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -52.22 66.66 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.614 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.51 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.68 -44.9 93.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.6 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.861 ' HB ' HG21 ' B' ' 21' ' ' THR . 37.4 mt -70.66 -39.6 76.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.015 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.493 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 49.3 m -65.15 -20.46 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.776 0.322 . . . . 0.0 110.669 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.5 m -68.15 -6.88 25.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.068 0.461 . . . . 0.0 110.93 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.455 HD11 HD23 ' A' ' 6' ' ' LEU . 69.1 mt -105.33 19.66 20.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.6 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.411 179.401 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.69 -171.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.557 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 61.8 mtp180 -89.88 123.93 34.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.088 0.47 . . . . 0.0 109.883 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.649 HD12 ' HG3' ' B' ' 13' ' ' GLU . 2.1 mm? -114.98 115.26 26.59 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.129 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 79.7 m -109.26 118.77 37.58 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.78 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.57 -102.57 0.05 OUTLIER Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.465 -0.789 . . . . 0.0 114.345 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.532 ' O ' ' HD2' ' B' ' 12' ' ' ARG . 4.4 tmm_? -57.16 -32.21 66.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.239 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.649 ' HG3' HD12 ' B' ' 9' ' ' LEU . 5.6 tp10 -70.59 -38.28 74.0 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.601 ' O ' HG23 ' B' ' 18' ' ' VAL . 45.3 t80 -59.65 -55.45 34.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.582 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.578 ' O ' HG12 ' B' ' 19' ' ' ILE . 62.3 mt -58.88 -48.52 86.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.967 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.502 ' HA ' ' HD2' ' B' ' 16' ' ' ARG . 5.1 tpt180 -65.58 -33.28 75.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.302 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -40.31 96.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.601 HG23 ' O ' ' B' ' 14' ' ' PHE . 60.6 t -60.64 -49.26 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.809 HG23 ' HD1' ' B' ' 27' ' ' TRP . 39.0 mm -55.8 -51.08 63.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.308 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.553 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.3 m-30 -58.53 -46.19 87.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.047 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.674 HG22 ' HG2' ' A' ' 17' ' ' LYS . 18.4 p -65.05 -39.74 93.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.984 0.421 . . . . 0.0 110.808 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' CYS . . . . . 0.491 ' HB3' HH11 ' B' ' 26' ' ' ARG . 73.5 m -67.86 -24.39 65.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.737 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.14 -21.94 0.22 Allowed Glycine 0 C--O 1.227 -0.333 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.495 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.08 -51.58 4.49 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.7 m -101.08 27.81 5.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.411 0.624 . . . . 0.0 110.139 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.491 HH11 ' HB3' ' B' ' 22' ' ' CYS . 72.0 ttt180 -88.52 -32.8 18.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.658 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.809 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.202 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.505 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.2 p-10 . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.491 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 45.2 t -111.99 -42.61 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.156 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.9 mt -69.26 -56.35 7.84 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.505 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -60.71 -32.9 72.13 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.91 -43.38 98.11 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.31 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.807 HD12 HD11 ' A' ' 23' ' ' LEU . 44.9 mt -80.31 -43.14 21.75 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -49.31 -47.01 47.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.532 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.1 p -62.48 -46.57 87.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.568 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 33.1 m -67.5 -38.53 84.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.227 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.572 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 83.3 m -62.58 -39.46 93.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.921 0.391 . . . . 0.0 110.234 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 41.3 t -79.22 -44.03 22.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.237 0.541 . . . . 0.0 110.389 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.5 ttpt -62.13 -49.59 75.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.568 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.471 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 23.0 m0 -119.19 -58.07 1.96 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.579 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.9 171.94 13.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.8 m -145.72 145.6 30.93 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.853 0.326 . . . . 0.0 110.417 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.545 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 4.1 m -92.53 164.77 13.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.563 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.674 ' HG2' HG22 ' B' ' 21' ' ' THR . 10.4 tmtt? -54.27 -35.47 62.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.788 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -52.17 63.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.029 0.443 . . . . 0.0 111.737 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.32 -42.48 95.69 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.739 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' B' ' 18' ' ' VAL . 26.6 mt -69.2 -39.57 79.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.489 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 70.3 m -66.29 -17.58 64.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.625 0.25 . . . . 0.0 111.296 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.7 m -67.58 -10.05 48.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.191 0.519 . . . . 0.0 110.345 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.807 HD11 HD12 ' A' ' 6' ' ' LEU . 95.8 mt -105.54 23.21 14.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.952 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 80.2 m . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.681 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 CA--C 1.508 -0.364 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 m -149.61 -167.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.57 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 62.9 mtp180 -86.27 126.12 34.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.042 0.449 . . . . 0.0 110.151 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.5 mm? -119.48 118.48 31.21 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.04 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' CYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 65.2 m -112.69 110.75 21.09 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 53.2 -94.56 0.01 OUTLIER Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.834 -0.621 . . . . 0.0 114.577 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' B' ' 12' ' ' ARG . 12.1 mtm180 -55.64 -42.3 74.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.267 0.556 . . . . 0.0 111.138 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.621 ' HB3' HD12 ' B' ' 9' ' ' LEU . 34.3 mp0 -68.84 -34.19 75.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.431 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.602 ' O ' HG23 ' B' ' 18' ' ' VAL . 48.6 t80 -63.07 -52.31 63.22 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.829 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.626 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.3 mt -59.88 -48.56 87.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.603 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.1 mmp_? -61.86 -34.98 76.97 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.55 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.595 ' HB1' HD13 ' A' ' 20' ' ' ILE . . . -64.12 -41.42 97.25 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 14' ' ' PHE . 48.9 t -58.8 -48.27 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.84 HG23 ' HD1' ' B' ' 27' ' ' TRP . 36.5 mm -56.18 -50.6 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.704 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.613 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.8 m-30 -57.29 -43.84 83.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.519 -1.218 . . . . 0.0 112.792 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.918 HG21 ' HB ' ' A' ' 20' ' ' ILE . 14.7 p -66.22 -40.83 90.59 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.328 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 34.9 m -67.45 -32.75 73.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.429 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.1 -30.28 0.09 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.31 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 92.16 -53.2 2.85 Favored Glycine 0 C--O 1.225 -0.457 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.7 m -102.39 45.66 0.96 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.584 0.707 . . . . 0.0 109.204 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.421 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.9 tpm_? -108.66 -37.92 5.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.356 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.84 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.074 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.175 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.5 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 25.9 p-10 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 41.9 t -112.12 -41.82 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.213 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.7 mt -68.89 -56.67 7.17 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -61.04 -33.07 72.72 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.69 -43.57 97.67 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.262 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.786 HD12 HD11 ' A' ' 23' ' ' LEU . 27.0 mt -80.47 -42.95 21.67 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -48.66 -47.13 40.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.223 0.609 . . . . 0.0 111.435 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 p -63.99 -46.31 85.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.8 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.404 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 25.6 m -67.92 -39.11 83.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.418 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 73.2 m -62.79 -39.81 95.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.953 0.406 . . . . 0.0 110.185 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 45.9 t -78.59 -42.73 28.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.136 0.493 . . . . 0.0 110.437 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.7 ttpt -64.27 -50.15 69.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.566 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.511 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 22.7 m0 -117.71 -58.85 1.98 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.452 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.57 172.9 14.71 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 78.7 m -147.94 147.78 30.07 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.814 0.307 . . . . 0.0 110.673 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.564 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.7 m -96.88 166.09 11.79 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.537 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.777 ' HG2' HG22 ' B' ' 21' ' ' THR . 11.3 tmtt? -53.64 -35.63 61.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.278 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -51.59 65.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.964 0.411 . . . . 0.0 111.627 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.491 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.17 -44.28 92.14 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.481 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.918 ' HB ' HG21 ' B' ' 21' ' ' THR . 27.1 mt -70.42 -35.57 62.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.495 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.528 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 68.2 m -65.32 -23.24 66.96 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.736 0.303 . . . . 0.0 110.711 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.5 m -69.13 -0.94 6.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.797 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.786 HD11 HD12 ' A' ' 6' ' ' LEU . 96.3 mt -108.7 13.91 24.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.206 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.473 179.553 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.447 ' O ' HD22 ' B' ' 9' ' ' LEU . 7.2 t -134.2 165.59 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.559 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 70.0 mtp180 -74.34 130.48 39.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.377 0.608 . . . . 0.0 110.845 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.67 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 1.4 mm? -117.34 115.04 24.45 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.03 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 70.9 m -116.52 116.9 28.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.529 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.09 -101.82 0.05 OUTLIER Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.69 -0.686 . . . . 0.0 114.347 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -57.67 -36.2 71.58 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.954 0.502 . . . . 0.0 111.637 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.2 -29.97 65.82 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.9 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.67 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 47.4 t80 -68.78 -54.96 12.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.706 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.534 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.5 mt -60.65 -47.34 93.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.583 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.493 ' HA ' ' HD2' ' B' ' 16' ' ' ARG . 4.2 tpt180 -66.17 -30.22 70.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.69 97.8 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.664 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.74 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.3 t -60.13 -50.45 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.79 HG23 ' HD1' ' B' ' 27' ' ' TRP . 29.1 mm -57.05 -52.22 58.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.493 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.535 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -58.51 -46.41 86.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.948 -1.023 . . . . 0.0 113.058 -178.507 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.451 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 19.7 p -63.53 -41.05 98.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.944 0.402 . . . . 0.0 111.679 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.9 m -74.41 -20.82 59.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.301 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.5 -30.58 0.18 Allowed Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.876 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.27 -52.3 4.49 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 112.259 -0.336 . . . . 0.0 112.259 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 15.9 p -99.42 29.05 4.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.478 0.656 . . . . 0.0 110.558 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.9 tpm_? -89.49 -36.57 15.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.997 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.79 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.132 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.52 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.7 p-10 . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.67 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 49.0 t -109.72 -44.15 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.08 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.74 -57.63 6.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.52 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.11 -32.9 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.51 -46.88 93.22 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.25 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 30.6 mt -74.4 -39.47 62.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.8 t -52.57 -38.51 60.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -59.49 -36.52 76.21 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.89 0.376 . . . . 0.0 110.795 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 m -86.33 -41.23 14.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.664 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.563 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 98.0 m -61.8 -39.43 91.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.709 0.29 . . . . 0.0 110.87 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.3 t -78.43 -39.4 38.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.927 0.394 . . . . 0.0 110.804 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 2.1 ttmp? -68.3 -57.67 5.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.202 0.525 . . . . 0.0 111.372 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.532 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 9.7 m0 -103.43 -60.91 1.49 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.288 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.83 170.06 11.98 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.438 ' HB2' HD23 ' B' ' 9' ' ' LEU . 83.4 m -145.32 151.4 38.26 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 117.121 0.46 . . . . 0.0 110.574 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.568 ' HB3' ' OE1' ' A' ' 19' ' ' GLU . 34.0 t -95.63 169.42 10.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.626 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -56.13 -37.16 69.07 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.149 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -52.96 63.51 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.996 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.568 ' OE1' ' HB3' ' A' ' 16' ' ' SER . 2.4 mp0 -60.62 -45.97 92.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.974 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.74 HG22 ' HA ' ' B' ' 18' ' ' VAL . 45.0 mt -69.32 -44.75 80.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.451 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 71.5 m -62.34 -29.03 70.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.564 0.221 . . . . 0.0 111.437 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.2 m -65.45 -4.11 5.28 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 6' ' ' LEU . 10.4 mp -84.84 -19.52 32.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.706 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.894 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.423 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 12.6 m -144.92 -169.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 110.652 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 -88.12 128.96 35.43 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -125.89 113.04 16.69 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.154 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 78.9 m -111.28 116.1 30.45 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.07 -101.65 0.05 OUTLIER Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.74 -0.664 . . . . 0.0 114.404 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.699 ' HB2' ' NH1' ' B' ' 12' ' ' ARG . 5.7 mtm105 -57.34 -36.58 71.35 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.604 0.362 . . . . 0.0 111.779 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.416 ' HB2' ' H ' ' B' ' 10' ' ' CYS . 8.0 mp0 -67.32 -37.55 83.5 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.604 ' O ' HG23 ' B' ' 18' ' ' VAL . 39.3 t80 -62.6 -53.05 60.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.728 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.549 ' O ' HG12 ' B' ' 19' ' ' ILE . 69.1 mt -57.35 -48.74 81.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.644 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.491 ' HA ' ' HD2' ' B' ' 16' ' ' ARG . 5.3 tpt180 -66.6 -33.03 74.76 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.05 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.32 93.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.506 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.604 HG23 ' O ' ' B' ' 14' ' ' PHE . 83.7 t -60.89 -49.95 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.734 HG23 ' HD1' ' B' ' 27' ' ' TRP . 36.4 mm -53.98 -51.12 48.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.539 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -43.91 97.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.988 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.532 HG21 ' HB ' ' A' ' 20' ' ' ILE . 19.4 p -64.94 -41.19 95.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.757 0.313 . . . . 0.0 110.794 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' CYS . . . . . 0.45 ' HB3' HH11 ' B' ' 26' ' ' ARG . 85.7 m -63.97 -31.19 72.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.146 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.26 -21.14 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.396 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.4 -56.27 4.99 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -92.16 44.33 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.402 0.62 . . . . 0.0 110.326 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.45 HH11 ' HB3' ' B' ' 22' ' ' CYS . 75.3 ttt180 -110.04 -33.75 6.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.753 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.734 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.508 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.9 p-10 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.0 t -111.59 -42.26 4.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.08 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.39 -57.02 5.81 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.49 -33.66 71.61 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.02 -47.86 87.15 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.38 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.1 tp -73.02 -38.66 66.47 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 43.0 t -54.97 -41.93 71.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.288 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 t -59.22 -48.01 83.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.752 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 m -67.57 -39.41 84.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.682 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 61.4 m -61.46 -39.7 91.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 111.383 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.423 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 38.3 t -81.04 -38.61 27.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.267 0.556 . . . . 0.0 110.459 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -69.97 -53.1 19.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.297 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -114.93 -40.67 3.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.037 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 121.23 176.13 15.28 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' SG ' HD23 ' B' ' 9' ' ' LEU . 6.3 p -158.8 150.94 21.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.196 0.522 . . . . 0.0 111.465 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.498 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 8.2 m -96.62 173.34 7.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.03 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -54.86 -38.1 67.08 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.923 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -52.85 63.97 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.275 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.498 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.6 mp0 -60.08 -45.43 92.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.823 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' B' ' 18' ' ' VAL . 42.3 mt -69.47 -45.11 79.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.068 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.55 ' HA ' ' SG ' ' A' ' 24' ' ' CYS . 65.6 m -64.58 -16.7 63.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -65.43 -14.88 61.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.181 0.515 . . . . 0.0 110.371 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 72.4 mt -106.98 25.89 10.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.444 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 96.7 m . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.506 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 CA--C 1.509 -0.302 0 N-CA-C 112.085 -0.406 . . . . 0.0 112.085 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 m -148.03 -173.73 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.504 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 52.3 mtt85 -82.81 133.16 35.14 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.541 0.686 . . . . 0.0 110.832 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.5 mm? -129.68 118.45 21.93 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.632 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' CYS . . . . . 0.42 ' H ' ' HB2' ' B' ' 13' ' ' GLU . 35.0 m -114.14 117.81 32.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 46.91 -98.61 0.01 OUTLIER Glycine 0 C--N 1.336 0.555 0 O-C-N 123.742 0.651 . . . . 0.0 114.658 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -54.15 -39.56 66.64 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.146 0.578 . . . . 0.0 111.555 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.541 ' HB3' HD12 ' B' ' 9' ' ' LEU . 34.7 mm-40 -72.03 -35.01 69.25 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.758 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.571 ' O ' HG23 ' B' ' 18' ' ' VAL . 38.5 t80 -62.93 -53.48 53.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.535 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.592 ' O ' HG12 ' B' ' 19' ' ' ILE . 72.4 mt -59.31 -50.78 78.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.421 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.584 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.3 mmp_? -63.7 -31.03 72.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.503 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.416 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -64.35 -41.52 96.71 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.127 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.843 ' HA ' HG22 ' A' ' 20' ' ' ILE . 93.0 t -59.36 -50.86 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-O 121.9 0.857 . . . . 0.0 108.814 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.783 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.9 mm -58.24 -52.14 62.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.707 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.401 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.8 OUTLIER -59.3 -44.4 92.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.568 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 19.9 p -62.78 -41.18 99.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.076 0.465 . . . . 0.0 110.757 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 56.5 m -75.03 -22.27 58.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.651 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.07 -29.36 0.21 Allowed Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.881 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 87.41 -54.86 4.48 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 38.3 p -96.03 49.11 1.13 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.323 0.582 . . . . 0.0 110.703 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.536 ' NH1' ' HB3' ' A' ' 24' ' ' CYS . 56.1 ttt180 -111.45 -36.44 5.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.255 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.783 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.956 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.062 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.63 -49.76 75.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.547 0.53 . . . . 0.0 110.365 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.89 -44.98 95.7 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.92 -38.19 64.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.79 0.329 . . . . 0.0 111.056 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.13 -44.2 97.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.176 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.588 HD12 HD11 ' A' ' 23' ' ' LEU . 32.3 mt -78.89 -44.4 22.85 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.245 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.2 t -48.91 -46.12 42.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.3 0.64 . . . . 0.0 111.646 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.4 p -64.69 -46.37 82.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.689 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -68.06 -39.6 82.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.431 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.547 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 73.9 m -63.11 -35.5 80.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.868 0.366 . . . . 0.0 110.618 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.6 t -83.39 -41.98 17.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.199 0.523 . . . . 0.0 110.197 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -64.8 -48.65 73.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.522 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -118.45 -53.98 2.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.503 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 134.57 169.76 12.05 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.2 m -145.24 147.44 32.4 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.922 0.361 . . . . 0.0 110.945 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.553 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.2 m -93.71 165.15 12.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.068 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -51.16 -40.12 57.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.508 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -53.71 55.25 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.693 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.99 -43.2 95.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.109 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.843 HG22 ' HA ' ' B' ' 18' ' ' VAL . 40.6 mt -70.9 -46.9 65.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.489 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.568 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 70.2 m -62.09 -23.72 66.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.5 m -63.93 -11.56 29.37 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 6' ' ' LEU . 21.9 mt -85.22 -6.89 59.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.536 ' HB3' ' NH1' ' B' ' 26' ' ' ARG . 77.5 m . . . . . 0 C--O 1.243 0.734 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.334 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.367 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -142.2 -171.83 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.349 . . . . 0.0 110.881 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -87.03 126.35 34.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.659 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.719 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.6 mm? -123.05 114.46 20.4 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.028 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 58.1 m -113.26 119.68 38.58 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.0 -102.64 0.06 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.92 -0.582 . . . . 0.0 114.417 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -57.13 -34.63 68.59 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.47 -33.83 69.65 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.615 ' O ' HG23 ' B' ' 18' ' ' VAL . 45.3 t80 -62.61 -54.54 38.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.302 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.584 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.1 mt -58.44 -50.13 79.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.295 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.53 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.7 mmp_? -62.33 -32.72 73.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.29 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.21 96.46 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.315 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.786 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.7 t -59.05 -50.02 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 122.042 0.925 . . . . 0.0 108.837 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.799 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.3 mm -59.04 -53.04 53.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.185 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.477 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.0 m-30 -56.3 -45.57 80.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.177 -0.92 . . . . 0.0 113.411 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.592 HG21 ' HB ' ' A' ' 20' ' ' ILE . 15.7 p -64.44 -41.6 96.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.807 0.337 . . . . 0.0 111.42 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 58.3 m -75.58 -27.67 58.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.493 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.92 -29.52 0.08 OUTLIER Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.326 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.39 -54.13 4.65 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.749 -0.262 . . . . 0.0 112.477 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m -101.14 52.84 0.84 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.59 0.71 . . . . 0.0 110.102 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.522 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 3.5 tpm_? -115.9 -38.15 3.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.846 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.799 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.179 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.987 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.508 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.6 p-10 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 27.4 t -111.57 -42.49 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.109 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.87 -57.26 5.8 Favored 'General case' 0 C--O 1.218 -0.555 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.508 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.44 -33.47 71.31 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.16 -45.47 95.98 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.408 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 59.8 mt -78.65 -44.37 23.99 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 40.8 t -48.42 -48.71 37.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.688 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.5 p -65.82 -45.45 82.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.683 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.536 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 23.8 m -65.69 -38.27 88.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.904 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.719 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 80.0 m -63.76 -34.54 78.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.999 0.428 . . . . 0.0 110.762 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 t -85.46 -38.69 18.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.31 0.576 . . . . 0.0 110.068 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.7 ttpt -68.03 -44.49 76.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.707 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -124.13 -48.65 1.85 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.886 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 128.21 165.74 11.87 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 78.9 m -143.44 146.98 33.89 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 117.129 0.464 . . . . 0.0 111.205 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.6 m -96.27 165.41 12.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.076 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -52.36 -40.09 61.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.353 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 m -57.03 -53.75 54.53 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 123.69 0.619 . . . . 0.0 111.532 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.618 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.7 mp0 -60.64 -43.52 97.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.43 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.786 HG22 ' HA ' ' B' ' 18' ' ' VAL . 31.5 mt -72.58 -39.23 61.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.264 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.416 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 51.1 m -64.12 -37.95 89.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.763 0.316 . . . . 0.0 110.807 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p -69.97 7.34 0.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.022 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.448 HD23 ' CG2' ' B' ' 18' ' ' VAL . 19.6 tp -92.27 -24.38 19.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.872 0.368 . . . . 0.0 110.159 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.6 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.84 179.615 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.42 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.03 -173.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.479 0.18 . . . . 0.0 110.522 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 26.4 mmt85 -87.58 130.97 34.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.153 0.501 . . . . 0.0 110.303 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.723 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -124.94 109.16 12.66 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.731 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 42.1 m -111.54 116.56 31.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.691 0.282 . . . . 0.0 111.642 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 50.98 -103.95 0.12 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.733 -0.667 . . . . 0.0 114.54 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -57.9 -32.87 68.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 122.519 0.328 . . . . 0.0 111.563 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.486 ' HG3' HD12 ' B' ' 9' ' ' LEU . 3.6 tp10 -68.25 -38.56 81.93 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 51.0 t80 -60.95 -53.59 55.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.001 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.61 ' O ' HG12 ' B' ' 19' ' ' ILE . 63.1 mt -60.0 -49.7 82.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.688 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.62 ' NH2' HG13 ' B' ' 19' ' ' ILE . 0.1 OUTLIER -65.25 -28.58 69.45 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.881 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.83 -42.82 94.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.002 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.764 ' HA ' HG22 ' A' ' 20' ' ' ILE . 62.1 t -58.94 -49.22 83.91 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.079 0.943 . . . . 0.0 108.517 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.818 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.3 mm -57.79 -53.16 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.571 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.551 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.4 OUTLIER -57.92 -45.18 86.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.323 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.515 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 17.4 p -63.5 -39.55 94.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.986 0.422 . . . . 0.0 111.553 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 60.9 m -79.49 -20.77 46.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.636 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.61 -31.13 0.14 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.112 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 85.36 -56.47 4.94 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.783 -0.246 . . . . 0.0 112.516 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m -97.21 50.32 1.07 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.565 0.697 . . . . 0.0 110.155 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 7.2 tpm_? -114.42 -38.96 3.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.626 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.818 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.032 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 27.3 p-10 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.97 -43.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.286 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.5 mp -70.43 -56.92 5.47 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -60.52 -34.65 74.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.83 -46.63 93.22 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.456 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.634 HD23 HD11 ' A' ' 23' ' ' LEU . 38.5 tp -73.55 -39.78 64.45 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.5 t -53.14 -45.09 68.23 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.601 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.4 m -60.55 -42.75 97.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.391 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 m -70.74 -38.7 73.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.812 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.723 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 90.7 m -62.11 -32.72 73.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.977 0.417 . . . . 0.0 110.776 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.451 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 49.0 t -85.31 -40.31 16.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.157 0.503 . . . . 0.0 110.393 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -70.82 -48.18 55.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.403 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -114.91 -41.43 3.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.566 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 116.54 165.44 14.05 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -141.18 149.58 41.64 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.909 0.355 . . . . 0.0 111.32 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.534 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.8 m -94.61 168.07 11.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.224 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HG3' HG22 ' B' ' 21' ' ' THR . 37.6 tttm -54.97 -37.19 66.2 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.273 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -52.59 65.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.218 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -60.83 -44.58 96.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.043 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.764 HG22 ' HA ' ' B' ' 18' ' ' VAL . 39.6 mt -70.62 -44.18 76.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.917 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.515 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 67.6 m -64.29 -28.7 69.9 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.522 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.1 m -69.32 -0.55 6.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.59 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.634 HD11 HD23 ' A' ' 6' ' ' LEU . 93.2 mt -90.62 -12.35 37.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.472 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.9 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.1 -0.953 . . . . 0.0 110.804 179.706 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.86 -173.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.7 mmm-85 -86.16 128.82 34.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.801 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.72 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -125.15 109.12 12.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.649 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 84.9 m -109.93 121.46 45.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.772 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 49.42 -106.34 0.2 Allowed Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.862 -0.608 . . . . 0.0 114.493 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.482 ' HG3' ' N ' ' B' ' 13' ' ' GLU . 8.2 ptt180 -56.18 -30.67 62.55 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.779 0.432 . . . . 0.0 111.772 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' B' ' 12' ' ' ARG . 54.8 mm-40 -70.62 -38.78 73.95 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 41.6 t80 -63.16 -51.26 67.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.402 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.657 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.6 mt -58.71 -52.59 58.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.32 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.614 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 1.5 mmp_? -65.24 -27.47 68.68 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.283 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.51 93.08 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.592 ' HA ' HG22 ' A' ' 20' ' ' ILE . 96.9 t -60.43 -50.94 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.748 HG23 ' HD1' ' B' ' 27' ' ' TRP . 28.4 mm -54.87 -50.44 61.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.034 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.626 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -58.86 -45.92 88.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.649 -178.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.516 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 15.3 p -64.14 -38.72 92.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.003 0.43 . . . . 0.0 110.432 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' B' ' 18' ' ' VAL . 86.1 m -67.42 -25.12 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.445 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.32 -19.81 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.107 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 85.41 -48.8 4.08 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 5.3 p -104.02 25.87 9.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.454 0.645 . . . . 0.0 109.856 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.414 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 3.2 tpp85 -79.1 -36.99 39.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.006 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.748 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.947 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.52 -49.97 78.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 123.516 0.51 . . . . 0.0 110.569 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.77 -46.59 88.93 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.578 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.0 -39.08 62.84 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.36 0.413 . . . . 0.0 110.789 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.41 -47.48 87.13 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.066 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HB2' ' CZ ' ' B' ' 14' ' ' PHE . 36.8 mt -71.54 -43.9 65.57 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -50.69 -44.97 58.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.7 m -62.91 -43.47 98.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.862 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -71.63 -41.25 69.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.081 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.72 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 74.1 m -62.33 -37.35 85.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.006 0.431 . . . . 0.0 110.752 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.5 t -79.29 -38.68 34.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.054 0.454 . . . . 0.0 110.481 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.473 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 37.2 ttmt -72.15 -58.46 3.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.139 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.473 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 9.4 m0 -104.81 -44.69 4.77 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.17 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 123.39 169.53 13.25 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 85.2 m -144.74 147.56 33.12 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 117.307 0.554 . . . . 0.0 111.394 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' HG13 ' A' ' 20' ' ' ILE . 2.5 m -95.58 169.46 10.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.012 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' HG3' HG22 ' B' ' 21' ' ' THR . 58.4 tttp -55.7 -37.16 68.0 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.756 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -54.72 43.81 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.665 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.07 -42.29 94.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.351 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.592 HG22 ' HA ' ' B' ' 18' ' ' VAL . 44.9 mt -72.42 -45.8 58.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.928 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.611 ' HA ' ' SG ' ' A' ' 24' ' ' CYS . 63.1 m -64.65 -13.21 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.692 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.3 m -63.24 -19.83 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.254 0.549 . . . . 0.0 110.185 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 54.7 mt -106.77 28.11 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.148 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 58.8 m . . . . . 0 C--O 1.259 1.567 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.662 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 112.302 -0.319 . . . . 0.0 112.302 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 m -150.76 -169.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.558 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.6 mtp180 -89.69 128.16 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.4 mm? -121.84 114.06 20.52 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.643 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' CYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 71.5 m -108.6 119.97 41.08 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 47.54 -101.57 0.04 OUTLIER Glycine 0 CA--C 1.518 0.281 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.674 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -57.87 -34.05 69.34 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.978 0.511 . . . . 0.0 111.29 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.491 ' HB3' HD12 ' B' ' 9' ' ' LEU . 0.1 OUTLIER -69.49 -36.81 76.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.262 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.596 ' O ' HG23 ' B' ' 18' ' ' VAL . 35.8 t80 -61.76 -52.99 61.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.169 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.543 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.3 mt -58.41 -47.73 87.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.333 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.466 ' CZ ' HG21 ' B' ' 19' ' ' ILE . 6.4 tpt180 -65.21 -34.28 78.0 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.039 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.433 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -62.78 -39.29 93.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.807 178.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 14' ' ' PHE . 61.0 t -60.15 -51.13 76.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.858 HG23 ' HD1' ' B' ' 27' ' ' TRP . 40.1 mm -52.68 -52.79 24.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.3 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.598 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.2 m-30 -60.37 -42.12 95.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.684 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.661 HG21 ' HB ' ' A' ' 20' ' ' ILE . 27.0 p -68.19 -42.53 79.78 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.352 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 47.4 m -65.33 -28.88 69.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.186 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.21 -24.21 0.09 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.492 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.9 -62.4 4.63 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.6 m -89.45 40.51 0.99 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.524 0.678 . . . . 0.0 110.177 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.416 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.8 tpm_? -105.17 -35.18 7.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.127 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.858 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.183 -1.372 . . . . 0.0 109.409 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.2 t -72.41 -45.06 61.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 123.487 0.492 . . . . 0.0 109.788 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.658 HD23 HD13 ' A' ' 23' ' ' LEU . 74.6 mt -69.21 -53.77 18.23 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.513 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.76 71.6 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.63 -49.03 83.09 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.424 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 48.9 tp -71.73 -37.91 70.52 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.5 t -54.9 -42.3 71.99 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.288 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.9 t -59.2 -42.21 90.39 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.093 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -74.04 -41.42 61.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.737 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.547 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 62.0 m -60.18 -45.56 92.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.624 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.405 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 48.1 t -74.7 -39.08 62.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.974 0.416 . . . . 0.0 110.858 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 3.2 ttmp? -68.95 -60.1 2.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.844 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.498 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 8.0 m0 -106.56 -54.74 2.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.236 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 139.77 -172.8 23.19 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.479 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.4 p -165.5 148.92 8.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.776 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.474 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 4.2 m -97.15 171.17 8.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.535 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HG3' HG22 ' B' ' 21' ' ' THR . 34.9 tttm -55.92 -36.28 67.56 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.493 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -51.83 68.37 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.46 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.84 -43.5 95.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.36 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.661 ' HB ' HG21 ' B' ' 21' ' ' THR . 39.8 mt -69.99 -44.94 78.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.925 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.523 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 75.2 m -64.4 -22.46 66.97 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.4 m -66.94 -8.52 30.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.917 0.389 . . . . 0.0 110.886 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.658 HD13 HD23 ' A' ' 3' ' ' LEU . 59.0 mt -116.8 26.2 10.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.536 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 70.5 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.44 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.515 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -144.69 -171.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.644 0.259 . . . . 0.0 110.847 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.535 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 70.0 mtp180 -87.87 130.39 34.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.309 0.576 . . . . 0.0 109.936 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.98 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 10.6 mp -116.25 109.4 17.35 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.562 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 72.3 m -112.14 116.95 31.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.923 0.392 . . . . 0.0 111.557 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 51.32 -109.55 0.8 Allowed Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.329 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -59.61 -29.46 68.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -69.4 -37.76 77.64 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.686 ' O ' HG23 ' B' ' 18' ' ' VAL . 55.0 t80 -61.11 -55.6 30.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.078 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.658 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.5 mt -57.26 -52.31 58.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.41 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.632 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.5 mmp_? -64.03 -33.73 76.41 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.276 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.43 83.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.718 ' HA ' HG22 ' A' ' 20' ' ' ILE . 75.6 t -60.16 -47.71 90.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.77 HG23 ' HD1' ' B' ' 27' ' ' TRP . 21.1 mm -59.69 -51.83 68.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.089 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.467 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.3 OUTLIER -55.9 -47.38 77.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.814 -179.056 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.534 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 19.5 p -62.86 -40.54 97.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.001 0.429 . . . . 0.0 111.274 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 57.6 m -80.69 -10.57 59.72 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.22 -30.26 0.42 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.537 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.34 -52.81 4.76 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.5 m -104.16 40.35 1.48 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.472 0.653 . . . . 0.0 110.085 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -98.52 -36.08 10.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.354 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.77 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.205 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.922 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 39.2 t -71.56 -46.35 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.473 0.483 . . . . 0.0 109.758 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.85 -53.87 18.92 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.546 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.25 -35.46 69.75 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.05 -50.14 70.7 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.595 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 42.8 mt -70.39 -42.52 71.59 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 t -52.34 -42.44 63.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.85 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.5 t -59.11 -45.33 91.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.586 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.5 m -76.35 -38.68 55.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.98 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 67.4 m -63.0 -42.71 99.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.694 0.283 . . . . 0.0 111.419 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.69 -40.16 49.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.109 0.481 . . . . 0.0 110.427 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -67.97 -48.31 66.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.442 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.503 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 9.2 m0 -118.78 -58.72 1.93 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.356 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 141.68 -174.6 22.95 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.452 ' SG ' HD22 ' B' ' 9' ' ' LEU . 1.8 p -162.36 152.82 16.96 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.885 0.342 . . . . 0.0 110.875 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.4 m -97.37 167.57 10.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.07 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -52.56 -37.95 58.91 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.072 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.22 -50.27 74.15 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.601 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.35 -42.83 87.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.498 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.718 HG22 ' HA ' ' B' ' 18' ' ' VAL . 24.5 mt -72.06 -46.14 60.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.534 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 66.4 m -65.68 -34.13 77.49 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.191 -0.318 . . . . 0.0 111.579 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 t -68.58 -1.14 6.1 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.355 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.475 HD22 HD12 ' A' ' 6' ' ' LEU . 23.7 tp -85.18 -23.69 28.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.674 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.4 m . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.879 -179.547 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.2 -172.67 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 122.837 -0.214 . . . . 0.0 110.438 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.573 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 66.3 mtp180 -90.79 129.36 36.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.082 0.467 . . . . 0.0 110.051 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.7 mm? -122.14 111.92 17.57 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.178 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 97.9 m -109.76 123.14 49.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.92 -105.49 0.13 Allowed Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.57 -0.741 . . . . 0.0 114.522 178.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -60.48 -29.72 69.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.42 -35.9 73.69 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.55 ' O ' HG23 ' B' ' 18' ' ' VAL . 48.2 t80 -65.18 -50.88 64.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.441 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.663 ' O ' HG12 ' B' ' 19' ' ' ILE . 66.6 mt -57.75 -50.33 77.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.877 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.571 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.7 mmp_? -63.72 -32.02 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.985 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.33 -44.68 94.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.118 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.55 HG23 ' O ' ' B' ' 14' ' ' PHE . 63.4 t -58.0 -50.3 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.859 HG23 ' HD1' ' B' ' 27' ' ' TRP . 34.6 mm -54.52 -50.98 54.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.147 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.49 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.1 m-30 -58.26 -45.41 87.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.747 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.862 HG21 ' HB ' ' A' ' 20' ' ' ILE . 11.9 p -63.54 -38.73 92.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.642 0.258 . . . . 0.0 111.557 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 34.0 m -70.76 -30.93 67.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.758 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.92 -22.14 0.09 OUTLIER Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.655 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 83.97 -60.03 4.89 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 112.176 -0.37 . . . . 0.0 112.176 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -92.6 48.88 1.41 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.524 0.678 . . . . 0.0 109.801 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.8 tpm_? -112.76 -37.4 4.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.985 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.859 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.988 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 39.4 t0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -108.54 -41.64 5.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.426 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.91 -55.4 19.54 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.8 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.49 -36.26 61.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.001 0.429 . . . . 0.0 110.306 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.93 66.53 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.034 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.5 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 44.8 tp -72.22 -39.18 68.7 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 t -54.32 -42.94 70.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.554 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.4 t -58.23 -44.11 88.09 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.203 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -74.16 -40.8 62.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.7 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.599 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 62.5 m -58.04 -44.95 87.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 111.705 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.9 t -78.2 -40.47 37.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.0 0.428 . . . . 0.0 110.995 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -66.85 -49.85 64.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.849 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.544 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 8.8 m0 -119.47 -54.72 2.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.211 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.06 -171.17 25.05 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.551 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.0 p -166.45 151.05 7.72 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.182 0.515 . . . . 0.0 111.355 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.483 ' O ' HG13 ' A' ' 20' ' ' ILE . 67.6 p -93.1 165.4 12.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.679 ' HG3' HG22 ' B' ' 21' ' ' THR . 37.4 tttm -56.72 -40.14 75.15 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.362 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 m -57.33 -48.17 79.67 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.393 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -63.45 -46.29 86.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.881 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.862 ' HB ' HG21 ' B' ' 21' ' ' THR . 32.5 mt -67.46 -39.53 82.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.588 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.433 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 44.8 m -64.74 -24.43 67.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.779 0.323 . . . . 0.0 110.944 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.0 m -67.88 -5.87 18.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.138 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -107.7 19.04 20.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.466 179.258 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 24.7 m -139.72 -179.96 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.542 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 67.1 mtp180 -86.32 127.79 34.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.176 0.512 . . . . 0.0 110.008 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.3 mm? -122.42 117.18 25.4 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.41 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 79.3 m -115.52 120.97 41.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.826 0.345 . . . . 0.0 111.893 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 53.41 -107.83 0.67 Allowed Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.285 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -59.48 -30.39 68.5 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.08 -36.63 75.07 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.634 ' O ' HG23 ' B' ' 18' ' ' VAL . 40.5 t80 -61.62 -53.04 61.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.218 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.62 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.2 mt -60.68 -49.27 85.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.347 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.547 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 5.0 mmp_? -61.89 -34.21 75.63 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.475 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.67 96.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.278 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.785 ' HA ' HG22 ' A' ' 20' ' ' ILE . 59.1 t -59.52 -49.28 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-O 122.041 0.924 . . . . 0.0 108.802 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.769 HG23 ' HD1' ' B' ' 27' ' ' TRP . 20.8 mm -59.07 -52.8 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.284 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.448 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.9 OUTLIER -57.74 -45.08 86.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.312 -178.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.554 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 18.6 p -63.48 -40.51 97.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.92 0.39 . . . . 0.0 111.267 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -78.33 -26.21 46.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.652 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.66 -31.47 0.09 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 119.998 -1.096 . . . . 0.0 113.359 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 87.2 -56.83 4.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.688 -0.291 . . . . 0.0 112.521 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.5 m -99.21 51.06 0.95 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.483 0.658 . . . . 0.0 110.114 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 7.2 tpm_? -113.94 -38.82 4.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.941 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.769 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.035 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.933 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.09 -44.81 64.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 123.392 0.433 . . . . 0.0 109.918 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.48 -54.52 13.83 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.749 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.14 75.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.01 -48.54 82.67 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.883 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.666 HD23 HD11 ' A' ' 23' ' ' LEU . 35.1 tp -71.0 -41.05 71.43 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 t -53.02 -41.72 64.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.675 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 m -58.81 -34.13 71.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.705 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 m -86.08 -38.27 17.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.352 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.553 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 71.1 m -60.26 -40.57 90.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.782 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.0 t -79.6 -41.56 26.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.989 0.423 . . . . 0.0 110.896 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -67.57 -50.04 60.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.878 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.538 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 11.2 m0 -114.64 -56.71 2.35 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.313 -178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.32 173.17 14.09 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 99.2 m -146.66 148.56 32.18 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.824 0.345 . . . . 0.0 110.935 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.516 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.4 m -94.63 166.19 12.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.617 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -52.94 -38.85 62.4 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.943 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -53.85 53.54 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.473 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -63.3 -42.54 99.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.561 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.785 HG22 ' HA ' ' B' ' 18' ' ' VAL . 45.8 mt -70.63 -45.21 75.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.554 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 73.1 m -64.82 -27.68 69.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.605 0.24 . . . . 0.0 111.601 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.3 m -69.29 -1.74 8.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.971 0.415 . . . . 0.0 111.364 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.666 HD11 HD23 ' A' ' 6' ' ' LEU . 97.3 mt -90.12 -11.18 42.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.807 179.672 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.817 HG22 ' H ' ' B' ' 8' ' ' ARG . 6.2 p -163.46 -173.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.817 ' H ' HG22 ' B' ' 7' ' ' VAL . 69.0 mtp180 -85.1 131.09 34.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.249 0.547 . . . . 0.0 110.398 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.62 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.2 mm? -126.44 115.76 20.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.86 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 73.1 m -111.73 120.78 43.18 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 45.56 -100.62 0.02 OUTLIER Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.425 ' HE ' ' CD ' ' B' ' 13' ' ' GLU . 7.1 tmm_? -54.57 -41.18 69.53 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.112 0.565 . . . . 0.0 111.661 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.62 ' HB3' HD12 ' B' ' 9' ' ' LEU . 14.1 mp0 -69.15 -36.08 77.03 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.626 ' O ' HG23 ' B' ' 18' ' ' VAL . 46.0 t80 -61.9 -56.52 18.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.013 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ILE . . . . . 0.591 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.9 mt -58.54 -48.06 86.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.529 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.508 ' NH1' HG13 ' B' ' 19' ' ' ILE . 13.1 mmm180 -64.13 -34.24 77.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.493 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.85 -40.45 97.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.153 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.784 ' HA ' HG22 ' A' ' 20' ' ' ILE . 57.9 t -59.42 -49.5 83.35 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.862 HG23 ' HD1' ' B' ' 27' ' ' TRP . 19.6 mm -57.87 -53.56 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.333 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.51 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.6 m-30 -57.17 -45.21 83.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.576 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' THR . . . . . 0.5 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 21.2 p -64.89 -40.77 95.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.05 0.452 . . . . 0.0 111.378 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -76.93 -20.38 56.24 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.651 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.84 -30.4 0.16 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.094 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.4 -55.56 5.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.707 -0.283 . . . . 0.0 112.548 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.2 m -97.06 46.53 1.04 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.43 0.633 . . . . 0.0 110.335 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 7.3 tpm_? -110.41 -37.49 5.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.327 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' TRP . . . . . 0.862 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.372 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.44 -49.35 60.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.401 0.438 . . . . 0.0 110.68 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.538 ' HG ' HD21 ' A' ' 23' ' ' LEU . 10.7 mp -72.17 -51.38 21.51 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.408 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.29 70.87 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.88 -49.29 77.25 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.75 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.492 HD23 HD22 ' A' ' 23' ' ' LEU . 40.9 tp -71.01 -39.91 72.11 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.6 t -55.12 -42.52 73.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.406 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 t -57.77 -44.16 85.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.334 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -74.68 -40.53 61.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.969 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.472 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 56.1 m -60.3 -43.11 96.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 111.603 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.65 -39.57 36.63 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.904 0.383 . . . . 0.0 110.874 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -68.31 -50.85 50.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.825 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.521 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 8.4 m0 -116.39 -55.11 2.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.29 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.6 -173.64 23.01 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -164.98 149.56 9.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.964 0.412 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.531 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 3.6 m -94.8 168.74 10.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.478 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' HG3' HG22 ' B' ' 21' ' ' THR . 37.7 tttm -54.33 -37.15 64.53 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.903 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -50.36 74.32 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.357 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.531 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -63.2 -45.18 92.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.784 HG22 ' HA ' ' B' ' 18' ' ' VAL . 33.2 mt -69.76 -43.13 80.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.545 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.5 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 71.4 m -64.11 -36.7 84.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.754 0.311 . . . . 0.0 111.14 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.5 m -70.13 5.19 1.74 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.667 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.538 HD21 ' HG ' ' A' ' 3' ' ' LEU . 21.6 tp -92.23 -22.48 19.77 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.849 0.356 . . . . 0.0 110.234 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.8 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.025 179.668 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.02 -150.93 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.23 136.56 95.3 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.708 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.456 ' HA ' HG22 ' B' ' 7' ' ' VAL . 68.7 Cg_endo -74.02 52.74 2.72 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.028 2.485 . . . . 0.0 112.454 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.585 ' CE1' ' HA ' ' B' ' 21' ' ' THR . 9.5 m-30 -97.74 18.49 15.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.485 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 162.22 58.08 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' B' ' 4' ' ' PRO . 15.7 m -147.04 -171.14 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.449 0.166 . . . . 0.0 110.646 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.564 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 67.5 mtp180 -86.27 129.02 34.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.211 0.529 . . . . 0.0 109.965 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -125.69 117.42 23.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.407 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 69.2 m -113.22 122.01 46.18 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.98 -104.97 0.13 Allowed Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.396 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -57.59 -33.69 68.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.437 ' HB3' HD12 ' B' ' 9' ' ' LEU . 53.8 mm-40 -70.82 -34.89 72.19 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.595 ' O ' HG23 ' B' ' 18' ' ' VAL . 41.3 t80 -62.15 -54.08 46.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.334 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.596 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.5 mt -59.51 -50.69 78.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.505 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.609 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.0 mmp_? -62.22 -33.24 74.19 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.732 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.438 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -65.18 -39.52 93.0 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.81 ' HA ' HG22 ' A' ' 20' ' ' ILE . 91.7 t -59.7 -49.04 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-O 121.92 0.867 . . . . 0.0 108.714 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.778 HG23 ' HD1' ' B' ' 27' ' ' TRP . 13.9 mm -59.72 -52.69 58.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.165 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.46 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.5 m-30 -56.51 -45.39 81.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.201 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.585 ' HA ' ' CE1' ' B' ' 5' ' ' TYR . 23.4 p -63.57 -39.8 95.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.36 0.6 . . . . 0.0 110.876 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 59.4 m -81.55 -13.25 58.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.03 -30.19 0.33 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.351 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.14 -49.29 4.08 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.62 -0.324 . . . . 0.0 112.502 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.5 m -105.18 41.47 1.35 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.291 0.567 . . . . 0.0 110.538 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.51 ' NH1' ' HB3' ' A' ' 24' ' ' CYS . 54.7 ttt180 -98.7 -36.35 9.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.778 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.848 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.65 -49.85 43.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.37 . . . . 0.0 110.735 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 70.6 mt -70.57 -50.69 34.69 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.787 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.64 76.82 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.67 90.05 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.501 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.819 HD23 HD11 ' A' ' 23' ' ' LEU . 33.4 tp -72.26 -40.0 68.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.0 t -53.27 -41.55 65.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.527 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.3 m -59.16 -44.48 92.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.395 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -72.73 -39.4 66.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.619 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.493 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 82.4 m -60.8 -38.24 84.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.565 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.23 -43.1 19.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.015 0.436 . . . . 0.0 110.786 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -65.35 -51.25 61.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.852 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.505 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 13.0 m0 -113.61 -55.55 2.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.384 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.54 174.92 14.2 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.1 m -147.5 147.54 30.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.852 0.326 . . . . 0.0 110.72 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.558 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.5 m -94.78 164.44 12.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.28 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -53.02 -36.89 61.02 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -53.51 57.6 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.345 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.99 -42.68 99.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.428 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' B' ' 18' ' ' VAL . 34.2 mt -70.77 -46.09 70.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.664 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.515 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 66.3 m -64.6 -27.14 68.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.6 m -68.92 -3.87 14.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.932 0.396 . . . . 0.0 111.54 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.819 HD11 HD23 ' A' ' 6' ' ' LEU . 93.8 mt -91.47 -4.26 55.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.68 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.51 ' HB3' ' NH1' ' B' ' 26' ' ' ARG . 71.0 m . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.327 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 7.7 ppt_? . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.13 -149.44 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.923 0.392 . . . . 0.0 111.326 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.09 76.1 2.5 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.87 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.04 54.86 4.77 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.988 2.459 . . . . 0.0 111.144 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.681 ' CE1' ' HA ' ' B' ' 21' ' ' THR . 14.6 m-30 -81.68 34.35 0.39 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.866 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 158.88 56.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.341 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.64 -172.15 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.681 0.24 . . . . 0.0 110.714 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.565 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 53.0 mtp85 -87.15 127.39 35.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -124.07 119.0 28.22 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.802 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' CYS . . . . . 0.4 ' H ' ' HB2' ' B' ' 13' ' ' GLU . 82.5 m -115.09 120.62 40.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.594 0.235 . . . . 0.0 111.556 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.41 -103.36 0.07 OUTLIER Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.945 -0.571 . . . . 0.0 114.269 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -57.63 -35.29 70.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.513 ' HB3' HD12 ' B' ' 9' ' ' LEU . 3.2 mp0 -69.26 -35.46 76.11 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.588 ' O ' HG23 ' B' ' 18' ' ' VAL . 33.6 t80 -61.95 -51.95 66.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.062 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.538 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.6 mt -59.03 -48.58 86.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.429 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 5.9 mmp_? -61.92 -38.11 87.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.336 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.489 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -63.13 -38.2 90.25 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.299 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 20' ' ' ILE . 98.8 t -59.97 -50.82 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.877 HD12 ' CD1' ' B' ' 27' ' ' TRP . 7.6 mm -57.26 -50.88 75.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.845 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -57.76 -41.88 82.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.209 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.735 HG21 ' HB ' ' A' ' 20' ' ' ILE . 22.8 p -66.91 -43.78 82.49 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.62 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.01 -37.86 89.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.705 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.73 -31.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.638 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.84 28.35 42.57 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 32.5 p -172.09 88.79 0.1 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -167.36 -38.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.646 0.736 . . . . 0.0 110.057 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.877 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.502 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t -72.24 -44.71 63.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 123.54 0.525 . . . . 0.0 109.791 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.406 ' HG ' HD13 ' A' ' 23' ' ' LEU . 11.0 mp -69.49 -54.48 14.04 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.531 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.52 74.45 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.4 81.94 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.699 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.505 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 40.6 tp -70.75 -43.37 68.95 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.8 t -52.43 -42.66 64.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.635 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 t -58.93 -43.28 91.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.196 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.9 m -74.1 -38.66 63.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.999 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 70.8 m -60.14 -41.51 92.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.76 0.314 . . . . 0.0 111.08 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.8 t -81.54 -39.28 24.89 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.024 0.44 . . . . 0.0 111.042 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -68.68 -43.82 75.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.82 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.447 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 10.5 m0 -123.48 -56.33 1.71 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.123 0.487 . . . . 0.0 111.385 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.89 173.6 15.49 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.2 m -147.23 145.91 29.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.117 0.459 . . . . 0.0 111.033 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.499 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.5 m -94.4 168.72 10.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.536 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -54.64 -37.97 66.31 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.847 0.356 . . . . 0.0 110.884 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.54 -53.96 51.49 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.493 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.57 -44.1 97.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.6 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.735 ' HB ' HG21 ' B' ' 21' ' ' THR . 34.0 mt -70.54 -44.36 77.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.22 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.471 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 67.6 m -65.53 -18.81 65.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.406 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.2 m -65.58 -11.38 43.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.045 0.45 . . . . 0.0 110.518 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.406 HD13 ' HG ' ' A' ' 3' ' ' LEU . 77.4 mt -111.08 26.53 10.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.823 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 95.9 m . . . . . 0 C--O 1.257 1.477 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.32 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.75 -151.8 0.34 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' B' ' 4' ' ' PRO . . . -160.47 121.0 1.66 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.652 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' B' ' 17' ' ' ALA . 5.3 Cg_exo -80.07 48.45 2.87 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.454 2.769 . . . . 0.0 111.492 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.554 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 4.0 m-30 -86.69 65.64 9.1 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.551 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.25 49.85 0.8 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.303 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.21 178.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 O-C-N 122.847 -0.208 . . . . 0.0 110.47 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.563 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 68.3 mtp180 -86.7 129.08 35.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.144 0.497 . . . . 0.0 110.039 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -123.99 118.24 26.56 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.271 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' CYS . . . . . 0.403 ' H ' ' HB2' ' B' ' 13' ' ' GLU . 84.3 m -114.38 120.06 39.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.8 -103.59 0.09 OUTLIER Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.882 -0.599 . . . . 0.0 114.309 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -57.89 -34.53 69.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.44 ' HB3' HD12 ' B' ' 9' ' ' LEU . 2.9 mp0 -69.11 -35.55 76.57 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.545 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 38.6 t80 -62.94 -50.08 72.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.095 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.646 ' O ' HG12 ' B' ' 19' ' ' ILE . 66.8 mt -59.5 -50.66 79.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.964 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.658 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.1 mmp_? -62.43 -33.39 74.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.435 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' B' ' 4' ' ' PRO . . . -63.11 -43.3 98.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.619 ' HA ' HG22 ' A' ' 20' ' ' ILE . 96.3 t -58.31 -48.1 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.756 HD12 ' CD1' ' B' ' 27' ' ' TRP . 18.4 mm -57.84 -49.54 80.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.877 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.466 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.4 m-30 -58.61 -43.23 89.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.98 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.798 HG21 ' HB ' ' A' ' 20' ' ' ILE . 11.1 p -65.64 -40.58 92.66 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.716 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 37.4 m -67.01 -34.66 78.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.251 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.68 -37.31 0.13 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.04 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 106.56 -42.53 1.89 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -112.04 41.09 2.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.4 0.619 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 77.2 ttt180 -96.31 -36.61 10.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.412 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.756 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.698 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.513 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 27.7 p-10 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.97 -42.02 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.089 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.52 -58.15 4.74 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.999 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.513 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.74 -35.01 73.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.98 -46.93 93.06 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.437 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.513 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 42.5 tp -72.7 -42.98 63.63 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 t -51.26 -43.64 61.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.973 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -58.3 -43.89 88.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.509 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.2 m -74.13 -36.69 64.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.931 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.513 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 83.6 m -60.46 -39.87 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.957 0.408 . . . . 0.0 110.343 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.7 t -81.27 -42.98 19.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.947 0.404 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.525 ' HG2' ' CD1' ' A' ' 13' ' ' TRP . 18.8 ttpp -62.9 -50.16 71.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.941 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.525 ' CD1' ' HG2' ' A' ' 12' ' ' LYS . 32.4 m0 -118.66 -54.32 2.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.546 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 141.54 174.46 14.43 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 92.1 m -147.11 146.41 29.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.916 0.358 . . . . 0.0 110.894 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.504 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.5 m -93.99 169.64 10.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.997 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.554 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 52.7 tttp -55.1 -38.39 68.07 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.962 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -51.25 70.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.605 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -61.57 -45.58 93.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.924 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.798 ' HB ' HG21 ' B' ' 21' ' ' THR . 31.5 mt -70.75 -42.37 77.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.36 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.46 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 47.0 m -65.72 -20.23 66.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 111.025 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.7 t -66.49 -10.39 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.506 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -109.62 23.6 14.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.184 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 C--O 1.256 1.405 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.18 179.589 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 30.6 mmm-85 . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.34 -150.49 0.29 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.753 0.658 . . . . 0.0 109.228 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.28 129.34 93.44 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 123.371 0.42 . . . . 0.0 110.746 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.518 ' HB3' HD11 ' B' ' 9' ' ' LEU . 74.5 Cg_endo -75.93 50.15 2.71 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 123.109 2.539 . . . . 0.0 112.504 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -102.06 49.28 0.86 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.335 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 126.2 55.3 0.15 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.697 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 m -148.64 -168.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.557 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.4 mtp180 -88.22 130.36 35.1 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.18 0.514 . . . . 0.0 109.789 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.563 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.3 mm? -124.06 114.64 19.99 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.409 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' CYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 78.7 m -109.12 117.66 34.72 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 46.06 -100.36 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 O-C-N 123.871 0.732 . . . . 0.0 114.384 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -53.71 -38.45 64.28 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.285 0.634 . . . . 0.0 112.138 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -70.74 -36.34 73.1 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.573 ' O ' HG23 ' B' ' 18' ' ' VAL . 35.6 t80 -63.52 -53.49 51.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.487 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.572 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.4 mt -59.13 -48.29 87.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.626 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.49 ' HA ' ' HD2' ' B' ' 16' ' ' ARG . 5.2 tpt180 -66.14 -32.88 74.6 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.264 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.89 95.96 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.587 ' HA ' HG22 ' A' ' 20' ' ' ILE . 91.3 t -60.3 -49.83 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.776 HG23 ' HD1' ' B' ' 27' ' ' TRP . 35.8 mm -55.19 -50.79 61.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.335 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.498 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.9 m-30 -58.49 -46.07 87.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.924 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.655 HG22 ' HG2' ' A' ' 17' ' ' LYS . 18.2 p -65.1 -39.22 92.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.044 0.449 . . . . 0.0 110.756 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.513 ' HB3' HH11 ' B' ' 26' ' ' ARG . 78.6 m -66.91 -26.55 66.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.503 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.32 -19.75 0.23 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.283 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.39 -50.42 4.33 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 112.329 -0.308 . . . . 0.0 112.329 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -101.18 29.2 4.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.315 0.578 . . . . 0.0 110.39 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.513 HH11 ' HB3' ' B' ' 22' ' ' CYS . 72.3 ttt180 -88.65 -33.27 17.66 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.744 0.783 . . . . 0.0 109.491 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.776 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.312 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.71 -45.32 66.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 123.424 0.452 . . . . 0.0 109.955 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.81 -54.05 15.37 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.534 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.08 -36.78 73.34 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.91 -49.43 75.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.766 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.71 -39.63 73.3 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.6 t -55.27 -43.59 74.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.37 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.6 m -60.86 -35.58 76.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.555 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 m -80.35 -38.49 30.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.58 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 52.2 m -61.73 -41.79 98.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 110.716 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.416 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 49.6 t -76.88 -40.47 47.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.931 0.396 . . . . 0.0 110.682 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -69.47 -50.77 42.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.86 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.51 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 10.6 m0 -114.17 -57.1 2.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.271 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.58 -172.06 23.75 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.427 ' SG ' HD23 ' B' ' 9' ' ' LEU . 1.8 p -164.81 150.12 9.77 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.867 0.365 . . . . 0.0 110.73 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.584 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.9 m -94.04 169.77 10.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.064 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.655 ' HG2' HG22 ' B' ' 21' ' ' THR . 10.5 tmtt? -54.42 -35.36 62.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.039 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -51.34 64.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.993 0.425 . . . . 0.0 111.474 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -58.71 -44.54 90.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.168 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.587 HG22 ' HA ' ' B' ' 18' ' ' VAL . 40.0 mt -67.69 -40.89 84.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.2 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.472 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 68.8 m -64.69 -18.09 64.67 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 m -66.39 -13.15 60.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.929 0.395 . . . . 0.0 111.047 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.75 -5.08 42.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.106 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 80.6 m . . . . . 0 C--O 1.257 1.453 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.33 -178.901 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.64 -150.39 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.98 133.74 94.88 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.762 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.447 ' HA ' HG22 ' B' ' 7' ' ' VAL . 69.5 Cg_endo -74.59 52.08 2.79 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 123.048 2.499 . . . . 0.0 112.572 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' B' ' 21' ' ' THR . 9.4 m-30 -99.14 18.36 17.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.522 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 162.25 59.28 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' B' ' 4' ' ' PRO . 14.5 m -148.65 -169.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.508 0.194 . . . . 0.0 110.484 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.568 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 65.5 mtp180 -86.92 127.93 35.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.19 0.519 . . . . 0.0 109.711 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.4 mm? -122.97 115.07 21.3 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.59 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' CYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 65.0 m -109.46 119.93 40.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.53 -104.04 0.09 OUTLIER Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.464 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.439 HH11 ' HG2' ' B' ' 12' ' ' ARG . 33.4 ttp85 -56.86 -32.13 65.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.695 0.398 . . . . 0.0 111.7 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.507 ' HB3' HD12 ' B' ' 9' ' ' LEU . 25.5 mm-40 -70.02 -38.68 75.99 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.613 ' O ' HG23 ' B' ' 18' ' ' VAL . 39.8 t80 -59.36 -53.39 58.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.349 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.6 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.1 mt -59.45 -51.93 66.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.849 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.683 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 2.2 mmp_? -63.68 -31.72 72.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.709 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.33 -38.39 89.98 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.795 ' HA ' HG22 ' A' ' 20' ' ' ILE . 84.6 t -59.61 -49.73 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.756 HG23 ' HD1' ' B' ' 27' ' ' TRP . 13.4 mm -57.47 -53.41 44.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.136 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.659 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.6 m-30 -56.38 -45.09 80.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.43 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.617 HG21 ' HB ' ' A' ' 20' ' ' ILE . 24.7 p -65.63 -40.68 92.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.356 0.598 . . . . 0.0 111.051 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -74.32 -18.21 60.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.753 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.83 -21.89 0.23 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.917 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.45 -51.16 4.52 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.3 m -104.31 38.52 1.85 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.324 0.583 . . . . 0.0 109.771 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.423 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 9.4 tpp85 -87.48 -38.8 15.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.114 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.756 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.665 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.52 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.5 p-10 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 47.2 t -111.22 -44.19 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.157 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -68.99 -57.27 5.68 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.52 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.11 -33.29 70.68 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.1 -43.71 98.03 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.579 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 42.2 mt -82.2 -43.21 17.95 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 39.7 t -49.47 -45.14 46.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.588 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 p -62.32 -46.54 88.24 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.568 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 m -68.88 -39.47 79.79 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.35 0.26 . . . . 0.0 111.115 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.48 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 78.3 m -62.28 -38.78 90.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.916 0.389 . . . . 0.0 110.092 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.435 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 44.5 t -78.97 -44.46 22.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.099 0.476 . . . . 0.0 110.459 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -63.2 -50.24 71.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.688 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.511 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 22.1 m0 -117.08 -57.73 2.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.548 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.47 173.96 14.67 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.8 m -147.78 147.54 29.98 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 116.994 0.397 . . . . 0.0 110.61 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.57 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.7 m -95.09 163.84 13.13 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.417 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -52.51 -38.22 59.11 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.497 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -52.37 66.04 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.452 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -60.38 -44.78 95.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.795 HG22 ' HA ' ' B' ' 18' ' ' VAL . 27.1 mt -70.71 -44.06 76.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.695 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 70.7 m -63.53 -25.09 68.09 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.431 -0.168 . . . . 0.0 111.382 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.7 m -64.61 -8.55 14.64 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.487 HD11 HD12 ' A' ' 6' ' ' LEU . 7.8 mp -80.74 -21.94 40.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.4 m . . . . . 0 C--O 1.244 0.785 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.82 -179.311 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ARG . . . . . 0.552 ' HB3' ' OE2' ' B' ' 13' ' ' GLU . 7.2 ptm85 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.49 -146.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.192 0.307 . . . . 0.0 110.31 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' B' ' 4' ' ' PRO . . . -67.09 115.68 28.07 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.0 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.691 ' HB3' HD11 ' B' ' 9' ' ' LEU . 12.1 Cg_endo -90.34 44.44 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.41 2.74 . . . . 0.0 111.844 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -93.81 68.13 3.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.516 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 101.58 53.89 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.086 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.41 ' CG2' ' HA ' ' B' ' 4' ' ' PRO . 20.4 m -144.22 -167.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.616 0.246 . . . . 0.0 110.532 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -89.18 130.96 35.51 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.691 HD11 ' HB3' ' B' ' 4' ' ' PRO . 2.6 mm? -127.14 112.39 15.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.322 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 85.5 m -109.75 119.09 38.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.752 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.51 -105.55 0.16 Allowed Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.736 -0.666 . . . . 0.0 114.556 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -57.02 -32.14 65.84 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 122.752 0.421 . . . . 0.0 112.051 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.552 ' OE2' ' HB3' ' B' ' 1' ' ' ARG . 5.7 mm-40 -68.38 -40.17 81.49 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.663 ' O ' HG23 ' B' ' 18' ' ' VAL . 55.2 t80 -61.23 -53.7 53.61 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.623 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.554 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.3 mt -56.51 -50.2 74.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.037 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.527 ' HA ' ' HD2' ' B' ' 16' ' ' ARG . 3.7 tpt180 -67.27 -31.78 72.34 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.953 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.4 96.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.805 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.747 ' HA ' HG22 ' A' ' 20' ' ' ILE . 92.0 t -59.97 -50.37 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.816 HG23 ' HD1' ' B' ' 27' ' ' TRP . 26.7 mm -57.58 -52.46 57.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.457 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.55 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.4 m-30 -56.57 -47.6 79.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.904 -1.043 . . . . 0.0 113.4 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.483 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 21.7 p -64.18 -41.22 97.19 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.167 0.508 . . . . 0.0 111.532 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 57.3 m -77.08 -14.27 59.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.995 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.13 -29.38 0.25 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 119.778 -1.201 . . . . 0.0 113.205 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.68 -48.68 4.04 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -106.51 26.44 9.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.198 0.523 . . . . 0.0 110.16 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -84.83 -33.05 22.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.789 0.804 . . . . 0.0 109.49 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.816 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.12 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.541 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 27.2 p-10 . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 26.3 t -111.29 -42.81 4.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.111 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.454 ' HG ' HD21 ' A' ' 23' ' ' LEU . 9.3 mp -68.86 -57.61 5.32 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.541 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -57.52 -33.92 68.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.72 84.86 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.373 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 62.8 mt -72.85 -39.59 66.4 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 29.3 t -52.86 -43.81 66.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.736 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.2 m -60.69 -44.82 96.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.445 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -71.12 -38.23 72.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.717 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.683 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 64.7 m -63.82 -37.18 86.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 110.865 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 34.9 t -79.62 -37.73 35.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.181 0.515 . . . . 0.0 110.297 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -73.29 -52.52 13.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.16 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -113.32 -42.3 3.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.249 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 120.16 -179.1 16.53 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.48 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.1 p -161.36 150.41 16.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.935 0.398 . . . . 0.0 111.155 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.527 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.0 m -96.9 167.33 11.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.911 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.423 ' HG3' HG22 ' B' ' 21' ' ' THR . 38.2 tttm -54.21 -37.42 64.55 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.16 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -50.55 73.64 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.426 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -62.89 -45.01 94.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.094 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.747 HG22 ' HA ' ' B' ' 18' ' ' VAL . 24.2 mt -71.51 -42.3 72.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.681 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.483 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 70.5 m -64.04 -36.16 83.08 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.142 -0.349 . . . . 0.0 111.314 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.2 m -69.03 3.72 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.82 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.454 HD21 ' HG ' ' A' ' 3' ' ' LEU . 20.2 tp -90.04 -22.48 21.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.698 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.2 m . . . . . 0 C--O 1.243 0.73 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.91 -179.512 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.7 56.71 3.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.9 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.34 55.33 0.61 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.47 ' HB3' HD11 ' B' ' 9' ' ' LEU . 69.4 Cg_endo -86.27 38.98 0.62 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.6 2.2 . . . . 0.0 112.553 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -102.51 70.26 1.14 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.941 0.4 . . . . 0.0 111.112 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.71 46.68 2.44 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.829 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' B' ' 4' ' ' PRO . 35.1 m -142.35 -177.0 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.571 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 72.3 mtp180 -83.29 129.71 35.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.123 0.487 . . . . 0.0 110.339 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.4 mm? -123.87 118.49 27.22 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.992 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 65.8 m -117.79 119.66 35.57 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.37 -98.66 0.02 OUTLIER Glycine 0 CA--C 1.519 0.316 0 N-CA-C 114.761 0.665 . . . . 0.0 114.761 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.423 ' H ' ' HG3' ' B' ' 12' ' ' ARG . 15.6 mtm180 -53.4 -44.37 68.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.281 0.632 . . . . 0.0 111.941 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.572 ' HB3' HD12 ' B' ' 9' ' ' LEU . 3.0 mp0 -72.29 -30.98 65.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.896 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.591 ' O ' HG23 ' B' ' 18' ' ' VAL . 41.7 t80 -65.1 -51.68 59.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.038 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.642 ' O ' HG12 ' B' ' 19' ' ' ILE . 80.1 mt -61.53 -49.22 85.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.865 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.574 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.5 mmp_? -62.83 -32.11 73.25 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.298 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.547 ' HB1' HD13 ' A' ' 20' ' ' ILE . . . -63.92 -44.0 94.24 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.601 ' HA ' HG22 ' A' ' 20' ' ' ILE . 61.8 t -57.8 -51.11 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.861 HG23 ' HD1' ' B' ' 27' ' ' TRP . 37.9 mm -53.42 -51.42 41.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.311 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.534 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.8 m-30 -58.82 -44.74 90.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.732 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.861 HG21 ' HB ' ' A' ' 20' ' ' ILE . 17.0 p -63.7 -39.38 94.17 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.589 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 m -69.39 -31.33 69.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.652 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.39 -22.23 0.09 OUTLIER Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.674 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.21 -62.26 4.6 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.4 m -90.85 48.18 1.5 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.565 0.698 . . . . 0.0 109.641 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.8 tpm_? -112.55 -37.19 5.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.124 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.861 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.12 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.117 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.95 -44.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 123.511 0.507 . . . . 0.0 109.865 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.97 -54.46 13.2 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.68 -35.79 73.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.47 -49.48 73.48 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.647 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.475 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 43.5 tp -70.8 -39.93 72.83 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.9 t -55.65 -37.81 68.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.476 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 t -59.8 -41.73 91.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.882 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.7 m -76.23 -43.16 43.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.53 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 75.5 m -60.03 -39.48 86.05 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.256 0.347 . . . . 0.0 111.467 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.45 -38.72 25.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.838 0.352 . . . . 0.0 111.009 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 3.2 ttmp? -68.43 -61.5 1.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.278 0.561 . . . . 0.0 111.631 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.532 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 6.0 m0 -101.18 -54.35 2.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.902 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 138.05 174.33 13.35 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.7 m -148.56 146.61 28.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.983 0.42 . . . . 0.0 110.672 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.51 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 3.2 m -91.91 170.05 10.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.629 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.662 ' HG3' HG22 ' B' ' 21' ' ' THR . 40.7 tttm -55.9 -36.87 68.13 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.682 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -52.22 66.66 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.614 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.51 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.68 -44.9 93.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.6 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.861 ' HB ' HG21 ' B' ' 21' ' ' THR . 37.4 mt -70.66 -39.6 76.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.015 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.493 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 49.3 m -65.15 -20.46 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.776 0.322 . . . . 0.0 110.669 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.5 m -68.15 -6.88 25.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.068 0.461 . . . . 0.0 110.93 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.455 HD11 HD23 ' A' ' 6' ' ' LEU . 69.1 mt -105.33 19.66 20.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.6 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.411 179.401 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.56 61.28 2.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.044 0.449 . . . . 0.0 111.324 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.98 127.28 1.94 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.049 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.62 45.66 1.5 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.168 2.578 . . . . 0.0 112.512 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -111.05 90.85 3.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.27 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 80.42 52.3 4.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.872 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.69 -171.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.557 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 61.8 mtp180 -89.88 123.93 34.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.088 0.47 . . . . 0.0 109.883 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.649 HD12 ' HG3' ' B' ' 13' ' ' GLU . 2.1 mm? -114.98 115.26 26.59 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.129 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 79.7 m -109.26 118.77 37.58 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.78 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.57 -102.57 0.05 OUTLIER Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.465 -0.789 . . . . 0.0 114.345 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.532 ' O ' ' HD2' ' B' ' 12' ' ' ARG . 4.4 tmm_? -57.16 -32.21 66.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.239 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.649 ' HG3' HD12 ' B' ' 9' ' ' LEU . 5.6 tp10 -70.59 -38.28 74.0 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.601 ' O ' HG23 ' B' ' 18' ' ' VAL . 45.3 t80 -59.65 -55.45 34.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.582 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.578 ' O ' HG12 ' B' ' 19' ' ' ILE . 62.3 mt -58.88 -48.52 86.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.967 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.502 ' HA ' ' HD2' ' B' ' 16' ' ' ARG . 5.1 tpt180 -65.58 -33.28 75.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.302 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -40.31 96.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.601 HG23 ' O ' ' B' ' 14' ' ' PHE . 60.6 t -60.64 -49.26 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.809 HG23 ' HD1' ' B' ' 27' ' ' TRP . 39.0 mm -55.8 -51.08 63.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.308 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.553 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.3 m-30 -58.53 -46.19 87.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.047 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.674 HG22 ' HG2' ' A' ' 17' ' ' LYS . 18.4 p -65.05 -39.74 93.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.984 0.421 . . . . 0.0 110.808 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.491 ' HB3' HH11 ' B' ' 26' ' ' ARG . 73.5 m -67.86 -24.39 65.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.737 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.14 -21.94 0.22 Allowed Glycine 0 C--O 1.227 -0.333 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.495 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.08 -51.58 4.49 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.7 m -101.08 27.81 5.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.411 0.624 . . . . 0.0 110.139 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.491 HH11 ' HB3' ' B' ' 22' ' ' CYS . 72.0 ttt180 -88.52 -32.8 18.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.658 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.809 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.202 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.505 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.2 p-10 . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.491 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 45.2 t -111.99 -42.61 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.156 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.9 mt -69.26 -56.35 7.84 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.505 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -60.71 -32.9 72.13 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.91 -43.38 98.11 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.31 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.807 HD12 HD11 ' A' ' 23' ' ' LEU . 44.9 mt -80.31 -43.14 21.75 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -49.31 -47.01 47.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.532 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.1 p -62.48 -46.57 87.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.568 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 33.1 m -67.5 -38.53 84.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.227 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.572 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 83.3 m -62.58 -39.46 93.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.921 0.391 . . . . 0.0 110.234 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 41.3 t -79.22 -44.03 22.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.237 0.541 . . . . 0.0 110.389 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.5 ttpt -62.13 -49.59 75.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.568 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.471 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 23.0 m0 -119.19 -58.07 1.96 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.579 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.9 171.94 13.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.8 m -145.72 145.6 30.93 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.853 0.326 . . . . 0.0 110.417 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.545 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 4.1 m -92.53 164.77 13.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.563 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.674 ' HG2' HG22 ' B' ' 21' ' ' THR . 10.4 tmtt? -54.27 -35.47 62.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.788 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -52.17 63.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.029 0.443 . . . . 0.0 111.737 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.32 -42.48 95.69 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.739 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' B' ' 18' ' ' VAL . 26.6 mt -69.2 -39.57 79.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.489 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 70.3 m -66.29 -17.58 64.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.625 0.25 . . . . 0.0 111.296 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.7 m -67.58 -10.05 48.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.191 0.519 . . . . 0.0 110.345 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.807 HD11 HD12 ' A' ' 6' ' ' LEU . 95.8 mt -105.54 23.21 14.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.952 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 80.2 m . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.681 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.29 -153.8 0.42 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.05 70.54 2.65 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.336 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.581 ' HB2' HD11 ' B' ' 9' ' ' LEU . 73.9 Cg_endo -76.3 48.88 2.44 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.806 2.337 . . . . 0.0 111.616 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.872 ' HB3' ' HB2' ' A' ' 17' ' ' LYS . 18.7 m-30 -84.82 34.03 0.54 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.604 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 162.73 53.69 0.02 OUTLIER Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.531 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 m -149.61 -167.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.57 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 62.9 mtp180 -86.27 126.12 34.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.042 0.449 . . . . 0.0 110.151 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.5 mm? -119.48 118.48 31.21 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.04 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' CYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 65.2 m -112.69 110.75 21.09 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 53.2 -94.56 0.01 OUTLIER Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.834 -0.621 . . . . 0.0 114.577 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' B' ' 12' ' ' ARG . 12.1 mtm180 -55.64 -42.3 74.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.267 0.556 . . . . 0.0 111.138 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.621 ' HB3' HD12 ' B' ' 9' ' ' LEU . 34.3 mp0 -68.84 -34.19 75.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.431 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.602 ' O ' HG23 ' B' ' 18' ' ' VAL . 48.6 t80 -63.07 -52.31 63.22 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.829 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.626 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.3 mt -59.88 -48.56 87.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.603 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.1 mmp_? -61.86 -34.98 76.97 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.55 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.595 ' HB1' HD13 ' A' ' 20' ' ' ILE . . . -64.12 -41.42 97.25 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 14' ' ' PHE . 48.9 t -58.8 -48.27 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.84 HG23 ' HD1' ' B' ' 27' ' ' TRP . 36.5 mm -56.18 -50.6 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.704 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.613 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.8 m-30 -57.29 -43.84 83.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.519 -1.218 . . . . 0.0 112.792 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.918 HG21 ' HB ' ' A' ' 20' ' ' ILE . 14.7 p -66.22 -40.83 90.59 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.328 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 34.9 m -67.45 -32.75 73.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.429 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.1 -30.28 0.09 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.31 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 92.16 -53.2 2.85 Favored Glycine 0 C--O 1.225 -0.457 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.7 m -102.39 45.66 0.96 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.584 0.707 . . . . 0.0 109.204 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.421 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.9 tpm_? -108.66 -37.92 5.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.356 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.84 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.074 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.175 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.5 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 25.9 p-10 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 41.9 t -112.12 -41.82 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.213 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.7 mt -68.89 -56.67 7.17 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -61.04 -33.07 72.72 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.69 -43.57 97.67 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.262 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.786 HD12 HD11 ' A' ' 23' ' ' LEU . 27.0 mt -80.47 -42.95 21.67 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -48.66 -47.13 40.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.223 0.609 . . . . 0.0 111.435 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 p -63.99 -46.31 85.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.8 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.404 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 25.6 m -67.92 -39.11 83.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.418 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 73.2 m -62.79 -39.81 95.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.953 0.406 . . . . 0.0 110.185 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 45.9 t -78.59 -42.73 28.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.136 0.493 . . . . 0.0 110.437 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.7 ttpt -64.27 -50.15 69.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.566 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.511 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 22.7 m0 -117.71 -58.85 1.98 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.452 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.57 172.9 14.71 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 78.7 m -147.94 147.78 30.07 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.814 0.307 . . . . 0.0 110.673 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.564 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.7 m -96.88 166.09 11.79 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.537 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.872 ' HB2' ' HB3' ' B' ' 5' ' ' TYR . 11.3 tmtt? -53.64 -35.63 61.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.278 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -51.59 65.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.964 0.411 . . . . 0.0 111.627 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.491 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.17 -44.28 92.14 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.481 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.918 ' HB ' HG21 ' B' ' 21' ' ' THR . 27.1 mt -70.42 -35.57 62.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.495 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.528 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 68.2 m -65.32 -23.24 66.96 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.736 0.303 . . . . 0.0 110.711 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.5 m -69.13 -0.94 6.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.797 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.786 HD11 HD12 ' A' ' 6' ' ' LEU . 96.3 mt -108.7 13.91 24.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.206 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.473 179.553 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ARG . . . . . 0.826 ' HD2' ' HG3' ' B' ' 13' ' ' GLU . 4.4 tpt180 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.647 0.26 . . . . 0.0 111.328 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.59 -152.78 0.41 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' B' ' 4' ' ' PRO . . . -62.2 118.3 38.4 Favored Pre-proline 0 C--N 1.323 -0.585 0 O-C-N 122.97 0.169 . . . . 0.0 110.555 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' B' ' 3' ' ' ALA . 19.6 Cg_endo -93.1 44.27 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.456 2.771 . . . . 0.0 112.591 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -106.06 83.55 1.92 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.701 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.613 ' H ' ' HA ' ' A' ' 16' ' ' SER . . . 77.71 45.83 10.36 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.447 ' O ' HD22 ' B' ' 9' ' ' LEU . 7.2 t -134.2 165.59 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.559 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 70.0 mtp180 -74.34 130.48 39.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.377 0.608 . . . . 0.0 110.845 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.67 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 1.4 mm? -117.34 115.04 24.45 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.03 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 70.9 m -116.52 116.9 28.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.529 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.09 -101.82 0.05 OUTLIER Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.69 -0.686 . . . . 0.0 114.347 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -57.67 -36.2 71.58 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.954 0.502 . . . . 0.0 111.637 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.826 ' HG3' ' HD2' ' B' ' 1' ' ' ARG . 0.4 OUTLIER -71.2 -29.97 65.82 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.9 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.67 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 47.4 t80 -68.78 -54.96 12.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.706 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.534 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.5 mt -60.65 -47.34 93.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.583 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.493 ' HA ' ' HD2' ' B' ' 16' ' ' ARG . 4.2 tpt180 -66.17 -30.22 70.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.69 97.8 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.664 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.74 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.3 t -60.13 -50.45 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.79 HG23 ' HD1' ' B' ' 27' ' ' TRP . 29.1 mm -57.05 -52.22 58.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.493 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.535 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -58.51 -46.41 86.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.948 -1.023 . . . . 0.0 113.058 -178.507 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.451 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 19.7 p -63.53 -41.05 98.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.944 0.402 . . . . 0.0 111.679 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.9 m -74.41 -20.82 59.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.301 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.5 -30.58 0.18 Allowed Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.876 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.27 -52.3 4.49 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 112.259 -0.336 . . . . 0.0 112.259 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 15.9 p -99.42 29.05 4.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.478 0.656 . . . . 0.0 110.558 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.9 tpm_? -89.49 -36.57 15.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.997 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.79 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.132 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.52 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.7 p-10 . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.67 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 49.0 t -109.72 -44.15 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.08 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.74 -57.63 6.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.52 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.11 -32.9 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.51 -46.88 93.22 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.25 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 30.6 mt -74.4 -39.47 62.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.8 t -52.57 -38.51 60.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -59.49 -36.52 76.21 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.89 0.376 . . . . 0.0 110.795 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 m -86.33 -41.23 14.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.664 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.563 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 98.0 m -61.8 -39.43 91.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.709 0.29 . . . . 0.0 110.87 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.3 t -78.43 -39.4 38.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.927 0.394 . . . . 0.0 110.804 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 2.1 ttmp? -68.3 -57.67 5.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.202 0.525 . . . . 0.0 111.372 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.532 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 9.7 m0 -103.43 -60.91 1.49 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.288 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.83 170.06 11.98 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.438 ' HB2' HD23 ' B' ' 9' ' ' LEU . 83.4 m -145.32 151.4 38.26 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 117.121 0.46 . . . . 0.0 110.574 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.613 ' HA ' ' H ' ' B' ' 6' ' ' GLY . 34.0 t -95.63 169.42 10.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.626 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -56.13 -37.16 69.07 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.149 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -52.96 63.51 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.996 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.568 ' OE1' ' HB3' ' A' ' 16' ' ' SER . 2.4 mp0 -60.62 -45.97 92.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.974 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.74 HG22 ' HA ' ' B' ' 18' ' ' VAL . 45.0 mt -69.32 -44.75 80.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.451 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 71.5 m -62.34 -29.03 70.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.564 0.221 . . . . 0.0 111.437 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.2 m -65.45 -4.11 5.28 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 6' ' ' LEU . 10.4 mp -84.84 -19.52 32.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.706 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.894 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.6 44.93 2.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.455 0.645 . . . . 0.0 109.636 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.32 151.13 6.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.521 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.13 45.25 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.45 2.767 . . . . 0.0 112.796 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.532 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 6.2 m-30 -96.0 80.56 3.31 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.716 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.423 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . 96.82 55.12 1.24 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.46 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 12.6 m -144.92 -169.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 110.652 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 -88.12 128.96 35.43 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -125.89 113.04 16.69 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.154 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 78.9 m -111.28 116.1 30.45 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.07 -101.65 0.05 OUTLIER Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.74 -0.664 . . . . 0.0 114.404 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.699 ' HB2' ' NH1' ' B' ' 12' ' ' ARG . 5.7 mtm105 -57.34 -36.58 71.35 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.604 0.362 . . . . 0.0 111.779 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.416 ' HB2' ' H ' ' B' ' 10' ' ' CYS . 8.0 mp0 -67.32 -37.55 83.5 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.604 ' O ' HG23 ' B' ' 18' ' ' VAL . 39.3 t80 -62.6 -53.05 60.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.728 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.549 ' O ' HG12 ' B' ' 19' ' ' ILE . 69.1 mt -57.35 -48.74 81.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.644 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.491 ' HA ' ' HD2' ' B' ' 16' ' ' ARG . 5.3 tpt180 -66.6 -33.03 74.76 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.05 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.32 93.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.506 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.604 HG23 ' O ' ' B' ' 14' ' ' PHE . 83.7 t -60.89 -49.95 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.734 HG23 ' HD1' ' B' ' 27' ' ' TRP . 36.4 mm -53.98 -51.12 48.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.539 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -43.91 97.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.988 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.532 HG21 ' HB ' ' A' ' 20' ' ' ILE . 19.4 p -64.94 -41.19 95.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.757 0.313 . . . . 0.0 110.794 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.45 ' HB3' HH11 ' B' ' 26' ' ' ARG . 85.7 m -63.97 -31.19 72.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.146 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.26 -21.14 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.396 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.4 -56.27 4.99 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -92.16 44.33 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.402 0.62 . . . . 0.0 110.326 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.45 HH11 ' HB3' ' B' ' 22' ' ' CYS . 75.3 ttt180 -110.04 -33.75 6.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.753 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.734 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.508 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.9 p-10 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.0 t -111.59 -42.26 4.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.08 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.39 -57.02 5.81 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.49 -33.66 71.61 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.02 -47.86 87.15 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.38 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.1 tp -73.02 -38.66 66.47 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 43.0 t -54.97 -41.93 71.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.288 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 t -59.22 -48.01 83.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.752 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 m -67.57 -39.41 84.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.682 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 61.4 m -61.46 -39.7 91.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 111.383 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.423 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 38.3 t -81.04 -38.61 27.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.267 0.556 . . . . 0.0 110.459 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -69.97 -53.1 19.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.297 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -114.93 -40.67 3.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.037 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 121.23 176.13 15.28 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' SG ' HD23 ' B' ' 9' ' ' LEU . 6.3 p -158.8 150.94 21.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.196 0.522 . . . . 0.0 111.465 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.498 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 8.2 m -96.62 173.34 7.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.03 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 51.0 tttp -54.86 -38.1 67.08 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -52.85 63.97 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.275 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.498 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.6 mp0 -60.08 -45.43 92.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.823 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' B' ' 18' ' ' VAL . 42.3 mt -69.47 -45.11 79.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.068 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.55 ' HA ' ' SG ' ' A' ' 24' ' ' CYS . 65.6 m -64.58 -16.7 63.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -65.43 -14.88 61.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.181 0.515 . . . . 0.0 110.371 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 72.4 mt -106.98 25.89 10.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.444 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 96.7 m . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.506 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ARG . . . . . 0.426 ' HG2' ' OE1' ' B' ' 13' ' ' GLU . 30.0 ptt-85 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.97 53.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ALA . . . . . 0.564 ' N ' ' HD3' ' B' ' 4' ' ' PRO . . . -167.79 54.49 0.28 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.377 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' B' ' 3' ' ' ALA . 73.9 Cg_endo -99.26 41.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.15 2.566 . . . . 0.0 112.401 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -109.4 73.14 0.83 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 94.37 50.75 2.14 Favored Glycine 0 CA--C 1.509 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.085 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 m -148.03 -173.73 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.504 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 52.3 mtt85 -82.81 133.16 35.14 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.541 0.686 . . . . 0.0 110.832 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.5 mm? -129.68 118.45 21.93 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.632 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' CYS . . . . . 0.42 ' H ' ' HB2' ' B' ' 13' ' ' GLU . 35.0 m -114.14 117.81 32.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 46.91 -98.61 0.01 OUTLIER Glycine 0 C--N 1.336 0.555 0 O-C-N 123.742 0.651 . . . . 0.0 114.658 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -54.15 -39.56 66.64 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.146 0.578 . . . . 0.0 111.555 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.541 ' HB3' HD12 ' B' ' 9' ' ' LEU . 34.7 mm-40 -72.03 -35.01 69.25 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.758 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.571 ' O ' HG23 ' B' ' 18' ' ' VAL . 38.5 t80 -62.93 -53.48 53.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.535 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.592 ' O ' HG12 ' B' ' 19' ' ' ILE . 72.4 mt -59.31 -50.78 78.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.421 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.584 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.3 mmp_? -63.7 -31.03 72.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.503 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.416 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -64.35 -41.52 96.71 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.127 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.843 ' HA ' HG22 ' A' ' 20' ' ' ILE . 93.0 t -59.36 -50.86 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-O 121.9 0.857 . . . . 0.0 108.814 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.783 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.9 mm -58.24 -52.14 62.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.707 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.401 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.8 OUTLIER -59.3 -44.4 92.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.568 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 19.9 p -62.78 -41.18 99.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.076 0.465 . . . . 0.0 110.757 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 56.5 m -75.03 -22.27 58.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.651 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.07 -29.36 0.21 Allowed Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.881 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 87.41 -54.86 4.48 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 38.3 p -96.03 49.11 1.13 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.323 0.582 . . . . 0.0 110.703 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.536 ' NH1' ' HB3' ' A' ' 24' ' ' CYS . 56.1 ttt180 -111.45 -36.44 5.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.255 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.783 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.956 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.062 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.63 -49.76 75.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.547 0.53 . . . . 0.0 110.365 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.89 -44.98 95.7 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.92 -38.19 64.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.79 0.329 . . . . 0.0 111.056 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.13 -44.2 97.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.176 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.588 HD12 HD11 ' A' ' 23' ' ' LEU . 32.3 mt -78.89 -44.4 22.85 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.245 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.2 t -48.91 -46.12 42.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.3 0.64 . . . . 0.0 111.646 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.4 p -64.69 -46.37 82.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.689 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -68.06 -39.6 82.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.431 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.547 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 73.9 m -63.11 -35.5 80.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.868 0.366 . . . . 0.0 110.618 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.6 t -83.39 -41.98 17.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.199 0.523 . . . . 0.0 110.197 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -64.8 -48.65 73.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.522 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -118.45 -53.98 2.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.503 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 134.57 169.76 12.05 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.2 m -145.24 147.44 32.4 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.922 0.361 . . . . 0.0 110.945 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.553 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.2 m -93.71 165.15 12.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.068 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -51.16 -40.12 57.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.508 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -53.71 55.25 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.693 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.99 -43.2 95.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.109 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.843 HG22 ' HA ' ' B' ' 18' ' ' VAL . 40.6 mt -70.9 -46.9 65.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.489 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.568 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 70.2 m -62.09 -23.72 66.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.5 m -63.93 -11.56 29.37 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 6' ' ' LEU . 21.9 mt -85.22 -6.89 59.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.536 ' HB3' ' NH1' ' B' ' 26' ' ' ARG . 77.5 m . . . . . 0 C--O 1.243 0.734 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.334 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.29 41.07 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.373 . . . . 0.0 111.419 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ALA . . . . . 0.438 ' N ' ' HD3' ' B' ' 4' ' ' PRO . . . -173.91 61.32 0.25 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.381 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' B' ' 3' ' ' ALA . 81.3 Cg_endo -90.47 41.75 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.957 2.438 . . . . 0.0 112.709 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 5.3 m-30 -107.5 79.28 1.28 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.717 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . 86.54 51.59 3.43 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.588 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' B' ' 4' ' ' PRO . 25.4 m -142.2 -171.83 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.349 . . . . 0.0 110.881 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -87.03 126.35 34.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.659 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.719 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.6 mm? -123.05 114.46 20.4 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.028 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 58.1 m -113.26 119.68 38.58 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.0 -102.64 0.06 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.92 -0.582 . . . . 0.0 114.417 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -57.13 -34.63 68.59 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.47 -33.83 69.65 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.615 ' O ' HG23 ' B' ' 18' ' ' VAL . 45.3 t80 -62.61 -54.54 38.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.302 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.584 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.1 mt -58.44 -50.13 79.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.295 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.53 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.7 mmp_? -62.33 -32.72 73.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.29 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.21 96.46 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.315 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.786 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.7 t -59.05 -50.02 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 122.042 0.925 . . . . 0.0 108.837 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.799 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.3 mm -59.04 -53.04 53.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.185 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.477 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.0 m-30 -56.3 -45.57 80.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.177 -0.92 . . . . 0.0 113.411 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.592 HG21 ' HB ' ' A' ' 20' ' ' ILE . 15.7 p -64.44 -41.6 96.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.807 0.337 . . . . 0.0 111.42 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 58.3 m -75.58 -27.67 58.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.493 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.92 -29.52 0.08 OUTLIER Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.326 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.39 -54.13 4.65 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.749 -0.262 . . . . 0.0 112.477 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m -101.14 52.84 0.84 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.59 0.71 . . . . 0.0 110.102 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.522 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 3.5 tpm_? -115.9 -38.15 3.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.846 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.799 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.179 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.987 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.508 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.6 p-10 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 27.4 t -111.57 -42.49 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.109 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.87 -57.26 5.8 Favored 'General case' 0 C--O 1.218 -0.555 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.508 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.44 -33.47 71.31 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.16 -45.47 95.98 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.408 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 59.8 mt -78.65 -44.37 23.99 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 40.8 t -48.42 -48.71 37.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.688 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.5 p -65.82 -45.45 82.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.683 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.536 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 23.8 m -65.69 -38.27 88.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.904 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.719 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 80.0 m -63.76 -34.54 78.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.999 0.428 . . . . 0.0 110.762 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 t -85.46 -38.69 18.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.31 0.576 . . . . 0.0 110.068 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.7 ttpt -68.03 -44.49 76.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.707 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -124.13 -48.65 1.85 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.886 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 128.21 165.74 11.87 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 78.9 m -143.44 146.98 33.89 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 117.129 0.464 . . . . 0.0 111.205 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.6 m -96.27 165.41 12.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.076 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 49.3 tttp -52.36 -40.09 61.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.353 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 m -57.03 -53.75 54.53 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 123.69 0.619 . . . . 0.0 111.532 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.618 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.7 mp0 -60.64 -43.52 97.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.43 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.786 HG22 ' HA ' ' B' ' 18' ' ' VAL . 31.5 mt -72.58 -39.23 61.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.264 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.416 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 51.1 m -64.12 -37.95 89.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.763 0.316 . . . . 0.0 110.807 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p -69.97 7.34 0.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.022 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.448 HD23 ' CG2' ' B' ' 18' ' ' VAL . 19.6 tp -92.27 -24.38 19.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.872 0.368 . . . . 0.0 110.159 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.6 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.84 179.615 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ARG . . . . . 0.511 ' NE ' ' HA ' ' B' ' 1' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.362 0.125 . . . . 0.0 110.673 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.54 -156.76 0.18 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.14 114.06 58.72 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.577 ' HB3' ' HB1' ' B' ' 17' ' ' ALA . 6.1 Cg_exo -78.69 46.63 2.21 Favored 'Trans proline' 0 CA--C 1.527 0.141 0 C-N-CA 123.308 2.672 . . . . 0.0 112.304 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.485 ' HD1' ' C ' ' B' ' 4' ' ' PRO . 4.0 m-30 -111.41 59.65 0.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.58 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.42 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . 98.38 51.7 1.42 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.506 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.03 -173.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.479 0.18 . . . . 0.0 110.522 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 26.4 mmt85 -87.58 130.97 34.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.153 0.501 . . . . 0.0 110.303 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.723 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -124.94 109.16 12.66 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.731 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 42.1 m -111.54 116.56 31.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.691 0.282 . . . . 0.0 111.642 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 50.98 -103.95 0.12 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.733 -0.667 . . . . 0.0 114.54 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -57.9 -32.87 68.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 122.519 0.328 . . . . 0.0 111.563 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.486 ' HG3' HD12 ' B' ' 9' ' ' LEU . 3.6 tp10 -68.25 -38.56 81.93 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 51.0 t80 -60.95 -53.59 55.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.001 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.61 ' O ' HG12 ' B' ' 19' ' ' ILE . 63.1 mt -60.0 -49.7 82.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.688 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.62 ' NH2' HG13 ' B' ' 19' ' ' ILE . 0.1 OUTLIER -65.25 -28.58 69.45 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.881 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.577 ' HB1' ' HB3' ' B' ' 4' ' ' PRO . . . -64.83 -42.82 94.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.002 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.764 ' HA ' HG22 ' A' ' 20' ' ' ILE . 62.1 t -58.94 -49.22 83.91 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.079 0.943 . . . . 0.0 108.517 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.818 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.3 mm -57.79 -53.16 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.571 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.551 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.4 OUTLIER -57.92 -45.18 86.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.323 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.515 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 17.4 p -63.5 -39.55 94.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.986 0.422 . . . . 0.0 111.553 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 60.9 m -79.49 -20.77 46.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.636 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.61 -31.13 0.14 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.112 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 85.36 -56.47 4.94 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.783 -0.246 . . . . 0.0 112.516 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m -97.21 50.32 1.07 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.565 0.697 . . . . 0.0 110.155 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 7.2 tpm_? -114.42 -38.96 3.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.626 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.818 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.032 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 27.3 p-10 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.97 -43.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.286 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.5 mp -70.43 -56.92 5.47 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -60.52 -34.65 74.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.83 -46.63 93.22 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.456 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.634 HD23 HD11 ' A' ' 23' ' ' LEU . 38.5 tp -73.55 -39.78 64.45 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.5 t -53.14 -45.09 68.23 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.601 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.4 m -60.55 -42.75 97.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.391 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 m -70.74 -38.7 73.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.812 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.723 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 90.7 m -62.11 -32.72 73.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.977 0.417 . . . . 0.0 110.776 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.451 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 49.0 t -85.31 -40.31 16.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.157 0.503 . . . . 0.0 110.393 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -70.82 -48.18 55.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.403 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -114.91 -41.43 3.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.566 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 116.54 165.44 14.05 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -141.18 149.58 41.64 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.909 0.355 . . . . 0.0 111.32 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.534 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.8 m -94.61 168.07 11.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.224 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HG3' HG22 ' B' ' 21' ' ' THR . 37.6 tttm -54.97 -37.19 66.2 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.273 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -52.59 65.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.218 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -60.83 -44.58 96.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.043 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.764 HG22 ' HA ' ' B' ' 18' ' ' VAL . 39.6 mt -70.62 -44.18 76.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.917 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.515 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 67.6 m -64.29 -28.7 69.9 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.522 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.1 m -69.32 -0.55 6.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.59 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.634 HD11 HD23 ' A' ' 6' ' ' LEU . 93.2 mt -90.62 -12.35 37.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.472 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.9 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.1 -0.953 . . . . 0.0 110.804 179.706 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ARG . . . . . 0.412 ' O ' ' HD3' ' B' ' 4' ' ' PRO . 2.3 ttm180 . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.54 33.13 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 0.0 111.752 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.63 53.09 0.18 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.972 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.433 ' C ' ' HD1' ' B' ' 5' ' ' TYR . 98.9 Cg_endo -78.51 46.0 2.01 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.803 2.336 . . . . 0.0 113.117 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.433 ' HD1' ' C ' ' B' ' 4' ' ' PRO . 4.3 m-30 -112.3 59.02 0.63 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.057 0.456 . . . . 0.0 110.692 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.14 51.38 1.15 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.875 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.86 -173.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.7 mmm-85 -86.16 128.82 34.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.801 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.72 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -125.15 109.12 12.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.649 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 84.9 m -109.93 121.46 45.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.772 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 49.42 -106.34 0.2 Allowed Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.862 -0.608 . . . . 0.0 114.493 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.482 ' HG3' ' N ' ' B' ' 13' ' ' GLU . 8.2 ptt180 -56.18 -30.67 62.55 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.779 0.432 . . . . 0.0 111.772 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' B' ' 12' ' ' ARG . 54.8 mm-40 -70.62 -38.78 73.95 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 41.6 t80 -63.16 -51.26 67.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.402 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.657 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.6 mt -58.71 -52.59 58.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.32 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.614 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 1.5 mmp_? -65.24 -27.47 68.68 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.283 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.51 93.08 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.592 ' HA ' HG22 ' A' ' 20' ' ' ILE . 96.9 t -60.43 -50.94 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.748 HG23 ' HD1' ' B' ' 27' ' ' TRP . 28.4 mm -54.87 -50.44 61.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.034 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.626 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -58.86 -45.92 88.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.649 -178.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.516 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 15.3 p -64.14 -38.72 92.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.003 0.43 . . . . 0.0 110.432 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' B' ' 18' ' ' VAL . 86.1 m -67.42 -25.12 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.445 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.32 -19.81 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.107 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 85.41 -48.8 4.08 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 5.3 p -104.02 25.87 9.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.454 0.645 . . . . 0.0 109.856 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.414 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 3.2 tpp85 -79.1 -36.99 39.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.006 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.748 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.947 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.52 -49.97 78.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 123.516 0.51 . . . . 0.0 110.569 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.77 -46.59 88.93 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.578 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.0 -39.08 62.84 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.36 0.413 . . . . 0.0 110.789 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.41 -47.48 87.13 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.066 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HB2' ' CZ ' ' B' ' 14' ' ' PHE . 36.8 mt -71.54 -43.9 65.57 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -50.69 -44.97 58.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.7 m -62.91 -43.47 98.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.862 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -71.63 -41.25 69.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.081 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.72 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 74.1 m -62.33 -37.35 85.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.006 0.431 . . . . 0.0 110.752 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.5 t -79.29 -38.68 34.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.054 0.454 . . . . 0.0 110.481 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.473 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 37.2 ttmt -72.15 -58.46 3.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.139 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.473 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 9.4 m0 -104.81 -44.69 4.77 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.17 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 123.39 169.53 13.25 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 85.2 m -144.74 147.56 33.12 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 117.307 0.554 . . . . 0.0 111.394 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' HG13 ' A' ' 20' ' ' ILE . 2.5 m -95.58 169.46 10.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.012 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' HG3' HG22 ' B' ' 21' ' ' THR . 58.4 tttp -55.7 -37.16 68.0 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.756 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -54.72 43.81 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.665 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.07 -42.29 94.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.351 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.592 HG22 ' HA ' ' B' ' 18' ' ' VAL . 44.9 mt -72.42 -45.8 58.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.928 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.611 ' HA ' ' SG ' ' A' ' 24' ' ' CYS . 63.1 m -64.65 -13.21 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.692 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.3 m -63.24 -19.83 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.254 0.549 . . . . 0.0 110.185 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 54.7 mt -106.77 28.11 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.148 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 58.8 m . . . . . 0 C--O 1.259 1.567 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.662 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.33 49.98 1.86 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 111.343 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.33 126.17 0.47 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.519 ' HA ' ' CG2' ' B' ' 7' ' ' VAL . 87.9 Cg_endo -82.99 21.73 0.99 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.968 2.445 . . . . 0.0 112.27 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -86.28 56.44 3.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.151 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 120.04 56.98 0.24 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.302 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.519 ' CG2' ' HA ' ' B' ' 4' ' ' PRO . 13.4 m -150.76 -169.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.558 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.6 mtp180 -89.69 128.16 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.4 mm? -121.84 114.06 20.52 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.643 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' CYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 71.5 m -108.6 119.97 41.08 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 47.54 -101.57 0.04 OUTLIER Glycine 0 CA--C 1.518 0.281 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.674 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -57.87 -34.05 69.34 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.978 0.511 . . . . 0.0 111.29 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.491 ' HB3' HD12 ' B' ' 9' ' ' LEU . 0.1 OUTLIER -69.49 -36.81 76.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.262 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.596 ' O ' HG23 ' B' ' 18' ' ' VAL . 35.8 t80 -61.76 -52.99 61.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.169 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.543 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.3 mt -58.41 -47.73 87.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.333 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.466 ' CZ ' HG21 ' B' ' 19' ' ' ILE . 6.4 tpt180 -65.21 -34.28 78.0 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.039 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.433 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -62.78 -39.29 93.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.807 178.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 14' ' ' PHE . 61.0 t -60.15 -51.13 76.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.858 HG23 ' HD1' ' B' ' 27' ' ' TRP . 40.1 mm -52.68 -52.79 24.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.3 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.598 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.2 m-30 -60.37 -42.12 95.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.684 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.661 HG21 ' HB ' ' A' ' 20' ' ' ILE . 27.0 p -68.19 -42.53 79.78 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.352 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 47.4 m -65.33 -28.88 69.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.186 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.21 -24.21 0.09 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.492 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.9 -62.4 4.63 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.6 m -89.45 40.51 0.99 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.524 0.678 . . . . 0.0 110.177 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.416 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.8 tpm_? -105.17 -35.18 7.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.127 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.858 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.183 -1.372 . . . . 0.0 109.409 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.2 t -72.41 -45.06 61.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 123.487 0.492 . . . . 0.0 109.788 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.658 HD23 HD13 ' A' ' 23' ' ' LEU . 74.6 mt -69.21 -53.77 18.23 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.513 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.76 71.6 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.63 -49.03 83.09 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.424 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 48.9 tp -71.73 -37.91 70.52 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.5 t -54.9 -42.3 71.99 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.288 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.9 t -59.2 -42.21 90.39 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.093 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -74.04 -41.42 61.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.737 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.547 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 62.0 m -60.18 -45.56 92.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.624 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.405 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 48.1 t -74.7 -39.08 62.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.974 0.416 . . . . 0.0 110.858 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 3.2 ttmp? -68.95 -60.1 2.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.844 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.498 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 8.0 m0 -106.56 -54.74 2.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.236 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 139.77 -172.8 23.19 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.479 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.4 p -165.5 148.92 8.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.776 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.474 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 4.2 m -97.15 171.17 8.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.535 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HG3' HG22 ' B' ' 21' ' ' THR . 34.9 tttm -55.92 -36.28 67.56 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.493 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -51.83 68.37 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.46 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.84 -43.5 95.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.36 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.661 ' HB ' HG21 ' B' ' 21' ' ' THR . 39.8 mt -69.99 -44.94 78.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.925 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.523 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 75.2 m -64.4 -22.46 66.97 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.4 m -66.94 -8.52 30.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.917 0.389 . . . . 0.0 110.886 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.658 HD13 HD23 ' A' ' 3' ' ' LEU . 59.0 mt -116.8 26.2 10.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.536 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 70.5 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.44 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.71 -152.35 0.5 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.18 125.65 90.78 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.658 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.61 53.49 3.61 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 123.034 2.489 . . . . 0.0 112.209 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.571 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 6.9 m-30 -100.43 22.1 12.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.584 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 157.86 60.31 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -144.69 -171.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.644 0.259 . . . . 0.0 110.847 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.535 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 70.0 mtp180 -87.87 130.39 34.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.309 0.576 . . . . 0.0 109.936 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.98 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 10.6 mp -116.25 109.4 17.35 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.562 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 72.3 m -112.14 116.95 31.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.923 0.392 . . . . 0.0 111.557 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 51.32 -109.55 0.8 Allowed Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.329 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -59.61 -29.46 68.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -69.4 -37.76 77.64 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.686 ' O ' HG23 ' B' ' 18' ' ' VAL . 55.0 t80 -61.11 -55.6 30.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.078 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.658 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.5 mt -57.26 -52.31 58.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.41 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.632 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.5 mmp_? -64.03 -33.73 76.41 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.276 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.43 83.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.718 ' HA ' HG22 ' A' ' 20' ' ' ILE . 75.6 t -60.16 -47.71 90.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.77 HG23 ' HD1' ' B' ' 27' ' ' TRP . 21.1 mm -59.69 -51.83 68.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.089 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.467 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.3 OUTLIER -55.9 -47.38 77.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.814 -179.056 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.534 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 19.5 p -62.86 -40.54 97.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.001 0.429 . . . . 0.0 111.274 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 57.6 m -80.69 -10.57 59.72 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.22 -30.26 0.42 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.537 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.34 -52.81 4.76 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.5 m -104.16 40.35 1.48 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.472 0.653 . . . . 0.0 110.085 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -98.52 -36.08 10.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.354 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.77 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.205 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.922 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 39.2 t -71.56 -46.35 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.473 0.483 . . . . 0.0 109.758 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.85 -53.87 18.92 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.546 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.25 -35.46 69.75 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.05 -50.14 70.7 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.595 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 42.8 mt -70.39 -42.52 71.59 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 t -52.34 -42.44 63.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.85 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.5 t -59.11 -45.33 91.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.586 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.5 m -76.35 -38.68 55.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.98 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 67.4 m -63.0 -42.71 99.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.694 0.283 . . . . 0.0 111.419 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.69 -40.16 49.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.109 0.481 . . . . 0.0 110.427 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -67.97 -48.31 66.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.442 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.503 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 9.2 m0 -118.78 -58.72 1.93 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.356 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 141.68 -174.6 22.95 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' SG ' HD22 ' B' ' 9' ' ' LEU . 1.8 p -162.36 152.82 16.96 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.885 0.342 . . . . 0.0 110.875 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.4 m -97.37 167.57 10.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.07 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.571 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 53.4 tttp -52.56 -37.95 58.91 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.072 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.22 -50.27 74.15 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.601 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.35 -42.83 87.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.498 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.718 HG22 ' HA ' ' B' ' 18' ' ' VAL . 24.5 mt -72.06 -46.14 60.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.534 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 66.4 m -65.68 -34.13 77.49 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.191 -0.318 . . . . 0.0 111.579 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 t -68.58 -1.14 6.1 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.355 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.475 HD22 HD12 ' A' ' 6' ' ' LEU . 23.7 tp -85.18 -23.69 28.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.674 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.4 m . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.879 -179.547 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.748 0.309 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.38 143.3 1.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' B' ' 4' ' ' PRO . . . -64.32 113.25 9.78 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 123.183 0.302 . . . . 0.0 110.355 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.506 ' C ' ' HD1' ' B' ' 5' ' ' TYR . 44.4 Cg_endo -67.64 45.36 0.28 Allowed 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.697 2.931 . . . . 0.0 114.025 -178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.506 ' HD1' ' C ' ' B' ' 4' ' ' PRO . 4.5 m-30 -117.45 37.43 3.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.187 0.518 . . . . 0.0 109.845 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.92 47.37 0.29 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.127 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.2 -172.67 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 122.837 -0.214 . . . . 0.0 110.438 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.573 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 66.3 mtp180 -90.79 129.36 36.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.082 0.467 . . . . 0.0 110.051 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.7 mm? -122.14 111.92 17.57 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.178 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 97.9 m -109.76 123.14 49.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.92 -105.49 0.13 Allowed Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.57 -0.741 . . . . 0.0 114.522 178.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -60.48 -29.72 69.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.42 -35.9 73.69 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.55 ' O ' HG23 ' B' ' 18' ' ' VAL . 48.2 t80 -65.18 -50.88 64.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.441 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.663 ' O ' HG12 ' B' ' 19' ' ' ILE . 66.6 mt -57.75 -50.33 77.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.877 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.571 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.7 mmp_? -63.72 -32.02 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.985 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' B' ' 4' ' ' PRO . . . -63.33 -44.68 94.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.118 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.55 HG23 ' O ' ' B' ' 14' ' ' PHE . 63.4 t -58.0 -50.3 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.859 HG23 ' HD1' ' B' ' 27' ' ' TRP . 34.6 mm -54.52 -50.98 54.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.147 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.49 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.1 m-30 -58.26 -45.41 87.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.747 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.862 HG21 ' HB ' ' A' ' 20' ' ' ILE . 11.9 p -63.54 -38.73 92.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.642 0.258 . . . . 0.0 111.557 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 34.0 m -70.76 -30.93 67.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.758 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.92 -22.14 0.09 OUTLIER Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.655 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 83.97 -60.03 4.89 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 112.176 -0.37 . . . . 0.0 112.176 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -92.6 48.88 1.41 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.524 0.678 . . . . 0.0 109.801 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.8 tpm_? -112.76 -37.4 4.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.985 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.859 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.988 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 39.4 t0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -108.54 -41.64 5.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.426 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.91 -55.4 19.54 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.8 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.49 -36.26 61.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.001 0.429 . . . . 0.0 110.306 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.93 66.53 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.034 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.5 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 44.8 tp -72.22 -39.18 68.7 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 t -54.32 -42.94 70.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.554 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.4 t -58.23 -44.11 88.09 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.203 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -74.16 -40.8 62.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.7 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.599 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 62.5 m -58.04 -44.95 87.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 111.705 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.9 t -78.2 -40.47 37.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.0 0.428 . . . . 0.0 110.995 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -66.85 -49.85 64.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.849 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.544 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 8.8 m0 -119.47 -54.72 2.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.211 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.06 -171.17 25.05 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.551 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.0 p -166.45 151.05 7.72 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.182 0.515 . . . . 0.0 111.355 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.483 ' O ' HG13 ' A' ' 20' ' ' ILE . 67.6 p -93.1 165.4 12.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.679 ' HG3' HG22 ' B' ' 21' ' ' THR . 37.4 tttm -56.72 -40.14 75.15 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.362 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 m -57.33 -48.17 79.67 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.393 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -63.45 -46.29 86.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.881 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.862 ' HB ' HG21 ' B' ' 21' ' ' THR . 32.5 mt -67.46 -39.53 82.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.588 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.433 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 44.8 m -64.74 -24.43 67.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.779 0.323 . . . . 0.0 110.944 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.0 m -67.88 -5.87 18.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.138 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -107.7 19.04 20.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.466 179.258 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.65 56.59 0.32 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 110.512 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.16 137.0 4.61 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.182 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.483 ' HA ' ' CG2' ' B' ' 7' ' ' VAL . 70.7 Cg_endo -74.63 41.01 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.193 2.596 . . . . 0.0 112.397 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.494 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 4.9 m-30 -106.92 85.79 2.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.886 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.05 50.85 3.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.712 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' B' ' 4' ' ' PRO . 24.7 m -139.72 -179.96 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.542 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 67.1 mtp180 -86.32 127.79 34.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.176 0.512 . . . . 0.0 110.008 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.3 mm? -122.42 117.18 25.4 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.41 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 79.3 m -115.52 120.97 41.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.826 0.345 . . . . 0.0 111.893 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 53.41 -107.83 0.67 Allowed Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.285 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -59.48 -30.39 68.5 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.08 -36.63 75.07 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.634 ' O ' HG23 ' B' ' 18' ' ' VAL . 40.5 t80 -61.62 -53.04 61.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.218 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.62 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.2 mt -60.68 -49.27 85.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.347 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.547 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 5.0 mmp_? -61.89 -34.21 75.63 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.475 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.67 96.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.278 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.785 ' HA ' HG22 ' A' ' 20' ' ' ILE . 59.1 t -59.52 -49.28 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-O 122.041 0.924 . . . . 0.0 108.802 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.769 HG23 ' HD1' ' B' ' 27' ' ' TRP . 20.8 mm -59.07 -52.8 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.284 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.448 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.9 OUTLIER -57.74 -45.08 86.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.312 -178.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.554 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 18.6 p -63.48 -40.51 97.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.92 0.39 . . . . 0.0 111.267 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -78.33 -26.21 46.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.652 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.66 -31.47 0.09 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 119.998 -1.096 . . . . 0.0 113.359 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 87.2 -56.83 4.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.688 -0.291 . . . . 0.0 112.521 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.5 m -99.21 51.06 0.95 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.483 0.658 . . . . 0.0 110.114 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 7.2 tpm_? -113.94 -38.82 4.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.941 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.769 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.035 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.933 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.09 -44.81 64.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 123.392 0.433 . . . . 0.0 109.918 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.48 -54.52 13.83 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.749 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.14 75.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.01 -48.54 82.67 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.883 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.666 HD23 HD11 ' A' ' 23' ' ' LEU . 35.1 tp -71.0 -41.05 71.43 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 t -53.02 -41.72 64.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.675 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 m -58.81 -34.13 71.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.705 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 m -86.08 -38.27 17.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.352 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.553 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 71.1 m -60.26 -40.57 90.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.782 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.0 t -79.6 -41.56 26.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.989 0.423 . . . . 0.0 110.896 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -67.57 -50.04 60.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.878 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.538 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 11.2 m0 -114.64 -56.71 2.35 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.313 -178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.32 173.17 14.09 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 99.2 m -146.66 148.56 32.18 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.824 0.345 . . . . 0.0 110.935 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.516 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.4 m -94.63 166.19 12.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.617 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.494 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 47.1 tttp -52.94 -38.85 62.4 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.943 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -53.85 53.54 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.473 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -63.3 -42.54 99.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.561 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.785 HG22 ' HA ' ' B' ' 18' ' ' VAL . 45.8 mt -70.63 -45.21 75.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.554 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 73.1 m -64.82 -27.68 69.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.605 0.24 . . . . 0.0 111.601 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.3 m -69.29 -1.74 8.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.971 0.415 . . . . 0.0 111.364 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.666 HD11 HD23 ' A' ' 6' ' ' LEU . 97.3 mt -90.12 -11.18 42.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.807 179.672 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.95 52.62 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.985 0.421 . . . . 0.0 111.153 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.79 85.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.602 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.96 39.03 0.68 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.039 2.493 . . . . 0.0 112.7 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -114.67 90.4 3.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.898 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.21 63.13 1.99 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.188 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.817 HG22 ' H ' ' B' ' 8' ' ' ARG . 6.2 p -163.46 -173.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.817 ' H ' HG22 ' B' ' 7' ' ' VAL . 69.0 mtp180 -85.1 131.09 34.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.249 0.547 . . . . 0.0 110.398 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.62 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.2 mm? -126.44 115.76 20.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.86 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 73.1 m -111.73 120.78 43.18 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 45.56 -100.62 0.02 OUTLIER Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.425 ' HE ' ' CD ' ' B' ' 13' ' ' GLU . 7.1 tmm_? -54.57 -41.18 69.53 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.112 0.565 . . . . 0.0 111.661 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.62 ' HB3' HD12 ' B' ' 9' ' ' LEU . 14.1 mp0 -69.15 -36.08 77.03 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.626 ' O ' HG23 ' B' ' 18' ' ' VAL . 46.0 t80 -61.9 -56.52 18.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.013 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.591 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.9 mt -58.54 -48.06 86.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.529 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.508 ' NH1' HG13 ' B' ' 19' ' ' ILE . 13.1 mmm180 -64.13 -34.24 77.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.493 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.85 -40.45 97.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.153 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.784 ' HA ' HG22 ' A' ' 20' ' ' ILE . 57.9 t -59.42 -49.5 83.35 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.862 HG23 ' HD1' ' B' ' 27' ' ' TRP . 19.6 mm -57.87 -53.56 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.333 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.51 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.6 m-30 -57.17 -45.21 83.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.576 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' THR . . . . . 0.5 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 21.2 p -64.89 -40.77 95.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.05 0.452 . . . . 0.0 111.378 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -76.93 -20.38 56.24 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.651 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.84 -30.4 0.16 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.094 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.4 -55.56 5.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.707 -0.283 . . . . 0.0 112.548 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.2 m -97.06 46.53 1.04 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.43 0.633 . . . . 0.0 110.335 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 7.3 tpm_? -110.41 -37.49 5.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.327 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' TRP . . . . . 0.862 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.372 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.44 -49.35 60.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.401 0.438 . . . . 0.0 110.68 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.538 ' HG ' HD21 ' A' ' 23' ' ' LEU . 10.7 mp -72.17 -51.38 21.51 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.408 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.29 70.87 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.88 -49.29 77.25 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.75 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.492 HD23 HD22 ' A' ' 23' ' ' LEU . 40.9 tp -71.01 -39.91 72.11 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.6 t -55.12 -42.52 73.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.406 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 t -57.77 -44.16 85.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.334 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -74.68 -40.53 61.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.969 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.472 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 56.1 m -60.3 -43.11 96.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 111.603 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.65 -39.57 36.63 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.904 0.383 . . . . 0.0 110.874 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -68.31 -50.85 50.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.825 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.521 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 8.4 m0 -116.39 -55.11 2.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.29 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.6 -173.64 23.01 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -164.98 149.56 9.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.964 0.412 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.531 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 3.6 m -94.8 168.74 10.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.478 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' HG3' HG22 ' B' ' 21' ' ' THR . 37.7 tttm -54.33 -37.15 64.53 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.903 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -50.36 74.32 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.357 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.531 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -63.2 -45.18 92.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.784 HG22 ' HA ' ' B' ' 18' ' ' VAL . 33.2 mt -69.76 -43.13 80.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.545 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.5 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 71.4 m -64.11 -36.7 84.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.754 0.311 . . . . 0.0 111.14 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.5 m -70.13 5.19 1.74 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.667 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.538 HD21 ' HG ' ' A' ' 3' ' ' LEU . 21.6 tp -92.23 -22.48 19.77 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.849 0.356 . . . . 0.0 110.234 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.8 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.025 179.668 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.04 -171.14 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.449 0.166 . . . . 0.0 110.646 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.564 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 67.5 mtp180 -86.27 129.02 34.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.211 0.529 . . . . 0.0 109.965 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -125.69 117.42 23.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.407 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 69.2 m -113.22 122.01 46.18 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.98 -104.97 0.13 Allowed Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.396 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -57.59 -33.69 68.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.437 ' HB3' HD12 ' B' ' 9' ' ' LEU . 53.8 mm-40 -70.82 -34.89 72.19 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.595 ' O ' HG23 ' B' ' 18' ' ' VAL . 41.3 t80 -62.15 -54.08 46.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.334 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.596 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.5 mt -59.51 -50.69 78.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.505 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.609 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.0 mmp_? -62.22 -33.24 74.19 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.732 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.438 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -65.18 -39.52 93.0 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.81 ' HA ' HG22 ' A' ' 20' ' ' ILE . 91.7 t -59.7 -49.04 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-O 121.92 0.867 . . . . 0.0 108.714 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.778 HG23 ' HD1' ' B' ' 27' ' ' TRP . 13.9 mm -59.72 -52.69 58.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.165 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.46 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.5 m-30 -56.51 -45.39 81.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.201 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.515 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 23.4 p -63.57 -39.8 95.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.36 0.6 . . . . 0.0 110.876 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 59.4 m -81.55 -13.25 58.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.03 -30.19 0.33 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.351 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.14 -49.29 4.08 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.62 -0.324 . . . . 0.0 112.502 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.5 m -105.18 41.47 1.35 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.291 0.567 . . . . 0.0 110.538 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.51 ' NH1' ' HB3' ' A' ' 24' ' ' CYS . 54.7 ttt180 -98.7 -36.35 9.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.778 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.848 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.65 -49.85 43.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.37 . . . . 0.0 110.735 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 70.6 mt -70.57 -50.69 34.69 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.787 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.64 76.82 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.67 90.05 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.501 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.819 HD23 HD11 ' A' ' 23' ' ' LEU . 33.4 tp -72.26 -40.0 68.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.0 t -53.27 -41.55 65.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.527 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.3 m -59.16 -44.48 92.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.395 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -72.73 -39.4 66.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.619 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.493 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 82.4 m -60.8 -38.24 84.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.565 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.23 -43.1 19.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.015 0.436 . . . . 0.0 110.786 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -65.35 -51.25 61.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.852 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.505 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 13.0 m0 -113.61 -55.55 2.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.384 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.54 174.92 14.2 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.1 m -147.5 147.54 30.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.852 0.326 . . . . 0.0 110.72 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.558 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.5 m -94.78 164.44 12.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.28 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -53.02 -36.89 61.02 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -53.51 57.6 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.345 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.99 -42.68 99.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.428 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' B' ' 18' ' ' VAL . 34.2 mt -70.77 -46.09 70.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.664 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.515 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 66.3 m -64.6 -27.14 68.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.6 m -68.92 -3.87 14.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.932 0.396 . . . . 0.0 111.54 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.819 HD11 HD23 ' A' ' 6' ' ' LEU . 93.8 mt -91.47 -4.26 55.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.68 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.51 ' HB3' ' NH1' ' B' ' 26' ' ' ARG . 71.0 m . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.327 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.341 -0.303 . . . . 0.0 112.341 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.64 -172.15 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.681 0.24 . . . . 0.0 110.714 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.565 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 53.0 mtp85 -87.15 127.39 35.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -124.07 119.0 28.22 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.802 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . 0.4 ' H ' ' HB2' ' B' ' 13' ' ' GLU . 82.5 m -115.09 120.62 40.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.594 0.235 . . . . 0.0 111.556 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.41 -103.36 0.07 OUTLIER Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.945 -0.571 . . . . 0.0 114.269 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -57.63 -35.29 70.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.513 ' HB3' HD12 ' B' ' 9' ' ' LEU . 3.2 mp0 -69.26 -35.46 76.11 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.588 ' O ' HG23 ' B' ' 18' ' ' VAL . 33.6 t80 -61.95 -51.95 66.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.062 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.538 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.6 mt -59.03 -48.58 86.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.429 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 5.9 mmp_? -61.92 -38.11 87.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.336 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.489 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -63.13 -38.2 90.25 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.299 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 20' ' ' ILE . 98.8 t -59.97 -50.82 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.877 HD12 ' CD1' ' B' ' 27' ' ' TRP . 7.6 mm -57.26 -50.88 75.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.845 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -57.76 -41.88 82.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.209 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.735 HG21 ' HB ' ' A' ' 20' ' ' ILE . 22.8 p -66.91 -43.78 82.49 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.62 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.01 -37.86 89.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.705 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.73 -31.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.638 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.84 28.35 42.57 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 32.5 p -172.09 88.79 0.1 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -167.36 -38.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.646 0.736 . . . . 0.0 110.057 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.877 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.502 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t -72.24 -44.71 63.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 123.54 0.525 . . . . 0.0 109.791 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.406 ' HG ' HD13 ' A' ' 23' ' ' LEU . 11.0 mp -69.49 -54.48 14.04 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.531 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.52 74.45 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.4 81.94 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.699 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.505 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 40.6 tp -70.75 -43.37 68.95 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.8 t -52.43 -42.66 64.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.635 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 t -58.93 -43.28 91.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.196 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.9 m -74.1 -38.66 63.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.999 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 70.8 m -60.14 -41.51 92.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.76 0.314 . . . . 0.0 111.08 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.8 t -81.54 -39.28 24.89 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.024 0.44 . . . . 0.0 111.042 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -68.68 -43.82 75.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.82 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.447 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 10.5 m0 -123.48 -56.33 1.71 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.123 0.487 . . . . 0.0 111.385 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.89 173.6 15.49 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.2 m -147.23 145.91 29.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.117 0.459 . . . . 0.0 111.033 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.499 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.5 m -94.4 168.72 10.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.536 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -54.64 -37.97 66.31 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.847 0.356 . . . . 0.0 110.884 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.54 -53.96 51.49 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.493 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.57 -44.1 97.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.6 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.735 ' HB ' HG21 ' B' ' 21' ' ' THR . 34.0 mt -70.54 -44.36 77.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.22 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.471 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 67.6 m -65.53 -18.81 65.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.406 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.2 m -65.58 -11.38 43.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.045 0.45 . . . . 0.0 110.518 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.406 HD13 ' HG ' ' A' ' 3' ' ' LEU . 77.4 mt -111.08 26.53 10.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.823 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 95.9 m . . . . . 0 C--O 1.257 1.477 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.32 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.21 178.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 O-C-N 122.847 -0.208 . . . . 0.0 110.47 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.563 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 68.3 mtp180 -86.7 129.08 35.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.144 0.497 . . . . 0.0 110.039 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -123.99 118.24 26.56 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.271 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . 0.403 ' H ' ' HB2' ' B' ' 13' ' ' GLU . 84.3 m -114.38 120.06 39.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.8 -103.59 0.09 OUTLIER Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.882 -0.599 . . . . 0.0 114.309 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -57.89 -34.53 69.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.44 ' HB3' HD12 ' B' ' 9' ' ' LEU . 2.9 mp0 -69.11 -35.55 76.57 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.545 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 38.6 t80 -62.94 -50.08 72.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.095 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.646 ' O ' HG12 ' B' ' 19' ' ' ILE . 66.8 mt -59.5 -50.66 79.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.964 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.658 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.1 mmp_? -62.43 -33.39 74.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.435 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.458 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -63.11 -43.3 98.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.619 ' HA ' HG22 ' A' ' 20' ' ' ILE . 96.3 t -58.31 -48.1 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.756 HD12 ' CD1' ' B' ' 27' ' ' TRP . 18.4 mm -57.84 -49.54 80.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.877 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.466 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.4 m-30 -58.61 -43.23 89.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.98 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.798 HG21 ' HB ' ' A' ' 20' ' ' ILE . 11.1 p -65.64 -40.58 92.66 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.716 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 37.4 m -67.01 -34.66 78.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.251 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.68 -37.31 0.13 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.04 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 106.56 -42.53 1.89 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -112.04 41.09 2.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.4 0.619 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 77.2 ttt180 -96.31 -36.61 10.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.412 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.756 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.698 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.513 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 27.7 p-10 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.97 -42.02 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.089 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.52 -58.15 4.74 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.999 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.513 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.74 -35.01 73.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.98 -46.93 93.06 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.437 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.513 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 42.5 tp -72.7 -42.98 63.63 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 t -51.26 -43.64 61.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.973 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -58.3 -43.89 88.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.509 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.2 m -74.13 -36.69 64.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.931 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.513 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 83.6 m -60.46 -39.87 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.957 0.408 . . . . 0.0 110.343 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.7 t -81.27 -42.98 19.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.947 0.404 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.525 ' HG2' ' CD1' ' A' ' 13' ' ' TRP . 18.8 ttpp -62.9 -50.16 71.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.941 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.525 ' CD1' ' HG2' ' A' ' 12' ' ' LYS . 32.4 m0 -118.66 -54.32 2.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.546 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 141.54 174.46 14.43 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 92.1 m -147.11 146.41 29.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.916 0.358 . . . . 0.0 110.894 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.504 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.5 m -93.99 169.64 10.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.997 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -55.1 -38.39 68.07 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.962 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -51.25 70.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.605 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -61.57 -45.58 93.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.924 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.798 ' HB ' HG21 ' B' ' 21' ' ' THR . 31.5 mt -70.75 -42.37 77.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.36 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.46 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 47.0 m -65.72 -20.23 66.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 111.025 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.7 t -66.49 -10.39 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.506 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -109.62 23.6 14.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.184 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 C--O 1.256 1.405 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.18 179.589 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 m -148.64 -168.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.557 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.4 mtp180 -88.22 130.36 35.1 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.18 0.514 . . . . 0.0 109.789 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.563 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.3 mm? -124.06 114.64 19.99 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.409 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 78.7 m -109.12 117.66 34.72 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 46.06 -100.36 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 O-C-N 123.871 0.732 . . . . 0.0 114.384 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -53.71 -38.45 64.28 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.285 0.634 . . . . 0.0 112.138 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -70.74 -36.34 73.1 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.573 ' O ' HG23 ' B' ' 18' ' ' VAL . 35.6 t80 -63.52 -53.49 51.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.487 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.572 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.4 mt -59.13 -48.29 87.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.626 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 5.2 tpt180 -66.14 -32.88 74.6 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.264 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.89 95.96 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.587 ' HA ' HG22 ' A' ' 20' ' ' ILE . 91.3 t -60.3 -49.83 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.776 HG23 ' HD1' ' B' ' 27' ' ' TRP . 35.8 mm -55.19 -50.79 61.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.335 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.498 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.9 m-30 -58.49 -46.07 87.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.924 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.655 HG22 ' HG2' ' A' ' 17' ' ' LYS . 18.2 p -65.1 -39.22 92.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.044 0.449 . . . . 0.0 110.756 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . 0.513 ' HB3' HH11 ' B' ' 26' ' ' ARG . 78.6 m -66.91 -26.55 66.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.503 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.32 -19.75 0.23 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.283 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.39 -50.42 4.33 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 112.329 -0.308 . . . . 0.0 112.329 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -101.18 29.2 4.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.315 0.578 . . . . 0.0 110.39 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.513 HH11 ' HB3' ' B' ' 22' ' ' CYS . 72.3 ttt180 -88.65 -33.27 17.66 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.744 0.783 . . . . 0.0 109.491 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.776 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.312 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.71 -45.32 66.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 123.424 0.452 . . . . 0.0 109.955 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.81 -54.05 15.37 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.534 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.08 -36.78 73.34 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.91 -49.43 75.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.766 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.71 -39.63 73.3 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.6 t -55.27 -43.59 74.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.37 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.6 m -60.86 -35.58 76.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.555 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 m -80.35 -38.49 30.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.58 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 52.2 m -61.73 -41.79 98.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 110.716 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.416 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 49.6 t -76.88 -40.47 47.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.931 0.396 . . . . 0.0 110.682 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -69.47 -50.77 42.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.86 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.51 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 10.6 m0 -114.17 -57.1 2.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.271 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.58 -172.06 23.75 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.427 ' SG ' HD23 ' B' ' 9' ' ' LEU . 1.8 p -164.81 150.12 9.77 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.867 0.365 . . . . 0.0 110.73 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.584 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.9 m -94.04 169.77 10.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.064 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.655 ' HG2' HG22 ' B' ' 21' ' ' THR . 10.5 tmtt? -54.42 -35.36 62.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.039 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -51.34 64.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.993 0.425 . . . . 0.0 111.474 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -58.71 -44.54 90.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.168 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.587 HG22 ' HA ' ' B' ' 18' ' ' VAL . 40.0 mt -67.69 -40.89 84.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.2 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.472 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 68.8 m -64.69 -18.09 64.67 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 m -66.39 -13.15 60.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.929 0.395 . . . . 0.0 111.047 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.75 -5.08 42.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.106 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 80.6 m . . . . . 0 C--O 1.257 1.453 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.33 -178.901 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.449 -0.44 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 m -148.65 -169.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.508 0.194 . . . . 0.0 110.484 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.568 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 65.5 mtp180 -86.92 127.93 35.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.19 0.519 . . . . 0.0 109.711 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.4 mm? -122.97 115.07 21.3 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.59 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 65.0 m -109.46 119.93 40.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.53 -104.04 0.09 OUTLIER Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.464 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' B' ' 12' ' ' ARG . 33.4 ttp85 -56.86 -32.13 65.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.695 0.398 . . . . 0.0 111.7 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.507 ' HB3' HD12 ' B' ' 9' ' ' LEU . 25.5 mm-40 -70.02 -38.68 75.99 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.613 ' O ' HG23 ' B' ' 18' ' ' VAL . 39.8 t80 -59.36 -53.39 58.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.349 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.6 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.1 mt -59.45 -51.93 66.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.849 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.683 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 2.2 mmp_? -63.68 -31.72 72.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.709 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.33 -38.39 89.98 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.795 ' HA ' HG22 ' A' ' 20' ' ' ILE . 84.6 t -59.61 -49.73 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.756 HG23 ' HD1' ' B' ' 27' ' ' TRP . 13.4 mm -57.47 -53.41 44.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.136 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.659 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.6 m-30 -56.38 -45.09 80.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.43 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.617 HG21 ' HB ' ' A' ' 20' ' ' ILE . 24.7 p -65.63 -40.68 92.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.356 0.598 . . . . 0.0 111.051 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -74.32 -18.21 60.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.753 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.83 -21.89 0.23 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.917 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.45 -51.16 4.52 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.3 m -104.31 38.52 1.85 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.324 0.583 . . . . 0.0 109.771 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.423 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 9.4 tpp85 -87.48 -38.8 15.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.114 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.756 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.665 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.52 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.5 p-10 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 47.2 t -111.22 -44.19 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.157 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -68.99 -57.27 5.68 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.52 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.11 -33.29 70.68 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.1 -43.71 98.03 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.579 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 42.2 mt -82.2 -43.21 17.95 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 39.7 t -49.47 -45.14 46.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.588 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 p -62.32 -46.54 88.24 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.568 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 m -68.88 -39.47 79.79 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.35 0.26 . . . . 0.0 111.115 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.48 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 78.3 m -62.28 -38.78 90.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.916 0.389 . . . . 0.0 110.092 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.435 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 44.5 t -78.97 -44.46 22.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.099 0.476 . . . . 0.0 110.459 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -63.2 -50.24 71.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.688 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.511 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 22.1 m0 -117.08 -57.73 2.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.548 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.47 173.96 14.67 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.8 m -147.78 147.54 29.98 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 116.994 0.397 . . . . 0.0 110.61 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.57 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.7 m -95.09 163.84 13.13 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.417 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -52.51 -38.22 59.11 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.497 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -52.37 66.04 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.452 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -60.38 -44.78 95.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.795 HG22 ' HA ' ' B' ' 18' ' ' VAL . 27.1 mt -70.71 -44.06 76.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.695 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 70.7 m -63.53 -25.09 68.09 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.431 -0.168 . . . . 0.0 111.382 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.7 m -64.61 -8.55 14.64 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.487 HD11 HD12 ' A' ' 6' ' ' LEU . 7.8 mp -80.74 -21.94 40.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.4 m . . . . . 0 C--O 1.244 0.785 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.82 -179.311 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.086 -0.405 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 20.4 m -144.22 -167.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.616 0.246 . . . . 0.0 110.532 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -89.18 130.96 35.51 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.6 mm? -127.14 112.39 15.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.322 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 85.5 m -109.75 119.09 38.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.752 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.51 -105.55 0.16 Allowed Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.736 -0.666 . . . . 0.0 114.556 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -57.02 -32.14 65.84 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 122.752 0.421 . . . . 0.0 112.051 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.38 -40.17 81.49 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.663 ' O ' HG23 ' B' ' 18' ' ' VAL . 55.2 t80 -61.23 -53.7 53.61 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.623 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.554 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.3 mt -56.51 -50.2 74.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.037 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.527 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 3.7 tpt180 -67.27 -31.78 72.34 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.953 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.4 96.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.805 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.747 ' HA ' HG22 ' A' ' 20' ' ' ILE . 92.0 t -59.97 -50.37 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.816 HG23 ' HD1' ' B' ' 27' ' ' TRP . 26.7 mm -57.58 -52.46 57.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.457 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.55 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.4 m-30 -56.57 -47.6 79.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.904 -1.043 . . . . 0.0 113.4 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.483 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 21.7 p -64.18 -41.22 97.19 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.167 0.508 . . . . 0.0 111.532 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 57.3 m -77.08 -14.27 59.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.995 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.13 -29.38 0.25 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 119.778 -1.201 . . . . 0.0 113.205 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.68 -48.68 4.04 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -106.51 26.44 9.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.198 0.523 . . . . 0.0 110.16 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -84.83 -33.05 22.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.789 0.804 . . . . 0.0 109.49 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.816 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.12 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.541 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 27.2 p-10 . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 26.3 t -111.29 -42.81 4.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.111 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.454 ' HG ' HD21 ' A' ' 23' ' ' LEU . 9.3 mp -68.86 -57.61 5.32 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.541 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -57.52 -33.92 68.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.72 84.86 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.373 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 62.8 mt -72.85 -39.59 66.4 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 29.3 t -52.86 -43.81 66.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.736 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.2 m -60.69 -44.82 96.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.445 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -71.12 -38.23 72.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.717 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.683 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 64.7 m -63.82 -37.18 86.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 110.865 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 34.9 t -79.62 -37.73 35.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.181 0.515 . . . . 0.0 110.297 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -73.29 -52.52 13.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.16 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -113.32 -42.3 3.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.249 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 120.16 -179.1 16.53 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.48 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.1 p -161.36 150.41 16.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.935 0.398 . . . . 0.0 111.155 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.527 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.0 m -96.9 167.33 11.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.911 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.423 ' HG3' HG22 ' B' ' 21' ' ' THR . 38.2 tttm -54.21 -37.42 64.55 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.16 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -50.55 73.64 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.426 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -62.89 -45.01 94.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.094 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.747 HG22 ' HA ' ' B' ' 18' ' ' VAL . 24.2 mt -71.51 -42.3 72.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.681 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.483 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 70.5 m -64.04 -36.16 83.08 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.142 -0.349 . . . . 0.0 111.314 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.2 m -69.03 3.72 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.82 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.454 HD21 ' HG ' ' A' ' 3' ' ' LEU . 20.2 tp -90.04 -22.48 21.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.698 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.2 m . . . . . 0 C--O 1.243 0.73 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.91 -179.512 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.47 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m -142.35 -177.0 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.571 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 72.3 mtp180 -83.29 129.71 35.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.123 0.487 . . . . 0.0 110.339 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.4 mm? -123.87 118.49 27.22 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.992 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 65.8 m -117.79 119.66 35.57 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.37 -98.66 0.02 OUTLIER Glycine 0 CA--C 1.519 0.316 0 N-CA-C 114.761 0.665 . . . . 0.0 114.761 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.423 ' H ' ' HG3' ' B' ' 12' ' ' ARG . 15.6 mtm180 -53.4 -44.37 68.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.281 0.632 . . . . 0.0 111.941 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.572 ' HB3' HD12 ' B' ' 9' ' ' LEU . 3.0 mp0 -72.29 -30.98 65.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.896 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.591 ' O ' HG23 ' B' ' 18' ' ' VAL . 41.7 t80 -65.1 -51.68 59.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.038 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.642 ' O ' HG12 ' B' ' 19' ' ' ILE . 80.1 mt -61.53 -49.22 85.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.865 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.574 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.5 mmp_? -62.83 -32.11 73.25 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.298 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.547 ' HB1' HD13 ' A' ' 20' ' ' ILE . . . -63.92 -44.0 94.24 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.601 ' HA ' HG22 ' A' ' 20' ' ' ILE . 61.8 t -57.8 -51.11 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.861 HG23 ' HD1' ' B' ' 27' ' ' TRP . 37.9 mm -53.42 -51.42 41.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.311 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.534 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.8 m-30 -58.82 -44.74 90.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.732 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.861 HG21 ' HB ' ' A' ' 20' ' ' ILE . 17.0 p -63.7 -39.38 94.17 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.589 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 m -69.39 -31.33 69.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.652 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.39 -22.23 0.09 OUTLIER Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.674 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.21 -62.26 4.6 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.4 m -90.85 48.18 1.5 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.565 0.698 . . . . 0.0 109.641 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.8 tpm_? -112.55 -37.19 5.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.124 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.861 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.12 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.117 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.95 -44.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 123.511 0.507 . . . . 0.0 109.865 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.97 -54.46 13.2 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.68 -35.79 73.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.47 -49.48 73.48 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.647 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 43.5 tp -70.8 -39.93 72.83 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.9 t -55.65 -37.81 68.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.476 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 t -59.8 -41.73 91.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.882 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.7 m -76.23 -43.16 43.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.53 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 75.5 m -60.03 -39.48 86.05 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.256 0.347 . . . . 0.0 111.467 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.45 -38.72 25.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.838 0.352 . . . . 0.0 111.009 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 3.2 ttmp? -68.43 -61.5 1.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.278 0.561 . . . . 0.0 111.631 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.532 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 6.0 m0 -101.18 -54.35 2.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.902 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 138.05 174.33 13.35 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.7 m -148.56 146.61 28.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.983 0.42 . . . . 0.0 110.672 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.51 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 3.2 m -91.91 170.05 10.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.629 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.662 ' HG3' HG22 ' B' ' 21' ' ' THR . 40.7 tttm -55.9 -36.87 68.13 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.682 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -52.22 66.66 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.614 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.51 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.68 -44.9 93.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.6 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.861 ' HB ' HG21 ' B' ' 21' ' ' THR . 37.4 mt -70.66 -39.6 76.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.015 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.493 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 49.3 m -65.15 -20.46 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.776 0.322 . . . . 0.0 110.669 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.5 m -68.15 -6.88 25.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.068 0.461 . . . . 0.0 110.93 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.455 HD11 HD23 ' A' ' 6' ' ' LEU . 69.1 mt -105.33 19.66 20.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.6 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.411 179.401 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.69 -171.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.557 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 61.8 mtp180 -89.88 123.93 34.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.088 0.47 . . . . 0.0 109.883 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.649 HD12 ' HG3' ' B' ' 13' ' ' GLU . 2.1 mm? -114.98 115.26 26.59 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.129 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 79.7 m -109.26 118.77 37.58 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.78 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.57 -102.57 0.05 OUTLIER Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.465 -0.789 . . . . 0.0 114.345 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' B' ' 12' ' ' ARG . 4.4 tmm_? -57.16 -32.21 66.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.239 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.649 ' HG3' HD12 ' B' ' 9' ' ' LEU . 5.6 tp10 -70.59 -38.28 74.0 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.601 ' O ' HG23 ' B' ' 18' ' ' VAL . 45.3 t80 -59.65 -55.45 34.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.582 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.578 ' O ' HG12 ' B' ' 19' ' ' ILE . 62.3 mt -58.88 -48.52 86.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.967 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.502 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 5.1 tpt180 -65.58 -33.28 75.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.302 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -40.31 96.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.601 HG23 ' O ' ' B' ' 14' ' ' PHE . 60.6 t -60.64 -49.26 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.809 HG23 ' HD1' ' B' ' 27' ' ' TRP . 39.0 mm -55.8 -51.08 63.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.308 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.553 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.3 m-30 -58.53 -46.19 87.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.047 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.674 HG22 ' HG2' ' A' ' 17' ' ' LYS . 18.4 p -65.05 -39.74 93.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.984 0.421 . . . . 0.0 110.808 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . 0.491 ' HB3' HH11 ' B' ' 26' ' ' ARG . 73.5 m -67.86 -24.39 65.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.737 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.14 -21.94 0.22 Allowed Glycine 0 C--O 1.227 -0.333 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.495 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.08 -51.58 4.49 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.7 m -101.08 27.81 5.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.411 0.624 . . . . 0.0 110.139 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.491 HH11 ' HB3' ' B' ' 22' ' ' CYS . 72.0 ttt180 -88.52 -32.8 18.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.658 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.809 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.202 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.505 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.2 p-10 . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.491 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 45.2 t -111.99 -42.61 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.156 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.9 mt -69.26 -56.35 7.84 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.505 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -60.71 -32.9 72.13 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.91 -43.38 98.11 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.31 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.807 HD12 HD11 ' A' ' 23' ' ' LEU . 44.9 mt -80.31 -43.14 21.75 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -49.31 -47.01 47.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.532 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.1 p -62.48 -46.57 87.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.568 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 33.1 m -67.5 -38.53 84.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.227 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.572 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 83.3 m -62.58 -39.46 93.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.921 0.391 . . . . 0.0 110.234 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 41.3 t -79.22 -44.03 22.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.237 0.541 . . . . 0.0 110.389 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.5 ttpt -62.13 -49.59 75.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.568 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.471 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 23.0 m0 -119.19 -58.07 1.96 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.579 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.9 171.94 13.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.8 m -145.72 145.6 30.93 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.853 0.326 . . . . 0.0 110.417 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.545 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 4.1 m -92.53 164.77 13.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.563 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.674 ' HG2' HG22 ' B' ' 21' ' ' THR . 10.4 tmtt? -54.27 -35.47 62.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.788 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -52.17 63.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.029 0.443 . . . . 0.0 111.737 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.32 -42.48 95.69 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.739 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' B' ' 18' ' ' VAL . 26.6 mt -69.2 -39.57 79.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.489 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 70.3 m -66.29 -17.58 64.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.625 0.25 . . . . 0.0 111.296 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.7 m -67.58 -10.05 48.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.191 0.519 . . . . 0.0 110.345 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.807 HD11 HD12 ' A' ' 6' ' ' LEU . 95.8 mt -105.54 23.21 14.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.952 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 80.2 m . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.681 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 CA--C 1.508 -0.364 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 m -149.61 -167.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.57 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 62.9 mtp180 -86.27 126.12 34.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.042 0.449 . . . . 0.0 110.151 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.5 mm? -119.48 118.48 31.21 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.04 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 65.2 m -112.69 110.75 21.09 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 53.2 -94.56 0.01 OUTLIER Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.834 -0.621 . . . . 0.0 114.577 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' B' ' 12' ' ' ARG . 12.1 mtm180 -55.64 -42.3 74.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.267 0.556 . . . . 0.0 111.138 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.621 ' HB3' HD12 ' B' ' 9' ' ' LEU . 34.3 mp0 -68.84 -34.19 75.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.431 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.602 ' O ' HG23 ' B' ' 18' ' ' VAL . 48.6 t80 -63.07 -52.31 63.22 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.829 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.626 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.3 mt -59.88 -48.56 87.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.603 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.1 mmp_? -61.86 -34.98 76.97 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.55 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.595 ' HB1' HD13 ' A' ' 20' ' ' ILE . . . -64.12 -41.42 97.25 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 14' ' ' PHE . 48.9 t -58.8 -48.27 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.84 HG23 ' HD1' ' B' ' 27' ' ' TRP . 36.5 mm -56.18 -50.6 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.704 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.613 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.8 m-30 -57.29 -43.84 83.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.519 -1.218 . . . . 0.0 112.792 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.918 HG21 ' HB ' ' A' ' 20' ' ' ILE . 14.7 p -66.22 -40.83 90.59 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.328 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 34.9 m -67.45 -32.75 73.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.429 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.1 -30.28 0.09 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.31 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 92.16 -53.2 2.85 Favored Glycine 0 C--O 1.225 -0.457 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.7 m -102.39 45.66 0.96 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.584 0.707 . . . . 0.0 109.204 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.421 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.9 tpm_? -108.66 -37.92 5.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.356 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.84 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.074 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.175 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.5 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 25.9 p-10 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 41.9 t -112.12 -41.82 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.213 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.7 mt -68.89 -56.67 7.17 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -61.04 -33.07 72.72 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.69 -43.57 97.67 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.262 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.786 HD12 HD11 ' A' ' 23' ' ' LEU . 27.0 mt -80.47 -42.95 21.67 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -48.66 -47.13 40.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.223 0.609 . . . . 0.0 111.435 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 p -63.99 -46.31 85.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.8 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.404 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 25.6 m -67.92 -39.11 83.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.418 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 73.2 m -62.79 -39.81 95.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.953 0.406 . . . . 0.0 110.185 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 45.9 t -78.59 -42.73 28.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.136 0.493 . . . . 0.0 110.437 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.7 ttpt -64.27 -50.15 69.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.566 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.511 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 22.7 m0 -117.71 -58.85 1.98 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.452 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.57 172.9 14.71 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 78.7 m -147.94 147.78 30.07 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.814 0.307 . . . . 0.0 110.673 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.564 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.7 m -96.88 166.09 11.79 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.537 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.777 ' HG2' HG22 ' B' ' 21' ' ' THR . 11.3 tmtt? -53.64 -35.63 61.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.278 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -51.59 65.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.964 0.411 . . . . 0.0 111.627 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.491 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.17 -44.28 92.14 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.481 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.918 ' HB ' HG21 ' B' ' 21' ' ' THR . 27.1 mt -70.42 -35.57 62.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.495 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.528 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 68.2 m -65.32 -23.24 66.96 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.736 0.303 . . . . 0.0 110.711 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.5 m -69.13 -0.94 6.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.797 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.786 HD11 HD12 ' A' ' 6' ' ' LEU . 96.3 mt -108.7 13.91 24.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.206 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.473 179.553 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.447 ' O ' HD22 ' B' ' 9' ' ' LEU . 7.2 t -134.2 165.59 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.559 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 70.0 mtp180 -74.34 130.48 39.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.377 0.608 . . . . 0.0 110.845 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.67 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 1.4 mm? -117.34 115.04 24.45 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.03 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 70.9 m -116.52 116.9 28.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.529 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.09 -101.82 0.05 OUTLIER Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.69 -0.686 . . . . 0.0 114.347 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -57.67 -36.2 71.58 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.954 0.502 . . . . 0.0 111.637 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.2 -29.97 65.82 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.9 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.67 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 47.4 t80 -68.78 -54.96 12.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.706 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.534 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.5 mt -60.65 -47.34 93.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.583 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 4.2 tpt180 -66.17 -30.22 70.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.69 97.8 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.664 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.74 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.3 t -60.13 -50.45 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.79 HG23 ' HD1' ' B' ' 27' ' ' TRP . 29.1 mm -57.05 -52.22 58.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.493 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.535 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -58.51 -46.41 86.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.948 -1.023 . . . . 0.0 113.058 -178.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.451 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 19.7 p -63.53 -41.05 98.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.944 0.402 . . . . 0.0 111.679 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.9 m -74.41 -20.82 59.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.301 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.5 -30.58 0.18 Allowed Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.876 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.27 -52.3 4.49 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 112.259 -0.336 . . . . 0.0 112.259 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 15.9 p -99.42 29.05 4.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.478 0.656 . . . . 0.0 110.558 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.9 tpm_? -89.49 -36.57 15.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.997 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.79 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.132 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.52 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.7 p-10 . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.67 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 49.0 t -109.72 -44.15 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.08 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.74 -57.63 6.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.52 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.11 -32.9 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.51 -46.88 93.22 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.25 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 30.6 mt -74.4 -39.47 62.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.8 t -52.57 -38.51 60.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -59.49 -36.52 76.21 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.89 0.376 . . . . 0.0 110.795 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 m -86.33 -41.23 14.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.664 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.563 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 98.0 m -61.8 -39.43 91.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.709 0.29 . . . . 0.0 110.87 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.3 t -78.43 -39.4 38.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.927 0.394 . . . . 0.0 110.804 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 2.1 ttmp? -68.3 -57.67 5.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.202 0.525 . . . . 0.0 111.372 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.532 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 9.7 m0 -103.43 -60.91 1.49 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.288 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.83 170.06 11.98 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.438 ' HB2' HD23 ' B' ' 9' ' ' LEU . 83.4 m -145.32 151.4 38.26 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 117.121 0.46 . . . . 0.0 110.574 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.568 ' HB3' ' OE1' ' A' ' 19' ' ' GLU . 34.0 t -95.63 169.42 10.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.626 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -56.13 -37.16 69.07 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.149 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -52.96 63.51 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.996 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.568 ' OE1' ' HB3' ' A' ' 16' ' ' SER . 2.4 mp0 -60.62 -45.97 92.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.974 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.74 HG22 ' HA ' ' B' ' 18' ' ' VAL . 45.0 mt -69.32 -44.75 80.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.451 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 71.5 m -62.34 -29.03 70.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.564 0.221 . . . . 0.0 111.437 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.2 m -65.45 -4.11 5.28 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 6' ' ' LEU . 10.4 mp -84.84 -19.52 32.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.706 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.894 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.423 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 12.6 m -144.92 -169.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 110.652 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 -88.12 128.96 35.43 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -125.89 113.04 16.69 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.154 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 78.9 m -111.28 116.1 30.45 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.07 -101.65 0.05 OUTLIER Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.74 -0.664 . . . . 0.0 114.404 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.699 ' NH1' ' HB2' ' B' ' 12' ' ' ARG . 5.7 mtm105 -57.34 -36.58 71.35 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.604 0.362 . . . . 0.0 111.779 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.416 ' HB2' ' H ' ' B' ' 10' ' ' CYS . 8.0 mp0 -67.32 -37.55 83.5 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.604 ' O ' HG23 ' B' ' 18' ' ' VAL . 39.3 t80 -62.6 -53.05 60.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.728 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.549 ' O ' HG12 ' B' ' 19' ' ' ILE . 69.1 mt -57.35 -48.74 81.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.644 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.491 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 5.3 tpt180 -66.6 -33.03 74.76 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.05 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.32 93.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.506 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.604 ' HA ' HG22 ' A' ' 20' ' ' ILE . 83.7 t -60.89 -49.95 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.734 HG23 ' HD1' ' B' ' 27' ' ' TRP . 36.4 mm -53.98 -51.12 48.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.539 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -43.91 97.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.988 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.532 HG21 ' HB ' ' A' ' 20' ' ' ILE . 19.4 p -64.94 -41.19 95.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.757 0.313 . . . . 0.0 110.794 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . 0.45 ' HB3' HH11 ' B' ' 26' ' ' ARG . 85.7 m -63.97 -31.19 72.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.146 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.26 -21.14 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.396 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.4 -56.27 4.99 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -92.16 44.33 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.402 0.62 . . . . 0.0 110.326 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.45 HH11 ' HB3' ' B' ' 22' ' ' CYS . 75.3 ttt180 -110.04 -33.75 6.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.753 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.734 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.508 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.9 p-10 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.0 t -111.59 -42.26 4.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.08 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.39 -57.02 5.81 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.49 -33.66 71.61 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.02 -47.86 87.15 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.38 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.1 tp -73.02 -38.66 66.47 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 43.0 t -54.97 -41.93 71.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.288 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 t -59.22 -48.01 83.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.752 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 m -67.57 -39.41 84.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.682 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 61.4 m -61.46 -39.7 91.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 111.383 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.423 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 38.3 t -81.04 -38.61 27.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.267 0.556 . . . . 0.0 110.459 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -69.97 -53.1 19.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.297 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -114.93 -40.67 3.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.037 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 121.23 176.13 15.28 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' SG ' HD23 ' B' ' 9' ' ' LEU . 6.3 p -158.8 150.94 21.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.196 0.522 . . . . 0.0 111.465 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.498 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 8.2 m -96.62 173.34 7.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.03 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -54.86 -38.1 67.08 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.923 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -52.85 63.97 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.275 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.498 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.6 mp0 -60.08 -45.43 92.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.823 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' B' ' 18' ' ' VAL . 42.3 mt -69.47 -45.11 79.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.068 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.55 ' HA ' ' SG ' ' A' ' 24' ' ' CYS . 65.6 m -64.58 -16.7 63.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -65.43 -14.88 61.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.181 0.515 . . . . 0.0 110.371 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 72.4 mt -106.98 25.89 10.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.444 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 96.7 m . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.506 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 CA--C 1.509 -0.302 0 N-CA-C 112.085 -0.406 . . . . 0.0 112.085 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 m -148.03 -173.73 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.504 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 52.3 mtt85 -82.81 133.16 35.14 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.541 0.686 . . . . 0.0 110.832 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.5 mm? -129.68 118.45 21.93 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.632 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . 0.42 ' H ' ' HB2' ' B' ' 13' ' ' GLU . 35.0 m -114.14 117.81 32.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 46.91 -98.61 0.01 OUTLIER Glycine 0 C--N 1.336 0.555 0 O-C-N 123.742 0.651 . . . . 0.0 114.658 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -54.15 -39.56 66.64 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.146 0.578 . . . . 0.0 111.555 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.541 ' HB3' HD12 ' B' ' 9' ' ' LEU . 34.7 mm-40 -72.03 -35.01 69.25 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.758 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.571 ' O ' HG23 ' B' ' 18' ' ' VAL . 38.5 t80 -62.93 -53.48 53.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.535 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.592 ' O ' HG12 ' B' ' 19' ' ' ILE . 72.4 mt -59.31 -50.78 78.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.421 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.584 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.3 mmp_? -63.7 -31.03 72.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.503 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.416 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -64.35 -41.52 96.71 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.127 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.843 ' HA ' HG22 ' A' ' 20' ' ' ILE . 93.0 t -59.36 -50.86 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-O 121.9 0.857 . . . . 0.0 108.814 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.783 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.9 mm -58.24 -52.14 62.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.707 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.401 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.8 OUTLIER -59.3 -44.4 92.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.568 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 19.9 p -62.78 -41.18 99.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.076 0.465 . . . . 0.0 110.757 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 56.5 m -75.03 -22.27 58.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.651 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.07 -29.36 0.21 Allowed Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.881 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 87.41 -54.86 4.48 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 38.3 p -96.03 49.11 1.13 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.323 0.582 . . . . 0.0 110.703 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.536 ' NH1' ' HB3' ' A' ' 24' ' ' CYS . 56.1 ttt180 -111.45 -36.44 5.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.255 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.783 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.956 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.062 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.63 -49.76 75.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.547 0.53 . . . . 0.0 110.365 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.89 -44.98 95.7 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.92 -38.19 64.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.79 0.329 . . . . 0.0 111.056 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.13 -44.2 97.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.176 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.588 HD12 HD11 ' A' ' 23' ' ' LEU . 32.3 mt -78.89 -44.4 22.85 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.245 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.2 t -48.91 -46.12 42.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.3 0.64 . . . . 0.0 111.646 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.4 p -64.69 -46.37 82.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.689 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -68.06 -39.6 82.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.431 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.547 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 73.9 m -63.11 -35.5 80.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.868 0.366 . . . . 0.0 110.618 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.6 t -83.39 -41.98 17.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.199 0.523 . . . . 0.0 110.197 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -64.8 -48.65 73.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.522 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -118.45 -53.98 2.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.503 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 134.57 169.76 12.05 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.2 m -145.24 147.44 32.4 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.922 0.361 . . . . 0.0 110.945 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.553 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.2 m -93.71 165.15 12.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.068 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -51.16 -40.12 57.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.508 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -53.71 55.25 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.693 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.99 -43.2 95.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.109 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.843 HG22 ' HA ' ' B' ' 18' ' ' VAL . 40.6 mt -70.9 -46.9 65.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.489 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.568 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 70.2 m -62.09 -23.72 66.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.5 m -63.93 -11.56 29.37 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 6' ' ' LEU . 21.9 mt -85.22 -6.89 59.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.536 ' HB3' ' NH1' ' B' ' 26' ' ' ARG . 77.5 m . . . . . 0 C--O 1.243 0.734 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.334 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.367 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 25.4 m -142.2 -171.83 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.349 . . . . 0.0 110.881 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -87.03 126.35 34.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.659 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.719 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.6 mm? -123.05 114.46 20.4 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.028 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 58.1 m -113.26 119.68 38.58 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.0 -102.64 0.06 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.92 -0.582 . . . . 0.0 114.417 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -57.13 -34.63 68.59 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.47 -33.83 69.65 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.615 ' O ' HG23 ' B' ' 18' ' ' VAL . 45.3 t80 -62.61 -54.54 38.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.302 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.584 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.1 mt -58.44 -50.13 79.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.295 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.53 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.7 mmp_? -62.33 -32.72 73.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.29 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.21 96.46 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.315 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.786 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.7 t -59.05 -50.02 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 122.042 0.925 . . . . 0.0 108.837 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.799 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.3 mm -59.04 -53.04 53.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.185 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.477 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.0 m-30 -56.3 -45.57 80.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.177 -0.92 . . . . 0.0 113.411 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.592 HG21 ' HB ' ' A' ' 20' ' ' ILE . 15.7 p -64.44 -41.6 96.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.807 0.337 . . . . 0.0 111.42 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 58.3 m -75.58 -27.67 58.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.493 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.92 -29.52 0.08 OUTLIER Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.326 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.39 -54.13 4.65 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.749 -0.262 . . . . 0.0 112.477 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m -101.14 52.84 0.84 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.59 0.71 . . . . 0.0 110.102 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.522 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 3.5 tpm_? -115.9 -38.15 3.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.846 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.799 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.179 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.987 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.508 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.6 p-10 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 27.4 t -111.57 -42.49 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.109 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.87 -57.26 5.8 Favored 'General case' 0 C--O 1.218 -0.555 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.508 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.44 -33.47 71.31 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.16 -45.47 95.98 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.408 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 59.8 mt -78.65 -44.37 23.99 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 40.8 t -48.42 -48.71 37.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.688 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.5 p -65.82 -45.45 82.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.683 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.536 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 23.8 m -65.69 -38.27 88.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.904 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.719 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 80.0 m -63.76 -34.54 78.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.999 0.428 . . . . 0.0 110.762 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 t -85.46 -38.69 18.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.31 0.576 . . . . 0.0 110.068 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.7 ttpt -68.03 -44.49 76.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.707 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -124.13 -48.65 1.85 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.886 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 128.21 165.74 11.87 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 78.9 m -143.44 146.98 33.89 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 117.129 0.464 . . . . 0.0 111.205 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.6 m -96.27 165.41 12.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.076 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -52.36 -40.09 61.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.353 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 m -57.03 -53.75 54.53 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 123.69 0.619 . . . . 0.0 111.532 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.618 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.7 mp0 -60.64 -43.52 97.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.43 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.786 HG22 ' HA ' ' B' ' 18' ' ' VAL . 31.5 mt -72.58 -39.23 61.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.264 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.416 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 51.1 m -64.12 -37.95 89.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.763 0.316 . . . . 0.0 110.807 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p -69.97 7.34 0.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.022 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.448 HD23 ' CG2' ' B' ' 18' ' ' VAL . 19.6 tp -92.27 -24.38 19.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.872 0.368 . . . . 0.0 110.159 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.6 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.84 179.615 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.42 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.03 -173.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.479 0.18 . . . . 0.0 110.522 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 26.4 mmt85 -87.58 130.97 34.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.153 0.501 . . . . 0.0 110.303 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.723 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -124.94 109.16 12.66 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.731 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 42.1 m -111.54 116.56 31.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.691 0.282 . . . . 0.0 111.642 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 50.98 -103.95 0.12 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.733 -0.667 . . . . 0.0 114.54 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -57.9 -32.87 68.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 122.519 0.328 . . . . 0.0 111.563 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.486 ' HG3' HD12 ' B' ' 9' ' ' LEU . 3.6 tp10 -68.25 -38.56 81.93 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 51.0 t80 -60.95 -53.59 55.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.001 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.61 ' O ' HG12 ' B' ' 19' ' ' ILE . 63.1 mt -60.0 -49.7 82.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.688 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.62 ' NH2' HG13 ' B' ' 19' ' ' ILE . 0.1 OUTLIER -65.25 -28.58 69.45 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.881 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.83 -42.82 94.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.002 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.764 ' HA ' HG22 ' A' ' 20' ' ' ILE . 62.1 t -58.94 -49.22 83.91 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.079 0.943 . . . . 0.0 108.517 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.818 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.3 mm -57.79 -53.16 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.571 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.551 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.4 OUTLIER -57.92 -45.18 86.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.323 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.515 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 17.4 p -63.5 -39.55 94.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.986 0.422 . . . . 0.0 111.553 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 60.9 m -79.49 -20.77 46.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.636 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.61 -31.13 0.14 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.112 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 85.36 -56.47 4.94 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.783 -0.246 . . . . 0.0 112.516 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m -97.21 50.32 1.07 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.565 0.697 . . . . 0.0 110.155 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 7.2 tpm_? -114.42 -38.96 3.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.626 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.818 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.032 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 27.3 p-10 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.97 -43.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.286 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.5 mp -70.43 -56.92 5.47 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -60.52 -34.65 74.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.83 -46.63 93.22 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.456 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.634 HD23 HD11 ' A' ' 23' ' ' LEU . 38.5 tp -73.55 -39.78 64.45 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.5 t -53.14 -45.09 68.23 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.601 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.4 m -60.55 -42.75 97.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.391 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 m -70.74 -38.7 73.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.812 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.723 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 90.7 m -62.11 -32.72 73.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.977 0.417 . . . . 0.0 110.776 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.451 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 49.0 t -85.31 -40.31 16.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.157 0.503 . . . . 0.0 110.393 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -70.82 -48.18 55.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.403 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -114.91 -41.43 3.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.566 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 116.54 165.44 14.05 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -141.18 149.58 41.64 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.909 0.355 . . . . 0.0 111.32 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.534 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.8 m -94.61 168.07 11.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.224 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HG3' HG22 ' B' ' 21' ' ' THR . 37.6 tttm -54.97 -37.19 66.2 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.273 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -52.59 65.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.218 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -60.83 -44.58 96.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.043 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.764 HG22 ' HA ' ' B' ' 18' ' ' VAL . 39.6 mt -70.62 -44.18 76.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.917 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.515 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 67.6 m -64.29 -28.7 69.9 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.522 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.1 m -69.32 -0.55 6.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.59 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.634 HD11 HD23 ' A' ' 6' ' ' LEU . 93.2 mt -90.62 -12.35 37.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.472 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.9 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.1 -0.953 . . . . 0.0 110.804 179.706 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.86 -173.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.7 mmm-85 -86.16 128.82 34.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.801 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.72 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -125.15 109.12 12.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.649 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 84.9 m -109.93 121.46 45.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.772 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 49.42 -106.34 0.2 Allowed Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.862 -0.608 . . . . 0.0 114.493 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.482 ' HG3' ' N ' ' B' ' 13' ' ' GLU . 8.2 ptt180 -56.18 -30.67 62.55 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.779 0.432 . . . . 0.0 111.772 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' B' ' 12' ' ' ARG . 54.8 mm-40 -70.62 -38.78 73.95 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 41.6 t80 -63.16 -51.26 67.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.402 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.657 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.6 mt -58.71 -52.59 58.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.32 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.614 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 1.5 mmp_? -65.24 -27.47 68.68 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.283 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.51 93.08 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.592 ' HA ' HG22 ' A' ' 20' ' ' ILE . 96.9 t -60.43 -50.94 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.748 HG23 ' HD1' ' B' ' 27' ' ' TRP . 28.4 mm -54.87 -50.44 61.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.034 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.626 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -58.86 -45.92 88.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.649 -178.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.516 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 15.3 p -64.14 -38.72 92.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.003 0.43 . . . . 0.0 110.432 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' B' ' 18' ' ' VAL . 86.1 m -67.42 -25.12 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.445 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.32 -19.81 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.107 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 85.41 -48.8 4.08 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 5.3 p -104.02 25.87 9.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.454 0.645 . . . . 0.0 109.856 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.414 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 3.2 tpp85 -79.1 -36.99 39.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.006 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.748 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.947 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.52 -49.97 78.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 123.516 0.51 . . . . 0.0 110.569 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.77 -46.59 88.93 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.578 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.0 -39.08 62.84 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.36 0.413 . . . . 0.0 110.789 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.41 -47.48 87.13 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.066 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HB2' ' CZ ' ' B' ' 14' ' ' PHE . 36.8 mt -71.54 -43.9 65.57 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -50.69 -44.97 58.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.7 m -62.91 -43.47 98.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.862 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -71.63 -41.25 69.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.081 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.72 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 74.1 m -62.33 -37.35 85.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.006 0.431 . . . . 0.0 110.752 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.5 t -79.29 -38.68 34.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.054 0.454 . . . . 0.0 110.481 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.473 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 37.2 ttmt -72.15 -58.46 3.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.139 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.473 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 9.4 m0 -104.81 -44.69 4.77 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.17 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 123.39 169.53 13.25 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 85.2 m -144.74 147.56 33.12 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 117.307 0.554 . . . . 0.0 111.394 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' HG13 ' A' ' 20' ' ' ILE . 2.5 m -95.58 169.46 10.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.012 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' HG3' HG22 ' B' ' 21' ' ' THR . 58.4 tttp -55.7 -37.16 68.0 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.756 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -54.72 43.81 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.665 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.07 -42.29 94.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.351 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.592 HG22 ' HA ' ' B' ' 18' ' ' VAL . 44.9 mt -72.42 -45.8 58.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.928 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.611 ' HA ' ' SG ' ' A' ' 24' ' ' CYS . 63.1 m -64.65 -13.21 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.692 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.3 m -63.24 -19.83 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.254 0.549 . . . . 0.0 110.185 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 54.7 mt -106.77 28.11 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.148 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 58.8 m . . . . . 0 C--O 1.259 1.567 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.662 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 112.302 -0.319 . . . . 0.0 112.302 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 m -150.76 -169.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.558 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.6 mtp180 -89.69 128.16 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.4 mm? -121.84 114.06 20.52 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.643 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 71.5 m -108.6 119.97 41.08 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 47.54 -101.57 0.04 OUTLIER Glycine 0 CA--C 1.518 0.281 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.674 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -57.87 -34.05 69.34 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.978 0.511 . . . . 0.0 111.29 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.491 ' HB3' HD12 ' B' ' 9' ' ' LEU . 0.1 OUTLIER -69.49 -36.81 76.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.596 ' O ' HG23 ' B' ' 18' ' ' VAL . 35.8 t80 -61.76 -52.99 61.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.169 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.543 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.3 mt -58.41 -47.73 87.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.333 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.466 ' CZ ' HG21 ' B' ' 19' ' ' ILE . 6.4 tpt180 -65.21 -34.28 78.0 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.039 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.433 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -62.78 -39.29 93.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.807 178.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 14' ' ' PHE . 61.0 t -60.15 -51.13 76.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.858 HG23 ' HD1' ' B' ' 27' ' ' TRP . 40.1 mm -52.68 -52.79 24.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.3 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.598 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.2 m-30 -60.37 -42.12 95.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.684 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.661 HG21 ' HB ' ' A' ' 20' ' ' ILE . 27.0 p -68.19 -42.53 79.78 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.352 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 47.4 m -65.33 -28.88 69.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.186 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.21 -24.21 0.09 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.492 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.9 -62.4 4.63 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.6 m -89.45 40.51 0.99 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.524 0.678 . . . . 0.0 110.177 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.416 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.8 tpm_? -105.17 -35.18 7.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.127 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.858 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.183 -1.372 . . . . 0.0 109.409 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.2 t -72.41 -45.06 61.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 123.487 0.492 . . . . 0.0 109.788 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.658 HD23 HD13 ' A' ' 23' ' ' LEU . 74.6 mt -69.21 -53.77 18.23 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.513 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.76 71.6 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.63 -49.03 83.09 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.424 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 48.9 tp -71.73 -37.91 70.52 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.5 t -54.9 -42.3 71.99 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.288 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.9 t -59.2 -42.21 90.39 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.093 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -74.04 -41.42 61.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.737 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.547 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 62.0 m -60.18 -45.56 92.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.624 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.405 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 48.1 t -74.7 -39.08 62.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.974 0.416 . . . . 0.0 110.858 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 3.2 ttmp? -68.95 -60.1 2.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.844 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.498 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 8.0 m0 -106.56 -54.74 2.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.236 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 139.77 -172.8 23.19 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.479 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.4 p -165.5 148.92 8.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.776 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.474 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 4.2 m -97.15 171.17 8.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.535 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HG3' HG22 ' B' ' 21' ' ' THR . 34.9 tttm -55.92 -36.28 67.56 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.493 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -51.83 68.37 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.46 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.84 -43.5 95.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.36 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.661 ' HB ' HG21 ' B' ' 21' ' ' THR . 39.8 mt -69.99 -44.94 78.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.925 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.523 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 75.2 m -64.4 -22.46 66.97 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.4 m -66.94 -8.52 30.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.917 0.389 . . . . 0.0 110.886 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.658 HD13 HD23 ' A' ' 3' ' ' LEU . 59.0 mt -116.8 26.2 10.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.536 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 70.5 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.44 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.515 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -144.69 -171.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.644 0.259 . . . . 0.0 110.847 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.535 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 70.0 mtp180 -87.87 130.39 34.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.309 0.576 . . . . 0.0 109.936 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.98 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 10.6 mp -116.25 109.4 17.35 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.562 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 72.3 m -112.14 116.95 31.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.923 0.392 . . . . 0.0 111.557 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 51.32 -109.55 0.8 Allowed Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.329 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -59.61 -29.46 68.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -69.4 -37.76 77.64 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.686 ' O ' HG23 ' B' ' 18' ' ' VAL . 55.0 t80 -61.11 -55.6 30.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.078 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.658 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.5 mt -57.26 -52.31 58.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.41 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.632 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.5 mmp_? -64.03 -33.73 76.41 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.276 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.43 83.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.718 ' HA ' HG22 ' A' ' 20' ' ' ILE . 75.6 t -60.16 -47.71 90.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.77 HG23 ' HD1' ' B' ' 27' ' ' TRP . 21.1 mm -59.69 -51.83 68.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.089 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.467 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.3 OUTLIER -55.9 -47.38 77.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.814 -179.056 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.534 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 19.5 p -62.86 -40.54 97.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.001 0.429 . . . . 0.0 111.274 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 57.6 m -80.69 -10.57 59.72 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.22 -30.26 0.42 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.537 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.34 -52.81 4.76 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.5 m -104.16 40.35 1.48 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.472 0.653 . . . . 0.0 110.085 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -98.52 -36.08 10.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.354 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.77 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.205 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.922 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 39.2 t -71.56 -46.35 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.473 0.483 . . . . 0.0 109.758 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.85 -53.87 18.92 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.546 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.25 -35.46 69.75 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.05 -50.14 70.7 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.595 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 42.8 mt -70.39 -42.52 71.59 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 t -52.34 -42.44 63.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.85 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.5 t -59.11 -45.33 91.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.586 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.5 m -76.35 -38.68 55.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.98 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 67.4 m -63.0 -42.71 99.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.694 0.283 . . . . 0.0 111.419 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.69 -40.16 49.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.109 0.481 . . . . 0.0 110.427 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -67.97 -48.31 66.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.442 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.503 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 9.2 m0 -118.78 -58.72 1.93 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.356 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 141.68 -174.6 22.95 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.452 ' SG ' HD22 ' B' ' 9' ' ' LEU . 1.8 p -162.36 152.82 16.96 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.885 0.342 . . . . 0.0 110.875 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.4 m -97.37 167.57 10.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.07 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -52.56 -37.95 58.91 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.072 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.22 -50.27 74.15 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.601 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.35 -42.83 87.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.498 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.718 HG22 ' HA ' ' B' ' 18' ' ' VAL . 24.5 mt -72.06 -46.14 60.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.534 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 66.4 m -65.68 -34.13 77.49 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.191 -0.318 . . . . 0.0 111.579 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 t -68.58 -1.14 6.1 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.355 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.475 HD22 HD12 ' A' ' 6' ' ' LEU . 23.7 tp -85.18 -23.69 28.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.674 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.4 m . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.879 -179.547 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.2 -172.67 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 122.837 -0.214 . . . . 0.0 110.438 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.573 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 66.3 mtp180 -90.79 129.36 36.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.082 0.467 . . . . 0.0 110.051 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.7 mm? -122.14 111.92 17.57 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.178 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 97.9 m -109.76 123.14 49.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.92 -105.49 0.13 Allowed Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.57 -0.741 . . . . 0.0 114.522 178.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -60.48 -29.72 69.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.42 -35.9 73.69 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.55 ' O ' HG23 ' B' ' 18' ' ' VAL . 48.2 t80 -65.18 -50.88 64.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.441 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.663 ' O ' HG12 ' B' ' 19' ' ' ILE . 66.6 mt -57.75 -50.33 77.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.877 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.571 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.7 mmp_? -63.72 -32.02 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.985 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.33 -44.68 94.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.118 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.55 HG23 ' O ' ' B' ' 14' ' ' PHE . 63.4 t -58.0 -50.3 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.859 HG23 ' HD1' ' B' ' 27' ' ' TRP . 34.6 mm -54.52 -50.98 54.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.147 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.49 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.1 m-30 -58.26 -45.41 87.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.747 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.862 HG21 ' HB ' ' A' ' 20' ' ' ILE . 11.9 p -63.54 -38.73 92.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.642 0.258 . . . . 0.0 111.557 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 34.0 m -70.76 -30.93 67.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.758 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.92 -22.14 0.09 OUTLIER Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.655 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 83.97 -60.03 4.89 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 112.176 -0.37 . . . . 0.0 112.176 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -92.6 48.88 1.41 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.524 0.678 . . . . 0.0 109.801 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.8 tpm_? -112.76 -37.4 4.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.985 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.859 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.988 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 39.4 t0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -108.54 -41.64 5.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.426 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.91 -55.4 19.54 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.8 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.49 -36.26 61.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.001 0.429 . . . . 0.0 110.306 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.93 66.53 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.034 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.5 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 44.8 tp -72.22 -39.18 68.7 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 t -54.32 -42.94 70.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.554 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.4 t -58.23 -44.11 88.09 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.203 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -74.16 -40.8 62.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.7 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.599 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 62.5 m -58.04 -44.95 87.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 111.705 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.9 t -78.2 -40.47 37.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.0 0.428 . . . . 0.0 110.995 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -66.85 -49.85 64.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.849 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.544 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 8.8 m0 -119.47 -54.72 2.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.211 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.06 -171.17 25.05 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.551 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.0 p -166.45 151.05 7.72 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.182 0.515 . . . . 0.0 111.355 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.483 ' O ' HG13 ' A' ' 20' ' ' ILE . 67.6 p -93.1 165.4 12.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.679 ' HG3' HG22 ' B' ' 21' ' ' THR . 37.4 tttm -56.72 -40.14 75.15 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.362 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 m -57.33 -48.17 79.67 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.393 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -63.45 -46.29 86.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.881 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.862 ' HB ' HG21 ' B' ' 21' ' ' THR . 32.5 mt -67.46 -39.53 82.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.588 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.433 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 44.8 m -64.74 -24.43 67.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.779 0.323 . . . . 0.0 110.944 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.0 m -67.88 -5.87 18.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.138 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -107.7 19.04 20.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.466 179.258 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 24.7 m -139.72 -179.96 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.542 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 67.1 mtp180 -86.32 127.79 34.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.176 0.512 . . . . 0.0 110.008 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.3 mm? -122.42 117.18 25.4 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.41 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 79.3 m -115.52 120.97 41.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.826 0.345 . . . . 0.0 111.893 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 53.41 -107.83 0.67 Allowed Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.285 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -59.48 -30.39 68.5 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.08 -36.63 75.07 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.634 ' O ' HG23 ' B' ' 18' ' ' VAL . 40.5 t80 -61.62 -53.04 61.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.218 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.62 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.2 mt -60.68 -49.27 85.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.347 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.547 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 5.0 mmp_? -61.89 -34.21 75.63 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.475 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.67 96.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.278 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.785 ' HA ' HG22 ' A' ' 20' ' ' ILE . 59.1 t -59.52 -49.28 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-O 122.041 0.924 . . . . 0.0 108.802 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.769 HG23 ' HD1' ' B' ' 27' ' ' TRP . 20.8 mm -59.07 -52.8 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.284 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.448 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.9 OUTLIER -57.74 -45.08 86.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.312 -178.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.554 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 18.6 p -63.48 -40.51 97.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.92 0.39 . . . . 0.0 111.267 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -78.33 -26.21 46.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.652 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.66 -31.47 0.09 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 119.998 -1.096 . . . . 0.0 113.359 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 87.2 -56.83 4.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.688 -0.291 . . . . 0.0 112.521 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.5 m -99.21 51.06 0.95 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.483 0.658 . . . . 0.0 110.114 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 7.2 tpm_? -113.94 -38.82 4.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.941 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.769 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.035 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.933 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.09 -44.81 64.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 123.392 0.433 . . . . 0.0 109.918 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.48 -54.52 13.83 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.749 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.14 75.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.01 -48.54 82.67 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.883 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.666 HD23 HD11 ' A' ' 23' ' ' LEU . 35.1 tp -71.0 -41.05 71.43 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 t -53.02 -41.72 64.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.675 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 m -58.81 -34.13 71.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.705 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 m -86.08 -38.27 17.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.352 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.553 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 71.1 m -60.26 -40.57 90.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.782 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.0 t -79.6 -41.56 26.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.989 0.423 . . . . 0.0 110.896 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -67.57 -50.04 60.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.878 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.538 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 11.2 m0 -114.64 -56.71 2.35 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.313 -178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.32 173.17 14.09 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 99.2 m -146.66 148.56 32.18 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.824 0.345 . . . . 0.0 110.935 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.516 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.4 m -94.63 166.19 12.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.617 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -52.94 -38.85 62.4 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.943 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -53.85 53.54 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.473 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -63.3 -42.54 99.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.561 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.785 HG22 ' HA ' ' B' ' 18' ' ' VAL . 45.8 mt -70.63 -45.21 75.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.554 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 73.1 m -64.82 -27.68 69.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.605 0.24 . . . . 0.0 111.601 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.3 m -69.29 -1.74 8.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.971 0.415 . . . . 0.0 111.364 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.666 HD11 HD23 ' A' ' 6' ' ' LEU . 97.3 mt -90.12 -11.18 42.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.807 179.672 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.817 HG22 ' H ' ' B' ' 8' ' ' ARG . 6.2 p -163.46 -173.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.817 ' H ' HG22 ' B' ' 7' ' ' VAL . 69.0 mtp180 -85.1 131.09 34.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.249 0.547 . . . . 0.0 110.398 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.62 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.2 mm? -126.44 115.76 20.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.86 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 73.1 m -111.73 120.78 43.18 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 45.56 -100.62 0.02 OUTLIER Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.425 ' HE ' ' CD ' ' B' ' 13' ' ' GLU . 7.1 tmm_? -54.57 -41.18 69.53 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.112 0.565 . . . . 0.0 111.661 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.62 ' HB3' HD12 ' B' ' 9' ' ' LEU . 14.1 mp0 -69.15 -36.08 77.03 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.626 ' O ' HG23 ' B' ' 18' ' ' VAL . 46.0 t80 -61.9 -56.52 18.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.013 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ILE . . . . . 0.591 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.9 mt -58.54 -48.06 86.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.529 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.508 ' NH1' HG13 ' B' ' 19' ' ' ILE . 13.1 mmm180 -64.13 -34.24 77.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.493 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.85 -40.45 97.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.153 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.784 ' HA ' HG22 ' A' ' 20' ' ' ILE . 57.9 t -59.42 -49.5 83.35 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.862 HG23 ' HD1' ' B' ' 27' ' ' TRP . 19.6 mm -57.87 -53.56 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.333 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.51 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.6 m-30 -57.17 -45.21 83.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.576 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' THR . . . . . 0.5 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 21.2 p -64.89 -40.77 95.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.05 0.452 . . . . 0.0 111.378 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -76.93 -20.38 56.24 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.651 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.84 -30.4 0.16 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.094 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.4 -55.56 5.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.707 -0.283 . . . . 0.0 112.548 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.2 m -97.06 46.53 1.04 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.43 0.633 . . . . 0.0 110.335 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 7.3 tpm_? -110.41 -37.49 5.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.327 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' TRP . . . . . 0.862 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.372 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.44 -49.35 60.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.401 0.438 . . . . 0.0 110.68 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.538 ' HG ' HD21 ' A' ' 23' ' ' LEU . 10.7 mp -72.17 -51.38 21.51 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.408 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.29 70.87 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.88 -49.29 77.25 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.75 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.492 HD23 HD22 ' A' ' 23' ' ' LEU . 40.9 tp -71.01 -39.91 72.11 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.6 t -55.12 -42.52 73.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.406 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 t -57.77 -44.16 85.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.334 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -74.68 -40.53 61.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.969 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.472 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 56.1 m -60.3 -43.11 96.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 111.603 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.65 -39.57 36.63 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.904 0.383 . . . . 0.0 110.874 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -68.31 -50.85 50.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.825 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.521 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 8.4 m0 -116.39 -55.11 2.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.29 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.6 -173.64 23.01 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -164.98 149.56 9.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.964 0.412 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.531 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 3.6 m -94.8 168.74 10.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.478 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' HG3' HG22 ' B' ' 21' ' ' THR . 37.7 tttm -54.33 -37.15 64.53 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.903 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -50.36 74.32 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.357 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.531 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -63.2 -45.18 92.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.784 HG22 ' HA ' ' B' ' 18' ' ' VAL . 33.2 mt -69.76 -43.13 80.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.545 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.5 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 71.4 m -64.11 -36.7 84.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.754 0.311 . . . . 0.0 111.14 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.5 m -70.13 5.19 1.74 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.667 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.538 HD21 ' HG ' ' A' ' 3' ' ' LEU . 21.6 tp -92.23 -22.48 19.77 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.849 0.356 . . . . 0.0 110.234 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.8 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.025 179.668 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.02 -150.93 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.23 136.56 95.3 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.708 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.456 ' HA ' HG22 ' B' ' 7' ' ' VAL . 68.7 Cg_endo -74.02 52.74 2.72 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.028 2.485 . . . . 0.0 112.454 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.585 ' CE1' ' HA ' ' B' ' 21' ' ' THR . 9.5 m-30 -97.74 18.49 15.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.485 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 162.22 58.08 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' B' ' 4' ' ' PRO . 15.7 m -147.04 -171.14 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.449 0.166 . . . . 0.0 110.646 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.564 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 67.5 mtp180 -86.27 129.02 34.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.211 0.529 . . . . 0.0 109.965 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -125.69 117.42 23.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.407 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 69.2 m -113.22 122.01 46.18 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.98 -104.97 0.13 Allowed Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.829 -0.623 . . . . 0.0 114.396 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -57.59 -33.69 68.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.437 ' HB3' HD12 ' B' ' 9' ' ' LEU . 53.8 mm-40 -70.82 -34.89 72.19 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.595 ' O ' HG23 ' B' ' 18' ' ' VAL . 41.3 t80 -62.15 -54.08 46.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.334 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.596 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.5 mt -59.51 -50.69 78.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.505 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.609 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.0 mmp_? -62.22 -33.24 74.19 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.732 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.438 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -65.18 -39.52 93.0 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.81 ' HA ' HG22 ' A' ' 20' ' ' ILE . 91.7 t -59.7 -49.04 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-O 121.92 0.867 . . . . 0.0 108.714 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.778 HG23 ' HD1' ' B' ' 27' ' ' TRP . 13.9 mm -59.72 -52.69 58.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.165 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.46 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.5 m-30 -56.51 -45.39 81.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.201 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.585 ' HA ' ' CE1' ' B' ' 5' ' ' TYR . 23.4 p -63.57 -39.8 95.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.36 0.6 . . . . 0.0 110.876 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 59.4 m -81.55 -13.25 58.29 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.03 -30.19 0.33 Allowed Glycine 0 C--O 1.227 -0.313 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.351 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.14 -49.29 4.08 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.62 -0.324 . . . . 0.0 112.502 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.5 m -105.18 41.47 1.35 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.291 0.567 . . . . 0.0 110.538 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.51 ' NH1' ' HB3' ' A' ' 24' ' ' CYS . 54.7 ttt180 -98.7 -36.35 9.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.778 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.848 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.65 -49.85 43.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.37 . . . . 0.0 110.735 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 70.6 mt -70.57 -50.69 34.69 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.787 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.64 76.82 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.67 90.05 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.501 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.819 HD23 HD11 ' A' ' 23' ' ' LEU . 33.4 tp -72.26 -40.0 68.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.0 t -53.27 -41.55 65.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.527 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.3 m -59.16 -44.48 92.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.395 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 m -72.73 -39.4 66.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.619 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.493 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 82.4 m -60.8 -38.24 84.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.565 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.23 -43.1 19.72 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.015 0.436 . . . . 0.0 110.786 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -65.35 -51.25 61.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.852 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.505 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 13.0 m0 -113.61 -55.55 2.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.384 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.54 174.92 14.2 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.1 m -147.5 147.54 30.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.852 0.326 . . . . 0.0 110.72 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.558 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.5 m -94.78 164.44 12.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.28 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -53.02 -36.89 61.02 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.145 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -53.51 57.6 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.345 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.99 -42.68 99.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.428 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' B' ' 18' ' ' VAL . 34.2 mt -70.77 -46.09 70.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.664 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.515 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 66.3 m -64.6 -27.14 68.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.6 m -68.92 -3.87 14.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.932 0.396 . . . . 0.0 111.54 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.819 HD11 HD23 ' A' ' 6' ' ' LEU . 93.8 mt -91.47 -4.26 55.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.68 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.51 ' HB3' ' NH1' ' B' ' 26' ' ' ARG . 71.0 m . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.327 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 7.7 ppt_? . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.13 -149.44 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.923 0.392 . . . . 0.0 111.326 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.09 76.1 2.5 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.87 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.04 54.86 4.77 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.988 2.459 . . . . 0.0 111.144 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.681 ' CE1' ' HA ' ' B' ' 21' ' ' THR . 14.6 m-30 -81.68 34.35 0.39 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.866 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 158.88 56.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.341 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.64 -172.15 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.681 0.24 . . . . 0.0 110.714 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.565 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 53.0 mtp85 -87.15 127.39 35.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -124.07 119.0 28.22 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.802 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . 0.4 ' H ' ' HB2' ' B' ' 13' ' ' GLU . 82.5 m -115.09 120.62 40.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.594 0.235 . . . . 0.0 111.556 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.41 -103.36 0.07 OUTLIER Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.945 -0.571 . . . . 0.0 114.269 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -57.63 -35.29 70.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.513 ' HB3' HD12 ' B' ' 9' ' ' LEU . 3.2 mp0 -69.26 -35.46 76.11 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.588 ' O ' HG23 ' B' ' 18' ' ' VAL . 33.6 t80 -61.95 -51.95 66.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.062 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.538 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.6 mt -59.03 -48.58 86.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.916 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.429 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 5.9 mmp_? -61.92 -38.11 87.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.336 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.489 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -63.13 -38.2 90.25 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.299 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 20' ' ' ILE . 98.8 t -59.97 -50.82 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.877 HD12 ' CD1' ' B' ' 27' ' ' TRP . 7.6 mm -57.26 -50.88 75.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.845 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -57.76 -41.88 82.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.584 -1.189 . . . . 0.0 113.209 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.735 HG21 ' HB ' ' A' ' 20' ' ' ILE . 22.8 p -66.91 -43.78 82.49 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.62 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.01 -37.86 89.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.705 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.73 -31.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.638 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.84 28.35 42.57 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 32.5 p -172.09 88.79 0.1 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -167.36 -38.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.646 0.736 . . . . 0.0 110.057 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.877 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.921 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.502 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t -72.24 -44.71 63.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 123.54 0.525 . . . . 0.0 109.791 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.406 ' HG ' HD13 ' A' ' 23' ' ' LEU . 11.0 mp -69.49 -54.48 14.04 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.531 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.52 74.45 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.4 81.94 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.699 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.505 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 40.6 tp -70.75 -43.37 68.95 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.8 t -52.43 -42.66 64.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.635 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.4 t -58.93 -43.28 91.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.196 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.9 m -74.1 -38.66 63.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.999 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 70.8 m -60.14 -41.51 92.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.76 0.314 . . . . 0.0 111.08 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.8 t -81.54 -39.28 24.89 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.024 0.44 . . . . 0.0 111.042 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -68.68 -43.82 75.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.82 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.447 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 10.5 m0 -123.48 -56.33 1.71 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.123 0.487 . . . . 0.0 111.385 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.89 173.6 15.49 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 90.2 m -147.23 145.91 29.61 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.117 0.459 . . . . 0.0 111.033 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.499 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.5 m -94.4 168.72 10.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.536 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -54.64 -37.97 66.31 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.847 0.356 . . . . 0.0 110.884 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.54 -53.96 51.49 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.493 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.57 -44.1 97.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.6 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.735 ' HB ' HG21 ' B' ' 21' ' ' THR . 34.0 mt -70.54 -44.36 77.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.22 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.471 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 67.6 m -65.53 -18.81 65.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.406 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.2 m -65.58 -11.38 43.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.045 0.45 . . . . 0.0 110.518 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.406 HD13 ' HG ' ' A' ' 3' ' ' LEU . 77.4 mt -111.08 26.53 10.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.823 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 95.9 m . . . . . 0 C--O 1.257 1.477 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.32 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.75 -151.8 0.34 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' B' ' 4' ' ' PRO . . . -160.47 121.0 1.66 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.652 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' B' ' 17' ' ' ALA . 5.3 Cg_exo -80.07 48.45 2.87 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.454 2.769 . . . . 0.0 111.492 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.554 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 4.0 m-30 -86.69 65.64 9.1 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.551 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.25 49.85 0.8 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.303 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.21 178.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 O-C-N 122.847 -0.208 . . . . 0.0 110.47 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.563 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 68.3 mtp180 -86.7 129.08 35.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.144 0.497 . . . . 0.0 110.039 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.4 mm? -123.99 118.24 26.56 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.271 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . 0.403 ' H ' ' HB2' ' B' ' 13' ' ' GLU . 84.3 m -114.38 120.06 39.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.8 -103.59 0.09 OUTLIER Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.882 -0.599 . . . . 0.0 114.309 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -57.89 -34.53 69.89 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.44 ' HB3' HD12 ' B' ' 9' ' ' LEU . 2.9 mp0 -69.11 -35.55 76.57 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.545 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 38.6 t80 -62.94 -50.08 72.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.095 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.646 ' O ' HG12 ' B' ' 19' ' ' ILE . 66.8 mt -59.5 -50.66 79.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.964 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.658 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.1 mmp_? -62.43 -33.39 74.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.435 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' B' ' 4' ' ' PRO . . . -63.11 -43.3 98.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.619 ' HA ' HG22 ' A' ' 20' ' ' ILE . 96.3 t -58.31 -48.1 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.756 HD12 ' CD1' ' B' ' 27' ' ' TRP . 18.4 mm -57.84 -49.54 80.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.877 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.466 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.4 m-30 -58.61 -43.23 89.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.98 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.798 HG21 ' HB ' ' A' ' 20' ' ' ILE . 11.1 p -65.64 -40.58 92.66 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.716 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 37.4 m -67.01 -34.66 78.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.251 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.68 -37.31 0.13 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.04 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 106.56 -42.53 1.89 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -112.04 41.09 2.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.4 0.619 . . . . 0.0 110.082 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 77.2 ttt180 -96.31 -36.61 10.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.412 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.756 ' CD1' HD12 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.698 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.513 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 27.7 p-10 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.97 -42.02 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.089 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.52 -58.15 4.74 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.999 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.513 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.74 -35.01 73.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.98 -46.93 93.06 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.437 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.513 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 42.5 tp -72.7 -42.98 63.63 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 t -51.26 -43.64 61.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.973 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -58.3 -43.89 88.31 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.509 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.2 m -74.13 -36.69 64.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.931 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.513 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 83.6 m -60.46 -39.87 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.957 0.408 . . . . 0.0 110.343 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.7 t -81.27 -42.98 19.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.947 0.404 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.525 ' HG2' ' CD1' ' A' ' 13' ' ' TRP . 18.8 ttpp -62.9 -50.16 71.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.941 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.525 ' CD1' ' HG2' ' A' ' 12' ' ' LYS . 32.4 m0 -118.66 -54.32 2.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.546 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 141.54 174.46 14.43 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 92.1 m -147.11 146.41 29.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.916 0.358 . . . . 0.0 110.894 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.504 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.5 m -93.99 169.64 10.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.997 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.554 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 52.7 tttp -55.1 -38.39 68.07 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.962 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -51.25 70.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.605 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -61.57 -45.58 93.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.924 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.798 ' HB ' HG21 ' B' ' 21' ' ' THR . 31.5 mt -70.75 -42.37 77.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.36 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.46 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 47.0 m -65.72 -20.23 66.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 111.025 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.7 t -66.49 -10.39 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.506 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.2 mt -109.62 23.6 14.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.184 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 C--O 1.256 1.405 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.18 179.589 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 30.6 mmm-85 . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.34 -150.49 0.29 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.753 0.658 . . . . 0.0 109.228 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.28 129.34 93.44 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 123.371 0.42 . . . . 0.0 110.746 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.518 ' HB3' HD11 ' B' ' 9' ' ' LEU . 74.5 Cg_endo -75.93 50.15 2.71 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 123.109 2.539 . . . . 0.0 112.504 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -102.06 49.28 0.86 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.335 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 126.2 55.3 0.15 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.697 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.2 m -148.64 -168.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.557 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.4 mtp180 -88.22 130.36 35.1 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.18 0.514 . . . . 0.0 109.789 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.563 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.3 mm? -124.06 114.64 19.99 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.409 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 78.7 m -109.12 117.66 34.72 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 46.06 -100.36 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 O-C-N 123.871 0.732 . . . . 0.0 114.384 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -53.71 -38.45 64.28 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.285 0.634 . . . . 0.0 112.138 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -70.74 -36.34 73.1 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.573 ' O ' HG23 ' B' ' 18' ' ' VAL . 35.6 t80 -63.52 -53.49 51.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.487 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.572 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.4 mt -59.13 -48.29 87.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.626 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 5.2 tpt180 -66.14 -32.88 74.6 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.264 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.89 95.96 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.587 ' HA ' HG22 ' A' ' 20' ' ' ILE . 91.3 t -60.3 -49.83 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.776 HG23 ' HD1' ' B' ' 27' ' ' TRP . 35.8 mm -55.19 -50.79 61.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.206 -0.907 . . . . 0.0 110.335 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.498 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.9 m-30 -58.49 -46.07 87.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.924 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.655 HG22 ' HG2' ' A' ' 17' ' ' LYS . 18.2 p -65.1 -39.22 92.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.044 0.449 . . . . 0.0 110.756 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.513 ' HB3' HH11 ' B' ' 26' ' ' ARG . 78.6 m -66.91 -26.55 66.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.503 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.32 -19.75 0.23 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.283 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.39 -50.42 4.33 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 112.329 -0.308 . . . . 0.0 112.329 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 5.9 m -101.18 29.2 4.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.315 0.578 . . . . 0.0 110.39 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.513 HH11 ' HB3' ' B' ' 22' ' ' CYS . 72.3 ttt180 -88.65 -33.27 17.66 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.744 0.783 . . . . 0.0 109.491 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.776 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.312 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.71 -45.32 66.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 123.424 0.452 . . . . 0.0 109.955 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.81 -54.05 15.37 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.534 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.08 -36.78 73.34 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.91 -49.43 75.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.766 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.71 -39.63 73.3 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.6 t -55.27 -43.59 74.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.37 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.6 m -60.86 -35.58 76.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.555 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 m -80.35 -38.49 30.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.58 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 52.2 m -61.73 -41.79 98.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.41 . . . . 0.0 110.716 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.416 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 49.6 t -76.88 -40.47 47.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.931 0.396 . . . . 0.0 110.682 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -69.47 -50.77 42.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.86 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.51 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 10.6 m0 -114.17 -57.1 2.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.271 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.58 -172.06 23.75 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.427 ' SG ' HD23 ' B' ' 9' ' ' LEU . 1.8 p -164.81 150.12 9.77 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.867 0.365 . . . . 0.0 110.73 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.584 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.9 m -94.04 169.77 10.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.064 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.655 ' HG2' HG22 ' B' ' 21' ' ' THR . 10.5 tmtt? -54.42 -35.36 62.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.039 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -51.34 64.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.993 0.425 . . . . 0.0 111.474 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -58.71 -44.54 90.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.168 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.587 HG22 ' HA ' ' B' ' 18' ' ' VAL . 40.0 mt -67.69 -40.89 84.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.2 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.472 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 68.8 m -64.69 -18.09 64.67 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 m -66.39 -13.15 60.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.929 0.395 . . . . 0.0 111.047 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -95.75 -5.08 42.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.106 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 80.6 m . . . . . 0 C--O 1.257 1.453 0 CA-C-O 117.762 -1.113 . . . . 0.0 112.33 -178.901 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.64 -150.39 0.44 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.98 133.74 94.88 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.762 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.447 ' HA ' HG22 ' B' ' 7' ' ' VAL . 69.5 Cg_endo -74.59 52.08 2.79 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 123.048 2.499 . . . . 0.0 112.572 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' B' ' 21' ' ' THR . 9.4 m-30 -99.14 18.36 17.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.522 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 162.25 59.28 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' B' ' 4' ' ' PRO . 14.5 m -148.65 -169.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.508 0.194 . . . . 0.0 110.484 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.568 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 65.5 mtp180 -86.92 127.93 35.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.19 0.519 . . . . 0.0 109.711 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.4 mm? -122.97 115.07 21.3 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.59 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 65.0 m -109.46 119.93 40.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.53 -104.04 0.09 OUTLIER Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.464 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' B' ' 12' ' ' ARG . 33.4 ttp85 -56.86 -32.13 65.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.695 0.398 . . . . 0.0 111.7 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.507 ' HB3' HD12 ' B' ' 9' ' ' LEU . 25.5 mm-40 -70.02 -38.68 75.99 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.613 ' O ' HG23 ' B' ' 18' ' ' VAL . 39.8 t80 -59.36 -53.39 58.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.349 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.6 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.1 mt -59.45 -51.93 66.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.849 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.683 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 2.2 mmp_? -63.68 -31.72 72.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.709 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.33 -38.39 89.98 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.795 ' HA ' HG22 ' A' ' 20' ' ' ILE . 84.6 t -59.61 -49.73 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.756 HG23 ' HD1' ' B' ' 27' ' ' TRP . 13.4 mm -57.47 -53.41 44.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.136 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.659 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.6 m-30 -56.38 -45.09 80.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.43 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.617 HG21 ' HB ' ' A' ' 20' ' ' ILE . 24.7 p -65.63 -40.68 92.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.356 0.598 . . . . 0.0 111.051 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -74.32 -18.21 60.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.753 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.83 -21.89 0.23 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.917 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.45 -51.16 4.52 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.3 m -104.31 38.52 1.85 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.324 0.583 . . . . 0.0 109.771 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.423 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 9.4 tpp85 -87.48 -38.8 15.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.114 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.756 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.665 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.52 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.5 p-10 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 47.2 t -111.22 -44.19 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.157 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -68.99 -57.27 5.68 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.52 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.11 -33.29 70.68 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.1 -43.71 98.03 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.579 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 42.2 mt -82.2 -43.21 17.95 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 39.7 t -49.47 -45.14 46.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.588 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.9 p -62.32 -46.54 88.24 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.568 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 m -68.88 -39.47 79.79 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.35 0.26 . . . . 0.0 111.115 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.48 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 78.3 m -62.28 -38.78 90.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.916 0.389 . . . . 0.0 110.092 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.435 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 44.5 t -78.97 -44.46 22.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.099 0.476 . . . . 0.0 110.459 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -63.2 -50.24 71.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.688 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.511 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 22.1 m0 -117.08 -57.73 2.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.548 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.47 173.96 14.67 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 95.8 m -147.78 147.54 29.98 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 116.994 0.397 . . . . 0.0 110.61 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.57 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.7 m -95.09 163.84 13.13 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.417 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -52.51 -38.22 59.11 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.497 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -52.37 66.04 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.452 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -60.38 -44.78 95.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.795 HG22 ' HA ' ' B' ' 18' ' ' VAL . 27.1 mt -70.71 -44.06 76.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.695 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 70.7 m -63.53 -25.09 68.09 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.431 -0.168 . . . . 0.0 111.382 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.7 m -64.61 -8.55 14.64 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.487 HD11 HD12 ' A' ' 6' ' ' LEU . 7.8 mp -80.74 -21.94 40.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.4 m . . . . . 0 C--O 1.244 0.785 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.82 -179.311 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . 0.552 ' HB3' ' OE2' ' B' ' 13' ' ' GLU . 7.2 ptm85 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.49 -146.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.192 0.307 . . . . 0.0 110.31 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' B' ' 4' ' ' PRO . . . -67.09 115.68 28.07 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.0 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.691 ' HB3' HD11 ' B' ' 9' ' ' LEU . 12.1 Cg_endo -90.34 44.44 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.41 2.74 . . . . 0.0 111.844 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -93.81 68.13 3.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.516 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 101.58 53.89 0.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.086 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.41 ' CG2' ' HA ' ' B' ' 4' ' ' PRO . 20.4 m -144.22 -167.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.616 0.246 . . . . 0.0 110.532 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -89.18 130.96 35.51 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.691 HD11 ' HB3' ' B' ' 4' ' ' PRO . 2.6 mm? -127.14 112.39 15.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.322 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 85.5 m -109.75 119.09 38.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.752 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.51 -105.55 0.16 Allowed Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.736 -0.666 . . . . 0.0 114.556 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -57.02 -32.14 65.84 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 122.752 0.421 . . . . 0.0 112.051 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.552 ' OE2' ' HB3' ' B' ' 1' ' ' ARG . 5.7 mm-40 -68.38 -40.17 81.49 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.663 ' O ' HG23 ' B' ' 18' ' ' VAL . 55.2 t80 -61.23 -53.7 53.61 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.623 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.554 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.3 mt -56.51 -50.2 74.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.037 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.527 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 3.7 tpt180 -67.27 -31.78 72.34 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.953 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.4 96.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.805 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.747 ' HA ' HG22 ' A' ' 20' ' ' ILE . 92.0 t -59.97 -50.37 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.816 HG23 ' HD1' ' B' ' 27' ' ' TRP . 26.7 mm -57.58 -52.46 57.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.457 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.55 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.4 m-30 -56.57 -47.6 79.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.904 -1.043 . . . . 0.0 113.4 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.483 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 21.7 p -64.18 -41.22 97.19 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.167 0.508 . . . . 0.0 111.532 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 57.3 m -77.08 -14.27 59.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.995 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.13 -29.38 0.25 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 119.778 -1.201 . . . . 0.0 113.205 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.68 -48.68 4.04 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -106.51 26.44 9.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.198 0.523 . . . . 0.0 110.16 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -84.83 -33.05 22.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.789 0.804 . . . . 0.0 109.49 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.816 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.12 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.541 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 27.2 p-10 . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 26.3 t -111.29 -42.81 4.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.111 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.454 ' HG ' HD21 ' A' ' 23' ' ' LEU . 9.3 mp -68.86 -57.61 5.32 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.541 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -57.52 -33.92 68.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.72 84.86 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.373 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 62.8 mt -72.85 -39.59 66.4 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.489 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 29.3 t -52.86 -43.81 66.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.736 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.2 m -60.69 -44.82 96.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.445 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -71.12 -38.23 72.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.717 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.683 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 64.7 m -63.82 -37.18 86.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 110.865 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 34.9 t -79.62 -37.73 35.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.181 0.515 . . . . 0.0 110.297 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -73.29 -52.52 13.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.16 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -113.32 -42.3 3.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.249 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 120.16 -179.1 16.53 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.48 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.1 p -161.36 150.41 16.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.935 0.398 . . . . 0.0 111.155 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.527 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.0 m -96.9 167.33 11.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.911 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.423 ' HG3' HG22 ' B' ' 21' ' ' THR . 38.2 tttm -54.21 -37.42 64.55 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.16 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -50.55 73.64 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.426 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -62.89 -45.01 94.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.094 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.747 HG22 ' HA ' ' B' ' 18' ' ' VAL . 24.2 mt -71.51 -42.3 72.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.681 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.483 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 70.5 m -64.04 -36.16 83.08 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.142 -0.349 . . . . 0.0 111.314 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.2 m -69.03 3.72 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.82 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.454 HD21 ' HG ' ' A' ' 3' ' ' LEU . 20.2 tp -90.04 -22.48 21.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.698 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.2 m . . . . . 0 C--O 1.243 0.73 0 CA-C-O 118.755 -0.64 . . . . 0.0 111.91 -179.512 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.7 56.71 3.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.9 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.34 55.33 0.61 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.47 ' HB3' HD11 ' B' ' 9' ' ' LEU . 69.4 Cg_endo -86.27 38.98 0.62 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.6 2.2 . . . . 0.0 112.553 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -102.51 70.26 1.14 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.941 0.4 . . . . 0.0 111.112 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.71 46.68 2.44 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.829 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' B' ' 4' ' ' PRO . 35.1 m -142.35 -177.0 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.571 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 72.3 mtp180 -83.29 129.71 35.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.123 0.487 . . . . 0.0 110.339 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.4 mm? -123.87 118.49 27.22 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.992 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 65.8 m -117.79 119.66 35.57 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.37 -98.66 0.02 OUTLIER Glycine 0 CA--C 1.519 0.316 0 N-CA-C 114.761 0.665 . . . . 0.0 114.761 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.423 ' H ' ' HG3' ' B' ' 12' ' ' ARG . 15.6 mtm180 -53.4 -44.37 68.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.281 0.632 . . . . 0.0 111.941 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.572 ' HB3' HD12 ' B' ' 9' ' ' LEU . 3.0 mp0 -72.29 -30.98 65.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.896 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.591 ' O ' HG23 ' B' ' 18' ' ' VAL . 41.7 t80 -65.1 -51.68 59.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.038 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.642 ' O ' HG12 ' B' ' 19' ' ' ILE . 80.1 mt -61.53 -49.22 85.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.865 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.574 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.5 mmp_? -62.83 -32.11 73.25 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.298 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.547 ' HB1' HD13 ' A' ' 20' ' ' ILE . . . -63.92 -44.0 94.24 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.601 ' HA ' HG22 ' A' ' 20' ' ' ILE . 61.8 t -57.8 -51.11 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.861 HG23 ' HD1' ' B' ' 27' ' ' TRP . 37.9 mm -53.42 -51.42 41.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.311 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.534 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 1.8 m-30 -58.82 -44.74 90.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.732 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.861 HG21 ' HB ' ' A' ' 20' ' ' ILE . 17.0 p -63.7 -39.38 94.17 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.589 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 m -69.39 -31.33 69.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.652 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.39 -22.23 0.09 OUTLIER Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.674 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.21 -62.26 4.6 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.4 m -90.85 48.18 1.5 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.565 0.698 . . . . 0.0 109.641 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.8 tpm_? -112.55 -37.19 5.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.124 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.861 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.12 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.117 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.95 -44.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 123.511 0.507 . . . . 0.0 109.865 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mp -69.97 -54.46 13.2 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.68 -35.79 73.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.47 -49.48 73.48 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.647 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.475 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 43.5 tp -70.8 -39.93 72.83 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.9 t -55.65 -37.81 68.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.476 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 t -59.8 -41.73 91.86 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.882 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.7 m -76.23 -43.16 43.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.53 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 75.5 m -60.03 -39.48 86.05 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.256 0.347 . . . . 0.0 111.467 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.2 t -81.45 -38.72 25.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.838 0.352 . . . . 0.0 111.009 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 3.2 ttmp? -68.43 -61.5 1.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.278 0.561 . . . . 0.0 111.631 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.532 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 6.0 m0 -101.18 -54.35 2.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.902 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 138.05 174.33 13.35 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.7 m -148.56 146.61 28.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.983 0.42 . . . . 0.0 110.672 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.51 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 3.2 m -91.91 170.05 10.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.629 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.662 ' HG3' HG22 ' B' ' 21' ' ' THR . 40.7 tttm -55.9 -36.87 68.13 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.682 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -52.22 66.66 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.614 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.51 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.68 -44.9 93.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.6 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.861 ' HB ' HG21 ' B' ' 21' ' ' THR . 37.4 mt -70.66 -39.6 76.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.015 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.493 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 49.3 m -65.15 -20.46 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.776 0.322 . . . . 0.0 110.669 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.5 m -68.15 -6.88 25.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.068 0.461 . . . . 0.0 110.93 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.455 HD11 HD23 ' A' ' 6' ' ' LEU . 69.1 mt -105.33 19.66 20.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.6 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.411 179.401 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.56 61.28 2.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.044 0.449 . . . . 0.0 111.324 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.98 127.28 1.94 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.049 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.62 45.66 1.5 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.168 2.578 . . . . 0.0 112.512 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -111.05 90.85 3.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.27 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 80.42 52.3 4.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.872 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.69 -171.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.557 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 61.8 mtp180 -89.88 123.93 34.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.088 0.47 . . . . 0.0 109.883 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.649 HD12 ' HG3' ' B' ' 13' ' ' GLU . 2.1 mm? -114.98 115.26 26.59 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.129 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 79.7 m -109.26 118.77 37.58 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.78 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.57 -102.57 0.05 OUTLIER Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.465 -0.789 . . . . 0.0 114.345 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' B' ' 12' ' ' ARG . 4.4 tmm_? -57.16 -32.21 66.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.239 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.649 ' HG3' HD12 ' B' ' 9' ' ' LEU . 5.6 tp10 -70.59 -38.28 74.0 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.601 ' O ' HG23 ' B' ' 18' ' ' VAL . 45.3 t80 -59.65 -55.45 34.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.582 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.578 ' O ' HG12 ' B' ' 19' ' ' ILE . 62.3 mt -58.88 -48.52 86.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.967 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.502 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 5.1 tpt180 -65.58 -33.28 75.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.302 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -40.31 96.13 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.601 HG23 ' O ' ' B' ' 14' ' ' PHE . 60.6 t -60.64 -49.26 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.809 HG23 ' HD1' ' B' ' 27' ' ' TRP . 39.0 mm -55.8 -51.08 63.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.308 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.553 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.3 m-30 -58.53 -46.19 87.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.047 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.674 HG22 ' HG2' ' A' ' 17' ' ' LYS . 18.4 p -65.05 -39.74 93.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.984 0.421 . . . . 0.0 110.808 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.491 ' HB3' HH11 ' B' ' 26' ' ' ARG . 73.5 m -67.86 -24.39 65.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.737 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.14 -21.94 0.22 Allowed Glycine 0 C--O 1.227 -0.333 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.495 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.08 -51.58 4.49 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.7 m -101.08 27.81 5.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.411 0.624 . . . . 0.0 110.139 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.491 HH11 ' HB3' ' B' ' 22' ' ' CYS . 72.0 ttt180 -88.52 -32.8 18.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.658 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.809 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.202 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.505 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.2 p-10 . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.491 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 45.2 t -111.99 -42.61 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.156 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.9 mt -69.26 -56.35 7.84 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.505 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -60.71 -32.9 72.13 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.91 -43.38 98.11 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.31 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.807 HD12 HD11 ' A' ' 23' ' ' LEU . 44.9 mt -80.31 -43.14 21.75 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -49.31 -47.01 47.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.532 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.1 p -62.48 -46.57 87.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.568 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 33.1 m -67.5 -38.53 84.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.227 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.572 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 83.3 m -62.58 -39.46 93.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.921 0.391 . . . . 0.0 110.234 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 41.3 t -79.22 -44.03 22.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.237 0.541 . . . . 0.0 110.389 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.5 ttpt -62.13 -49.59 75.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.568 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.471 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 23.0 m0 -119.19 -58.07 1.96 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.579 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.9 171.94 13.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.8 m -145.72 145.6 30.93 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.853 0.326 . . . . 0.0 110.417 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.545 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 4.1 m -92.53 164.77 13.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.563 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.674 ' HG2' HG22 ' B' ' 21' ' ' THR . 10.4 tmtt? -54.27 -35.47 62.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.788 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -52.17 63.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.029 0.443 . . . . 0.0 111.737 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.32 -42.48 95.69 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.739 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' B' ' 18' ' ' VAL . 26.6 mt -69.2 -39.57 79.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.489 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 70.3 m -66.29 -17.58 64.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.625 0.25 . . . . 0.0 111.296 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.7 m -67.58 -10.05 48.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.191 0.519 . . . . 0.0 110.345 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.807 HD11 HD12 ' A' ' 6' ' ' LEU . 95.8 mt -105.54 23.21 14.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.952 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 80.2 m . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.681 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.29 -153.8 0.42 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.05 70.54 2.65 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.336 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.581 ' HB2' HD11 ' B' ' 9' ' ' LEU . 73.9 Cg_endo -76.3 48.88 2.44 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.806 2.337 . . . . 0.0 111.616 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.872 ' HB3' ' HB2' ' A' ' 17' ' ' LYS . 18.7 m-30 -84.82 34.03 0.54 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.604 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 162.73 53.69 0.02 OUTLIER Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.531 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 m -149.61 -167.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.57 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 62.9 mtp180 -86.27 126.12 34.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.042 0.449 . . . . 0.0 110.151 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.5 mm? -119.48 118.48 31.21 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.04 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 65.2 m -112.69 110.75 21.09 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 53.2 -94.56 0.01 OUTLIER Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.834 -0.621 . . . . 0.0 114.577 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' B' ' 12' ' ' ARG . 12.1 mtm180 -55.64 -42.3 74.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.267 0.556 . . . . 0.0 111.138 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.621 ' HB3' HD12 ' B' ' 9' ' ' LEU . 34.3 mp0 -68.84 -34.19 75.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.431 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.602 ' O ' HG23 ' B' ' 18' ' ' VAL . 48.6 t80 -63.07 -52.31 63.22 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.829 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.626 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.3 mt -59.88 -48.56 87.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.603 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.1 mmp_? -61.86 -34.98 76.97 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.55 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.595 ' HB1' HD13 ' A' ' 20' ' ' ILE . . . -64.12 -41.42 97.25 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 14' ' ' PHE . 48.9 t -58.8 -48.27 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.84 HG23 ' HD1' ' B' ' 27' ' ' TRP . 36.5 mm -56.18 -50.6 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.704 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.613 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.8 m-30 -57.29 -43.84 83.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.519 -1.218 . . . . 0.0 112.792 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.918 HG21 ' HB ' ' A' ' 20' ' ' ILE . 14.7 p -66.22 -40.83 90.59 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.328 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 34.9 m -67.45 -32.75 73.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.429 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.1 -30.28 0.09 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.31 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 92.16 -53.2 2.85 Favored Glycine 0 C--O 1.225 -0.457 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.7 m -102.39 45.66 0.96 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.584 0.707 . . . . 0.0 109.204 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.421 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 6.9 tpm_? -108.66 -37.92 5.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.356 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.84 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.074 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.175 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.5 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 25.9 p-10 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 41.9 t -112.12 -41.82 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.213 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.7 mt -68.89 -56.67 7.17 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -61.04 -33.07 72.72 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.69 -43.57 97.67 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.262 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.786 HD12 HD11 ' A' ' 23' ' ' LEU . 27.0 mt -80.47 -42.95 21.67 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -48.66 -47.13 40.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.223 0.609 . . . . 0.0 111.435 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 p -63.99 -46.31 85.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.8 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.404 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 25.6 m -67.92 -39.11 83.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.418 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 73.2 m -62.79 -39.81 95.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.953 0.406 . . . . 0.0 110.185 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 45.9 t -78.59 -42.73 28.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.136 0.493 . . . . 0.0 110.437 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.7 ttpt -64.27 -50.15 69.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.566 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.511 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 22.7 m0 -117.71 -58.85 1.98 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.452 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.57 172.9 14.71 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 78.7 m -147.94 147.78 30.07 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.814 0.307 . . . . 0.0 110.673 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.564 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 1.7 m -96.88 166.09 11.79 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.537 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.872 ' HB2' ' HB3' ' B' ' 5' ' ' TYR . 11.3 tmtt? -53.64 -35.63 61.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.278 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -51.59 65.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.964 0.411 . . . . 0.0 111.627 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.491 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.17 -44.28 92.14 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.481 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.918 ' HB ' HG21 ' B' ' 21' ' ' THR . 27.1 mt -70.42 -35.57 62.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.495 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.528 ' OG ' ' HD3' ' A' ' 17' ' ' LYS . 68.2 m -65.32 -23.24 66.96 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.736 0.303 . . . . 0.0 110.711 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.5 m -69.13 -0.94 6.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.797 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.786 HD11 HD12 ' A' ' 6' ' ' LEU . 96.3 mt -108.7 13.91 24.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.206 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.473 179.553 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . 0.826 ' HD2' ' HG3' ' B' ' 13' ' ' GLU . 4.4 tpt180 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.647 0.26 . . . . 0.0 111.328 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.59 -152.78 0.41 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' B' ' 4' ' ' PRO . . . -62.2 118.3 38.4 Favored Pre-proline 0 C--N 1.323 -0.585 0 O-C-N 122.97 0.169 . . . . 0.0 110.555 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' B' ' 3' ' ' ALA . 19.6 Cg_endo -93.1 44.27 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.456 2.771 . . . . 0.0 112.591 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -106.06 83.55 1.92 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.701 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.613 ' H ' ' HA ' ' A' ' 16' ' ' SER . . . 77.71 45.83 10.36 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.447 ' O ' HD22 ' B' ' 9' ' ' LEU . 7.2 t -134.2 165.59 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.559 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 70.0 mtp180 -74.34 130.48 39.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.377 0.608 . . . . 0.0 110.845 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.67 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 1.4 mm? -117.34 115.04 24.45 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.03 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 70.9 m -116.52 116.9 28.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.529 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.09 -101.82 0.05 OUTLIER Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.69 -0.686 . . . . 0.0 114.347 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -57.67 -36.2 71.58 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.954 0.502 . . . . 0.0 111.637 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.826 ' HG3' ' HD2' ' B' ' 1' ' ' ARG . 0.4 OUTLIER -71.2 -29.97 65.82 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.9 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.67 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 47.4 t80 -68.78 -54.96 12.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.706 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.534 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.5 mt -60.65 -47.34 93.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.583 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 4.2 tpt180 -66.17 -30.22 70.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.049 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.69 97.8 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.664 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.74 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.3 t -60.13 -50.45 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.79 HG23 ' HD1' ' B' ' 27' ' ' TRP . 29.1 mm -57.05 -52.22 58.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.493 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.535 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.0 OUTLIER -58.51 -46.41 86.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.948 -1.023 . . . . 0.0 113.058 -178.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.451 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 19.7 p -63.53 -41.05 98.5 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.944 0.402 . . . . 0.0 111.679 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.9 m -74.41 -20.82 59.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.301 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.5 -30.58 0.18 Allowed Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.876 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.27 -52.3 4.49 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 112.259 -0.336 . . . . 0.0 112.259 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 15.9 p -99.42 29.05 4.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.478 0.656 . . . . 0.0 110.558 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.9 tpm_? -89.49 -36.57 15.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.997 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.79 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.132 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.52 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.7 p-10 . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.67 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 49.0 t -109.72 -44.15 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.08 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.74 -57.63 6.01 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.52 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.11 -32.9 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.51 -46.88 93.22 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.25 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 30.6 mt -74.4 -39.47 62.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.8 t -52.57 -38.51 60.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.109 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -59.49 -36.52 76.21 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.89 0.376 . . . . 0.0 110.795 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 m -86.33 -41.23 14.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.664 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.563 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 98.0 m -61.8 -39.43 91.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.709 0.29 . . . . 0.0 110.87 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.3 t -78.43 -39.4 38.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.927 0.394 . . . . 0.0 110.804 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 2.1 ttmp? -68.3 -57.67 5.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.202 0.525 . . . . 0.0 111.372 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.532 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 9.7 m0 -103.43 -60.91 1.49 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.288 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.83 170.06 11.98 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.438 ' HB2' HD23 ' B' ' 9' ' ' LEU . 83.4 m -145.32 151.4 38.26 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 117.121 0.46 . . . . 0.0 110.574 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.613 ' HA ' ' H ' ' B' ' 6' ' ' GLY . 34.0 t -95.63 169.42 10.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.626 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -56.13 -37.16 69.07 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.149 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -52.96 63.51 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.996 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.568 ' OE1' ' HB3' ' A' ' 16' ' ' SER . 2.4 mp0 -60.62 -45.97 92.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.974 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.74 HG22 ' HA ' ' B' ' 18' ' ' VAL . 45.0 mt -69.32 -44.75 80.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.451 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 71.5 m -62.34 -29.03 70.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.564 0.221 . . . . 0.0 111.437 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.2 m -65.45 -4.11 5.28 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 6' ' ' LEU . 10.4 mp -84.84 -19.52 32.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.706 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.894 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.6 44.93 2.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.455 0.645 . . . . 0.0 109.636 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.32 151.13 6.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.521 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.13 45.25 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.45 2.767 . . . . 0.0 112.796 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.532 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 6.2 m-30 -96.0 80.56 3.31 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.716 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.423 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . 96.82 55.12 1.24 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.46 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 12.6 m -144.92 -169.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 110.652 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 -88.12 128.96 35.43 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -125.89 113.04 16.69 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.154 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 78.9 m -111.28 116.1 30.45 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.07 -101.65 0.05 OUTLIER Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.74 -0.664 . . . . 0.0 114.404 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.699 ' NH1' ' HB2' ' B' ' 12' ' ' ARG . 5.7 mtm105 -57.34 -36.58 71.35 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.604 0.362 . . . . 0.0 111.779 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.416 ' HB2' ' H ' ' B' ' 10' ' ' CYS . 8.0 mp0 -67.32 -37.55 83.5 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.604 ' O ' HG23 ' B' ' 18' ' ' VAL . 39.3 t80 -62.6 -53.05 60.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.728 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.549 ' O ' HG12 ' B' ' 19' ' ' ILE . 69.1 mt -57.35 -48.74 81.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.644 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.491 ' HD2' ' HA ' ' B' ' 16' ' ' ARG . 5.3 tpt180 -66.6 -33.03 74.76 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.05 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.32 93.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.506 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.604 ' HA ' HG22 ' A' ' 20' ' ' ILE . 83.7 t -60.89 -49.95 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.734 HG23 ' HD1' ' B' ' 27' ' ' TRP . 36.4 mm -53.98 -51.12 48.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.539 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -43.91 97.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.988 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.532 HG21 ' HB ' ' A' ' 20' ' ' ILE . 19.4 p -64.94 -41.19 95.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.757 0.313 . . . . 0.0 110.794 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.45 ' HB3' HH11 ' B' ' 26' ' ' ARG . 85.7 m -63.97 -31.19 72.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.146 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.26 -21.14 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.396 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.4 -56.27 4.99 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m -92.16 44.33 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.402 0.62 . . . . 0.0 110.326 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.45 HH11 ' HB3' ' B' ' 22' ' ' CYS . 75.3 ttt180 -110.04 -33.75 6.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.753 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.734 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.508 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.9 p-10 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.0 t -111.59 -42.26 4.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.08 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.39 -57.02 5.81 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.49 -33.66 71.61 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.02 -47.86 87.15 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.38 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.1 tp -73.02 -38.66 66.47 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 43.0 t -54.97 -41.93 71.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.288 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 t -59.22 -48.01 83.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.752 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.8 m -67.57 -39.41 84.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.951 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.682 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 61.4 m -61.46 -39.7 91.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.846 0.355 . . . . 0.0 111.383 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.423 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 38.3 t -81.04 -38.61 27.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.267 0.556 . . . . 0.0 110.459 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -69.97 -53.1 19.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.297 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -114.93 -40.67 3.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.037 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 121.23 176.13 15.28 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' SG ' HD23 ' B' ' 9' ' ' LEU . 6.3 p -158.8 150.94 21.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.196 0.522 . . . . 0.0 111.465 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.498 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 8.2 m -96.62 173.34 7.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.03 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 51.0 tttp -54.86 -38.1 67.08 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -52.85 63.97 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.275 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.498 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.6 mp0 -60.08 -45.43 92.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.823 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' B' ' 18' ' ' VAL . 42.3 mt -69.47 -45.11 79.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.068 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.55 ' HA ' ' SG ' ' A' ' 24' ' ' CYS . 65.6 m -64.58 -16.7 63.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.4 m -65.43 -14.88 61.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.181 0.515 . . . . 0.0 110.371 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 72.4 mt -106.98 25.89 10.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.444 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 96.7 m . . . . . 0 C--O 1.244 0.806 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.506 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . 0.426 ' HG2' ' OE1' ' B' ' 13' ' ' GLU . 30.0 ptt-85 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.97 53.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . 0.564 ' N ' ' HD3' ' B' ' 4' ' ' PRO . . . -167.79 54.49 0.28 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.377 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' B' ' 3' ' ' ALA . 73.9 Cg_endo -99.26 41.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.15 2.566 . . . . 0.0 112.401 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -109.4 73.14 0.83 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 94.37 50.75 2.14 Favored Glycine 0 CA--C 1.509 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.085 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 m -148.03 -173.73 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.504 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 52.3 mtt85 -82.81 133.16 35.14 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.541 0.686 . . . . 0.0 110.832 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.5 mm? -129.68 118.45 21.93 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.632 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . 0.42 ' H ' ' HB2' ' B' ' 13' ' ' GLU . 35.0 m -114.14 117.81 32.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 46.91 -98.61 0.01 OUTLIER Glycine 0 C--N 1.336 0.555 0 O-C-N 123.742 0.651 . . . . 0.0 114.658 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -54.15 -39.56 66.64 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.146 0.578 . . . . 0.0 111.555 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.541 ' HB3' HD12 ' B' ' 9' ' ' LEU . 34.7 mm-40 -72.03 -35.01 69.25 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.758 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.571 ' O ' HG23 ' B' ' 18' ' ' VAL . 38.5 t80 -62.93 -53.48 53.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.535 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.592 ' O ' HG12 ' B' ' 19' ' ' ILE . 72.4 mt -59.31 -50.78 78.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.421 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.584 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.3 mmp_? -63.7 -31.03 72.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.503 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.416 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -64.35 -41.52 96.71 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.127 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.843 ' HA ' HG22 ' A' ' 20' ' ' ILE . 93.0 t -59.36 -50.86 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-O 121.9 0.857 . . . . 0.0 108.814 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.783 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.9 mm -58.24 -52.14 62.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.707 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.401 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.8 OUTLIER -59.3 -44.4 92.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -178.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.568 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 19.9 p -62.78 -41.18 99.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.076 0.465 . . . . 0.0 110.757 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 56.5 m -75.03 -22.27 58.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.651 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.07 -29.36 0.21 Allowed Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.137 -1.03 . . . . 0.0 112.881 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 87.41 -54.86 4.48 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 38.3 p -96.03 49.11 1.13 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.323 0.582 . . . . 0.0 110.703 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.536 ' NH1' ' HB3' ' A' ' 24' ' ' CYS . 56.1 ttt180 -111.45 -36.44 5.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.255 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.783 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.956 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.062 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.63 -49.76 75.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.547 0.53 . . . . 0.0 110.365 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.89 -44.98 95.7 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.92 -38.19 64.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.79 0.329 . . . . 0.0 111.056 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.13 -44.2 97.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.176 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.588 HD12 HD11 ' A' ' 23' ' ' LEU . 32.3 mt -78.89 -44.4 22.85 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.245 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.2 t -48.91 -46.12 42.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.3 0.64 . . . . 0.0 111.646 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.4 p -64.69 -46.37 82.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.689 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.9 m -68.06 -39.6 82.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.431 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.547 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 73.9 m -63.11 -35.5 80.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.868 0.366 . . . . 0.0 110.618 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.6 t -83.39 -41.98 17.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.199 0.523 . . . . 0.0 110.197 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -64.8 -48.65 73.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.522 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -118.45 -53.98 2.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.503 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 134.57 169.76 12.05 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.2 m -145.24 147.44 32.4 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.922 0.361 . . . . 0.0 110.945 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.553 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.2 m -93.71 165.15 12.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.068 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -51.16 -40.12 57.9 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.508 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -53.71 55.25 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.693 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -59.99 -43.2 95.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.109 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.843 HG22 ' HA ' ' B' ' 18' ' ' VAL . 40.6 mt -70.9 -46.9 65.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.489 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.568 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 70.2 m -62.09 -23.72 66.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.5 m -63.93 -11.56 29.37 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 6' ' ' LEU . 21.9 mt -85.22 -6.89 59.25 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.536 ' HB3' ' NH1' ' B' ' 26' ' ' ARG . 77.5 m . . . . . 0 C--O 1.243 0.734 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.334 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.29 41.07 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.884 0.373 . . . . 0.0 111.419 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . 0.438 ' N ' ' HD3' ' B' ' 4' ' ' PRO . . . -173.91 61.32 0.25 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.381 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' B' ' 3' ' ' ALA . 81.3 Cg_endo -90.47 41.75 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.957 2.438 . . . . 0.0 112.709 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 5.3 m-30 -107.5 79.28 1.28 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.717 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . 86.54 51.59 3.43 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.588 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' B' ' 4' ' ' PRO . 25.4 m -142.2 -171.83 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.349 . . . . 0.0 110.881 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -87.03 126.35 34.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.659 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.719 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.6 mm? -123.05 114.46 20.4 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.028 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 58.1 m -113.26 119.68 38.58 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 49.0 -102.64 0.06 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.92 -0.582 . . . . 0.0 114.417 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -57.13 -34.63 68.59 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.47 -33.83 69.65 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.615 ' O ' HG23 ' B' ' 18' ' ' VAL . 45.3 t80 -62.61 -54.54 38.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.302 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.584 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.1 mt -58.44 -50.13 79.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.295 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.53 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 4.7 mmp_? -62.33 -32.72 73.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.29 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.21 96.46 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.315 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.786 ' HA ' HG22 ' A' ' 20' ' ' ILE . 60.7 t -59.05 -50.02 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 122.042 0.925 . . . . 0.0 108.837 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.799 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.3 mm -59.04 -53.04 53.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.185 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.477 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.0 m-30 -56.3 -45.57 80.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.177 -0.92 . . . . 0.0 113.411 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.592 HG21 ' HB ' ' A' ' 20' ' ' ILE . 15.7 p -64.44 -41.6 96.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.807 0.337 . . . . 0.0 111.42 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 58.3 m -75.58 -27.67 58.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.493 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.92 -29.52 0.08 OUTLIER Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.085 -1.055 . . . . 0.0 113.326 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 86.39 -54.13 4.65 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.749 -0.262 . . . . 0.0 112.477 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m -101.14 52.84 0.84 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.59 0.71 . . . . 0.0 110.102 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.522 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 3.5 tpm_? -115.9 -38.15 3.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.846 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.799 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.179 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.987 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.508 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 26.6 p-10 . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 27.4 t -111.57 -42.49 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.109 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.87 -57.26 5.8 Favored 'General case' 0 C--O 1.218 -0.555 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.508 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -59.44 -33.47 71.31 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.16 -45.47 95.98 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.408 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 59.8 mt -78.65 -44.37 23.99 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 40.8 t -48.42 -48.71 37.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.688 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.5 p -65.82 -45.45 82.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.683 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.536 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 23.8 m -65.69 -38.27 88.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.904 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.719 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 80.0 m -63.76 -34.54 78.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.999 0.428 . . . . 0.0 110.762 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.1 t -85.46 -38.69 18.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.31 0.576 . . . . 0.0 110.068 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 9' ' ' SER . 32.7 ttpt -68.03 -44.49 76.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.707 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.5 m0 -124.13 -48.65 1.85 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.886 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 128.21 165.74 11.87 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 78.9 m -143.44 146.98 33.89 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 117.129 0.464 . . . . 0.0 111.205 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.6 m -96.27 165.41 12.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.076 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 49.3 tttp -52.36 -40.09 61.55 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.353 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.9 m -57.03 -53.75 54.53 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 123.69 0.619 . . . . 0.0 111.532 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.618 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.7 mp0 -60.64 -43.52 97.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.43 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.786 HG22 ' HA ' ' B' ' 18' ' ' VAL . 31.5 mt -72.58 -39.23 61.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.264 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.416 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 51.1 m -64.12 -37.95 89.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.763 0.316 . . . . 0.0 110.807 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p -69.97 7.34 0.96 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.022 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.448 HD23 ' CG2' ' B' ' 18' ' ' VAL . 19.6 tp -92.27 -24.38 19.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.872 0.368 . . . . 0.0 110.159 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.6 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.84 179.615 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . 0.511 ' HA ' ' NE ' ' B' ' 1' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.362 0.125 . . . . 0.0 110.673 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.54 -156.76 0.18 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.14 114.06 58.72 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.577 ' HB3' ' HB1' ' B' ' 17' ' ' ALA . 6.1 Cg_exo -78.69 46.63 2.21 Favored 'Trans proline' 0 CA--C 1.527 0.141 0 C-N-CA 123.308 2.672 . . . . 0.0 112.304 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.485 ' HD1' ' C ' ' B' ' 4' ' ' PRO . 4.0 m-30 -111.41 59.65 0.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.58 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.42 ' N ' ' HA ' ' A' ' 16' ' ' SER . . . 98.38 51.7 1.42 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.506 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.03 -173.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.479 0.18 . . . . 0.0 110.522 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 11' ' ' CYS . 26.4 mmt85 -87.58 130.97 34.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.153 0.501 . . . . 0.0 110.303 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.723 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -124.94 109.16 12.66 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.731 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 42.1 m -111.54 116.56 31.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.691 0.282 . . . . 0.0 111.642 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 50.98 -103.95 0.12 Allowed Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.733 -0.667 . . . . 0.0 114.54 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -57.9 -32.87 68.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 122.519 0.328 . . . . 0.0 111.563 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.486 ' HG3' HD12 ' B' ' 9' ' ' LEU . 3.6 tp10 -68.25 -38.56 81.93 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 51.0 t80 -60.95 -53.59 55.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.001 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.61 ' O ' HG12 ' B' ' 19' ' ' ILE . 63.1 mt -60.0 -49.7 82.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.688 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.62 ' NH2' HG13 ' B' ' 19' ' ' ILE . 0.1 OUTLIER -65.25 -28.58 69.45 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.881 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.577 ' HB1' ' HB3' ' B' ' 4' ' ' PRO . . . -64.83 -42.82 94.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.002 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.764 ' HA ' HG22 ' A' ' 20' ' ' ILE . 62.1 t -58.94 -49.22 83.91 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.079 0.943 . . . . 0.0 108.517 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.818 HG23 ' HD1' ' B' ' 27' ' ' TRP . 18.3 mm -57.79 -53.16 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.571 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.551 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.4 OUTLIER -57.92 -45.18 86.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.323 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.515 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 17.4 p -63.5 -39.55 94.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.986 0.422 . . . . 0.0 111.553 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 60.9 m -79.49 -20.77 46.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.636 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.61 -31.13 0.14 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.112 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 85.36 -56.47 4.94 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.783 -0.246 . . . . 0.0 112.516 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m -97.21 50.32 1.07 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.565 0.697 . . . . 0.0 110.155 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 7.2 tpm_? -114.42 -38.96 3.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.626 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.818 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.032 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 27.3 p-10 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.97 -43.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.286 178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.5 mp -70.43 -56.92 5.47 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 1' ' ' ASP . . . -60.52 -34.65 74.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.83 -46.63 93.22 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.456 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.634 HD23 HD11 ' A' ' 23' ' ' LEU . 38.5 tp -73.55 -39.78 64.45 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.5 t -53.14 -45.09 68.23 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.601 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.4 m -60.55 -42.75 97.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.391 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 m -70.74 -38.7 73.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.812 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.723 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 90.7 m -62.11 -32.72 73.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.977 0.417 . . . . 0.0 110.776 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.451 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 49.0 t -85.31 -40.31 16.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.157 0.503 . . . . 0.0 110.393 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -70.82 -48.18 55.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.403 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 12.9 m0 -114.91 -41.43 3.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.566 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 116.54 165.44 14.05 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -141.18 149.58 41.64 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.909 0.355 . . . . 0.0 111.32 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.534 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 2.8 m -94.61 168.07 11.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.224 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HG3' HG22 ' B' ' 21' ' ' THR . 37.6 tttm -54.97 -37.19 66.2 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.273 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -52.59 65.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.218 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -60.83 -44.58 96.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.043 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.764 HG22 ' HA ' ' B' ' 18' ' ' VAL . 39.6 mt -70.62 -44.18 76.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.917 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.515 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 67.6 m -64.29 -28.7 69.9 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.522 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.1 m -69.32 -0.55 6.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.59 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.634 HD11 HD23 ' A' ' 6' ' ' LEU . 93.2 mt -90.62 -12.35 37.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.472 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.9 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.1 -0.953 . . . . 0.0 110.804 179.706 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . 0.412 ' O ' ' HD3' ' B' ' 4' ' ' PRO . 2.3 ttm180 . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.54 33.13 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 0.0 111.752 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.63 53.09 0.18 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.972 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.433 ' C ' ' HD1' ' B' ' 5' ' ' TYR . 98.9 Cg_endo -78.51 46.0 2.01 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.803 2.336 . . . . 0.0 113.117 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.433 ' HD1' ' C ' ' B' ' 4' ' ' PRO . 4.3 m-30 -112.3 59.02 0.63 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.057 0.456 . . . . 0.0 110.692 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.14 51.38 1.15 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.875 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.86 -173.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 39.7 mmm-85 -86.16 128.82 34.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.801 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.72 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.5 mm? -125.15 109.12 12.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.649 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 84.9 m -109.93 121.46 45.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.772 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 49.42 -106.34 0.2 Allowed Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.862 -0.608 . . . . 0.0 114.493 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.482 ' HG3' ' N ' ' B' ' 13' ' ' GLU . 8.2 ptt180 -56.18 -30.67 62.55 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.779 0.432 . . . . 0.0 111.772 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' B' ' 12' ' ' ARG . 54.8 mm-40 -70.62 -38.78 73.95 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' B' ' 9' ' ' LEU . 41.6 t80 -63.16 -51.26 67.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.402 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.657 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.6 mt -58.71 -52.59 58.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.32 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.614 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 1.5 mmp_? -65.24 -27.47 68.68 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.283 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.51 93.08 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.592 ' HA ' HG22 ' A' ' 20' ' ' ILE . 96.9 t -60.43 -50.94 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.748 HG23 ' HD1' ' B' ' 27' ' ' TRP . 28.4 mm -54.87 -50.44 61.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.034 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.626 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.1 OUTLIER -58.86 -45.92 88.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.649 -178.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.516 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 15.3 p -64.14 -38.72 92.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.003 0.43 . . . . 0.0 110.432 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' B' ' 18' ' ' VAL . 86.1 m -67.42 -25.12 65.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.445 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.32 -19.81 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.107 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 85.41 -48.8 4.08 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 5.3 p -104.02 25.87 9.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.454 0.645 . . . . 0.0 109.856 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.414 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 3.2 tpp85 -79.1 -36.99 39.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.006 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.748 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.947 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.52 -49.97 78.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 123.516 0.51 . . . . 0.0 110.569 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.77 -46.59 88.93 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.578 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.0 -39.08 62.84 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.36 0.413 . . . . 0.0 110.789 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.41 -47.48 87.13 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.066 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HB2' ' CZ ' ' B' ' 14' ' ' PHE . 36.8 mt -71.54 -43.9 65.57 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -50.69 -44.97 58.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.7 m -62.91 -43.47 98.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.862 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -71.63 -41.25 69.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.081 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.72 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 74.1 m -62.33 -37.35 85.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.006 0.431 . . . . 0.0 110.752 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.5 t -79.29 -38.68 34.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.054 0.454 . . . . 0.0 110.481 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.473 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 37.2 ttmt -72.15 -58.46 3.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.139 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.473 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 9.4 m0 -104.81 -44.69 4.77 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.17 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 10' ' ' CYS . . . 123.39 169.53 13.25 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 85.2 m -144.74 147.56 33.12 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 117.307 0.554 . . . . 0.0 111.394 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' HG13 ' A' ' 20' ' ' ILE . 2.5 m -95.58 169.46 10.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.012 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' HG3' HG22 ' B' ' 21' ' ' THR . 58.4 tttp -55.7 -37.16 68.0 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.756 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -54.72 43.81 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.665 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -60.07 -42.29 94.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.351 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.592 HG22 ' HA ' ' B' ' 18' ' ' VAL . 44.9 mt -72.42 -45.8 58.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.928 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.611 ' HA ' ' SG ' ' A' ' 24' ' ' CYS . 63.1 m -64.65 -13.21 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.692 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.3 m -63.24 -19.83 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.254 0.549 . . . . 0.0 110.185 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 54.7 mt -106.77 28.11 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.148 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 58.8 m . . . . . 0 C--O 1.259 1.567 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.662 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.33 49.98 1.86 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.0 111.343 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.33 126.17 0.47 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.519 ' HA ' ' CG2' ' B' ' 7' ' ' VAL . 87.9 Cg_endo -82.99 21.73 0.99 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.968 2.445 . . . . 0.0 112.27 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -86.28 56.44 3.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.151 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 120.04 56.98 0.24 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.302 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.519 ' CG2' ' HA ' ' B' ' 4' ' ' PRO . 13.4 m -150.76 -169.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.558 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 69.6 mtp180 -89.69 128.16 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.4 mm? -121.84 114.06 20.52 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.643 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 11' ' ' CYS . 71.5 m -108.6 119.97 41.08 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 47.54 -101.57 0.04 OUTLIER Glycine 0 CA--C 1.518 0.281 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.674 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -57.87 -34.05 69.34 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.978 0.511 . . . . 0.0 111.29 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.491 ' HB3' HD12 ' B' ' 9' ' ' LEU . 0.1 OUTLIER -69.49 -36.81 76.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.596 ' O ' HG23 ' B' ' 18' ' ' VAL . 35.8 t80 -61.76 -52.99 61.99 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.169 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.543 ' O ' HG12 ' B' ' 19' ' ' ILE . 65.3 mt -58.41 -47.73 87.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.333 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.466 ' CZ ' HG21 ' B' ' 19' ' ' ILE . 6.4 tpt180 -65.21 -34.28 78.0 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.039 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.433 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -62.78 -39.29 93.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.807 178.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 14' ' ' PHE . 61.0 t -60.15 -51.13 76.51 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.858 HG23 ' HD1' ' B' ' 27' ' ' TRP . 40.1 mm -52.68 -52.79 24.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.3 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.598 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.2 m-30 -60.37 -42.12 95.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.684 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.661 HG21 ' HB ' ' A' ' 20' ' ' ILE . 27.0 p -68.19 -42.53 79.78 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.352 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 47.4 m -65.33 -28.88 69.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.186 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.21 -24.21 0.09 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.492 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 82.9 -62.4 4.63 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 11.6 m -89.45 40.51 0.99 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.524 0.678 . . . . 0.0 110.177 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.416 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.8 tpm_? -105.17 -35.18 7.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.127 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.858 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.183 -1.372 . . . . 0.0 109.409 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.2 t -72.41 -45.06 61.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 123.487 0.492 . . . . 0.0 109.788 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.658 HD23 HD13 ' A' ' 23' ' ' LEU . 74.6 mt -69.21 -53.77 18.23 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.513 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.76 71.6 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.63 -49.03 83.09 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.424 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 48.9 tp -71.73 -37.91 70.52 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.5 t -54.9 -42.3 71.99 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.288 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.9 t -59.2 -42.21 90.39 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.093 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -74.04 -41.42 61.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.737 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.547 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 62.0 m -60.18 -45.56 92.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.624 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.405 ' HB2' ' HA ' ' B' ' 10' ' ' CYS . 48.1 t -74.7 -39.08 62.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.974 0.416 . . . . 0.0 110.858 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HD2' ' CE2' ' A' ' 13' ' ' TRP . 3.2 ttmp? -68.95 -60.1 2.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.844 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.498 ' CE2' ' HD2' ' A' ' 12' ' ' LYS . 8.0 m0 -106.56 -54.74 2.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.236 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 139.77 -172.8 23.19 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.479 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.4 p -165.5 148.92 8.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.776 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.474 ' HA ' ' HA2' ' B' ' 6' ' ' GLY . 4.2 m -97.15 171.17 8.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.535 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HG3' HG22 ' B' ' 21' ' ' THR . 34.9 tttm -55.92 -36.28 67.56 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.493 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -51.83 68.37 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.46 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.84 -43.5 95.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.36 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.661 ' HB ' HG21 ' B' ' 21' ' ' THR . 39.8 mt -69.99 -44.94 78.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.925 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.523 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 75.2 m -64.4 -22.46 66.97 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.4 m -66.94 -8.52 30.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.917 0.389 . . . . 0.0 110.886 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.658 HD13 HD23 ' A' ' 3' ' ' LEU . 59.0 mt -116.8 26.2 10.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.536 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 70.5 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.44 178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 14.2 tpp85 . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.71 -152.35 0.5 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.18 125.65 90.78 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.658 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.61 53.49 3.61 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 123.034 2.489 . . . . 0.0 112.209 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.571 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 6.9 m-30 -100.43 22.1 12.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.584 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 16' ' ' SER . . . 157.86 60.31 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -144.69 -171.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.644 0.259 . . . . 0.0 110.847 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.535 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 70.0 mtp180 -87.87 130.39 34.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.309 0.576 . . . . 0.0 109.936 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.98 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 10.6 mp -116.25 109.4 17.35 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.562 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 72.3 m -112.14 116.95 31.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.923 0.392 . . . . 0.0 111.557 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 51.32 -109.55 0.8 Allowed Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.329 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -59.61 -29.46 68.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -69.4 -37.76 77.64 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.686 ' O ' HG23 ' B' ' 18' ' ' VAL . 55.0 t80 -61.11 -55.6 30.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.078 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.658 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.5 mt -57.26 -52.31 58.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.41 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.632 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.5 mmp_? -64.03 -33.73 76.41 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.276 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.43 83.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.718 ' HA ' HG22 ' A' ' 20' ' ' ILE . 75.6 t -60.16 -47.71 90.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.77 HG23 ' HD1' ' B' ' 27' ' ' TRP . 21.1 mm -59.69 -51.83 68.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.089 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.467 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.3 OUTLIER -55.9 -47.38 77.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.814 -179.056 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.534 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 19.5 p -62.86 -40.54 97.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.001 0.429 . . . . 0.0 111.274 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 21' ' ' SER . 57.6 m -80.69 -10.57 59.72 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.22 -30.26 0.42 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.537 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.34 -52.81 4.76 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 13.5 m -104.16 40.35 1.48 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.472 0.653 . . . . 0.0 110.085 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -98.52 -36.08 10.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.354 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.77 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.205 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.922 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.51 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 39.2 t -71.56 -46.35 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.473 0.483 . . . . 0.0 109.758 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.85 -53.87 18.92 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.546 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.25 -35.46 69.75 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.05 -50.14 70.7 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.595 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 2' ' ' VAL . 42.8 mt -70.39 -42.52 71.59 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 t -52.34 -42.44 63.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.85 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.5 t -59.11 -45.33 91.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.586 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.5 m -76.35 -38.68 55.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.98 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 67.4 m -63.0 -42.71 99.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.694 0.283 . . . . 0.0 111.419 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.69 -40.16 49.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.109 0.481 . . . . 0.0 110.427 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -67.97 -48.31 66.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.442 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.503 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 9.2 m0 -118.78 -58.72 1.93 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.356 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 141.68 -174.6 22.95 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' SG ' HD22 ' B' ' 9' ' ' LEU . 1.8 p -162.36 152.82 16.96 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.885 0.342 . . . . 0.0 110.875 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.4 m -97.37 167.57 10.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.07 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.571 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 53.4 tttp -52.56 -37.95 58.91 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.072 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.22 -50.27 74.15 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.601 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.35 -42.83 87.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.498 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.718 HG22 ' HA ' ' B' ' 18' ' ' VAL . 24.5 mt -72.06 -46.14 60.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.534 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 66.4 m -65.68 -34.13 77.49 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.191 -0.318 . . . . 0.0 111.579 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 t -68.58 -1.14 6.1 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.355 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.475 HD22 HD12 ' A' ' 6' ' ' LEU . 23.7 tp -85.18 -23.69 28.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.674 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 31.4 m . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.879 -179.547 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.748 0.309 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.38 143.3 1.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' B' ' 4' ' ' PRO . . . -64.32 113.25 9.78 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 123.183 0.302 . . . . 0.0 110.355 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.506 ' C ' ' HD1' ' B' ' 5' ' ' TYR . 44.4 Cg_endo -67.64 45.36 0.28 Allowed 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.697 2.931 . . . . 0.0 114.025 -178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.506 ' HD1' ' C ' ' B' ' 4' ' ' PRO . 4.5 m-30 -117.45 37.43 3.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.187 0.518 . . . . 0.0 109.845 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.92 47.37 0.29 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.127 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.2 -172.67 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 122.837 -0.214 . . . . 0.0 110.438 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.573 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 66.3 mtp180 -90.79 129.36 36.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.082 0.467 . . . . 0.0 110.051 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 2.7 mm? -122.14 111.92 17.57 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.178 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 97.9 m -109.76 123.14 49.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 48.92 -105.49 0.13 Allowed Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.57 -0.741 . . . . 0.0 114.522 178.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -60.48 -29.72 69.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -70.42 -35.9 73.69 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.55 ' O ' HG23 ' B' ' 18' ' ' VAL . 48.2 t80 -65.18 -50.88 64.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.441 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.663 ' O ' HG12 ' B' ' 19' ' ' ILE . 66.6 mt -57.75 -50.33 77.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.877 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.571 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 3.7 mmp_? -63.72 -32.02 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.64 -0.424 . . . . 0.0 109.985 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' B' ' 4' ' ' PRO . . . -63.33 -44.68 94.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.118 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.55 HG23 ' O ' ' B' ' 14' ' ' PHE . 63.4 t -58.0 -50.3 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.859 HG23 ' HD1' ' B' ' 27' ' ' TRP . 34.6 mm -54.52 -50.98 54.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.147 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.49 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.1 m-30 -58.26 -45.41 87.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.747 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.862 HG21 ' HB ' ' A' ' 20' ' ' ILE . 11.9 p -63.54 -38.73 92.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.642 0.258 . . . . 0.0 111.557 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 34.0 m -70.76 -30.93 67.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.758 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.92 -22.14 0.09 OUTLIER Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.655 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 83.97 -60.03 4.89 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 112.176 -0.37 . . . . 0.0 112.176 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 10.2 m -92.6 48.88 1.41 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.524 0.678 . . . . 0.0 109.801 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 6.8 tpm_? -112.76 -37.4 4.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.985 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.859 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.988 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 39.4 t0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -108.54 -41.64 5.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.426 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.91 -55.4 19.54 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.8 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.49 -36.26 61.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.001 0.429 . . . . 0.0 110.306 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.35 -49.93 66.53 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.034 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.5 ' HG ' ' SG ' ' A' ' 10' ' ' CYS . 44.8 tp -72.22 -39.18 68.7 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 t -54.32 -42.94 70.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.554 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.4 t -58.23 -44.11 88.09 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.203 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.0 m -74.16 -40.8 62.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.7 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.599 ' HB3' ' HB2' ' B' ' 9' ' ' LEU . 62.5 m -58.04 -44.95 87.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 111.705 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.9 t -78.2 -40.47 37.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.0 0.428 . . . . 0.0 110.995 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -66.85 -49.85 64.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.849 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.544 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 8.8 m0 -119.47 -54.72 2.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.211 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 143.06 -171.17 25.05 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.551 ' SG ' HD23 ' B' ' 9' ' ' LEU . 3.0 p -166.45 151.05 7.72 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.182 0.515 . . . . 0.0 111.355 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.483 ' O ' HG13 ' A' ' 20' ' ' ILE . 67.6 p -93.1 165.4 12.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.664 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.679 ' HG3' HG22 ' B' ' 21' ' ' THR . 37.4 tttm -56.72 -40.14 75.15 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.362 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 m -57.33 -48.17 79.67 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.393 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -63.45 -46.29 86.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.881 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.862 ' HB ' HG21 ' B' ' 21' ' ' THR . 32.5 mt -67.46 -39.53 82.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.588 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.433 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 44.8 m -64.74 -24.43 67.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.779 0.323 . . . . 0.0 110.944 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.0 m -67.88 -5.87 18.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.138 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -107.7 19.04 20.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.466 179.258 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.65 56.59 0.32 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 110.512 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.16 137.0 4.61 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.182 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.483 ' HA ' ' CG2' ' B' ' 7' ' ' VAL . 70.7 Cg_endo -74.63 41.01 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.193 2.596 . . . . 0.0 112.397 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.494 ' CE2' ' HD2' ' A' ' 17' ' ' LYS . 4.9 m-30 -106.92 85.79 2.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.886 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.05 50.85 3.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.712 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' B' ' 4' ' ' PRO . 24.7 m -139.72 -179.96 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.542 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 67.1 mtp180 -86.32 127.79 34.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.176 0.512 . . . . 0.0 110.008 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' B' ' 14' ' ' PHE . 2.3 mm? -122.42 117.18 25.4 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.41 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 79.3 m -115.52 120.97 41.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.826 0.345 . . . . 0.0 111.893 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 53.41 -107.83 0.67 Allowed Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.285 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -59.48 -30.39 68.5 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.08 -36.63 75.07 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.634 ' O ' HG23 ' B' ' 18' ' ' VAL . 40.5 t80 -61.62 -53.04 61.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.218 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.62 ' O ' HG12 ' B' ' 19' ' ' ILE . 64.2 mt -60.68 -49.27 85.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.347 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.547 ' CZ ' HG13 ' B' ' 19' ' ' ILE . 5.0 mmp_? -61.89 -34.21 75.63 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.475 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.67 96.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.278 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.785 ' HA ' HG22 ' A' ' 20' ' ' ILE . 59.1 t -59.52 -49.28 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-O 122.041 0.924 . . . . 0.0 108.802 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.769 HG23 ' HD1' ' B' ' 27' ' ' TRP . 20.8 mm -59.07 -52.8 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.284 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.448 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 0.9 OUTLIER -57.74 -45.08 86.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.312 -178.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.554 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 18.6 p -63.48 -40.51 97.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.92 0.39 . . . . 0.0 111.267 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -78.33 -26.21 46.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.652 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.66 -31.47 0.09 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 119.998 -1.096 . . . . 0.0 113.359 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 87.2 -56.83 4.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.688 -0.291 . . . . 0.0 112.521 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 12.5 m -99.21 51.06 0.95 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.483 0.658 . . . . 0.0 110.114 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' B' ' 26' ' ' ARG . 7.2 tpm_? -113.94 -38.82 4.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.941 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.769 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.035 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.933 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.09 -44.81 64.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 123.392 0.433 . . . . 0.0 109.918 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.48 -54.52 13.83 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.749 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.14 75.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.01 -48.54 82.67 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.883 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.666 HD23 HD11 ' A' ' 23' ' ' LEU . 35.1 tp -71.0 -41.05 71.43 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 t -53.02 -41.72 64.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.675 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 m -58.81 -34.13 71.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.705 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.9 m -86.08 -38.27 17.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.352 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.553 ' SG ' ' HG ' ' A' ' 6' ' ' LEU . 71.1 m -60.26 -40.57 90.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.782 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.0 t -79.6 -41.56 26.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.989 0.423 . . . . 0.0 110.896 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -67.57 -50.04 60.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.878 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.538 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 11.2 m0 -114.64 -56.71 2.35 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.313 -178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 142.32 173.17 14.09 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 99.2 m -146.66 148.56 32.18 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.824 0.345 . . . . 0.0 110.935 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.516 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.4 m -94.63 166.19 12.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.617 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.494 ' HD2' ' CE2' ' B' ' 5' ' ' TYR . 47.1 tttp -52.94 -38.85 62.4 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.943 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -53.85 53.54 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.473 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -63.3 -42.54 99.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.561 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.785 HG22 ' HA ' ' B' ' 18' ' ' VAL . 45.8 mt -70.63 -45.21 75.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.554 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 73.1 m -64.82 -27.68 69.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.605 0.24 . . . . 0.0 111.601 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.3 m -69.29 -1.74 8.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.971 0.415 . . . . 0.0 111.364 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.666 HD11 HD23 ' A' ' 6' ' ' LEU . 97.3 mt -90.12 -11.18 42.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.807 179.672 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.95 52.62 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.985 0.421 . . . . 0.0 111.153 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.79 85.97 0.46 Allowed Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.602 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.96 39.03 0.68 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.039 2.493 . . . . 0.0 112.7 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -114.67 90.4 3.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.898 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.21 63.13 1.99 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.188 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.817 HG22 ' H ' ' B' ' 8' ' ' ARG . 6.2 p -163.46 -173.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.817 ' H ' HG22 ' B' ' 7' ' ' VAL . 69.0 mtp180 -85.1 131.09 34.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.249 0.547 . . . . 0.0 110.398 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.62 HD12 ' HB3' ' B' ' 13' ' ' GLU . 2.2 mm? -126.44 115.76 20.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.86 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . . . . . . . . . 73.1 m -111.73 120.78 43.18 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' B' ' 14' ' ' PHE . . . 45.56 -100.62 0.02 OUTLIER Glycine 0 CA--C 1.52 0.388 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.425 ' HE ' ' CD ' ' B' ' 13' ' ' GLU . 7.1 tmm_? -54.57 -41.18 69.53 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.112 0.565 . . . . 0.0 111.661 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.62 ' HB3' HD12 ' B' ' 9' ' ' LEU . 14.1 mp0 -69.15 -36.08 77.03 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.626 ' O ' HG23 ' B' ' 18' ' ' VAL . 46.0 t80 -61.9 -56.52 18.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.013 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.591 ' O ' HG12 ' B' ' 19' ' ' ILE . 70.9 mt -58.54 -48.06 86.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.529 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.508 ' NH1' HG13 ' B' ' 19' ' ' ILE . 13.1 mmm180 -64.13 -34.24 77.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.493 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.85 -40.45 97.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.153 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.784 ' HA ' HG22 ' A' ' 20' ' ' ILE . 57.9 t -59.42 -49.5 83.35 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.665 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.862 HG23 ' HD1' ' B' ' 27' ' ' TRP . 19.6 mm -57.87 -53.56 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.333 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.51 ' HA ' ' HA2' ' B' ' 24' ' ' GLY . 2.6 m-30 -57.17 -45.21 83.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.712 -1.131 . . . . 0.0 113.576 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' THR . . . . . 0.5 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 21.2 p -64.89 -40.77 95.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.05 0.452 . . . . 0.0 111.378 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -76.93 -20.38 56.24 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.651 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.84 -30.4 0.16 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.094 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' B' ' 20' ' ' PHE . . . 84.4 -55.56 5.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.707 -0.283 . . . . 0.0 112.548 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 7.2 m -97.06 46.53 1.04 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.43 0.633 . . . . 0.0 110.335 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' B' ' 27' ' ' TRP . 7.3 tpm_? -110.41 -37.49 5.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.327 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' TRP . . . . . 0.862 ' HD1' HG23 ' B' ' 19' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.372 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.44 -49.35 60.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.401 0.438 . . . . 0.0 110.68 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.538 ' HG ' HD21 ' A' ' 23' ' ' LEU . 10.7 mp -72.17 -51.38 21.51 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.408 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.29 70.87 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.88 -49.29 77.25 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.75 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.492 HD23 HD22 ' A' ' 23' ' ' LEU . 40.9 tp -71.01 -39.91 72.11 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.6 t -55.12 -42.52 73.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.406 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 t -57.77 -44.16 85.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.334 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -74.68 -40.53 61.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.969 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.472 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 56.1 m -60.3 -43.11 96.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 111.603 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.65 -39.57 36.63 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.904 0.383 . . . . 0.0 110.874 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -68.31 -50.85 50.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.825 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.521 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 8.4 m0 -116.39 -55.11 2.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.29 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' B' ' 8' ' ' ARG . . . 140.6 -173.64 23.01 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.4 p -164.98 149.56 9.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.964 0.412 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.531 ' HB2' ' OE1' ' A' ' 19' ' ' GLU . 3.6 m -94.8 168.74 10.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.478 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' HG3' HG22 ' B' ' 21' ' ' THR . 37.7 tttm -54.33 -37.15 64.53 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.903 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -50.36 74.32 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.357 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.531 ' OE1' ' HB2' ' A' ' 16' ' ' SER . 2.4 mp0 -63.2 -45.18 92.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.064 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.784 HG22 ' HA ' ' B' ' 18' ' ' VAL . 33.2 mt -69.76 -43.13 80.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.545 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.5 ' OG ' ' HB ' ' B' ' 21' ' ' THR . 71.4 m -64.11 -36.7 84.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.754 0.311 . . . . 0.0 111.14 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.5 m -70.13 5.19 1.74 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.667 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.538 HD21 ' HG ' ' A' ' 3' ' ' LEU . 21.6 tp -92.23 -22.48 19.77 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.849 0.356 . . . . 0.0 110.234 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.8 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.025 179.668 . . . . . . . . 0 0 . 1 stop_ save_